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ABSTRACT 
 
Comparative Neurotoxicity of Methylmercury and Mercuric Chloride 
In Vivo and In Vitro. (August 2009) 
Kerry Almeda Thuett, B.S.; M.S., Texas Tech University 
Co-Chairs of Advisory Committee:  Dr. Louise C. Abbott 
Dr. Evelyn Tiffany-Castiglioni 
 
It is impossible to remove methylmercury (MeHg) from biological systems 
because MeHg is found throughout our environment in many fresh and salt water fish. 
The consumption of fish is important to human nutrition and health. The mechanism of 
MeHg neurotoxicity must be understood to minimize adverse exposure consequences. 
The dissertation objective was to: 1) compare mechanisms of MeHg neurotoxicity 
between animals exposed as adults and those exposed during gestation, and 2) develop 
an in vitro test model of in vivo MeHg exposure. 
Total mercury (Hg) levels in tissue / cells were determined by combustion / 
trapping / atomic absorption. Cell death was determined by Fluoro-Jade histochemical 
staining and activated caspase 3 immunohistochemistry for in vivo studies, and Trypan 
blue exclusion, lactate dehydrogenase activity, and cytotoxicity assays for in vitro 
studies. Mitochondrial membrane potential (MMP), intracellular calcium ion 
concentration ([Ca2+]i), and production of reactive oxygen species (ROS) were 
determined using fluorescence microscopy or microplate reader assays. Young adult 
C57Bl/6 mice were exposed to a total dose of 0, 1.0, or 5.0 mg/kg body weight MeHg 
divided over postnatal days (P)35 to 39. Pregnant female mice were exposed to a total 
does of 0, 0.1, or 1.0 mg/kg body weight MeHg divided over gestational days (G)8 to 18. 
SY5Y cells were exposed to 0, 0.01, 0.1, or 1.0 µM MeHg or HgCl2 for 24, 48, or 72 
hours. 
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Total Hg in brains of young adult mice, mouse pups, and SY5Y cells accumulated 
in a dose-dependent manner. Cell death increased in SY5Y cells exposed to the highest 
concentrations of MeHg and HgCl2 used in this study. Cell death increased in the 
molecular and granule cerebellar cell layers of young adult mice exposed to the highest 
doses of MeHg used in this study. P0 mouse pups showed no increase in cell death 
within the cerebellum following MeHg exposure. Cerebella of mice at P10 exhibited 
decreased dying cells only in the external germinal layer. 
Low concentrations of MeHg affected MMP in both in vivo and in vitro studies, 
but did not result in decreased MMP typically associated with higher MeHg 
concentrations. [Ca2+]i was increased throughout the in vivo experiments in an age- , sex- 
and brain region-dependent manner. Generation of ROS was decreased in both in vivo 
and in vitro studies with both the MeHg and HgCl2 (in vitro) treatments. 
In summary, low and moderate MeHg exposure, both in vivo and in vitro, altered 
mitochondrial function, Ca2+ homeostasis, and ROS differently than what is reported in 
the literature for higher MeHg exposure concentrations. SY5Y cells were sensitive to 
low-levels of MeHg and HgCl2 and responded similarly to cells in the whole animal 
studies, thus making SY5Y cells realistic candidates for mechanistic MeHg studies.  
Cell culture and whole animal neuronal functional studies at chronic low-level 
MeHg exposure are limited. These data suggest that low-levels of MeHg may affect 
neuronal function. Therefore, further chronic low-level MeHg neuronal functional 
studies are warranted. 
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CHAPTER I 
 
 
INTRODUCTION 
 
HIPPOCAMPAL FORMATION 
Historical perspective 
The hippocampal formation is a part of each cerebral hemisphere that lies 
beneath the cortical surface and functions in emotion, learning, and memory. Its anatomy 
and function have been studied for more than 400 years. As referenced in Gurunluoglu 
and Gurunluoglu (2008), the term “hippocampus” (sea horse) was first used by Arantius 
in 1587 who thought the three dimensional form of the human hippocampus looked like 
a sea horse. In the 19th century, Pierre Paul Broca first observed the association of the 
hippocampus and other C-shaped structures with emotional states. Broca named this 
region le grande lobe limbique (limbus, Latin for “border”) because it encircles the 
diencephalon and borders the cerebral cortex (Broca, 1878; Finger, 2004). At this same 
time, Alois Alzheimer, a German neuroanatomist, observed that characteristic pathologic 
changes in the hippocampal formation were associated with dementia (Graeber et al., 
1997). In 1937, at Cornell University, James Papez observed neurodegenerative changes 
in the hippocampus, mammillary bodies, thalamus, and cingulate in post-mortem 
examinations of the brains of individuals with psychiatric disorders. He suggested that a 
complex set of specific connections between structures of the limbic lobe formed a 
circuit for emotional experience (Papez, 1937). Wilder Penfield was the first person to 
obtain evidence that memory processes might be localized to specific regions of the 
brain. In the 1940s, he began using electrical stimulation to map the motor, sensory and 
language functions in the cerebral cortex of patients undergoing brain surgery to relieve 
focal epilepsy. He found that stimulation of the temporal lobes produced coherent 
recollections of earlier experiences (Penfield, 1958a;  Penfield, 1958b;  Penfield, 1958c). 
____________ 
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Corroborating this evidence were studies of behavior in patients whose medial temporal 
lobe of the cerebrum had been ablated to ameliorate symptoms of temporal lobe 
epilepsy. In the 1950’s, Brenda Milner and William Scoville (Neylan, 2000) studied the 
patient “H.M.”. He had bilateral temporal lobe removal, which resulted in a lesion in the 
hippocampus. H.M. lost the ability to consolidate short-term memory into long-term 
memory; however, he retained the memory of events occurring before the surgery. 
Current research suggests that limbic areas associated with the medial temporal lobe 
have a role in learning, memory, cognition, and behavioral expression. These structures 
include the cingulate gyrus, parahippocampal gyrus, perirhinal cortex, entorhinal cortex, 
amygdala, mammillary bodies, and the hippocampal formation, particularly the 
hippocampus. 
 
Gross and histological structure and fiber connections 
The hippocampal formation and its efferent pathways (fornix) form a concentric 
ring that surrounds the diencephalon and midbrain (Fig I-1). There are three components 
comprising the hippocampal formation: dentate gyrus, hippocampus proper, and 
subiculum (Fig I-2). The components are organized as strips running rostrocaudally 
within the temporal lobe and together forming a cylinder. They are folded upon each 
other into the configuration of a “jelly-roll” pastry (Fig I-1). Each of the three 
components contains three cell layers. The dentate gyrus contains the molecular, granule 
cell, and hilus layers. The molecular layer is composed of apical dendrites of granule 
cells, but few cell bodies. Axons of granule cells synapse on other neurons of the 
hippocampal formation. The hilus contains interneurons. This region is complex and is 
often considered the “CA4” field, as opposed to a part of the dentate gyrus (Amaral, 
1978). However, it has been shown that cells originating in the hilus project only to the 
dentate gyrus and to no other field of the hippocampal formation (Laurberg and 
Sørensen, 1981). The three layers of the hippocampus proper and the subiculum are 
analogous to those of the dentate gyrus. However, the granule cell layer is replaced with 
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the pyramidal layer that contains pyramidal cells that are the major output neurons of the 
hippocampal formation (Kandel et al., 2000;  Martin, 1996). 
 
 
 
FIG. I-1. General spatial relationships of components of the hippocampal formation, its efferent pathway 
(fornix), and the entorhinal cortex. Modified from Martin, J. H. (1996). Neuroanatomy Text and Atlas. 2 
ed., p. 452. Appleton & Lange, Stamford. 
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FIG. I-2. Hippocampal subfields of a forty-day-old mouse. The subiculum, dentate gyrus and three 
regions of the hippocampus proper (Cornu Ammonis, Ammon's horn) are labeled: CA1, CA2, and CA3. 
The image is a paraformaldehyde-fixed, frozen sagittal section stained with 1% thionin. Scale bar is 125 
um. 
The major input to the hippocampal formation is the entorhinal cortex, located on 
the parahippocampal gyrus adjacent to the hippocampal formation (Fig I-1 and I-3). 
Other portions of the limbic cortex indirectly influence the hippocampal formation 
through the entorhinal cortex (Fig I-3). The perforant fiber pathway from the entorhinal 
cortex forms excitatory connections with the granule cells of the dentate gyrus (Fig I-3) 
(Andersen et al., 1966;  Witter and Amaral, 1991). The small (7 µm), highly compact 
granule cells give rise to axons that form the mossy fiber pathway, which connects to the 
pyramidal cells in the CA3 region of the hippocampus proper (Blackstad et al., 1970).  
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FIG. I-3. Principal afferent connections (A) and efferent projections (B) of the hippocampal formation. 
Inputs from the cingulate gyrus and other association areas of the cerebral cortex are transmitted to the 
hippocampal formation from the entorhinal cortex. Efferent projections from the subiculum and 
hippocampus to the rostral diencephalon and telencephalon are located in the fornix. Modified from 
Martin, J. H. (1996). Neuroanatomy Text and Atlas. 2 ed., p. 455. Appleton & Lange, Stamford. 
 
 
The hippocampus proper (also called Corno Ammonis or Ammon’s horn) has 
three distinct fields: CA3, CA2, and CA1 (Lorente de No, 1933) (Fig I-2). The subfields 
have different cell shapes and sizes, connectivity, electrophysiological properties and 
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susceptibility to insults (Taupin, 2007). Field CA3 borders the hilus of the dentate gyrus 
on one end and the CA2 region on the other. The CA3 region is larger and contains more 
cells than the CA2 region (Seress, 1988). Pyramidal cells in CA3 receive input from 
axons of granule cells from the dentate gyrus and are known as mossy fibers. Mossy 
fibers travel through the hilar region to synapse on CA3 pyramidal cells. Schaffer 
collateral project from CA3 pyramidal cells to the pyramidal cells in CA1. The CA2 
region is the smallest and most compact of the pyramidal cell regions, which is the main 
distinguishing characteristic of the CA2 region. The CA1 region borders the CA2 region 
on the end opposite CA3. The CA1 region is larger and contains more cells than either 
the CA2 or the CA3 region (Seress, 1988). Efferent collaterals of the CA1 pyramidal 
cells collect on the surface of the hippocampal formation to form a compact fiber bundle 
called the fornix, which contains axons that project to the subcortical telencephalon and 
diencephalon (Fig. I-3). 
Although each of the hippocampal fields is essentially one cell layer comprised 
of pyramidal cells, the plexiform layers above and below the pyramidal cell layer also 
have been named (Insausti and Amaral, 2004). The alveus is the outermost layer located 
nearest the lateral ventricle. It is composed of axons of pyramidal cells. The stratum 
oriens lies between the alveus and the pyramidal cell layer. It is composed mainly of 
basal dendrites of pyramidal cells and various interneurons. The region on the other side 
of the pyramidal cell layer, nearest the hippocampal fissure, contains apical dendrites of 
pyramidal cells and various interneurons. This plexiform layer has been divided into 
three layers: stratum lucidum, stratum radiatum, and stratum lacunosum-moleculare. The 
stratum lucidum contains mossy fibers from granule cells that travel through or synapse 
on proximal dendrites of pyramidal cells. The stratum lucidum only appears adjacent to 
CA3, because CA2 and CA1 do not receive mossy fiber inputs. The stratum radiatum of 
CA3 and CA2 contain associational projections from other regions of the hippocampus 
as well as subcortical inputs such as from the septal nuclei and the supramammillary 
region. The stratum radiatum and stratum lacunosum-moleculare of the CA1 region 
contain projections from CA3 and CA2 pyramidal cells (Schaffer collaterals) (Ishizuka 
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et al., 1990). The Schaffer collaterals form the last synapse in a powerful excitatory 
synaptic chain which includes the entorhinal cortex, dentate gyrus granule cells, and 
CA3 and CA1 pyramidal cells (Anderson et al., 1971). 
 
 
FIG. I-4. Simplified serial circuit from the entorhinal cortex to the hippocampal formation. Two outputs 
are shown: the fornix, which has a major projection to the septal nucleus and mammillary body, and the 
projection back to the entorhinal cortex. Modified from (Martin, J. H. (1996). Neuroanatomy Text and 
Atlas. 2 ed., p. 453. Appleton & Lange, Stamford. 
 
 
Axons from the CA1 region of the hippocampus synapse primarily in the 
subiculum (Finch and Babb, 1981) and the lateral septal nuclei in the rostral forebrain 
(Alonso and Köhler, 1984;  Swanson and Cowan, 1977). Axons project from the 
subiculum and the lateral septal nuclei to a large portion of the cerebral forebrain, thus 
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connecting the hippocampus indirectly to major learning, memory, and behavioral 
pathways (Fig I-3). Pyramidal cell axons from the subiculum synapse in the mammillary 
bodies, lateral septal nuclei, anterior thalamic nuclei, amygdala, entorhinal cortex, and 
nucleus accumbens (Kandel et al., 2000; Krettek and Price, 1977; Martin, 1996; 
Sørensen and Shipley, 1979). Projections from the septal nuclei travel through the fornix 
back to the hippocampus as a regulatory mechanism. Other brain areas that have 
connections to and from the hippocampal formation include: the hypothalamus (Segal 
and Landis, 1974), nucleus accumbens (Groenewegen et al., 1982), caudate nucleus and 
putamen (Groenewegen et al., 1982), and the thalamus (Chronister et al., 1975) (Fig I-
3). 
 
Adult neurogenesis 
The hippocampus is of particular interest because of the presence of adult 
neurogenesis that takes place in this brain region. In the mammalian CNS, most neurons 
are born during the prenatal phase of development, with the exception of the granule 
cells of the dentate gyrus of the hippocampus and the granule cells of the cerebellum, 
which are primarily born during the first two postnatal weeks in rats (Bayer, 1980). In 
guinea pigs, postnatal development in the dentate gyrus is high up to P20 then begins to 
slow significantly after P30 (Guidi et al., 2005). 
Previously, it was thought that the adult brain did not generate new nerve cells, 
and that the adult brain was devoid of stem cells. In the early 1960’s, Altman and Das 
(Altman, 1962;  Altman and Das, 1965) published data suggesting the generation of new 
neuronal cells in specific areas of the adult brain, the subventricular zone and the dentate 
gyrus. In the 1980’s, adult neurogenesis was confirmed in mammals, including primates 
(Gross, 2000;  Taupin and Gage, 2002). Reynolds and Weiss (1992) isolated adult neural 
stem cells from the rodent central nervous system (CNS). Eriksson et al. (1998) 
identified the subgranular zone of the dentate gyrus as one of the two major locations 
where adult neurogenesis occurs. In the dentate gyrus of mammals, newly generated 
neuronal cells in the subgranular zone migrate to the granule cell layer, where they 
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differentiate into neuronal cells, extend axonal projections and establish functional 
connections (Cameron et al., 1993; Eriksson et al., 1998; Gould et al., 1999; van Praag 
et al., 2002) (Fig I-5). In rats, new granule cells extend axons to the CA3 regions in four 
to ten days following mitosis (Hastings and Gould, 1999). It has been shown that newly 
established neurons in adult humans live for at least two years (Eriksson et al., 1998). 
 
 
FIG. I-5. Neurogenesis in the adult dentate gyrus. New neuronal cells in the subgranular zone of the 
dentate gyrus migrate to the granule layer and differentiate into neuronal cells and astrocytes. The new 
neurons in the granule layer extend axons to the CA3 region of the hippocampus. Modified from Taupin, 
P. (2007). The Hippocampus - Neurotransmission and Plasticity in the Nervous System. p. 103. Nova 
Science Publishers, New York. 
 
 
Confirmation of adult neurogenesis suggests that the development of the brain 
may be a lifelong process, and the CNS may be amenable to repair (Taupin, 2007), or 
susceptible to developmental disorders. Just as alterations in early developmental 
neurogenesis may result in abnormal hippocampal function, so also could alteration in 
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adult neurogenesis. The presence of adult neurogenesis has consequences for our 
understanding of CNS development, function, and therapeutic approaches.  
 
Learning and memory 
The major role of the hippocampus is the consolidation of learning and memory. 
As stated previously, hippocampal lesions may result in a type of amnesia in which 
memories of events prior to the damage are retained, but new information is not. This 
amnesia applies only to specific facts and events (explicit or declarative memory) and 
not to the learning of new skills and procedures (implicit memory). Basically, learning 
and memory not associated with conscious recall of specific items, such as pattern 
recognition, habits, conditioned autonomic reactions to stimuli, and motor skills, do not 
depend on the hippocampus, whereas consolidation of explicit memories of facts and 
events does depend on the hippocampus (Kandel et al., 2000;  Martin, 1996). 
Donald Hebb (Hebb, 1950) postulated that use-dependent changes in synaptic 
strength were the elemental units of learning. The CA1 region of the hippocampus is 
important in long-term potentiation (LTP). LTP is a brief period of synaptic activity that 
causes a long-lasting increase in the strength of activated synapses (Bliss and Gardner-
Medwin, 1973). Potentiation may last from two hours to many days. Treatments that 
block LTP decrease the formation of long-term memories (Morris, 2003). LTP is 
induced when repetitive synaptic activation causes sufficient depolarization of the 
postsynaptic neuron to relieve the constitutive block of the N-methyl-D-aspartate 
receptor (NMDAR)-gated ion channel by Mg2+ in the extracellular fluid (Malenka and 
Nicoll, 1999;  Malinow, 2003). These channels allow calcium ions (Ca2+) to enter the 
postsynaptic cell and activate various second messengers. Second messenger pathways 
may increase insertion of new glutamate receptors or increase phosphorylation of pre-
existing receptors, thereby increasing the cell’s ability to generate current (Malenka and 
Bear, 2004). In addition, second messenger pathways may lead to changes in gene 
expression and the encoding of proteins that underlie maintenance of the potentiation 
(Martin et al., 2000).  
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Other ways to increase the synaptic connection between neurons and enhance 
LTP include: 1) increasing the number of sites of contact between the two, 2) increasing 
the size of the dendritic spine heads to accommodate more receptors, or 3) increasing the 
diameter of the dendritic spine neck so that depolarization of the spine more readily 
translates to the whole dendrite (Fifková and Anderson, 1981;  Fischer et al., 1998;  
Moser et al., 1994). A unifying theme throughout the hypotheses of enhanced synaptic 
transmission is the idea that Ca2+ is involved. Proper functioning of the NMDAR-gated 
ion channel allows Ca2+ to enter the cell. The Ca2+-calmodulin-dependent protein kinase, 
CaMK, is a second messenger involved in LTP and spine morphogenesis (Jourdain et 
al., 2003); spines contain intracellular organelles that regulate [Ca2+]i (Cooney et al., 
2002). Blocking voltage-gated Ca2+ channels reduces synaptic transmission and the 
appearance of new spines (Engert and Bonhoeffer, 1999). Proper Ca2+ function and 
concentration appear to be instrumental in the morphological changes of neurons that are 
necessary for learning and memory. 
 
Disorders of the hippocampus 
Because the hippocampus is associated with many types of learning and memory 
and is connected to the cerebral cortex as well as the hypothalamus, alterations in normal 
hippocampal function can produce a wide variety of behavioral symptoms in addition to 
the abnormalities in declarative learning and memory already discussed. Altered 
hippocampal function has been associated with impaired odor-discrimination learning 
(Martin et al., 2007), decreased avoidance learning (Simonyi et al., 2007), altered spatial 
memory (Barhwal et al., 2007), depression (Campbell and Macqueen, 2004) , post-
traumatic stress disorder (Gilbertson et al., 2007), the acquisition and consolidation of 
memories associated with fear (Wallenstein and Vago, 2001), epilepsy (Myhrer, 2007), 
Alzheimer’s disease (Thompson et al., 2004), schizophrenia (Nestor et al., 2007), and 
autism (Dager et al., 2007). 
Cell loss in the hippocampal formation is associated with epilepsy (Sommer, 
1880). Two-thirds of the cases of temporal lobe epilepsy show the hippocampal 
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formation as the only structure with pathological modification (Meldrum and Corsellis, 
1984). Cell loss is mainly in CA1, while granule cell dispersion and organization 
changes occur in the dentate gyrus (Houser et al., 1992). Studies suggest that a 
hippocampal-seizure relationship may be established following episodes of infantile 
seizures (Meldrum and Corsellis, 1984). 
A large portion of memory loss associated with Alzheimer’s disease is linked to 
damage to the hippocampal formation. Recent studies showed that only the subiculum 
and the hilus of the dentate gyrus show substantial cell loss in normal aging (West, 1993;  
West et al., 1994). This cell loss, however, is not the case in individuals with 
Alzheimer’s disease. Afflicted patients have significant cell loss in the subiculum and 
dentate gyrus as well as in the entorhinal cortex (Insausti et al., 1998;  Price et al., 2001;  
Simic et al., 1997;  West et al., 1994). As the disease develops, the hippocampal 
formation essentially becomes functionally disconnected from its major afferent and 
efferent interactions (Hyman et al., 1984).  
Abnormalities in the development of the hippocampal system may contribute to 
schizophrenia. There is an altered distribution of nicotinamide-adenine dinucleotide 
phosphate-diaphorase-containing cells in the hippocampal formation of schizophrenic 
patients (Akbarian et al., 1993; Ribak and Seress, 1983; Sobreviela and Mufson, 1995). 
In addition, Jakob and Beckmann (1994;  1986) suggested that disturbances in neuronal 
migration might explain disorganization observed in the entorhinal cortex of individuals 
with schizophrenia. 
Finally, altered hippocampal function has been described in individuals with 
autism and related disorders (Lord et al., 2000). Bauman and Kemper (1985) reported an 
increase in cell density in all three fields of the hippocampus, as well as in the entorhinal 
cortex of autistic patients. More recently, MRI scans of autistic individuals showed an 
increase in the total volume of the left hippocampus (Rojas et al., 2006). In addition, 
neuropsychological tasks that determine the integrity of brain circuits linking the 
dorsolateral prefrontal cortex and the hippocampus indicated that individuals with 
autism performed poorer than those without autism (Loveland et al., 2008).  The 
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research in this area is new and incomplete; a clear connection between the hippocampus 
and autism has not been confirmed. 
 
CEREBELLUM 
Gross structure 
The cerebellum is a major subdivision of the CNS and is responsible for 
coordination of motor function and balance. It controls rate, range, and force of motion 
by monitoring sensory input from the body, head, eyes, and ears, as well as from the 
cerebral motor cortex (Nolte and Sundsten, 2001). The cerebellum has been the focus of 
extensive neurological research due, in part, to its simple and well documented 
organizational structure (Angevine et al., 1961;  Jansen, 1954;  Ziehen, 1934). 
The cerebellum is located dorsal to the 4th ventricle and caudal to the cerebral 
hemispheres. Grossly, it is divided into three regions: the vermis, two hemispheres, and 
the flocculonodular lobe (Fig I-6). The vermis is responsible for spinocerebellar/ 
somatosensory functions. The hemispheres are involved in motor planning for 
coordination of motor function of the limbs; the hemispheres are also involved in motor 
learning. The flocculonodular lobe is responsible for balance and equilibrium (Nolte and 
Sundsten, 2001). The primary fissure separates the cerebellum into rostral (anterior) and 
caudal (posterior) portions. The posterolateral fissure defines the flocculonodular lobe. 
(Altman and Bayer, 1997;  Marani and Voogd, 1979). 
The cerebellum is highly lobulated. There are 10 defined lobules (folia) (Altman 
and Bayer, 1997; Voogd and Glickstein, 1998). Different nomenclature is used for the 
lobules when referring to humans and mice (Table I-1). In mice, the vermis lobules I and 
II are fused, as are lobules IV and V (Marani and Voogd, 1979) (Fig I-7). 
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FIG. I-6. Dorsal view of the adult mouse cerebellum. V indicates vermis, H indicates hemispheres and 
arrows indicate flocculi. Scale bar is 2 mm. 
 
 
 
 
 
FIG. I-7. Microscopic anatomy of the adult mouse cerebellum. Sagittal view of a mouse cerebellar vermis 
showing lobules I through X. Section is paraformaldehyde-fixed, frozen, and stained with 1% thionin. 
Scale bar is 500 µm. 
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TABLE I-1 
Nomenclature of Cerebellar Lobules 
Vermis Hemispheres 
Human Other mammals Human Other mammals 
Lingual Lobule I Vincingulum lingulae Anterior lobule 
Central Lobule II & III Ala lobulus centralis Anterior lobule 
Culmen Lobule IV & V Anterior quadrangulate lobule Anterior lobule 
Declive Lobule IV Posterior quadrangulate lobule Lobule simplex 
Folium Lobule VIIA Superior semilunar lobule Ansiform lobule Crus I 
Tuber Lobule VIIB Inferior semilunar & gracile lobule Ansiform lobule Crus II 
Pyramis Lobule VIII Biventral lobule Paramedian lobule 
Uvula Lobule IX Tonsilla Dorsal paraflocculus 
Nodulus Lobule X Accessory paraflocculus Ventral paraflocculus 
  Flocculus Flocculus 
(Altman and Bayer, 1997; Voogd and Glickstein, 1998) 
 
 
Microscopic anatomy and circuitry 
The cerebellar cortex is arranged into three layers: the molecular, Purkinje, and 
granule cell layers (Fig I-8). The molecular layer contains stellate and basket cells, 
dendrites of Purkinje cells, axons of granule cells, known as parallel fibers, and inferior 
olive neurons (climbing fibers). The Purkinje layer is a single cell layer containing the 
cell bodies of Purkinje neurons. The granule cell layer is made up of granule cell 
neurons, unipolar brush cell interneurons, Golgi cell interneurons, and axons of Purkinje 
cells (Altman and Bayer, 1997). 
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FIG. I-8. Cell layers of the adult mouse cerebellum. Sagittal view of lobule VI of a mouse cerebellar 
vermis showing the molecular layer, the Purkinje cell layer, the granule cell layer, and the white matter or 
medullary layer. The section is paraformaldehyde-fixed, frozen, and stained with 1% thionin. Scale bar is 
100 µm. 
 
 
Purkinje cells have a pear-shaped cell body and a fan-shaped dendritic arbor that 
is oriented in the sagittal plane and extends the width of the cerebellar molecular layer. 
Purkinje cells are one of the largest cells in the brain with a cell body approximately 50 – 
80 µm in diameter (Ghez and Thach, 2000). Purkinje cells are inhibitory and are the only 
efferent neurons within the cerebellar cortex. They project primarily to the deep 
cerebellar nuclei and to the vestibular nuclei. The deep cerebellar nuclei include the 
fastigial, interpositus, and dentate nuclei (Marani and Voogd, 1979). The fastigial nuclei 
receive axons from the cerebellar vermis, while the interpositus and dentate nuclei 
receive axons from the paravermis and hemispheres, respectively. The fastigial and 
interpositus are responsible for modulation of motor activity. The dentate nuclei are 
involved in motor function and planning (Nolte and Sundsten, 2001). Purkinje cells in 
the flocculonodular lobe project to the vestibular nuclei and influence balance and 
equilibrium (Angaut and Brodal, 1967; De Zeeuw et al., 1994). The excitation of 
Purkinje cells produces inhibition in the target structure (Ito, 1984c). 
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Granule cells are the smallest and most numerous neurons of the cerebellar 
cortex and are approximately 5 – 8 µm in diameter. The initial vertical portion of the 
granule cell axon passes through the granular and Purkinje cell layers perpendicular to 
the surface of the lobule. In the molecular layer, the granule cell axon bifurcates and 
forms two “parallel fibers” that traverse the long axis of the cerebellum. They excite 
Purkinje neurons that synapse with them along the length of the parallel fibers (Palkovits 
et al., 1971). In addition to excitation of Purkinje neurons, granule cells also excite 
basket, stellate, and Golgi cells, which also are inhibitory neurons. The net result of 
granule cell excitation is the inhibition of all other neuronal cell types within the 
cerebellum (Altman and Bayer, 1997).  
Basket cells are located in the lower one third to one half of the molecular layer. 
They are excited by granule cells and exert inhibitory action upon Purkinje neurons (Ito, 
1984b). Stellate cells are typically located in the upper two thirds of the molecular layer. 
They are excited by granule cells and exert inhibitory action upon Purkinje neurons 
(Rakic, 1972). Golgi cells are located in the granule cell layer where they receive 
information from Purkinje cells (Eccles, 1967) and inhibit the activity of granule cells, 
resulting in a negative feedback loop. Unipolar brush cells, in contrast, receive input 
from mossy fibers and are excitatory to cerebellar granule cells, resulting in a positive 
feedback loop (Diño et al., 2000). 
There are two excitatory afferents associated with the cerebellum, the climbing 
fiber and the mossy fiber. Climbing fibers originate in the contralateral inferior olive 
(Courville and Faraco-Cantin, 1978;  Szentagothai and Rajkovits, 1959) and enter the 
cerebellum through the inferior cerebellar peduncle (Campbell and Armstrong, 1983). 
They ascend through the medullary layer, traverse the granule cell layer, and then 
“climb” up and the dendritic trees of Purkinje cells. Climbing fibers carry  
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somatosensory, visual, and cerebral cortical information and excite Purkinje neurons 
(Eccles et al., 1964). Mossy fibers carry sensory information from the periphery as well 
as information from the cerebral cortex to the granule cells. The axons of mossy fibers 
terminate in the glomeruli of granule cells as a large swelling called a rosette (Altman 
and Bayer, 1997). Fig I-9 provides an overview of the cerebellar neurons and circuitry. 
Table I-2 provides a summary of the postsynaptic targets and the neurotransmitters of 
the cerebellar neurons. 
The cerebellum has three functional divisions. The spinocerebellum receives 
somatic sensory input from the spinal cord and controls posture and movement of the 
trunk and limbs. The cerebellar components of the spinocerebellum are the vermis and 
the intermediate hemisphere, which project to the fastigial and interposed nuclei, 
respectively. The cerebrocerebellum receives input from the cerebral cortex via the 
pontine nuclei, and controls planning of movement. The cerebellar component of the 
cerebrocerebellum is the lateral hemisphere that projects to the dentate nucleus. The 
vestibulocerebellum receives input from the vestibular labyrinth, the eye, and the ear and 
controls head and eye movements and maintains balance. The cerebellar component of 
the vestibulocerebellum is the flocculonodular lobe that projects to the vestibular nuclei 
(Fig I-10). 
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FIG. I-9. Cytological organization and functional circuitry of the cerebellum. The distribution, 
orientation, connections, excitatory (+) or inhibitory (-) influence, and the target of principal cerebellar 
neurons is depicted. P cell layer is the Purkinje cell layer. Arrows indicate stimulus direction. Modified 
from Altman, J. and Bayer, S. A. (1997). Development of the Cerebellar System: In Relation to its 
Evolution, Structure, and Functions. CRC Press, Boca Raton. 
 
 
 
  
20
TABLE I-2 
Neurons of the Cerebellum, Their Postsynaptic Targets, and the Various 
Neurotransmitters Involved 
Presynaptic fibers  Neurotransmitter  Postsynaptic targets 
Mossy fibers   Glutamate, Acetylcholine Granule cells 
    Glutamate   Unipolar brush cells 
Climbing fibers  Aspartate, CRF  Purkinje cells 
    CRF    Deep cerebellar nuclei 
Granule cells   Glutamate   Purkinje cells 
Purkinje cells   GABA    Deep cerebellar nuclei 
        Golgi cells 
Golgi cells   GABA, Glycine  Granule cells 
Basket cells   GABA    Purkinje cells 
Stellate cells   GABA, Taurine  Purkinje cells 
Deep cerebellar nuclei GABA    Inferior olivary nuclei (ION) 
    Aspartate, Glutamate  Non-ION targets 
Unipolar brush cells   Glutamate   Granule cells 
CRF = corticotrophin releasing factor, GABA = gamma amino butyric acid 
(Altman and Bayer, 1997;  Diño et al., 2000;  Voogd and Glickstein, 1998) 
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FIG. I-10. Key features of the functional divisions of the cerebellum. The functional organization of the 
spinocerebellum (A), the cerebrocerebellum (B), and the vestibulocerebellum (C) are represented with 
their major inputs and the associated cerebellar region and deep nuclei. Modified from Martin, J. H. 
(1996). Neuroanatomy: Text and Atlas. 2nd ed. p. 297. Appleton & Lange, Stamford. 
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In the cerebellum and throughout the CNS, glia cells as well as neurons are 
present. The ratio of glia to neurons in the CNS is approximately 1.7 in humans (Friede, 
1954;  Hawkins and Olszewski, 1957). Glia in the cerebellum include: 1) microglia, 
which are phagocytic and respond to infection and damage, 2) oligodendrocytes, which 
form the myelin sheath around axons, 3) astrocytes, mainly protoplasmic, which are 
important for structure and the maintenance of neuronal metabolic function and 
environment, and 4) Golgi epithelial cells, a. k. a. Bergmann (radial) glia 
(Kierszenbaum, 2002). Microglia and oligodendrocytes are found mainly in the 
medullary layer (Ito, 1984a). Astrocytes are located primarily in the granule layer. They 
scavenge ions and remnants of neuronal metabolism, such as K+, glutamate (Hamberger 
et al., 1979), and α-aminobutyric acid that may accumulate in the neuronal environment.  
The most distinctive of the cerebellar glia are the Golgi epithelial cells, not to be 
confused with Golgi neurons. Their cell bodies lie in the upper border of the granule 
layer, just beneath the Purkinje cells; their long processes, known as Bergmann fibers, 
ascend through the molecular layer and form conical endfeet in contact with the pia 
(Bergmann, 1857). The ascending processes of radial glia are arranged tightly as thin 
walls, or palisades, in the parlobular plane, and between the palisades are broader, glia-
free vertical stacks of parallel fibers from granule cells. Several radial glia palisades cut 
across the dendritic arbor of individual Purkinje cells that are oriented in the translobular 
plane (Fig I-11) (Altman and Bayer, 1997). Radial glia fibers enwrap synapses on 
Purkinje cell dendrites (Yamada and Watanabe, 2002). 
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FIG. I-11. Schematic depicting the spatial relationship between Bergmann glial cells and Purkinje cells. 
Purkinje cell dendrites are restricted to the translobular plane of the cerebellar cortex. Radial fibers from 
neighboring Bergmann glial cells are aligned into palisades in the parlobular plane, and cut across and 
impinge upon Purkinje cell dendrites in a vertical orientation. Modified from Huang, Z. J., Di Cristo, G., 
and Ango, F. (2007). Development of GABA innervation in the cerebral and cerebellar cortices. Nature 
Rev Neurosci 8, 673-686, 10.1038/nrn2188. 
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Translobular zones in the cerebellar cortex 
In addition to the gross longitudinal compartmentalization of the cerebellum 
defined as vermis, paravermis, and hemispheres (Chambers and Sprague, 1955a;  
Chambers and Sprague, 1955b), one can also observe zonal longitudinal divisions based 
on the distribution of climbing fibers, histochemistry, and the immunocytochemical 
heterogeneity of Purkinje cells. Climbing fibers from specific portions of the inferior 
olive climb and terminate in specific areas within the cerebellum. This results in a 
translobular pattern of climbing fiber projections (Buisseret-Delmas and Angaut, 1993;  
Buisseret-Delmas et al., 1993). Longitudinally oriented light and dark stained 5’-
nucleotidase bands occur in the molecular layer of the vermis. Approximately twenty 
translobular alternating light and dark bands on each side of the cerebellar cortex have 
also been observed (Marani, 1986). The significance of this banding is currently 
unknown. In addition to this banding, (Chan-Palay et al., 1981) showed that motilin-
immunoreactive Purkinje cells alternate with glutamic acid decarboxylase-
immunoreactive Purkinje cells in the cerebellar cortex, and that neurons containing 
taurine are aligned in four active bands separated by three inactive bands. The taurine 
neurons included Purkinje, basket, and Golgi cells. Several other monoclonal antibody 
specific translobular molecules have been found (Herrup and Kuemerle, 1997). These 
include B1 (Ingram et al., 1985), zebrin I and zebrin II (Leclerc et al., 1992), tyrosine 
hydroxylase (Hess and Wilson, 1991) and calbindin (Wassef et al., 1985). Fig I-12 
shows a comparison of zebrin stripe patterns in various mammals (Sillitoe et al., 2005). 
Although the basic structure of the cerebellum is simple and well understood, the 
microscopic and genetic organization and patterning within the cerebellum is far more 
complex. This complex organization may significantly influence the pattern of neuronal 
dysfunction and cell death, which occurs in disorders of the cerebellum. 
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FIG. I-12. Comparison stripe patterns of the anterior lobe vermis of adult rodent cerebella. (A) Cartoon of 
zebrin II +/- compartmentalization in the mouse. P1+ stripe straddles the midline and strong P2 and P3+ 
stripes are visible on either side. A weak P4+ stripe lies at the interface of the vermis and the hemisphere. 
The P2+ stripe does not extend into more anterior lobules, but the P1 and P3+ stripes remain prominent. 
(B) Mouse anterior lobe vermis. (C) Hamster anterior lobe vermis. (D) Rat anterior lobe vermis. (E) 
Guinea pig anterior lobe vermis. Scale bar is 1 mm. Modified from Sillitoe, R. V., Marzban, H., Larouche, 
M., Zahedi, S., Affanni, J. and Hawkes, R. (2005). Conservation of the architecture of the anterior lobe 
vermis of the cerebellum across mammalian species. Prog Brain Res 148, 283-297. 
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Motor learning 
Motor learning by the cerebellum is a relatively new concept. Studies indicate 
that the cerebellum is associated with trial-and-error practice-type motor adaptation and 
learning. David Marr (Marr, 1969) and James Albus (Albus, 1971) proposed that 
climbing fiber inputs to Purkinje neurons modify the response to mossy fibers, and that 
this modification could occur over a prolonged time. Their theory was that during 
repetitive movement, climbing fibers provide error signals that depress parallel fibers 
and allow “correct” movements to emerge. This has been termed, long-term depression 
(LTD) (Ito, 1986;  Ito et al., 1982). In LTD, climbing fibers weaken parallel fiber-
Purkinje cell synapses (Ekerot and Kano, 1985; Ekerot and Oscarsson, 1981; Ito, 1986). 
Cerebellar damage often impairs this type of learning. In the vestibule-ocular reflex, a 
coordinated response maintains the eyes on a fixed target when the head is rotated. 
When humans wore prism glasses that reversed the visual field, the reflex was flawed. 
After wearing the glasses for several days, the reflex becomes reversed from “normal” 
(Ito, 1982). Vestibulocerebellar lesions block this adaptation. In addition, control of limb 
movements can be altered by wearing prism glasses. When people throw darts at a target 
with glasses that reverse the field of vision, the initial throw is off-target. After ten to 
thirty throws, the direction-of-throw becomes altered such that the darts then land on-
target (Martin et al., 1996a;  Martin et al., 1996b). Individuals with damaged cerebellar 
cortex or inferior olive are unable to adapt in this situation. Finally, studies also indicate 
that the cerebellum may be involved in associative learning. McCormick and Thompson 
(1984) and Yeo (1984) showed that cerebellar lesions disrupted the acquisition and 
retention of classically conditioned eyeblink reflex in rabbits. 
 
Disorders of the cerebellum 
Cerebellar disorders have three basic and distinct signs: 1) hypotonia, abnormally 
low muscle tone, 2) ataxia, abnormal execution of voluntary movements and lack of 
coordination, and 3) intention tremor (Ghez and Thach, 2000). Intention tremor is most 
obvious at the end of the movement when the antagonist muscle is engaged. Studies 
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show that newborn rats with decreased numbers of cells in the external germinal cell 
layer of the cerebellum have severe locomotor abilities that appear between postnatal 
day 22 and 29 and persist throughout life (Altman et al., 1971). In addition, these 
animals were unable to sit and maintain balance without forelimb support (Altman et al., 
1971). These disabilities made it difficult for the animals to use their paws for picking up 
food items and grooming themselves. Finally, skills such as learning to descend from a 
vertical rod head-down and learning to climb a rod to an overhead platform to escape 
danger were not mastered by the rats with extensive loss of external germinal layer cells 
(Altman et al., 1971). 
 
CENTRAL NERVOUS SYSTEM DEVELOPMENT 
General overview 
The embryonic period of mammalian development is particularly important 
because it is during this course that most major malformations occur. The developing 
embryo is highly sensitive to insult during early development (Muller and O'Rahilly, 
2004). The human prenatal period is divided into the embryonic period, which is eight 
weeks post-fertilization, and the fetal period, eight weeks post-fertilization to birth (Fig 
I-13). Specific morphological stages of brain development have been identified during 
the embryonic phase (Table I-3). 
Vertebrate embryos have three principal (germ) cell layers: ectoderm (outer), 
mesoderm (middle), and endoderm (inner). A specialized region of the ectoderm, the 
neural plate, is the source of the neurons and glia of the nervous system and lies along 
the midline of the embryo. Marginal cells of the neural plate proliferate and alter their 
shape to form a neural groove that deepens. The edges eventually shift dorsally and 
medially to appose each other, and then close to form a hollow neural tube. The caudal 
portion of the neural tube forms the spinal cord; the rostral portion forms the brain. 
Three layers exist around the neural tube: the innermost ependymal layer, which is also 
called neuroepithelium that gives rise to immature nerve cells; the middle or mantle 
layer, which forms specialized glia that serve as a scaffold for migrating neurons; and 
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the outermost marginal layer, which primarily contains the axonal processes of 
developing neurons.  In the mature spinal cord these three embryonic layers of the wall 
of the neural tube can still be identified. The ependymal layer lines the ventricular 
system, the mantle layer becomes the gray matter, and the marginal layer becomes the 
white matter (Jessell and Sanes, 2000;  Martin, 1996;  Sadler, 2006). In the mature brain, 
the ependymal layer still lines the ventricular system, but the other two layers are no 
longer clearly recognizable due to the complex growth and remodeling that takes place 
as the brain matures. 
From rostral to caudal, the cranial end of the neural tube develops into five brain 
regions: the telencephalon that becomes the cerebral hemispheres, the diencephalon that 
becomes the epithalamus, thalamus and hypothalamus, the mesencephalon that becomes 
the midbrain, the metencephalon that becomes the pons and cerebellum, and the 
myelencephalon that becomes the medulla. The large cavity within the developing 
neural tube forms the ventricular system that is filled with cerebrospinal fluid produced 
by the choroid plexus. Two lateral ventricles form in the region of the telencephalon; 
they are connected by the interventricular foramina to the third ventricle that forms in 
the diencephalon. The fourth ventricle develops in the region of the metencephalon and 
myelencephalon; it is connected to the third ventricle by the cerebral aquaduct that is 
located in the region of the mesencephalon (Jessell and Sanes, 2000;  Martin, 1996;  
Sadler, 2006). 
  
29
 
FIG. I-13. Gestational timeline of human developmental malformation potential. The risk of 
malformations is highest between gestational weeks 3 and 8. Gestational days 0, 3, 8 and 38 are identified. 
/ / indicates a break in the progression of time. Modified from Sadler, T. W. (2006). Langman's Medical 
Embryology. 10th ed. Lippincott, Williams & Wilkins, Philadelphia. 
 
 
TABLE I-3 
Initial Appearance of Various Features of the Human Nervous System 
Features Stage Weeks 
Neural folds and groove 8  
Mesencephalic flexure; primary neuromeres; rhombencephalon, mesencephalon, 
prosencephalon 
9  
Neural tube begins; telencephalon, medium and diencephalon 10 4 
Rostral neuropore closes 11  
Caudal neuropore closes; secondary neurulation begins 12 4.5 
Closed neural tube; cerebellar primordium; isthmus 13  
Pontine flexure; medial ventricular eminence; future cerebral hemispheres; all 16 
neuromeres present 
14  
Myelencephalon, metencephalon; hippocampal thickening; lateral ventricular eminence 15 5 
Epiphysial evagination 15,16  
Thalamus; all cranial nerves present 16  
Internal and external cerebellar swellings; neurophypophysial evagination; synapses in 
primordial plexiform layer 
17 6 
Future corpus striatum; defined interventricular foramina; choroids fissure; dentate 
nucleus; inferior cerebellar peduncles 
18  
Olfactory bulb; insula; choroid plexus of fourth ventricle 19  
Choroid plexus of lateral ventricles 20 7 
Cortical plate; anterior and inferior horns of lateral ventricle; circulus arteriosus 
complete 
21  
Internal and external capsules; claustrum 22  
Caudate nucleus and putamen; anterior commissure begins; external germinal layer in 
cerebellum 
23 8 
The weeks given are post-fertilizational.  
Modified from Muller, F. and O’Rahilly, R. (2004). The Human Nervous System (G. Paxinos and J. K. 
Mai, Eds.), 2nd ed., p. 23. Elsevier Academic Press, San Diego.
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Some developing areas of the embryo have inductive influence on other 
developing areas. These include the prechordal plate, the primitive streak, and the 
notochord process. The prechordal plate is in close contact with the neural groove, or 
future forebrain and provides signals to suppress the medial portion of the unseparated 
optic field, which induces two separate eye fields (retinas) to form. The primitive streak 
is a temporary caudal axial structure that exists during the process of gastrulation and 
lacks a basement membrane, allowing the emigration of surface epiblast cells to form the 
trilaminar embryo. The epiblast cells that migrate through the primitive streak gives rise 
to all three germ layers and most importantly to the paraxial mesoderm, notochord 
process, and endoderm. The notochord process becomes the notochord that, along with 
the adjacent paraxial mesoderm, induces formation of the floor plate in the neural plate 
by means of diffusible factors. The floor plate regulates differentiation of motor neurons 
and axonal growth in the developing neural tube (Muller and O'Rahilly, 2004). 
Inductive influence occurs through gene expression. Sonic hedgehog (SHH) is 
expressed in the prechordal plate and is involved in signaling the development of the 
hypothalamus and diencephalons in the cranial region of the neural tube. FOXG1 
regulates the development of the telencephalon. EN1, EN2 and WNT1 are involved in 
patterning of the mesencephalon and metencephalon in humans and mice (Song et al., 
1996). EN1 regulates development of the tectum and the cerebellum; EN2 is involved in 
cerebellar development only. WNT1 interacts with EN1 and EN2 to regulate the 
development of the cerebellum from as early as the neural plate stage (Fig I-14). PAX3 is 
expressed in the neural groove and neural tube and later in the mesencephalon, 
rhombencephalon, and spinal cord once they are formed. PAX5 is expressed in the mes-
rhombencephalic boundary and the spinal cord. PAX6 is expressed in the optic 
neuromeres of the neural tube and in the rhombencephalon and spinal cord (Gerard et 
al., 1995). In addition, HOX genes (Fig I-15) are expressed in human rhombomeres and 
pharyngeal arches (Vieille-Grosjean et al., 1997). The expression of many HOX genes 
determine position along the anterior-posterior axis of the hindbrain and identifies the 
rhombomeres and their derivatives (Sadler, 2006).  
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FIG. I-14. Patterns of gene expression for WNT1, EN1, EN2, and SHH, and for the signaling molecule, 
fibroblast growth factor 8 (FGF8). FGF8 signals the expression of these genes. The genes are involved in 
development of the mesencephalon and metencephalon. Modified from Sadler, T. W. (2006). Langman's 
Medical Embryology. 10th ed. p. 306. Lippincott, Williams & Wilkins, Philadelphia. 
 
 
 
 
 
 
FIG. I-15. Patterns of HOX gene expression in the hindbrain. HOX genes are expressed in overlapping 
patterns ending at specific rhombomere boundaries. These genes confer positional value along the 
anterior-posterior axis of the hindbrain. They determine the identity of the rhombomeres and their 
derivatives. Modified from Sadler, T. W. (2006). Langman's Medical Embryology. 10th ed. Lippincott, 
Williams & Wilkins, Philadelphia. 
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The above listed genes represent only a small portion of the numerous genes that 
must be activated and/or inactivated at the appropriate time and sequence in the 
developmental process. The exact regulation and specific timing of gene expression is of 
utmost importance to proper embryonic development. Any event, such as a chemical 
insult, that interferes with this time-course could have negative consequences for the 
embryo or fetus. 
 
Hippocampal development 
As the cerebral cortex develops, it encircles the diencephalon, that remains 
basically spherical, and takes on the shape of the letter C. Structures that take on the C-
shape have both a dorsal and a ventral component within the brain. These structures 
include the lateral ventricles, caudate nucleus, hippocampal formation, cingulated and 
parahippocampal gyri, and the fornix (Jessell and Sanes, 2000;  Martin, 1996;  Sadler, 
2006). 
The following summary of the development of the hippocampus is based on what 
is known for the human (Insausti and Amaral, 2004). Early in development, the 
hippocampus is located dorsal to the corpus callosum, but later is “dragged” into the 
temporal lobe. The hippocampal formation begins to enfold into the temporal lobe. As 
the hippocampal sulcus forms, the dentate gyrus and the subiculum become apposed. 
The pial surface of these structures fuses (Fig I-16). By nine weeks of gestation, the 
hippocampal area is located in the medial aspect of the developing cerebral hemisphere 
(Arnold and Trojanowski, 1996). The hippocampal fissure appears at ten weeks 
(Humphrey, 1967). The subiculum, the hippocampal fields, and the three layers of the 
dentate gyrus become apparent between fifteen and nineteen weeks of gestation. At 
twenty-five weeks, the hippocampal fissure is more pronounced and the fields have 
expanded. The dentate gyrus is greatly expanded, but many of the cells have immature 
features. At thirty-four weeks, the hippocampal formation has a basic mature 
appearance. The hippocampus is decreased in size slightly from earlier time points due 
to apoptosis and growth of neuronal processes. No significant morphological changes 
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occur into adulthood other than progressive myelination to completion. In contrast, the 
development of the entorhinal cortex, the primary hippocampal input, continues to 
develop until the end of the second postnatal year (Grateron et al., 1996). 
 
 
 
FIG. I-16. Schematic of the hippocampal formation during development. The hippocampal sulcus forms 
and the dentate gyrus and subiculum become apposed and fuse. The apparatus resembles a "jelly roll". The 
arrow indicates the direction of movement. Modified from Martin, J. H. (1996). Neuroanatomy: Text and 
Atlas. 2nd ed. p. 469. Appleton & Lange, Stamford. 
 
 
In mice, neural progenitor cells that become pyramidal cells of the CA regions of 
the hippocampus are born on embryonic (E) day 10.5 (Angevine, 1965). By E14.5, most 
of the progenitor cells have migrated to their final positions, and most of these will 
become pyramidal cells between E15 and E19 (Supèr and Soriano, 1994). The CA 
regions continue to develop and mature until the third postnatal week (Grove and Tole, 
1999;  Zimmer, 1978). The afferent fibers from the septum arrive at the CA regions at 
E17.5, and the afferent fibers from the entorhinal cortex reach the dentate gyrus at E. 
19.5 (Supèr and Soriano, 1994). 
The granule cells of the dentate gyrus exhibit a different pattern of development 
compared to the pyramidal cells of the CA regions. In mice, the birth of the granule cells 
occurs mainly after birth from postnatal (P) day 20 to two weeks (Altman and Bayer, 
1990). The first 15% of the granule cells are generated at the same time as the pyramidal 
cells, E10.5. The next 70% are generated during the first two postnatal weeks, and the 
last 15% appear after P16 (Bayer, 1980). The mossy fiber projections from the granule 
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cells to the CA3 pyramidal cells grow, mature, and make their final connections between 
P3 and P21 (Amaral and Dent, 1981;  Gaarskjaer, 1986). 
 
Cerebellar development 
The cerebellum develops from neuroblasts located from a specific region in the 
alar plate of the dorsolateral metencephalon called the rhombic lip. At first, the rhombic 
lips are widely separated, but eventually fuse long the midline. The midline region 
becomes the vermis, and the two lateral regions become the hemispheres. Fissures form 
on the cerebellar surface and are oriented from medial to lateral. The fissures divide the 
cerebellum into three lobes: anterior, posterior, and flocculonodular (Altman and Bayer, 
1997;  Martin, 1996;  Sadler, 2006). 
A summary of the development of the cerebellum is shown in Fig I-17. The 
rhombencephalon surrounds the fourth ventricle and is the source of neurons of the 
hindbrain. It can be divided into the myelencephalon (primordial medulla) and the 
metencephalon, (primordial cerebellum and pons) (Patten and Carlson, 1974), which 
both contain an alar (dorsal) and basal (ventral) plate. In rats and mice the cerebellum is 
derived from the alar plate just after neural tube closure at E8.5 (McMahon and Bradley, 
1990; Herrup and Kuemerle, 1997). Between E13 and E16 in rats, the medullary velum 
invaginates into the 4th ventricle; there is an increase in pontine flexure, and an increase 
in size and backward growth of the tectal primordium, which results in the permanent 
location placement of the cerebellum. By E16, differentiating zones have begun to 
develop within the primordial cerebellum. Between E17 and E22, the external germinal 
cell layer (ECL) is dispersed over the surface of the cerebellum, and the Purkinje cells 
have migrated to a location just below the ECL (Altman and Bayer, 1997).  
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FIG. I-17. The development of the cerebellum in the rat. (A) is embryonic day (E) 13 to E15 and shows 
the invagination of the medullary velum into the fourth ventricle. (B) is E16 to E20 showing the formation 
of the external granular and Purkinje cell layer. (C) is E22 at the beginning of lobulation and granule cell 
migration. (D) is the mature cerebellum with full lobulation and complete migration of cerebellar neurons 
to their final locations. Modified from Sadler, T. W. (2006). Langman's Medical Embryology. 10th ed. p. 
298. Lippincott Williams & Wilkins, Philadelphia. 
 
 
The cells in the cerebellum originate from two separate germinal zones. Purkinje 
cell, Golgi cells, and some glial cells emerge from the ventricular cell matrix, which 
covers the ventricular surface of the cerebellar plates. Granule, basket, stellate, and some 
glial cells are derived from the external granular layer, near the outer surface of the 
cerebellar plates. The cells migrate from the ventricular matrix and the external granular 
layer in opposite directions to their final destination (Fig I-18). 
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FIG. I-18. Development of the cerebellar cortex. (A) shows a developing cerebellar cortex with the 
external granular layer on the pial surface of the cerebellum and the immature Purkinje cells layered 
below. In (B), the mature cerebellum has a molecular layer, a single Purkinje cell layer, and an internal 
granule cell layer. Modified from Sadler, T. W. (2006). Langman's Medical Embryology. 10th ed. p. 298. 
Lippincott Williams & Wilkins, Philadelphia. 
 
 
Radial glial cells are some of the earliest cell types to appear during embryonic 
development. They have been linked to direct neuronal migration and laminar patterning 
of the cerebral and cerebellar cortex. During the perinatal period, radial glial cells are 
replaced by multipolar astrocytes and oligodendrocytes; however, in the cerebellum 
(Bergmann glia) and retina (Muller cells), they remain as specialized cells (Choi and 
Kim, 1985; Choi and Lapham, 1980; Stagaard et al., 1991). Bergmann radial glia are 
unipolar protoplasmic astrocytes that direct neuronal migration during pre- and postnatal 
periods (Rakic, 1971;  Yamada and Watanabe, 2002). Starting at embryonic day 17 
(E17), in mice, they migrate to their future location in the cerebellum and direct the 
migration of Purkinje cells (Altman and Bayer, 1997;  Yuasa, 1996). Bergmann glia 
proliferate once they are in the cerebellum from postnatal day (P) 1 to P 21 in mice 
(Reichenbach et al., 1995;  Shiga et al., 1983). Postnatally, they associate with the 
inward migrating postmitotic granule cells moving from the external granular layer to 
the internal granular layer (Rakic, 1971). 
Purkinje cells mature in three stages. Initially, they are distributed in multiple 
layers and are small and fusiform shaped. They then become multipolar and form a 
single row of cells. Finally, extra processes withdraw, and the dendrites are rearranged in 
a plane perpendicular to the long axis of the lobule. In the mouse, Purkinje cells stop 
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dividing at E12 (Miale and Sidman, 1961). At E21, the Purkinje cells are still in several 
layers (Uzman, 1960); they form a monolayer by P10 (Miale and Sidman, 1961). The 
dendritic trees develops during the second and third postnatal weeks (Weiss and Pysh, 
1978). 
In the mouse, matrix cells move from the neuroepithelial surface, across the 
rhombic lip to the outer pial surface of the developing cerebellum. A layer of 
proliferating precursor granule cells spreads across the external surface as more 
precursors migrate across the rhombic lip. The entire surface of the cerebellum is 
covered by the granule cells between E13 and E16 (Hatten et al., 1982). The cells in the 
external granule layer migrate inwardly starting at birth. They may migrate a short 
distance and become cells of the molecular layer, or they may migrate further and 
become granule cells. Most of the granule cell layer, 81 to 92% is formed after P7, with 
50% being formed after P10 (Altman, 1972a;  Altman, 1972c). Parallel fiber synapses on 
Purkinje cells dendrites that are formed during the third postnatal week (Altman, 1972b).  
Precise neuronal function requires highly ordered cell proliferation, 
differentiation, migration and synaptic specificity. Development of the central nervous 
system depends on both intrinsic and extrinsic factors that orchestrate neuronal 
migration to form laminae (Hatten, 1999;  Rakic, 1971), the compartments in which 
neurons become differentiated and specialized. During cortical development, postmitotic 
neuronal precursors use radial glia as a pathway for migration to final adult locations 
(laminae) (Kriegstein and Noctor, 2004). This applies to cortical regions of the cerebrum 
as well as the cerebellum. Thus, the molecular control of radial glial migration and 
differentiation is crucial for the formation of normal cortical architecture and synaptic 
circuitry. 
 
MITOCHONDRIA 
In the second half of the nineteenth century, Rudolf Albrecht von Köllicker, a 
Swiss anatomist and physiologist, noticed characteristically arranged granules in the 
sarcoplasm. In 1890, Altmann recognized the ubiquitous nature of “bioblasts” (Altmann, 
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1890), and in 1989, Carl Benda named the organelle the “mitochondrion”, meaning 
threadlike granules (Benda, 1989). The ultra-structure of mitochondria was described by 
Palade (1952), and mitochondrial DNA was defined by Nass and Nass (1963). In 1912, 
Kingsbury suggested that mitochondria serve “as a structural expression of reducing 
substances concerned in cellular respiration (Luft, 1997).” In 1978, the Nobel Prize in 
Chemistry was awarded to Peter Mitchell for his contribution to the understanding of 
biological energy transfer through the formulation of the chemiosmotic theory (Mitchell, 
1993). The primary role of mitochondria has been determined to be electron transport, 
oxidation processes, oxidative phosphorylation and respiratory control, thus, production 
of energy for the cell.  
Mitochondria are thought to have originated from free-living proteobacteria that 
became symbiotic with precursors to eukaryotic cells (Margulis, 1971). This relationship 
and the evolution of the oxidative phosphorylation system allowed the efficient 
metabolism of food, using oxygen, to produce energy. Mitochondria contain two 
membranes: a smooth outer membrane and a highly folded inner membrane. The outer 
membrane is selectively permeable to ions and small molecules (up to 10 kD) that can 
diffuse across the membrane through porin protein channels. In addition, the outer 
membrane contains voltage-dependent anionic channels (VDAC) that allow the import 
and export of specific ions, such as Ca2+ (Voet and Voet, 2004). The inner membrane is 
compartmentalized into cristae that increase the surface area of the membrane (Perkins 
et al., 2001). The cristae are not simple folds but are a complex array of invaginations 
and tubules of the inner membrane that divide and fuse continuously depending on the 
amount of mitochondrial activity (Mannella, 2006;  Renken et al., 2002). The inner 
membrane is the site of the electron transport chain which are the proteins that mediate 
electron transport, oxidative phosphorylation and ATP production (Duchen, 1999). The 
inner membrane is permeable only to O2, CO2, and H2O, but contains transport proteins 
that control the movement of molecules such as ATP, ADP, pyruvate, Ca2+, and 
phosphate across the membrane (Voet and Voet, 2004). This low permeability and tight 
control permits the generation of an ionic gradient across the inner membrane and 
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compartmentalization of metabolic functions. The matrix, bounded by the inner 
membrane, contains soluble enzymes of oxidative metabolism (tricarboxylic acid cycle 
(TCA) enzymes). The matrix also contains substrates, nucleotide cofactors, inorganic 
ions, and mitochondrial genetic machinery (Nicholls and Ferguson, 2002). Fig I-19 
shows a compilation of the functional components of the mitochondrion. 
 
FIG. I-19. The outer membrane is shown containing the VDAC for import and export of Ca2+. The inner 
membrane is shown containing Complexes I - V of the electron transport chain, Complex V for oxidative 
phosphorylation, the mitochondrial permeability transition pore (MPT), and the adenine nucleotide 
translocase (ANT) for exchange of ADP and ATP. H+ ions are shown being pumped across the inner 
mitochondrial membrane by Complexes I, III, IV, and V. The matrix is shown containing the sites of ADP 
phosphorylation and the TCA cycle. It is in the matrix where the mitochondrial membrane potential is 
created. Modified from Das, J. (2006). The role of mitochondrial respiration in physiological and 
evolutionary adaptation. BioEssays 28, 373. 
 
 
The TCA cycle and electron transport chain are involved in the break down of 
organic molecules for the production of energy as ATP. Energy sources such as glucose 
are initially metabolized in the cytoplasm. The products are imported into the matrix of 
the mitochondria where acetyl-CoA transfers its acetyl group to oxaloacetate to form 
citrate. The citrate loses two carboxyl groups as CO2. The energy from these reactions is 
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transferred in NADH to the process of oxidative phosphorylation to drive ATP synthesis 
(Voet and Voet, 2004). 
Oxidative phosphorylation occurs in the electron transport chain (Fig I-20). This 
chain couples a chemical reaction between the electron donor, NADH, and the electron 
acceptor, O2, to the transfer of H+ ions across the membrane, to the inner membrane 
space, through a set of mediating biochemical reactions. These H+ ions produce ATP as 
they move back across the membrane (Voet and Voet, 2004). There are four membrane-
spanning enzyme systems in the inner membrane. Three of them are proton pumps. In 
Complex I (NADH dehydrogenase), NADH is oxidized to NAD+ and two electrons are 
released and passed on to coenzyme Q (Q, ubiquinone). Complex I contains 
flavoproteins and non-heme-iron proteins. Coenzyme Q can accept one electron to form 
a semiquinone (free radical) or two to form a fully reduced ubiquinol form that diffuses 
across the membrane. Complex I moves four protons (H+) across the membrane from the 
matrix to the inner membrane space. Complex II (succinate dehydrogenase) is not a 
proton pump, but removes electrons from succinate and transfers them to Q (Das, 2006). 
The succinate is produced in the Krebs cycle and through β-oxidation of fatty acids. In 
Complex III (ubiquinol cytochrome C reductase), two electrons are removed from Q and 
transferred to two molecules of cytochrome C. Complex III contains an iron-sulphur 
protein plus cytochromes b and c1. Cytochromes are heme proteins which accept 
electrons by allowing Fe(III) at the center of the heme ring to be reduced to Fe2+. Two 
more protons are transferred across the membrane, and quinone is reduced to quinol. In 
Complex IV (cytochrome C oxidase), four electrons are removed from four molecules of 
cytochrome C and transferred to oxygen (O2) to produce two molecules of water. 
Complex IV contains cytochrome a, cytochrome a3, and copper ions. At the same time, 
four more protons are moved across the membrane to the inner membrane space. 
Complexes, I, II and III all contain non-heme iron; complex IV contains copper; 
Complex III, IV and cytochrome C contain heme (Duchen, 2004).  
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FIG. I-20. Diagram of the mitochondrial electron transport chain. Electrons are transferred between Complexes I and III by the membrane-soluble 
ubiquinone (Q) and between Complexes III and IV by the peripheral membrane protein cytochrome C (Cyt C). Complex II transfers electrons from 
succinate to Q. The path of electrons (solid black circles) is shown with dotted arrows. Complexes I, III and IV use the energy from electron transfer to 
pump protons into the intermembrane space, creating an electrochemical gradient, or mitochondrial membrane potential. Complex V uses the energy 
stored in the electrochemical gradient to phosphorylate ADP to form ATP. 
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The protons pumped into the intermembrane space establish an electrochemical 
proton gradient (proton-motive force). This gradient has two components: 1) a pH 
gradient due to the acidic property of the protons and 2) an ionic gradient created by the 
charge of the protons. The ionic gradient is called the mitochondrial membrane potential 
and is usually 150 – 180 mV negative relative to the cytosol (Duchen, 2004). ATP 
synthase uses the proton gradient to make ATP by oxidative phosphorylation. ATP 
synthase forms a channel that returns protons back to the mitochondrial matrix (inward) 
from the inner membrane space. Their movement depolarizes the mitochondrial 
membrane potential. During the inward proton movement, ATP synthase phosphorylates 
ADP, and ATP is released (Stock et al., 1999). Incoming ADP and outgoing ATP are 
exchanged across the inner mitochondrial membrane by adenine nucleotide translocase 
(ANT), making ATP available to the rest of the cell.  
Although the inner membrane is quite impermeable, because of the need to 
maintain the electrochemical gradient, there is a proton leak. As protons are leaked, the 
energy created by electron transport appears as heat rather than ATP. This leak is a 
major contributor to the body’s heat production (Hittelman et al., 1969). 
The rate at which the protein complexes function is correlated with the proton 
gradient. Respiration will run faster when the membrane is depolarized because the 
energy required to move protons is reduced. It will run slower when the membrane 
potential increases (hyperpolarizes) (Duchen, 2004). For example, carbonyl cyanide m-
chlorophenylhydrazone (CCCP) uncouples the process of oxidative phosphorylation and 
allows the membrane potential to dissipate. This action results in an increase in the 
respiratory rate (Chen et al., 2002). Similarly, oligomycin blocks the ATP synthase 
proton channel and prevents the movement of protons back into the matrix. This action 
increases the membrane potential and slows the respiratory rate (Chen et al., 2002). 
Mitochondrial membrane potential is maintained by cellular respiration. A drop in 
membrane potential may occur for several reasons: 1) respiratory inhibition, 2) substrate 
deprivation, or 3) uncoupling of oxidative phosphorylation (Duchen, 2004). 
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Although production of ATP is the primary role of mitochondria, they are also 
involved in cell signaling, differentiation, growth and death (McBride et al., 2006). In 
addition, mitochondria contribute to glucose homeostasis, calcium regulation, synthesis 
of steroids and lipids, DNA replication, transcription and translation of proteins, and 
oxygen sensing (Duchen and Biscoe, 1992;  McBride et al., 2006;  Rowe et al., 1981). 
 
REACTIVE OXYGEN SPECIES 
The demonstration that xanthine oxidase produces O2- (McCord and Fridovich, 
1968) and that erythrocytes contain an enzyme that efficiently and specifically catalyze 
the conversion of O2- into H2O2 + O2 (McCord and Fridovich, 1969) led to the 
understanding that O2- is commonly produced within aerobic biological systems and that 
there are cellular mechanisms that oxidize this molecule. O2- is known as a radical. 
Radicals, also called free radicals, are atoms or groups of atoms that have one or more 
unpaired electrons and have high chemical reactivity. A variety of normal biochemical 
reactions form radicals as necessary intermediates. 
Oxygen radicals are known as reactive oxygen species (ROS); although, the term 
ROS includes both oxygen radicals and non-radicals that are oxidizing agents that may 
be easily converted to radicals (Halliwell and Gutteridge, 2007). Oxygen has two 
unpaired electrons in each of two outer orbitals, making oxygen particularly susceptible 
to radical formation. Sequential reduction of molecular oxygen results in the formation 
of the following ROS: superoxide anion, peroxide ion, and hydroxyl radical (Halliwell 
and Gutteridge, 2007). A list of some ROS, both radical and non-radical, is shown in 
Table I-4. 
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TABLE I-4 
Nomenclature of Reactive Oxygen Species 
Free radicals Non-radicals 
Superoxide, O·2- Hydrogen peroxide, H2O2 
Hydroxyl, OH· Ozone, O3 
Hydroperoxyl, HO·2 Peroxide ion, O22- 
Peroxyl, RO·2  
Alkoxyl, RO·  
Carbon dioxide, CO·2-  
 
 
ROS are formed primarily in the mitochondria as oxygen is reduced along the 
electron transport chain during aerobic metabolism. Some non-mitochondrial enzymatic 
reactions also form ROS intermediates (Saez et al., 1982). In addition, white blood cells 
produce ROS as defense against pathogens (Bernhagen, 2005). Studies indicate that 
ROS may be involved in inter- and intracellular signalling (Nemoto et al., 2000). For 
example, addition of superoxide or hydrogen peroxide to cultured cells results in an 
increased rate of DNA replication and cell proliferation (Burdon et al., 1989). 
Mitochondria produce ATP by oxidative phosphorylation where hydrogen ions 
are transported across the inner mitochondrial membrane via the electron transport 
chain. In the chain, electrons are passed through a series of proteins via oxidation-
reduction reactions, with each acceptor protein along the chain having a greater 
reduction potential than the last. The last destination for an electron is an oxygen 
molecule. Normally, electrons pass from one component of the chain to the other, and 
oxygen is reduced to water; however, 0.1-2% of electrons that pass through the chain are 
leaked directly to oxygen, which is prematurely and incompletely reduced to form the 
superoxide radical, O2- (Muller, 2000). This occurs particularly in Complex I (Turrens 
and Boveris, 1980) and Complex III (Boveris et al., 1976;  Han et al., 2001;  St-Pierre et 
al., 2002), although Complex II can also produce the superoxide radical (Zhang et al., 
1998).  
Despite the beneficial activities associated with ROS, they may also be toxic to 
cells. When generated in excess or not properly controlled, ROS can cause damage to 
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macromolecules such as DNA, phospholipids, and proteins. When electron transfer is 
hindered by high membrane potential, point mutations or respiratory inhibitors such as 
antimycin A, there may be enhanced leakage of electrons to oxygen, particularly at 
Complex III. Events such as hypoxia (heart attack and stroke) (Carden and Granger, 
2000), extreme heat (Martindale and Holbrook, 2002), exposure to various chemicals 
and drugs (Munday, 1989), and ionizing radiation (Carugo and Carugo, 2005) generate 
excess ROS in cells and cause oxidative stress. For example, ROS damage cellular 
membranes by lipid peroxidation (Gardner, 1989). Peroxidation targets unsaturated fatty 
acids in the phospholipids of membranes. A chain reaction occurs: hydrogen is removed 
from the fatty acid by a hydroxyl radical, leaving a carbon-centered radical as part of the 
fatty acid. The new carbon radical reacts with oxygen to yield the peroxyl radical that 
then reacts with other fatty acids or proteins. Membrane peroxidation may result in 
increased membrane rigidity, decreased activity of membrane-bound enzymes (e.g. 
sodium pumps), altered activity of membrane receptors, and altered permeability 
(Gardner, 1989). Similarly, ROS may directly attack membrane proteins and induce 
lipid-lipid, lipid-protein, and protein-protein crosslinking (Davies, 2005), all of which 
have adversely affect membrane function. 
As a defense against oxidative stress and ROS damage, cells contain 
antioxidants. Antioxidants are any substance that delays, prevents, or removes oxidative 
damage to a target molecule (Halliwell and Gutteridge, 2007). Antioxidants may be 
enzymatic or non-enzymatic. Important enzymatic antioxidants include superoxide 
dismutase, catalase, and glutathione peroxidase. Non-enzymatic antioxidants include 
ascorbic acid (vitamin C) (Padayatty et al., 2003), glutathione, and vitamin E 
(tocopherol) (Yoshida et al., 2003). Vitamin E is lipid-soluble and protects membranes 
inhibiting lipid peroxidation because they scavenge lipid peroxyl radicals (LO·2) faster 
than the radical can react with adjacent fatty acid side chains or membrane proteins 
(Mukai et al., 1993;  Porter, 1993). 
Superoxide dismutase (SOD) catalyzes the conversion of two superoxides into 
hydrogen peroxide and oxygen. Hydrogen peroxide is significantly less toxic than 
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superoxide and can be removed by other antioxidants. SOD is associated with metals 
that are necessary for their function. Zinc (Zn2+) or copper (Cu2+) are bound to SOD 
(CuZnSOD) in the cytoplasm (Fridovich, 1995a). Manganese (Mn) binds to SOD 
(MnSOD) in the mitochondria (Fridovich, 1995a). In CuZnSOD, the copper ion 
catalyzes dismutation by undergoing alternate oxidation and reduction. A copper 
chaperone delivers copper to the metal-free SOD and ensures that the correct disulphide 
bridge forms (Furukawa et al., 2004). The Zn2+ is not catalytic, but stabilizes the 
enzyme. Non-biological metals such as mercury cannot replace the Cu2+, but can replace 
the Zn2+, which results in a functional, but less stable enzyme (Fridovich, 1995a). 
MnSOD catalyzes essentially the same reactions as CuZnSOD. It requires the presence 
of bound Mn to be functional; other metal ions can bind, but do not yield a functional 
enzyme.  
Catalase is located in peroxisomes. It catalyses a dismutation reaction where 
hydrogen peroxide is converted to water and oxygen, thus detoxifying the product of the 
SOD reaction (Chance et al., 1979). Mammalian catalases contain Fe(III)-heme at the 
active site (Reid et al., 1981). 
Glutathione peroxidases are enzymes that contain selenium at its active site 
(Brigelius-Flohé, 1999). They degrade H2O2 by coupling its reduction to water with 
oxidation of reduced glutathione, GSH, a thiol-containing tripeptide (glutamyl-cysteinyl-
glycine). Cysteine provides an exposed free sulphydryl group (SH) that is highly 
reactive, thus providing a target for H2O2 attack. The reaction oxidizes glutathione 
(GSSG). Glutathione peroxidases can also act on non-H2O2 peroxidases. For example, 
they catalyze GSH-dependent reduction of fatty acid hydroperoxides. The peroxide 
group is reduced to an alcohol (Brigelius-Flohé, 1999). 
Glutathione reductase converts GSSG back to GSH. Each of the two subunits 
contain FAD (Thieme et al., 1981). NADPH reduces the FAD, which passes its electrons 
onto a disulphide bridge. The two –SH groups then interact with GSSG and reduce it to 
2GSH, reforming the protein disulphide bridge. 
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CALCIUM 
Calcium function in neurons 
Normal neuronal action potentials and synaptic transmission is dependent upon 
calcium ions (Ca2+). Ca2+ is taken into neurons from the extracellular matrix by calcium 
channels such as voltage gated channels (VGCC), ligand gated channels (LGCC), and 
transient receptor potential ion channels (TRP) (Bezin et al., 2006;  Carafoli, 2004). 
VGCCs operate when the cell is depolarized by the influx of sodium (Na+) ions (Bear et 
al., 2001). Following depolarization, VGCCs open and allow Ca2+ to move down their 
concentration gradient and into the cytosol. LGCCs open in response to neurotransmitter 
binding (Kandel and Siegelbaum, 2000). TRP channels are activated primarily through 
signal transduction pathways. TRP channels are transported to the plasma membrane by 
the activity of phospholipase C and di-acyl glycerol (Clapham, 2003). 
In addition to action potential propagation and synaptic transmission, Ca2+ is a 
component of intracellular signaling pathways that initiate or control many cellular 
processes. In neurons, these processes include neurotransmitter release, excitability, 
neurite outgrowth, synaptogenesis, gene expression, cellular differentiation, plasticity, 
and cell death and survival (Pietrobon, 2002;  2005). 
 
Maintenance of calcium homeostasis 
Normally, intracellular free calcium (Ca2+) levels are around 0.1 µM or less. 
Total Ca2+ is greater, but most is sequestered within the mitochondria, the endoplasmic 
reticulum (ER) or bound to cytoplasmic proteins. Ca2+ concentration outside the cell is 
typically 1.5 mM (Berridge et al., 2000). Transient increases in free Ca2+ regulate many 
physiological processes, including cell proliferation and neurotransmitter release 
(Montell, 2005). However, uncontrolled rises in intracellular free Ca2+ can lead to cell 
injury or death (Dubin and Stoppani, 2000).  
Low intracellular Ca2+ levels are maintained by the coordinated activity of 
several systems: 1) plasma membrane ATP-dependent Ca2+ export proteins, 2) uptake of 
Ca2+ into the ER lumen, 3) uptake of Ca2+ by the nucleus, and 4) uptake of Ca2+ by 
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mitochondria, and 5) binding of Ca2+ to cytosolic calcium-binding proteins. A summary 
of the maintenance of Ca2+ homeostasis is shown in Fig I-21. 
 
 
FIG. I-21. Diagram of cellular Ca2+ homeostasis mechanisms. The membrane transporters of Ca2+ in the 
plasma membrane and in the organelles, as well as the Ca2+ sensor proteins that decipher the Ca2+ before 
passing it on to enzyme targets, are shown. The Ca2+ channel shown in the plasma membrane is 
representative of the three types - voltage-gated, ligand-gated, and store operated. Modified from Carafoli, 
E. (2004). Calcium-mediated cellular signals: a story of failures. Trends in Biochemical Sciences 29, 371-
379. 
 
 
Plasma membrane ATP-dependent Ca2+-export proteins function by energy from 
ATP that drives the Ca2+ out of the cell against its concentration gradient (Garcia and 
Strehler, 1999). Neurons also have Na+/Ca2+ exchange transporters. ATP hydrolysis 
links the export of Ca2+ to the entry of Na+ down its concentration gradient. Na+ is 
exported by the ATP-dependent sodium pump (Reuter and Porzig, 1995).  
The ER can sequester large amounts of Ca2+ and quickly release it. This is 
necessary because rapid intracellular Ca2+ mobilization from intracellular stores is 
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required for Ca2+ signaling (Meldolesi, 2001;  Meldolesi and Pozzan, 1998). 
Extracellular signalling molecules bind to cell surface receptors and lead to release of 
Ca2+ from the ER by stimulating synthesis of inositol triphosphate (IP3). This results in 
the opening of Ca2+ channels in the membrane of the ER, and Ca2+ is released into the 
cytosol (Venkatachalam et al., 2002). This surface receptor binding and subsequent Ca2+ 
release is called calcium induced Ca2+ release (CICR) (Berridge et al., 2000;  Carafoli, 
2004). Ca2+ enters the ER via ER Ca2+-ATPase (SERCA) pumps on the ER membrane 
(Carafoli, 2004). Once inside the ER, much of the Ca2+ becomes bound to calreticulin 
and calsequestrin. These CaBPs regulate the pool of free Ca2+ available for release upon 
stimulation (Meldolesi, 2001). 
Much of the nuclear Ca2+ uptake and release occurs in close association with the 
ER because the outer nuclear membrane is continuous with the ER membrane. Ca2+ in 
the ER is mobilized into the nucleus through IP3 receptors and RyRs in the nuclear 
envelope (Barbara, 2002; Hirose et al., 2008). Nuclei can also regulate Ca2+ independent 
of the SER. The ATP-dependent nuclear Ca2+-ATPase and the IP4-mediated inositol 
1,3,4,5-tetrakisphophate receptor transport cytosolic Ca2+ into the nucleus (Malviya and 
Klein, 2006). 
If intracellular Ca2+ levels increases so much that the ER can no longer transport 
the excess, the mitochondria become a second line of Ca2+ buffering (Gunter et al., 
2000;  Meldolesi, 2001). Mitochondria are biosensor of Ca2+ microdomains. They take 
up Ca2+ from high cytosolic Ca2+ areas near active Ca2+ channels in the plasma 
membrane. Mitochondria need a local Ca2+ concentration of at least 500 nM to begin to 
take up Ca2+ (Nicholls and Scott, 1980a;  Nicholls and Scott, 1980b). This allows a 
localized initiation of Ca2+ signaling, but prevents the newly entered Ca2+ from initiating 
Ca2+ signaling in all areas of the cell. This control over cytosolic Ca2+ signaling is 
necessary for regulation of compartmentalized cell functions (Alonso et al., 2006). 
The mitochondria have two Ca2+ uptake systems, the uniporter and the fast Ca2+ 
uptake. Ca2+ efflux is through two ion exchangers coupled with Na+ or H+ (Carafoli, 
1974;  Sparagna et al., 1995). The inner mitochondrial membrane has permeability 
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transition pores (PTP) that operate at two physiological states. The low conductance 
confirmation is involved in normal Ca2+ regulation through changes in the pH of the 
mitochondrial matrix (Davidson and Halestrap, 1990;  Ichas et al., 1994). The high 
conductance confirmation results in irreversible changes in the mitochondrial membrane 
potential. The outer membrane eventually ruptures and apoptosis signaling molecules are 
released into the cytosol (Ichas and Mazat, 1998; Scarlett and Murphy, 1997). 
Free Ca2+ within the cell can become bound to cytosolic calcium-binding proteins 
(CaBPs). One example is calmodulin (Klee and Means, 2002). Calmodulin regulates 
many enzymes, including calcineurin and nitric oxide synthase (Corti et al., 1999). It 
also regulates cellular processes such as cytoskeletal assembly (Rozenblum and Gimona, 
2008). Calmodulin is rich in methionine residues and is a potential target for oxidative 
damage. Other cytosolic calcium-binging proteins (CaBPs) include either Ca2+ sensors 
(calmodulin, caldendrin, and calneurons) or buffers (calretinin, calbindin, and 
parvalbumin) (Baimbridge et al., 1992;  Mikhaylova et al., 2006;  Seidenbecher et al., 
1998). 
 
Negative consequences of altered intracellular Ca2+ levels 
Oxidative stress can alter Ca2+ metabolism and cause a rise in free Ca2+. ROS can 
damage the ER-Ca2+ uptake system and interfere with Ca2+ efflux through the plasma 
membrane by oxidizing –SH groups within the transmembrane channels (Lehotsky et 
al., 2002). ROS may also cause voltage-gated Ca2+ channels in the plasma membrane to 
open and allow excess Ca2+ to enter the cell (Lehotsky et al., 2002). Negative 
consequences of excess intracellular free Ca2+ include disruption of the cytoskeleton, 
production of more ROS, and disruption of membrane organization.  
Polymerization and reorganization of actin, as well as its binding to focal 
adhesion sites for cell attachment are necessary for proper cell function. High 
intracellular Ca2+ activates calpains (proteinases) that cleave actin-binding proteins and 
cause the plasma membrane to separate from the cytoskeleton (Dourdin et al., 2001). 
High calpain activity has been implicated in diseases such as muscular dystrophy 
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(Bertipaglia and Carafoli, 2007) and Alzheimer’s disease (Raynaud and Marcilhac, 
2006).  
High free Ca2+ stimulates eNOS and nNOS (Duchen, 2000); their activity 
produces intermediates that ultimately cause the formation of superoxide (Baldelli et al., 
2008). One of the intermediates, nitric oxide (NO·), is toxic in high concentrations and 
inhibits cytochrome oxidase (Cooper et al., 2008). 
Phospholipase A2 is an enzyme that cleaves membrane phospholipids. It is 
stimulated by high Ca2+ levels. The production of excess free fatty acids and their 
hydrolysis products results in membrane disorganization (Vanlangenakker et al., 2008). 
In addition, transglutaminases are activated by Ca2+. These catalyze the crosslinking of 
proteins within membranes and produce insoluble aggregates (Shin et al., 2008). 
Finally, in the process of mitochondrial sequestration of Ca2+, the excess Ca2+ 
can trigger the mitochondrial permeability transition pore (MPT) in the inner membrane 
to open (Smaili and Russell, 1999). This causes a collapse in the membrane potential as 
well as the release of cytochrome C and apoptosis inducing factor (AIF) (Duchen, 2000), 
resulting in the death of the cell. 
 
NEUROTOXICOLOGY 
General overview 
The nervous system processes, stores, and transmits information. Biochemical 
and molecular events within the nervous system lead to conscious and unconscious 
actions or behavior. The nervous system is highly organized, but complex; this results in 
vulnerability to toxicant exposure. Cell types and functions, structural content, and 
energy consumption all play a role in the complexity and susceptibility of the nervous 
system to toxic effects. 
Cells within the nervous system are either neurons or glia. They each have a 
specific function, but also a specific relationship between each other. The maintenance 
of the relationship between the two cell types is necessary for normal function of the 
nervous system (Abbott et al., 1992;  LoPachin and Aschner, 1999). Although there are 
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basically only neurons and glia, the brain is heterogeneous in its cellular composition. 
The cells types and some of the specialized sub-populations of cells within the 
hippocampus and cerebellum have been discussed previously. These two brain regions 
alone provide examples of just how diverse and varied neuronal components may be. 
There are a number of enzyme systems involved in neurotransmitter production 
and maintenance that are unique to the nervous system, but vary from cell to cell 
depending on its function (i.e. nicotinic, muscarinic, cholinergic, dopaminergic 
functions). The German pathologist, Franz Nissl, observed that administration of 
particular agents consistently resulted in characteristic injury to neurons of defined areas 
of the brain (Lowndes et al., 1995). This became known as pathoclisis. Pathoclisis states 
that cells in particular regions of the brain, by virtue of unique biochemical or 
anatomical features, are vulnerable to intoxication by certain classes of xenobiotics and 
not by others. This is demonstrated by the vulnerability of dopaminergic neurons in the 
pars compacta of the substantia nigra to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine 
(MPTP) (Langston et al., 1984). 
The nervous system relies on aerobic glucose metabolism for energy production 
and has a very high metabolic rate. Twenty percent of the oxygen consumed by the body 
and 15 % of the total cardiac output are used to support the brain that is only 1.5 to 2 % 
of total body weight (Heiss, 1981). Therefore, toxicants that disrupt glucose metabolism 
and mitochondrial function may significantly affect the nervous system (Nichlas, 1992). 
The brain has low-levels of antioxidants and is highly composed of polyunsaturated fatty 
acids. This, along with the high metabolic rate, increases the possibility of oxidative 
damage (Evans, 1993) upon exposure to certain toxicant.  
 
Xenobiotic metabolism in the brain 
Metabolization of xenobiotics occurs primarily by phase I (biotransformation) 
and phase II (conjugation) enzyme processes. These phases usually result in 
detoxification and excretion; however, formation of toxic intermediates or products is 
possible. Phase I metabolism is achieved by monooxygenation, dealkylation, reduction, 
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aromatization, or hydrolysis. The important enzymes are the cytochrome P-450s and the 
mixed-function oxygenases. Phase II metabolism involves glucuronyltransferases, 
sulfotransferases, methyl- and acetyltransferases, and glutathione S-transferases 
(Parkinson, 2001). Neither Phase I, nor Phase II, enzymes are located homogeneously 
throughout the brain. Cytochrome P450s (Volk et al., 1991) and glutathione S-
transferases (Philbert et al., 1991;  Slivka et al., 1987) are found primarily in the 
neuropil, not in neurons, the exception being the olfactory bulb dorsal root ganglia, and 
Purkinje and cerebellar granule neurons in mice (Philbert et al., 1991;  Slivka et al., 
1987). Sulfotransferases are located primarily in catecholaminergic neurons such as 
those in the human hippocampal pyramidal and nonpyramidal neurons of CA2 and CA3 
(Zou et al., 1990). In the rat, methyltransferases are important in the metabolism of 
adrenergic neurotransmitters (Acquas et al., 1992;  Moghrabi et al., 1992), while 
acetyltransferases are important in the formation of neurotransmitters (Saji and Miura, 
1991); these enzymes, therefore, are located in neurons with neurotransmitter function. 
 
Blood-brain barrier 
A protective component of the central nervous system (CNS) is the blood-brain 
barrier (BBB). The BBB is not an absolute barrier to the passage of toxic agent into the 
CNS. Instead, it is a site of limited permeability compared to other areas of the body. 
There are four major anatomic and physiologic reasons some toxicants do not readily 
enter the CNS (Rozman and Klaassen, 2001). First, capillary endothelial cells of the 
CNS are continuous and contain tight junctions (Fig I-22). There are few or no pores 
between the cells. However, water, gases, and lipid-soluble molecules can diffuse across 
endothelial cells. Second, the endothelial cells contain ATP-dependent transporters. The 
endothelial cells have relatively few pinocytotic vesicles, and vesicular traffic is almost 
completely restricted to receptor-mediated transport (Gartner and Hiatt, 1997). The 
multi-drug-resistant (mdr) protein exudes some chemicals back into the blood (Schinkel 
et al., 1994). Ions are also transported across the blood-brain barrier through ion 
channels via active transport. Molecules, such as glucose, amino acids, certain vitamins, 
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and nucleosides, are transferred across the BBB by specific carrier proteins (Gartner and 
Hiatt, 1997). Third, the capillaries in the CNS are surrounded by protoplasmic astrocyte 
processes (end-feet). The end-feet cover neurons, the inner surface of the pia, and every 
blood vessel within the CNS (Fig I-23). Lipid-soluble compounds must traverse the 
membranes of the endothelial cells as well as those of the astrocyte end-feet (Rozman 
and Klaassen, 2001). For small to medium-sized water-soluble molecules, the tight 
junctions of the capillary endothelium and the lipid membranes of the glial cell processes 
are major barriers. Fourth, the protein concentration in the interstitial fluid of the CNS is 
much lower than that in other body fluids. This greatly limits the movement of water-
insoluble compounds by paracellular transport, which is possible in a largely aqueous 
medium only when such compounds are bound to proteins (Rozman and Klaassen, 
2001). 
 
 
 
FIG. I-22. Schematic of the tight junctions of the blood-brain barrier. The CNS capillaries are lined by 
continuous endothelial cell linked by tight junctions. The basal lamina and the astrocytic perivascular end-
feet are also components of the blood-brain barrier. Modified from Kierszenbaum, A. L. (2002). Histology 
and Cell Biology: An Introduction to Pathology. p. 208. St. Louis, Mosby Inc. 
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FIG. I-23. Schematic of the blood-brain barrier. Protoplasmic astrocytes in the CNS have cytoplasmic 
processes with end-feet. The end-feet cover neurons, the inner surface of the pia mater, and the blood 
vessels. The joined end-feet processes adjacent to the pia mater form the glia limitans. Modified from 
Kierszenbaum, A. L. (2002). Histology and Cell Biology: An Introduction to Pathology. p. 208. St. Louis. 
Mosby, Inc. 
 
 
The effectiveness of the BBB varies from one brain region to another. The 
cortex, lateral nuclei of the hypothalamus, pineal gland, and posterior lobe of pituitary 
are more permeable than other areas of the brain. This may be due to the increased blood 
supply in these areas, a more permeable barrier, or both. In general, however, only the 
non-protein-bound portion of a toxicant equilibrates rapidly with the brain (Rozman and 
Klaassen, 2001). Increased lipid solubility increases the rate of penetration of toxicant, 
whereas ionization decreases it. Some xenobiotics may enter the brain by carrier-
mediated processes. Methylmercury combines with cysteine, forming a structure similar 
to methionine, and is accepted by the large neutral amino acid carrier of the capillary 
endothelial cells (Clarkson, 1987). 
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DEVELOPMENTAL NEUROTOXICOLOGY 
General overview 
Exposure of the developing nervous system to toxicants may have a subtle or a 
profound affect. Development is characterized by changes in size, biochemistry, 
physiology, form, and function. These changes are orchestrated by factors that regulate 
the maternal transcription of genes and translation of proteins, which activate regulatory 
genes in the embryo, followed by sequential gene activation throughout development. 
Intercellular and intracellular signaling pathways, essential for normal development, rely 
on transcriptional, translational, and posttranslational controls. Toxicant exposure may 
result in alterations at any point in the developmental sequence leading to a life time of 
consequences for the individual as well as for the general public.  
The nervous system is important for coordinating motor and cognitive functions, 
therefore, toxicants that alter normal functions may cause impairment in muscular 
movement, senses, learning and memory. Alterations of chemical properties and 
physiology of neurons and glia during development can impair the intracellular 
environment, leading to structural abnormalities such as changes in neuron morphology 
and the intra- and extracellular environments. 
Several chemicals are known to be neurotoxic, especially for the developing 
nervous system. In children, lead exposure causes psychological deficits and learning 
disabilities (Davis et al., 1990;  Hansen et al., 1989;  Winneke et al., 1990). 
Polychlorinated biphenyl (PCB) causes low birth weights, hyperactivity, and altered 
visual recognition memory (Kimbrough, 1995;  Tilson et al., 1990). Substances of abuse, 
such as nicotine (Fried et al., 1999;  Jones, 1973;  Strauss, 1997), ethanol (Driscoll et al., 
1990), and cocaine (Chiriboga, 1998) are also developmentally neurotoxic. They cause 
decreased head circumference, delays in fine motor skills and speech development, 
increased impulsivity, and hypertonic tetraparesis. In addition to environmental 
toxicants, chemicals such as the prescription drug isotretinoin (Accutane) (Adams and 
Lammer, 1993) and thalidomide (McBride, 1961) are known to be neurotoxic These 
chemicals are toxic to the developing animal, as opposed to the adult animal, likely 
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because of the unique processes that occur during growth and development. Neuronal 
cell proliferation and subsequent migration, differentiation (including neurite outgrowth 
and formation of dendritic spines) and maturation are events that must be appropriately 
timed and occur with precision. Any alteration at any point along this path may have 
negative consequences to the developing nervous system. 
 
Causes of increased susceptibility to toxicants 
As previously mentioned, the brain and nervous system have a high metabolic 
rate. This is particularly true for the developing nervous system. In late gestation, there is 
an increase in respiration (Nakai et al., 2000) that is accompanied by an increase in 
mitochondrial proliferation (Stewart and Hayakawa, 1994). Just following parturition, 
there is a second increase in respiration that is associated with maturation of the 
mitochondria and the production of high energy phosphates necessary for fetal 
adaptation to birth (Nakai et al., 2000). As with the adult animal, toxicants that disrupt 
energy production and mitochondrial function may be toxic to the nervous system. 
The BBB is not fully developed at birth; therefore, some chemicals are more 
toxic in newborns than to adults. Morphine is three to ten times more toxic to newborns 
than to adult rats because of the non-developed BBB (Kupferberg and Way, 1963). Lead 
produces encephalomyelopathy in newborn rats but not in adults, apparently because of 
differences in the stages of development of the BBB (Pentschew and Garro, 1966). 
The placenta provides nutrition for the conceptus, exchanges maternal and fetal 
blood gases, disposes of fetal excretory material, and maintains pregnancy through 
complex hormonal regulation. Most of the vital nutrients necessary for the development 
of the fetus are transported by active transport systems. Vitamins, amino acids, essential 
sugars, and ions such as calcium and iron are transported from mother to fetus against a 
concentration gradient (Ginsburg, 1971). In contrast, most toxicants cross the placenta 
by passive diffusion.  
The placenta contains active transport systems that protect the fetus from some 
xenobiotics. Multi-drug-resistant null (mdr null) fetuses are more susceptible to cleft 
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palate produced by avermectin (Lankas et al., 1998). The placenta also has some 
biotransformation capabilities that may prevent some toxic substances from reaching the 
fetus (Juchau, 1972). As in the brain, increased lipid-solubility increased the rate at 
which a toxicant will enter the placenta. Under steady-state conditions, the 
concentrations of a toxic compound in the plasma of the mother and fetus are similar. An 
increase in the concentration a toxicant in the fetus compared to the mother depends on 
the ability of the fetus to concentrate the toxicant. For example, the concentration of 
diphenylhydantoin in the plasma of fetal goats was about half that in the mother, most 
like due to the differences in plasma protein concentration and the binding affinity of 
diphenylhydantoin to plasma proteins in the fetus (Shoeman et al., 1972). Different body 
compositions between mother and fetus may be another reason for differences in 
toxicant concentration. For example, fetuses have very little fat; therefore lipophilic 
chemicals such as TCDD accumulate at higher concentrations in the mother than the 
fetus (Li et al., 1995). In contrast, higher concentration of toxicants such as 
methylmercury may be found in the fetus compared to the mother because of the 
immature BBB (Null et al., 1973;  Reynolds and Pitkin, 1975). 
 
ARTIFACTS OF CELL CULTURE 
 Cell culture studies have given much valuable information about mechanisms of 
metabolism and signal transduction and of regulation of gene expression, proliferation, 
senescence, and death (Halliwell, 2003). However, cells in culture may behave 
differently from cells in vivo in many ways. Artifacts can affect the interpretation of cell 
culture studies. The process of cell culture imposes a state of oxidative stress on cells. 
The culture media can catalyze the oxidation of added compounds, resulting in an 
observed cellular effect that may in fact be due to ROS produced by the culture media 
(Halliwell, 2003). Culture media are often deficient in antioxidants (vitamins C and E) 
and antioxidant precursors (selenium) and contain “free” metal ions, present as 
contaminants or even added deliberately iron (III) salts are added to Dulbecco’s 
modified Eagle’s medium). These may present a problem in appropriate interpretation of 
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studies involving metal exposure, or studies that may be affected by the presence or 
absence of antioxidants (ROS studies). 
Most animal cells are cultured as a monolayer under 95% air:5% CO2 (152 
mmHg); they are also in a hyperoxic environment, which is likely to increase their rates 
of ROS formation (de Groot and Littauer, 1989). One study showed the intracellular 
partial pressure of oxygen (pO2) of cultured lung endothelial cells to be 140 mmHg 
(Kutala et al., 2004). This measurement is significantly higher than physiological levels. 
Studies involving the production of ROS may be affected by the environmental O2 levels 
and again, by the antioxidant status of the system. 
Other problems in cell culture studies include the use of proteinases such as 
trypsin in subculturing and the lack of growth factors, hormones and influences of 
surrounding cells. Proteinases can alter membrane permeability (Averdunk, 1970) and 
the proteins involved in adherence of the cells to a surface (Tiruppathi et al., 2002). 
Changes in these proteins often initiate intracellular signalling (Tiruppathi et al., 2002) 
of processes within the cell that may affect the results of the parameters being examined. 
Environmental factors affect the function of all cells. Neurons in culture are often 
delicate, but in the brain, glia help to protect them (Dhandapani and Brann, 2002). 
One must examine potential reactions of compounds with the culture medium, be 
aware of the absence or presence of compounds that might confound interpretation, and 
set up adequate controls to mitigate such problems, even when a potential confounding 
factor cannot be identified. It is essential to be cautious when interpreting data on cells in 
culture. In addition, whenever possible, one must use a combination of cell culture 
experimentation in tandem with in vivo studies to enhance the validity of the results 
observed in a culture system. 
 
MERCURY 
Historical perspective 
Mercury (Hg) is a ubiquitous and hazardous environmental contaminant found in 
ocean and freshwater fishes, shellfish, and plants (Hall and St. Louis, 2004;  Mikac et 
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al., 1985;  Westoo, 1973). The organic or methylated form of Hg, methylmercury 
(MeHg), accounts for most of the Hg to which humans are exposed and is known to have 
serious neurotoxic effects on both the developing and mature central nervous system 
(CNS) (Miura, 1998;  Spurgeon, 2006). 
Historically, MeHg toxicity has been associated with high morbidity and 
mortality rates. In 1865, George Edwards wrote the first case report on MeHg poisoning. 
It was not until 1940, that Hunter et al. published the first detailed account of four men 
exposed to MeHg during the manufacturing of seed fungicide. Their symptoms began 3 
to 4 months following initial exposure to MeHg and continued to progress after exposure 
cessation. Initial symptoms were paresthesia of the extremities, followed by ataxia of 
gate, dysarthria, and impaired peripheral vision. The cardinal signs were constricted 
visual fields, ataxia, dysarthria, and sensory deficits such as stereognosis and impaired 
two-point discrimination in the extremities. This array of symptoms became known as 
Hunter-Russell syndrome (Hunter and Russell, 1954). 
In Japan, in May 1956, the first mass outbreak of MeHg poisoning occurred in 
Minamata City, located in the southwest region of Kyushu Island. Residents in the 
Minamata Bay area began to notice phenomena such as birds falling from the sky while 
in flights and fish rotating continuously or floating upside down. Cats exhibited 
excessive salivation, convulsions, violent rotation movements and abnormal gait, 
followed by death. Some cats appeared frenzied and would jump into the sea to their 
death. The symptoms observed in cats were instrumental in determining the etiology of 
the disease (Harada, 1995). 
The source of the epidemic was traced to the Chisso Corporation’s factory that 
used inorganic mercury compounds as a catalyst to synthesize acetaldehyde. The 
resulting 81.3 tons of waste methylmercury chloride (Irukayama et al., 1977) was 
released into Minamata Bay with the factory’s wastewater, where it bioaccumulated in 
the fish and was consumed by humans in the area (Clarkson, 2002). Between April and 
December 1956, 50 cases of Hunter-Russell syndrome were diagnosed. By October 
1960, 111 cases were known, and by December 1965, 37 % of those diagnosed had died. 
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In the Minamata Bay area, over 1700 cases had been recognized by 1981 (Tokuomi et 
al., 1982). Hunter-Russell syndrome is now known as Minamata disease.  
A second outbreak of MeHg poisoning occurred in Niigata, Japan in 1965, this 
time, due to consumption of contaminated fish from the industrial contamination of the 
Agano River. By 1974, there were 520 recognized cases (Tsubaki and Irukayama, 1977). 
Around the same time, during the winter of 1971 – 1972, Minamata disease was 
identified in Iraq. Planting-wheat treated with MeHg was given, for free, to farmers 
throughout the country. Instead of planting the wheat, they washed out the red dye, 
ground it into flour, and used it to make bread. Over 6500 individuals were diagnosed 
with MeHg poisoning, and over 450 of those died (Bakir et al., 1973). 
The most common initial symptoms were paresthesia of the extremities, perioral 
paresthesia, constricted visual fields, ataxia of the limbs and gait, slow slurred speech 
that sometimes progressed to anarthria, deafness to high tones, and sensory deficits 
(Tokuomi, 1960). In addition to the sensory impairments described by Hunter et al. 
(1940), MeHg toxicity victims in Japan experienced impairment of pain and touch 
sensation, called glove and stocking distribution. Less frequent symptoms included 
rigidity of the limbs with chorea or arthetosis, mental impairment, emotional lability, 
depression, and excessive sweating. The most severely affected individuals became 
comatose and died within a few months of onset of symptoms (Tsubaki and Irukayama, 
1977). 
  
Mercury in the environment 
Mercury comes from both natural and man-made sources. It is present in the 
earth’s crust and can be released into the air through weathering of rock containing Hg 
ore or volcanic eruption (WHO, 1990). Mercury is used in the electrical industry in the 
production of instruments such as thermometers and barometers, fluorescent tubes, and 
alkaline batteries. It is produced from smelters, combustion of fossil fuel, and from 
mining and gold refining. Large quantities are used in the chloralkali industry during the 
production of chlorine and caustic soda through the electrolysis of NaCl solutions. In 
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addition, dental amalgam filling contain mercury (WHO, 1991). Although mercury is 
ubiquitous, it has no beneficial biological function (Eisler, 2004). 
Although mercury exists in several forms (Hg0, Hg+, Hg2+, MeHg, Me2Hg), 
MeHg is the form that is most important in human exposure (Massaro, 1996). Mercury 
in the environment is constantly cycled in six major steps: 1) degassing of mercury from 
rock, soils, and surface water, or emission from volcanoes and from human activities, 2) 
movement in gaseous form through the atmosphere, 3) deposition of mercury on land 
and into surface waters, 4) conversion of the element into insoluble mercury sulfide, 5) 
precipitation or bioconversion into more volatile or soluble forms such as 
methylmercury, and 6) re-entry into the atmosphere or bioaccumulation in food chains 
(Fig I-24). Mercury vapor is a very stable gas with approximate residence time of one 
year in the atmosphere. Therefore, mercury can be globally distributed from point 
sources to remote regions of the planet (Clarkson, 2002). Sulfate-reducing bacteria in 
aquatic environments methylate inorganic and elemental Hg, creating methylmercury 
(MeHg) (Heyes et al., 2006;  Sunderland et al., 2006). MeHg enters marine animals and 
is passed up the food chain. Most marine fish contain less than 0.5 ppm, but sharks, 
sailfish, and marlin may have over 1 ppm MeHg (Matthews, 1983). Fish from Minamata 
Bay were reported to contain up to 40 ppm (Myers and Davidson, 1998). Contaminated 
areas in Canada have fish with over 10 ppm (Harada et al., 1976). Individuals that eat 
fish regularly can have hair mercury levels up to 30 ppm or higher (Turner et al., 1980). 
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FIG. I-24. Biological mercury cycling. Natural and human activities release mercury vapor into the 
environment. Elemental mercury vapor undergoes photochemcial oxidation to become inorganic mercury 
that combines with water vapor and travels back to the earth's surface as rain. In water, inorganic mercury 
is converted into insoluble mercury sulfide, which is deposited into sediment where it is converted to 
methylmercury by sulfate reducing bacteria. Methylmercury adsorbs to plankton, which are consumed by 
higher organisms in the food chain. This pattern continues into small fish and progressively bigger fish, 
then finally humans. Image by Messenger, L. (1996). 
http://people.uwec.edu/piercech/Hg/mercury_water/cycling.htm 
 
 
Absorption, distribution, and excretion 
MeHg in the human diet is taken up by the gastrointestinal (GI) tract and rapidly 
enters the bloodstream (WHO, 1990). About 95% is distributed throughout the body 
over the next three to four days (Aberg et al., 1969). Blood contains 5% of the absorbed 
MeHg, and more than 90% of that is attached to hemoglobin (Kershaw et al., 1980). 
MeHg is metabolized at the rate of 1% of the body burden per day (Clarkson, 2002). The 
whole body half-life of MeHg in the human is 72 days (Aberg et al., 1969), and 7.4 days 
in the mouse (Kostyniak, 1980). MeHg dissociates to some degree into the inorganic 
ionic form of Hg2+. In rats, of total MeHg consumed, the percentage of inorganic Hg2+ in 
the total amount of mercury is approximately 4% in blood, 3% in the brain, 6% in the 
liver, and 12 to 46% in the kidneys (Magos et al., 1976;  Magos and Butler, 1976). 
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MeHg is excreted from the body in the feces and bile. Of the total mercury excreted, 
90% is in the form of MeHg in feces, and 10% is in the form of Hg2+ in urine. 
MeHg easily crosses the blood-brain barrier; about 10% of the MeHg absorbed 
through the GI tract accumulates within the brain. Studies in rodents indicate that MeHg 
is transported as a MeHg-L-Cysteine complex across the blood-brain barrier by a leucine 
preferring amino acid transporter (Aschner et al., 1991; Kerper et al., 1992). Formation 
of a MeHg-glutathione complex is another possible mechanism of MeHg transport into 
the brain (Fujiyama et al., 1994). Once in the brain, MeHg is slowly demethylated to the 
inorganic (Hg2+) form and becomes permanently trapped within the CNS. 
MeHg is not homogeneously distributed throughout the brain, neither is it 
consistently distributed. One study in rats showed a higher concentration in the 
cerebellum than the cerebral cortex (Magos et al., 1981); however, other studies have 
shown no difference in MeHg levels in different regions of the brain (Somjen et al., 
1973b). In guinea pigs, the concentration in the cerebellum was lower than in the 
cerebral cortex (Komsta-Szumska et al., 1983). In macaques, the corpus callosum had 
the highest concentration of MeHg in the cerebrum, and the dentate nucleus had the 
highest concentration in the cerebellum (Evans et al., 1977). 
Total mercury levels in the body can be measured using hair samples and 
standard cold-vapor analytical techniques. Hair samples taken from victims of Minamata 
disease within two months of onset of symptoms (1956) contained mean total mercury 
levels of 280 – 700 µg/g. By 1968, hair samples from symptomatic individuals contained 
10.5 µg/g total mercury and 7.1 µg/g as methylmercury. Again in 1968, the mean value 
for total mercury in the hair of individuals from the Minamata area with high fish 
consumption was 9.4 µg/g, whereas the total mercury in the hair of individuals eating 
small quantities of fish was 7.8 µg/g. The mercury content in hair was higher in males 
than in females, and higher in persons above 15 years of age, than below (Irukayama et 
al., 1977). Mercury content was also measured in some autopsy cases of individuals that 
died within ninety days of exposure. Brain mercury levels in these individuals were 5 – 
25 µg/g. The level was 2 µg/g in the brains of individuals that died after two years after 
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exposure (Irukayama et al., 1977). Current detection limits for assessing mercury hair 
levels are 0.01 – 0.04 ppm (Gaggi et al., 1996;  Lopez-Artiguez et al., 1994).  
Populations with little or no fish consumption had hair mercury levels of 0.2 – 0.8 ppm 
(Grandjean et al., 1992b;  Smith et al., 1997). In the Seychelles and Faroe Islands, mean 
levels of mercury in the hair were 6.8 and 4.8 ppm respectively (Cernichiari et al., 
1995b;  Grandjean et al., 1992b). 
The present detection limits for total Hg in the blood is 0.1 – 0.3 ppb (Grandjean 
et al., 1992b;  Mahaffey and Mergler, 1998). In modern non-fish or limited fish-eating 
populations, the mean total mercury level in blood is 2 ppb (Brune et al., 1991), while 
the mean total mercury blood levels in high fish-eating populations, such as in the Faroe 
Islands, is 24 ppb (Grandjean et al., 1992b). 
In addition to crossing the blood-brain barrier, MeHg easily crosses the placental 
barrier in the developing fetus. Methylmercury is easily transported from maternal blood 
into the fetus. MeHg has a higher affinity for fetal hemoglobin than adult hemoglobin 
and therefore accumulates in the fetus at 25% higher concentration than in the mother 
(Amin-Zaki et al., 1976). In rats (Null et al., 1973) and mice (Satoh and Suzuki, 1983), 
the MeHg concentration was higher in fetal brains than in maternal brains at fetal non-
lethal exposure levels. A significant amount of MeHg crosses the placentas of humans as 
well. High concentrations of MeHg were found in fetal livers and placentas of 
individuals in the Japanese (Marsh et al., 1977) and Iraqi (Magos et al., 1976) 
poisonings. Fetal brain mercury levels have been shown to be as much as 5 – 7 times 
higher than the maternal blood (Cernichiari et al., 1995a). 
Infants and newborn animals may also be exposed to MeHg during lactation. 
MeHg elimination in mice (Greenwood et al., 1978) is accelerated during lactation. 
Similarly, lactation decreased the biological half-life from sixty-six days to forty-five 
days in breast-feeding females poisoned in Iraq (Greenwood et al., 1978).  
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Pathology and clinical signs 
Adults 
The major target of MeHg is the CNS in both adult and developing organisms; 
however, the toxic effects and possibly the mechanism of action differ somewhat 
between the two (Bakir et al., 1980;  Counter and Buchanan, 2004). Clinical signs of 
MeHg exposure in adults in Minamata included concentric constriction of visual fields, 
sensory disturbances, ataxia, dysarthria, auditory disturbances and tremors (Harada, 
1995). Patients with chronic Minamata disease were categorized into one of three 
groups: 1) gradually progressive, 2) delayed onset, and 3) escalating or progressive with 
aging. Pathological changes included loss of neurons in the cerebral and cerebellar 
cortices. The visual, motor, sensory, and auditory cortices were the areas of the cerebral 
cortex that were most affected. Granule cells were the most affected target in the 
cerebellum (Harada, 1995;  Takeuchi et al., 1962;  Tokuomi, 1960). Although the CNS 
is the primary target, the peripheral nervous system (PNS) is also affected in adults. 
Damage and demyelination of the dorsal root and sensory nerve fiber have been 
observed in the PNS (Takeuchi et al., 1962).  
Similar symptoms and pathology were observed in individuals exposed to MeHg 
in Iraq. Numbness in the extremities and perioral area were the first symptoms observed. 
Some individuals developed symptoms immediately following the consumption of the 
contaminated bread, while others developed symptoms weeks (16 – 38 days) to months 
(60 days) later. The severity of symptoms and the delay of onset were correlated with the 
level of MeHg exposure. Short exposure times resulted in numbness and paresthesia 
only. Long-term exposure resulted in ataxia, constriction of visual fields, slurred speech, 
and hearing difficulties (Bakir et al., 1973; Clarkson et al., 1976). 
 
Children 
In Japan and Iraq, children exposed to high levels of MeHg in utero or during 
early childhood exhibited symptoms such as congenital cerebral palsy, mental 
retardation, primitive reflexes, cerebellar ataxia, disturbances in physical development 
  
67
and nutrition, dysarthria, deformed limbs, hyperkinesias, hypersalivation, and strabismus 
(Amin-Zaki et al., 1976;  Bakir et al., 1973;  Harada, 1977;  Takeuchi et al., 1979;  
Tsubaki and Irukayama, 1977). The mothers of affected newborns suffered very mild 
levels of sensory disturbances, ataxia, limb pain constriction of visual fields and tremors 
(Harada, 1995). Hair samples from the mothers in Minamata analyzed five to eight years 
following initial exposure indicated 1.82 – 191 ppm of mercury, whereas, their 
children’s hair samples indicated 5.25 – 110 ppm. Pathological findings upon autopsy of 
children exposed to MeHg in utero included atrophy and hypoplasia of the cortex, 
abnormal cytoarchitecture, hypoplasia of the corpus callosum, and dysmyelination of the 
pyramidal tract (Matsumoto et al., 1965). 
 
Mechanisms of toxicity 
Mercury and its compounds have an affinity for sulfur and sulphydryl groups. 
Mercury-containing molecules can bind to sulphydryl-rich proteins during translation, or 
in enzymes or membranes. This binding may constitute a general mechanism of mercury 
toxicity. Specific hypotheses for the mechanism of methylmercury toxicity include: 1) 
disturbances of protein and nucleic acid synthesis, 2) aberrant post-translational protein 
modification, 3) disturbance of Ca2+ homeostasis, and 4) oxidative injury. 
Disruption of protein synthesis may be an early indication of MeHg toxicity 
(Verity et al., 1977;  Yoshino et al., 1966). Cerebral and cerebellar slices from rats 
exposed to MeHg in vivo showed decreased incorporation of [14C] leucine prior to the 
appearance of neurological symptoms (Verity et al., 1977;  Yoshino et al., 1966). 
Similarly, decreased incorporation of [14C] leucine was observed in rat brain slices and 
synaptosomes exposed to MeHg in culture (Verity et al., 1975). Sarafian et al. (1984) 
showed a decrease in protein synthesis in 50% of isolated neonatal cerebellar cells 
exposed to 14 µM MeHg. The protein synthesis inhibition occurred independent of RNA 
synthesis, mitochondrial function, and ATP content. They suggested that the inhibition 
was due to direct interaction of MeHg with the protein synthetic machinery. MeHg has a 
high affinity for thiol or sulphydryl (-SH) groups and will form complexes with –SH-
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rich compounds, such as the amino acid cysteine. The methylmercury-cysteine complex 
resembles the amino acid methionine, which is important in the initiation of polypeptide 
chains (Fig I-25) (Clarkson, 1987). The substitution of the MeHg-cysteine complex with 
methionine may disrupt translation. 
 
 
FIG. I-25. Comparison of the methylmercury-cysteine complex structure to methionine. The MeHg-
cysteine and methionine structures are similar and could result in the MeHg-cysteine complex mimicking 
and competing with methionine. 
 
 
MeHg inhibits DNA and RNA synthesis as well (Brubaker et al., 1973;  Chang 
and Hartmann, 1972;  Syversen, 1982). In contrast to the progressive inhibition of DNA 
synthesis observed with MeHg, Hg2+ has been shown to stimulate DNA synthesis prior 
to the onset of inhibition (Nakada and Imura, 1980).  
Studies have revealed that inhibition of DNA, RNA, and protein synthesis, both 
in vivo and in vitro, are mediated by at least three separate, possible mechanisms. There 
is MeHg-inhibition of protein synthesis associated with: 1) selective inhibition of the 
activities of one or more aminoacyl-tRNA synthetases (post-transcriptional 
modification) (Cheung and Verity, 1985; Hasegawa et al., 1988); 2) reduction of the 
ATP/ADP ratio (mitochondrial involvement) (Kuznetsov and Richter, 1987;  Kuznetsov 
et al., 1987); and 3) formation of a complex that can block or interfere with protein 
synthesis (binding to –SH groups).   
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Other possibilities of MeHg alterations in post-transcriptional or translational 
modification have been studied. MeHg (3.0 µM) has been shown to enhance 
phosphorylation of proteins in cultured cerebellar granule neurons by 300 – 500% after 
twenty-four hours of exposure (Sarafian and Verity, 1990). However, 1.0 and 5.0 µM 
MeHg inhibits phosphorylation of intermediate filament proteins in rat cerebral cortex 
slices. This inhibition was ameliorated by application of 15 µM diselenide (Moretto et 
al., 2005). Data also indicate that MeHg affects the de-sialylation of neural cell adhesion 
molecules (NCAMs). NCAMs are molecules whose proper temporal and spatial 
expression is important during synaptic structuring in neurodevelopment. MeHg inhibits 
the conversion of embryonic NCAM to the adult form in the cerebella of neonatal mice 
treated for 4 days beginning at P1 (Reuhl et al., 1994). There is a failure of the 
embryonic NCAM to be de-sialylnated into the adult form. This failure may alter the 
stereotypic formation of neuronal contacts and could contribute to the behavioral and 
morphological disturbances observed following MeHg exposure during early 
development (Dey et al., 1999). In another study, the amount of detyrosinated tubulin 
and tubulin-tyrosine ligase in the cytosol of brain cells from rats treated with MeHg (10 
mg/kg/day, for 7 days) was decreased, suggesting that MeHg alters cellular activities 
associated with the tyrosination status of the tubulin (Ishida et al., 1997). Other studies 
have also indicated a connection between MeHg and tyrosination of tubulin (Falconer et 
al., 1994;  Graff et al., 1997). 
Several studies have implicated MeHg in microtubule disruption. MeHg binds to 
the tubulin dimer SH-groups and depolymerizes the cytoplasmic microtubules, or 
inhibits their polymerization in mouse glioma cells and fibroblasts (Miura et al., 1984;  
Sager et al., 1983), resulting in mitotic arrest (Miura et al., 1978; Sager, 1988). Similar 
findings were demonstrated in the developing rat brain (Rodier et al., 1984;  Sager et al., 
1984). In addition, tubulin mRNA and protein levels were decreased in mouse glioma 
cells exposed to 5.0 µM MeHg for three hours. This concentration completely 
depolymerized the tubules. It is thought that the disruption of the microtubules by MeHg 
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resulted in the inhibition of the synthesis of tubulin itself through autoregulatory 
repression in post-transcriptional processes (Miura et al., 1998). 
A number of studies have shown that MeHg alters intracellular calcium ion 
(Ca2+) homeostasis. Studies show that MeHg interacts with voltage-dependent Ca2+ 
channel in the plasma membrane (Atchison, 1986;  Shafer et al., 1990). Uptake of 
extracellular Ca2+ into depolarized rat forebrain synaptosomes through voltage-
dependent Ca2+ channels was depressed by MeHg (70% at 200 µM) and Hg2+ (5% at 200 
µM) (Atchison et al., 1986). In addition, low-micromolar concentrations of MeHg (0.25 
– 1 µM) reduced the amplitude of the current in depolarized cultured neonatal cerebellar 
granule cells. This reduction was attenuated with the application of various Ca2+ channel 
antagonists, indicating that the alteration in current amplitude was a result of MeHg 
interaction with the Ca2+ channels (Sirois and Atchison, 2000). Later, it was shown that 
incubation of rat cerebellar granule cells with 0.2 – 5.0 µM MeHg produced an increase 
in the intracellular Ca2+ levels, which could be blocked only through nifedipine- and 
omega-conotoxin-MVIIC-sensitive pathways, suggesting that L-, N-, and P/Q-type Ca2+ 
channels were involved in entry or mode of action of MeHg (Marty and Atchison, 1997). 
MeHg is known to cause release of acetylcholine in the neuromuscular junction 
(Levesque and Atchison, 1987). This release is thought to be a result of an increase in 
the free Ca2+ within the cell, most likely from mitochondria (Alnaes and Rahamimoff, 
1975), smooth endoplasmic reticulum (ER) (Blaustein et al., 1978), influx of 
extracellular Ca2+ (Kirischuk et al., 1996), or the decreased export of intracellular free 
Ca2+ across the plasma membrane (Garcia and Strehler, 1999). Studies suggest that the 
mitochondria, instead of the ER are a probable source because ruthenium red, which 
blocks mitochondrial transport of Ca2+ via the uptake uniport protein, and N,N-bis (3,4-
dimethoxyphenylethyl)-N-methylamine, which inhibits mitochondrial release of Ca2+ 
were more effective at blocking MeHg induced acetylcholine release than inhibitors that 
block the release of Ca2+ from ER (Levesque and Atchison, 1987). Supporting this 
evidence is a study showing that MeHg blocks the uptake and increases the release of 
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Ca2+ from isolated mitochondria at the same concentrations (10 – 20 µM) that result in 
spontaneous acetylcholine release from whole neurons (Levesque and Atchison, 1991).  
MeHg concentrations of 30 µM cause a moderate increase in intracellular Ca2+ 
levels, inhibit respiration, and cause partial depolarization of the mitochondrial 
membrane potential in guinea pig cerebral cortical synaptosomes (Kauppinen et al., 
1989). Marty and Atchison (1998) showed that 0.5 µM MeHg application for forty-five 
minutes to rat cerebellar granule cells resulted in decreased viability of the cells, which 
could be rescued by incubation with the Ca2+ chelator 1,2-bis(2-aminophenoxy)ethane-
N,N,N′,N′-tetraacetic acid tetrakis(acetoxymethyl)ester (BAPTA; 10 µM).  
Most of the Ca2+ associated changes that occur upon exposure to MeHg are also 
related to mitochondria. In addition to the studies previously mentioned, the 
mitochondria / MeHg relationship has been supported in other studies as well. Sone et 
al. (1977) showed that 10 to 50 nM concentrations of MeHg bind to mitochondrial 
proteins, inhibit oxidative phosphorylation, cause mitochondrial swelling, and dissipate 
the mitochondrial membrane potential in isolated mitochondria from rat livers. In 
neonatal rats receiving injections of MeHg (1.5 mg/kg) every forty-eight hours from 
postnatal (P) 2 to 50, mitochondria of cortical neurons were condensed, had disrupted 
cristae, and had accumulation of electron-dense material in the matrix. These 
observations are consistent with inhibition of mitochondrial respiration (O'Kusky, 1983). 
MeHg related decreases in the rate of respiration have been observed both in vitro, using 
synaptosomes from rats (Verity et al., 1975) and guinea pig slices (Fox et al., 1975) and 
in vivo in rats (Yoshino et al., 1966).  
More recently, MeHg has been implicated in the opening of the permeability 
transition pore (MTP) in the inner mitochondrial membrane. Dissipation of the 
mitochondrial membrane potential and opening of the mitochondrial transition pore were 
observed in cultured rat cerebellar granule cells at MeHg concentrations of 0.2 and 0.5 
µM. This effect was delayed by pretreatment of the cells with cyclosporine A (5 µM) 
(Limke and Atchison, 2002). Opening of the MTP results in the release of molecules < 
1.5 kDa, including proapoptotic cytochrome C, thus inducing cell death.  
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In contrast, MeHg (1.0 mg and 5.0 mg/kg) has been shown to decrease 
mitochondrial membrane potential and increase mitochondrial Ca2+ in acutely isolated 
cerebellar granule cells from adult mice exposed to MeHg in vivo. However, the changes 
in mitochondrial membrane potential and Ca2+ were not associated with increased cell 
death (Bellum et al., 2007a), but instead with a change in motor coordination and 
balance (Bellum et al., 2007b). The data from these studies imply that subcellular 
alterations and abnormal neuronal function resulting in behavioral changes may occur in 
the absence of cell death. 
Reactive oxygen species (ROS) are known to cause oxidative damage in cells. 
MeHg has been implicated in the elevation of ROS. MeHg induced increase in ROS 
have been observed in human monocytes (InSug et al., 1997), T-cells (Shenker et al., 
1998), and neurons from mice and rats (Ali et al., 1992). In addition, the antioxidant 
selenium has been shown to be protective against MeHg toxicity (Ganther, 1978;  
Ganther et al., 1972). MeHg stimulates the rate of ROS production in synaptosomal 
preparations from the cerebellum of rats and mice (LeBel et al., 1990). In HeLa cells, 
overexpression of the antioxidant Mn-SOD decreased the toxicity of MeHg (Naganuma 
et al., 1998). Increased levels of superoxide anion and hydrogen peroxide combined with 
reductions in the levels of antioxidants such as superoxide dismutase (SOD) and 
glutathione (GSH) have been observed in cellular fractions of mouse brains following 
exposure to MeHg (Yee and Choi, 1994). A study by Mori et al. (2007) that compared 
the oxygen consumption, ROS production rates, and antioxidant levels of the cerebrum, 
cerebellum, and liver of rats exposed to MeHg showed that in control animals, the 
cerebrum and cerebellum had higher mitochondrial oxygen consumption and ROS 
productions rates than the liver, and that glutathione peroxidase and superoxide 
dismutase activities were lower in the cerebrum and cerebellum than the liver. The 
cerebellum showed the highest oxygen consumption and ROS production rate and the 
lowest mitochondrial glutathione levels. In the MeHg treated rats, decreased oxygen 
consumption and increased ROS generation were observed in the cerebellum, but not the 
liver. Interestingly, this occurred in spite of the fact that the cerebellum contained lower 
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Hg levels than the liver. The metabolic activity and low defense system of the brain, 
specifically the cerebellum, may be a cause for the susceptibility of the CNS to MeHg 
toxicity. In addition, supplementation with succinate substrates increased ROS 
generation in the cerebellum. This suggests that oxidative stress might affect the 
complex II-III mediated pathway in the electron transport chain of the cerebellar 
mitochondria (Mori et al., 2007). 
Physiologically, changes in intracellular Ca2+, the production of ROS, and 
mitochondrial disruption are interrelated. MeHg has been shown to cause changes is 
each of these parameters individually. Some studies, however, have integrated the three. 
MeHg (5 µM) decreased mitochondrial function, increased cytosolic and mitochondrial 
Ca2+ concentrations, and increased ROS levels in rat striatal synaptosomes after thirty 
minutes of exposure (Dreiem and Seegal, 2007). In the same study, the antioxidant 
Trolox reduced ROS levels, but did not restore mitochondrial function. Similarly, in 
acutely isolated cerebellar granule cells from mice exposed to MeHg (1.0 µM and 5.0 
µM) in vivo, Bellum et al. (2007a) showed that these cells showed decreased 
mitochondrial membrane potential, increased mitochondrial Ca2+, and increased rate of 
ROS production. 
Mercury in the CNS interacts with many cellular components, exerting multiple 
actions at the same time, simultaneously inducing an array of damages and dysfunctions. 
There are many proposed mechanisms for methylmercury toxicity. Likely, there is not 
only one mechanism, but many (Fig I-26). The mechanism at work will depend on the 
exposure level, developmental stage of the organism, local neuronal environmental 
factors, the species of mercury, etc. Methylmercury is an insidious neurotoxicant with 
devastating consequence of exposure, and as such, requires complete and well thought 
out experimental attention. 
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FIG. I-26. Proposed mechanisms of methylmercury neurotoxicity. Modified from Chang, L. W. and 
Verity, M. A. (1995). Mercury neurotoxicity: Effects and mechanisms: in Handbook of Neurotoxicology 
(Chang, L. W. and Dyer, R. G. Eds.), p. 41. Marcel Kekker, Inc., New York. 
 
 
OBJECTIVE OF THIS DISSERTATION 
Exposures to chemicals in our environment and the resulting adverse 
consequences have become important topics of concern in the last century. Recently, 
concern over exposure to MeHg as a health problem has increased. Headlines in the 
media such as “Scientists study mercury in the Great Salt Lake: Source and danger of 
poison to birds, other wildlife remain a mystery” (MSNBC, 2008) and “Autism is linked 
to mercury poisoning” (Henderson, 2003), have brought the topic of mercury toxicity to 
the attention of the general public. Appropriate public awareness, toxicity prevention and 
amelioration of misplaced fear begin with basic scientific research followed by adequate 
education and subsequent appropriate action. 
Although many of the effects of MeHg exposure both in adults and during 
development are known, the mechanism(s) of toxicity are still unclear. Because it is 
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impossible to remove MeHg completely from any biological system, and the 
consumption of fish and associated omega-3 fatty acids are important to human nutrition 
and health (Domingo, 2007), it is necessary to investigate and understand the 
mechanisms of toxicity in order to control or minimize the adverse consequences of its 
exposure and accumulation in the central nervous system. 
Scientific literature suggests that mitochondria may be involved in the 
mechanism(s) of MeHg toxicity. The key function of mitochondria is to provide energy 
to eukaryotic cells by converting organic materials into adenosine triphosphate (ATP) to 
fuel cellular processes (Henze and Martin, 2003). In addition, mitochondria are involved 
in virtually every signaling cascade and metabolic process that has been described, as 
well as the synthesis and repair of DNA, RNA and proteins (McBride et al., 2006;  
Pedersen, 1999). Mitochondria are known to respond to calcium ions (Ca2+) and to 
contribute to the regulation of intracellular Ca2+ signaling (McBride et al., 2006). They 
can sequester intracellular Ca2+ to dampen or buffer potentially toxic increases of 
cytosolic Ca2+ (Chang and Reynolds, 2006;  Gunter, 1998;  Marty and Atchison, 1998). 
Conversely, mitochondria can be negatively affected by increased levels of cytosolic 
Ca2+ and initiate the death of the cell (Alberdi et al., 2005;  Levesque and Atchison, 
1991;  Sirois and Atchison, 2000). In addition, they are a major generator of reactive 
oxygen species (ROS). ROS production is an unavoidable by-product of ATP production 
that occurs through the electron transport chain located in the inner membrane of 
mitochondria (Alberdi et al., 2005;  Chang and Reynolds, 2006;  Lemasters et al., 1998). 
Overproduction of ROS results in cellular membrane and protein damage.  
The levels of MeHg exposure commonly used in both in vivo and in vitro 
laboratory experiments are significantly higher than those typically found in the blood of 
environmentally exposed humans. In addition, in vivo experiments, historically, have 
involved acute exposures via drinking water or intraperitoneal injection. We know 
however, that animals and humans are exposed to chronic levels of MeHg through the 
ingestion of food (Eto et al., 1999;  Futatsuka et al., 2000). Few studies have been 
conducted that focus on sub-lethal cellular effects of MeHg at chronic environmentally 
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relevant exposure levels with appropriate routes of exposure. Previous studies in our lab 
indicate that behavioral changes occur in adult animals exposed to low-levels of MeHg 
during gestation (Montgomery et al., 2008). Our studies suggest that MeHg can exert its 
toxic effects at low-levels as well as high. 
Many currently conducted mechanistic studies use immortalized or primary cell 
cultures. However, these types of cells may not function similarly to cells in vivo. Cell 
culture studies of both immortalized neuronal cell lines and primary cultured neurons 
have shown changes in mitochondrial function and in intracellular Ca2+ levels when cells 
are exposed to high concentrations of methylmercury (Allen et al., 2001;  Shanker and 
Aschner, 2001;  Soderstrom and Ebendal, 1995;  Wilke et al., 2003). These cells, when 
exposed to MeHg, may not behave the same way as neurons in vivo. As a result, the 
knowledge gained from these studies may not be applicable to the whole animal or to 
humans due to both the model systems and the MeHg concentrations used.  
Based on current literature we know that: 1) mitochondria, Ca2+, and ROS may be 
involved in MeHg toxicity, particularly at high MeHg concentrations; 2) there are few to 
no studies involving chronic low to moderate environmentally relevant concentrations of 
MeHg exposure; 3) there are few to no studies that provide side-by-side comparison of 
developmental and adult MeHg exposure; and 4) there has been no validation of in vitro 
culture data using in vivo models for MeHg. 
Therefore, the overall objective of this dissertation is to further elucidate the 
mechanism of MeHg induced neurotoxicity. Within this overall objective were two sub-
objectives: 1) compare the mechanism of MeHg neurotoxicity between animals exposed 
to MeHg as adults and those exposed during gestation, and 2) develop an in vitro model 
of in vivo MeHg exposure. 
 
I hypothesize that chronic exposures to moderate and low levels of 
methylmercury do not cause cell death, but disrupt neuronal cell function via Ca2+ 
dependent mitochondrial changes in both adult and developing neurons in vivo, and 
that an in vitro culture system can be used to model this process.  
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I have designed three specific aims to test the general hypothesis stated above. 
Specific Aim 1: evaluate mitochondrial associated subcellular changes in the cerebellum 
and hippocampus of young adult mice exposed to methylmercury. 
 
Working Hypothesis for Specific Aim 1: Chronic exposure to moderate and low-
levels of methylmercury in young adult mice results in mercury accumulation in the 
cerebellum and hippocampus. The mercury exposure does not result in neuronal cell 
death, but instead, results in an increase in mitochondrial membrane potential (initial 
stress response), an increase in cytosolic basal intracellular Ca2+ concentration and an 
increase in the generation of ROS in neurons. 
 
Specific Aim 2: evaluate mitochondrial associated subcellular changes in the developing 
cerebellum and hippocampus of mice exposed to methylmercury during gestation. 
 
Working Hypothesis for Specific Aim 2: Chronic exposure to moderate and low-
levels of methylmercury in utero will result in mercury accumulation in the 
developing cerebellum and hippocampus. Exposure to mercury does not result in cell 
death, but instead, causes an increase in MMP, an increase in basal intracellular Ca2+ 
concentration, and an increase in ROS generation in developing neurons. Similar 
results will be observed at postnatal day (P) 0 and P 10. 
 
Specific Aim 3: develop a neuronal in vitro model to assess mitochondrial associated 
subcellular changes in response to inorganic mercury or methylmercury treatment and 
determine which of the forms of mercury, organic or inorganic, produces effects in vitro 
that are most similar to those observed in the whole animal. 
 
Working Hypotheses for Specific Aim 3: Chronic exposure to moderate and low-
levels of methylmercury and inorganic mercury in undifferentiated human SH-SY5Y 
neuroblastoma cells will result in mercury accumulation within the cells. The 
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mercury exposure will not result in cell death, but instead, will result in an increase 
in MMP, an increase in basal intracellular Ca2+ concentration and an increase in the 
generation of ROS in the SY5Y cells. All changes will be concentration dependent 
and there will be no difference between inorganic and methylmercury treatments. 
 
The following information was collected for each of the Specific Aims: 
accumulation of total mercury in the tissues or cells, presence or absence of cell death, 
MMP, basal intracellular Ca2+ concentration, and the rate of production of ROS. 
MeHg concentrations used were: Specific Aim 1 – 0, 1.0, or 5.0 µM, Specific Aim 
2 – 0, 0.1, or 1.0 µM, and Specific Aim 3 – 0, 0.01, 0.1, and 1.0 µM. In addition, 
inorganic mercury (HgCl2) was used in Specific Aim 3 at the same concentrations as 
those for MeHg (0, 0.01, 0.1, and 1.0 µM HgCl2). MeHg was administered to live 
animals via oral ingestion in moistened rodent chow. 
Mercury levels in tissues / cells was determined by the combustion / trapping / 
atomic absorption method using a Milestone Direct Mercury Analyzer 80 (DMA 80). 
Cell death was determined as follows: Specific Aim 1 and 2 (in vivo) – Fluoro-
Jade staining and activated caspase 3 immunohistochemistry, and Specific Aim 3 (in 
vitro) – Trypan blue exclusion cell counts, lactate dehydrogenase measurement, and 
measurement of specific live cell and cell death proteins. 
Mitochondrial membrane potential (MMP) was determined using fluorescence 
microscopy and tetramethyl rhodamine methylester perchlorate (TMRM), a lipophilic 
potentiometric mitochondrial dye. 
Basal Ca2+ levels were determined using fluorescence microscopy and calcium 
green 1-AM (CG), a long-wavelength calcium indicator that exhibits an increase in 
fluorescence emission intensity upon binding to calcium. 
The rate of reactive oxygen species (ROS) production was measured using 
fluorescence microscopy and 5-(and-6)-chloromethyl-2’7’dichlorodihydrofluorescein 
diacetate acetyl ester (CM-H2DCFDA), a compound that is oxidized to fluorescent 
2’7’dichlorofluorescein (DCF) by the action of ROS. 
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CHAPTER II 
 
 
SUBCELLULAR CHANGES IN CEREBELLAR AND HIPPOCAMPAL 
GRANULE CELLS OF YOUNG ADULT MICE EXPOSED TO 
METHYLMERCURY 
 
 
 
SUMMARY 
Whole animal and cell culture studies indicate that cellular changes associated 
with high methylmercury (MeHg) exposure include induction of apoptosis typically 
through the intrinsic apoptotic cascade which includes dissipation of the mitochondrial 
membrane potential (MMP), increased [Ca2+]i, and increased production of reactive 
oxygen species (ROS). However, severe human MeHg toxicity epidemiological studies 
and the bulk of whole animal and cell culture laboratory studies have involved MeHg 
concentrations that are significantly higher than to what the modern human population is 
exposed. The number of previous whole animal studies using MeHg concentrations at or 
near environmentally relevant exposure levels are limited. The purpose of this study was 
to determine whether adult mice exposed to chronic low-levels of MeHg would exhibit 
increased cell death and changes in MMP, [Ca2+]i, and ROS similar to the changes 
known to occur with high MeHg exposure concentrations. 
Total Hg accumulation, cell death, changes in MMP, [Ca2+]i, and ROS 
production were determined in cerebella and hippocampi from C57Bl/6 young adult 
male and female mice exposed to 0, 0.2, or 1.0 mg/kg body weight MeHg per day in 
food from postnatal day (P)35 to 40. We observed dose-dependent uptake of MeHg by 
the cerebellum and hippocampus with brain total Hg concentrations representing 0.04 % 
of the original MeHg dose. Cell death was determined using Fluoro-Jade B staining and 
activated caspase 3 immunohistochemistry. Cell death in the cerebellum was increased 
primarily in the 5.0 mg/kg total dose MeHg treatment compared to controls, in females 
compared to males, and in the molecular and granule cell layers compared to the 
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Purkinje cell layer, whereas, no abnormal levels of cell death were observed in the 
hippocampus.  
MMP, [Ca2+]i, and ROS were measured in acutely isolated cerebellar and 
hippocampal granule cells using fluorescence microscopy. MMP and [Ca2+]i were 
increased with MeHg treatment to a greater extent in females than males, but ROS were 
decreased in females compared to males. MMP increases were greater in the cerebellum 
than the hippocampus, whereas [Ca2+]i increases were greater in the hippocampus than in 
the cerebellum. MeHg treatment had no effect on ROS production, but ROS production 
was increased in the hippocampus compared to the cerebellum. 
The changes observed in MMP, [Ca2+]i, and ROS were related primarily to sex 
and brain region differences rather than MeHg treatment. Varying combinations of 
MMP, [Ca2+]i, and ROS changes were indicated, suggesting responses associated with 
cell cycle regulation, cell proliferation, and cytoprotection through Ca2+ sequestering by 
mitochondria and induction of ROS as signaling molecules. These data indicate that 
MeHg may alter cellular function, rather than inducing cell death at concentrations near 
those experienced by modern fish eating populations. More thorough studies are 
necessary to determine the mechanism by which MeHg acts at environmentally relevant 
concentrations. Further investigation into the mechanism of action of chronic low-level 
MeHg exposure is warranted. 
 
INTRODUCTION 
Neurotoxic effects of methylmercury (MeHg) exposure have been well 
documented (Clarkson and Magos, 2006;  Takeuchi et al., 1962), and over the last 
decade, extensive research has been conducted to elucidate the mechanisms involved in 
MeHg toxicity. Early mechanistic studies were based on the premise that MeHg 
exposure resulted in apoptosis (Fonfria et al., 2002;  Kunimoto, 1994;  Li et al., 1998;  
Nagashima et al., 1996), as was suggested by early epidemiological evidence and post-
mortem examinations of individuals poisoned by MeHg in Japan and Iraq (Bakir et al., 
1973;  Matsumoto et al., 1965;  Yoshino et al., 1966). Processes associated with 
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apoptosis such as changes in intracellular calcium ion concentration ([Ca2+]i) (Orrenius 
et al., 2003;  Smaili et al., 2000), depolarization of the inner mitochondrial membrane 
(Green and Reed, 1998;  Montal, 1998), and increased production of reactive oxygen 
species (ROS) have all been studied in context of the apoptosis / methylmercury toxicity 
relationship.  
MeHg exposure is known to cause changes in [Ca2+]i, mitochondrial membrane 
potential (MMP), and production of ROS. MeHg produces increased [Ca2+]i in 
cerebrocortical synaptosomes (Kauppinen et al., 1989), cerebellar granule cells 
(Sarafian, 1993), and NG108-15 neuroblastoma/glial hybrid cells (Hare et al., 1993). 
MMP is decreased by MeHg exposure in astrocytes (Yin et al., 2007) and rat cerebellar 
granule cells (Limke and Atchison, 2002). Mitochondrial function is altered by MeHg in 
rat striatal synaptosome (Dreiem and Seegal, 2007). The production of ROS is increased 
in rat brain mitochondria (Mori et al., 2007) and C6-glial and B35-neuronal cell lines 
(Kaur et al., 2007) following exposure to MeHg. 
In the above listed studies, and a vast majority of others, MeHg experimentation 
was conducted at high concentrations for short periods of time, using cultured primary or 
immortalized cell lines. Typical in vitro MeHg experiments have used MeHg exposure 
concentrations ranging from 2.0 to 100.0 µM (Kauppinen et al., 1989;  Limke and 
Atchison, 2002;  Sarafian, 1993;  Yin et al., 2008). Exposure time periods typically have 
been 30 min and 1 hour, with exposure time periods ranging from 15 min to 24 hours 
(Dreiem and Seegal, 2007;  Kauppinen et al., 1989;  Kaur et al., 2007;  Limke and 
Atchison, 2002). In addition, cultured primary or immortalized cells lines may or may 
not respond to MeHg in the same manner as cells in the whole animal. 
Other than epidemiological studies associated with severe MeHg poisoning such 
as in Japan (Tsubaki and Irukayama, 1977) or Iraq (Clarkson et al., 1976), or those 
involving high fish-eating populations as in the Faroe Islands (Myers and Davidson, 
1998) and the Seychelles (Cernichiari et al., 1995b), far fewer MeHg studies have been 
conducted in vivo, compared to in vitro. As in cell culture studies, most MeHg studies in 
whole animals have involved relatively high doses that are not environmentally relevant 
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to modern fish-eating populations. Exposure times and concentrations for MeHg whole 
animal studies typically have included 2.5 mg/kg daily for 14 days (Yee and Choi, 
1994), 1.0 to 3.0 mg/kg for up to 26 months (Weiss et al., 2005), and 6.43 mg/kg daily 
for 14 days (Farina et al., 2005).  
The general human population is exposed to MeHg primarily through the diet 
and the consumption of both saltwater and freshwater fish. The average human daily 
intake of MeHg, which includes both fish eating and non-fish eating populations, is 2.4 
µg/day (International Programme on Chemical Safety, 1990). A number of high fish-
eating communities have been identified where individual intake of MeHg exceeds 200 
µg/day (International Programme on Chemical Safety, 1990). The maximum possible 
daily intake of MeHg from food stuffs in any population is estimated to be 1800 µg/day 
(International Programme on Chemical Safety, 1990). Assuming the average body 
weight of an adult individual to be 67 kg, reported daily MeHg intake values translate to 
0.036 µg/kg per day for average intake, 2.99 µg/kg per day for individuals in high fish-
eating communities, and 26.9 µg/kg per day as the maximum daily intake. Comparing 
the lowest exposure level for average human populations to the lowest exposure levels 
used in most MeHg laboratory studies, MeHg concentrations used in the laboratory 
studies are typically 28,000 times higher than what the average consumer would 
experience. The highest MeHg exposure level in humans of 26.9 µg/kg per day 
maximum compared to 6.43 mg/kg daily for laboratory studies (Farina et al., 2005), the 
experimental MeHg exposure level is 239 times higher than would be maximally 
experienced by a human individual. 
In addition to the high MeHg exposure levels used in most whole animal 
laboratory studies, the administration of MeHg in most previous studies is not provided 
through environmentally relevant routes of exposure. Examples of routes of MeHg 
exposure in whole animal experiments include intraperitoneal injection (Yee and Choi, 
1994), drinking water (Weiss et al., 2005), water through an oral catheter, also called 
gavage, (Mori et al., 2007), and brain microdialysis (Faro et al., 1997). The absorption, 
distribution, and metabolism of toxicants vary depending on the route of exposure, such 
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as oral, dermal, inhalational, or by injection. For each specific route of exposure, the 
vehicle in which the toxicant is carried may also affect the absorption, distribution, and 
metabolism. For example, MeHg ingested orally in water may not be absorbed in the 
same manner as MeHg ingested in food, or MeHg ingested orally in food, administered 
by oral gavage in one bolus, may not be absorbed in the same manner as MeHg ingested 
in that same quantity of food consumed over an eight to twelve hour time period. Bellum 
et al. (2007c) showed that MeHg administered in food at a single time point was 
absorbed by the gastrointestinal (GI) tract and transported into the brain to a greater 
degree than was MeHg administered at a single time point by intraperitoneal injection. 
Similarly, Bellum et al. (2007c) also showed that a specific quantity of MeHg 
administered over a five-day period was absorbed by the GI tract and transported into 
the brain to a greater degree than was the same quantity of MeHg administered orally at 
a single time point. 
Current scientific literature suggests that the cerebellum and hippocampus are 
important brain regions associated with MeHg toxicity. MeHg is known to specifically 
target and cause cell death in cerebellar granule cells in adult rats, cats, mice, monkeys, 
and humans (Bellum et al., 2007a;  Eto, 1997;  Garman et al., 1975;  Miller et al., 1985;  
Syversen et al., 1981). Cerebellar symptoms associated with MeHg toxicity include 
ataxia, tremor, posture disorders, and uncoordinated movement (Evans et al., 1975;  
Harada, 1995;  Weiss et al., 2005). Other symptoms associated with MeHg toxicity 
include learning and memory deficits and depression in humans and mice (Grandjean et 
al., 1999a;  Montgomery et al., 2008;  Onishchenko et al., 2007;  Yokoo et al., 2003). 
The hippocampus has been shown to be associated with learning and memory and 
depression in humans and rodents (Campbell and Macqueen, 2004;  Shors, 2004;  Zola-
Morgan et al., 1986). In addition, MeHg is known to cause reduction in neurogenesis, 
decreases in cell cycle regulator genes, and altered biogenic monoamines in the 
hippocampus of rats (Burke et al., 2006;  Falluel-Morel et al., 2007;  Falluel-Morel et 
al., 2006;  Sano et al., 1987). Therefore, the cerebellum and hippocampus were selected 
for analysis in the present study. 
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Clearly, mitochondria, Ca2+, and ROS are involved in MeHg toxicity and 
apoptotic cell death. However, the dose, route of exposure, or experimental model 
organism in most MeHg studies have not been relevant to human populations. It is the 
objective of this study to determine whether MeHg exposure in a whole animal model, at 
or near exposure levels seen in humans, would produce MMP, [Ca2+]i, and ROS effects 
similar to those described at high MeHg concentrations. We hypothesized that low-level 
MeHg exposure in young adult mice would result in effects similar to those described in 
the literature for higher concentrations of MeHg: a dose-dependent increase in total Hg 
accumulation, cell death, a dose-dependent decrease in MMP, and dose-dependent 
increases in basal [Ca2+]i and production of reactive oxygen species. To test this 
hypothesis, male and female C57Bl/6 mice were exposed to 0.2 or 1.0 mg/kg body 
weight MeHg per day for five days from postnatal (P) day 35 to 39 via their food. The 
selected MeHg concentrations ranged from 0.2 mg/kg per day, which is near maximum 
human consumption, to 1.0 mg/kg per day, which is a value that has been used in current 
MeHg studies (Weiss et al., 2005). P35 to 39 were selected as exposure time points 
because the mouse brain is considered to be fully developed by P35, and P35 to P39 
have been used in previous MeHg studies (Bellum et al., 2007b;  Bellum et al., 2007c). 
At P40, total Hg levels were measured in cerebellar and hippocampal samples. Sections 
from cerebella and hippocampi were stained with Fluoro-Jade B or immunolabeled with 
anti-activated caspase 3 to determine the presence of cell death via apoptosis or by other 
means. Neurons from cerebella and hippocampi were acutely isolated and examined for 
changes in MMP, [Ca2+]i, and ROS. Results of this study will provide MeHg toxicity 
data that can be used for human risk assessment. These data will be helpful in 
establishing an appropriate minimum exposure level (reference dose) for MeHg in 
humans. 
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MATERIALS AND METHODS 
Chemicals 
Methylmercuric chloride, 95% (MeHg) was purchased from Alfa Aesar (Ward 
Hill, MA). DOLT-2, DORM-2, and DOLT-3 were purchased from the National 
Research Council Canada (NRCC), Institute for Environmental Chemistry (Ottawa, 
Canada). Fluoro-Jade® B was purchased from Millipore (Temecula, Ca). Affinity-
Purified Rabbit Anti-human/mouse Activated Caspase 3 was purchased from R&D 
Systems Inc. (Minneapolis, MN). Biotynilated affinity purified Goat Anti-Rabbit IgG 
(H+L) was purchased from Vector Laboratories, Inc. (Burlingame, CA). Permount® was 
purchased from (Fisher Scientific). DPX Mounting Medium was purchased from 
Electron Microscopy Sciences (Fort Washington, PA). Minimum Essential Medium 
Eagle (spinner modification with Earle’s salts and NaHCO3, without calcium chloride 
and L-glutamine (SMEM)), Minimum Essential Medium Eagle (with Earle’s Salts and 
L-glutamine, without sodium bicarbonate (MEM)), deoxyribonuclease I from bovine 
pancreas (DNase I), poly-D-lysine hydrobromide >300,000 kD, L-alanyl-L-glutamine, 
tertiary-butyl hydroperoxide (tBHP), Hank’s Balanced Salt Solution (modified with 
NaHCO3 and without phenol red (HBSS)), protease type IX (bacterial from Bacillus 
polymyxa), carbonyl cyanide 3-chloro-phenylhydrazone (CCCP), and thapsigargin were 
purchased from Sigma-Aldrich, Inc. (St. Louis, MO). Fetal bovine serum (FBS) was 
purchased from Gemini (Woodland, CA). Anti-NeuN clone A60 IgG1was purchased 
from Chemicon. Tetramethylrhodamine methyl ester perchlorate (TMRM), Calcium 
Green™-1 AM, 5-(and 6)-chloromethyl-2’7’-dichlorodihydrofluorescein diacetate acetyl 
ester (CM-H2DCFDA), Pluronic® F-127, ProLong® Gold Antifade with DAPI, and 
Alexa Fluor® 488 donkey anti-rabbit IgG (H+L) were purchased from 
Invitrogen/Molecular Probes (Eugene, OR). Lab-Tek 2-well chambered coverglasses 
were purchased from Nunc Inc. (Naperville, IL). 
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Animals 
All animal procedures were carried out in accordance with guidelines described 
in the Guide for the Care and Use of Laboratory Animals (NRC, 1996). Adult male and 
female C57Bl/6 mice, originally obtained from The Jackson Laboratory (Bar Harbor, 
MA), were housed at the Laboratory Animal Research and Resource building, Texas 
A&M University, at constant temperature (21 - 22°C) and humidity (45 – 55%) with a 
12-hour light/dark photoperiod. Breeding animals were provided rodent chow and 
distilled water ad libitum. Mice were bred and the offspring weaned at postnatal day (P) 
30; the offspring were used for experimentation. 
 
Treatment 
MeHg stock solution (1.0 mg/mL) was prepared in distilled water, sterilized by 
filtration, and stored at 4°C. Working MeHg solutions were prepared from the 1.0 
mg/mL stock solution, diluted in sterile distilled water, and stored at 4°C. For each 
experiment, six male and six female mice were assigned to control (distilled water), 0.2 
mg/kg, or 1.0 mg/kg body weight MeHg. Experimental mice were housed individually. 
Litters were divided such that only one male and one female mouse from a single litter 
was used for any one experiment; the litter was the statistical unit of measure (EPA, 
2000;  OECD, 2007). Experimental mice were weaned at P25. The feeding and MeHg 
administration procedures used in this study have been used successfully in previously 
published experiments (Bellum et al., 2007a;  Bellum et al., 2007b;  Bellum et al., 
2007c). Dry rodent chow and distilled drinking water were provided ad libitum. Starting 
at P30 and continuing through P34 (a total of 5 days), mice were trained to consume all 
of 2.0 g of moistened rodent chow in a 12-hour time period. Dry rodent chow was 
provided ad libitum only during the 12 hours of light. During the 12 hours of dark, the 
dry chow was removed and replaced with 2.0 g of rodent chow that was moistened with 
distilled water to achieve a crumbled texture. The feeding dish and cage were examined 
each morning to ensure that each mouse was consistently consuming all of the moistened 
chow provided. Beginning at P35 and continuing to P39 (five days), MeHg was added to 
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the moistened rodent chow (distilled water for controls). Distilled drinking water was 
provided to all animals ad libitum. All experimental procedures were carried out on P40, 
24 hours following final MeHg administration. Total Hg content in the rodent chow was 
analyzed as described in the following section to identify any potential Hg exposure to 
the animals other than what was intentionally administered. 
 
Body, cerebellar, and hippocampal weights 
Body, cerebellar, and hippocampal formation (both sides) weights were 
measured at P40 at the time of tissue collection. Mean and standard error of the mean 
were calculated and data were analyzed by two-way analysis of variance (ANOVA) to 
determine main effects and interactions associated with sex and MeHg treatment. 
 
Mercury accumulation 
Total Hg was measured to determine the amount of total Hg transported into the 
cerebellum and hippocampus. Mice were anesthetized with isoflurane and decapitated. 
The whole brain was removed and the cerebellum and hippocampus dissected, weighed, 
rapidly frozen in powdered dry ice, and stored at -20°C. Cerebellar and hippocampal 
tissues were freeze-dried for 48 hours and total Hg content was measured in the Trace 
Element Research Laboratory at Texas A&M University, by combustion/ trapping / 
atomic absorption (Salvata and Pirola, 1994) on a Milestone Direct Mercury Analyzer 
80, DMA 80 (Milestone Inc., Shelton, CT) equipped with an autosampler and dual cell 
detector. The DMA 80 was calibrated using a calibration blank and a series of seven 
aliquots of certified reference standard ranging from 1 to 750 ng Hg. The calibration line 
was verified using an independent CRM standard (NRCC DOLT-2) and a blank nickel 
boat. Samples were weighed to the nearest 0.00001 g and placed into the DMA 80 in 
pre-combusted nickel boats. A method blank, two certified reference materials (DORM-
2 and DOLT-3), a spiked sample, and a duplicate sample were included at the beginning 
and end of each sample run to determine changes in an individual run from beginning to 
end, differences from one run to the next, and differences between duplicate samples 
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within a run. The DMA 80 has a detection limit of 0.005 ng Hg and a working range of 
up to 1000 ng Hg (Milestone, Inc. Shelton, CT). Total Hg accumulation (ng Hg / g wet 
sample weight) was determined for the cerebellum and hippocampus from each of four 
to six male and female mice for each treatment group. 
Total Hg concentrations, as total Hg content (ng Hg) per unit volume of wet 
brain (w. w.) tissue (ng/g), was calculated by dividing the total Hg measured in each 
sample by the measured wet brain tissue weight for that sample. Total Hg concentration 
values were analyzed by three-way ANOVA to determine main effects and interactions 
associated with sex, cerebellar and hippocampal brain regions, and MeHg treatment. 
Significant differences, as indicated by three-way ANOVA, were followed with Tukey’s 
Honest Significant Difference (HSD) and Student’s t post hoc tests, as appropriate, to 
determine differences among all treatments. The average amount of MeHg provided in 
the original dose was calculated by multiplying the MeHg dose administered (mg/kg) by 
five days of exposure, multiplied by the average body weight of the mice. The 
percentage of Hg accumulated in the cerebellum and hippocampus compared to the 
amount of MeHg provided in the original dose was calculated by dividing the average 
amount of total Hg measured in brain samples by the amount of MeHg provided in the 
original dose and multiplying by 100. 
 
Fluoro-Jade B staining 
To detect dying neurons, cells were stained with Fluoro-Jade B, an anionic 
fluorochrome that selectively stains cell bodies, dendrites, axons, and axon terminal of 
degenerating neurons, but does not stain healthy neurons, myelin, vascular elements or 
neuropil (Schmued et al., 1997a;  Schmued et al., 1997b). Mice were anesthetized by 
intraperitoneal injection of 150.0 g/kg ketamine and 15.0 mg/kg xylazine. Once 
anesthetized, the mice were fixed by transcardial perfusion with 50 mL Tyrode’s saline 
(room temperature) followed by 300 mL cold 4% phosphate buffered paraformaldehyde. 
Whole perfused mouse bodies were wrapped in foil and kept at 4°C for 24 hours to 
allow for greater fixation of brain tissue. Brains were removed, immersed in cold 4% 
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phosphate buffered paraformaldehyde for 48 hours, and then cryoprotected by 
immersion in cold 20% sucrose in 0.1 M PBS for 48 to 72 hours, or until the brain 
settled to the bottom of the sucrose solution. Once cryoprotected, brains were rapidly 
frozen in powdered dry ice and stored at -70°C. 
Serial sagittal sections (15 µm), through whole frozen brains, were cut with a 
SLEE cryostat (Slee, Mainz, Germany), mounted onto gelatin-coated slides, and stored 
at -70°C. Every seventh section was used for Fluoro-Jade B staining to ensure that no 
labeled cell was counted twice. Sections from testes of non-treated adult mice and 
sections of brains from P20-P60 leaner mouse cerebella were used as negative (Fluoro-
Jade B dye was excluded from the staining protocol) and positive controls, because both 
testes and leaner mouse cerebella exhibit a predictable and reliable pattern of cell death 
as revealed by Fluoro-Jade staining.. The leaner mouse exhibits extensive cell death in 
the cerebellum from P20-P60 and is therefore a good positive control (Frank et al., 2003;  
Lau et al., 2004). Leaner mice carry an autosomal recessive mutation in the CACNA1A 
gene coding for the α1A pore-forming subunit of CaV 2.1 voltage-gated calcium channel 
(P/Q-type) (Herrup and Wilczynski, 1982). This mutation results in extensive cerebellar 
granule cell death that begins around P10 and continues into adulthood (Herrup and 
Wilczynski, 1982;  Lau et al., 2004). Frozen sections were dried for 1 hour at 50°C, 
cooled for 10 min, and then stained as described by Schmued and Hopkins (2000). Dried 
sections were placed in a 1% sodium hydroxide in 80% alcohol solution for 5 min, 
followed by 70% alcohol for 5 min, distilled water for 2 min, and then immersed and 
gently shaken in 0.06% potassium permanganate in distilled water for 10 min. Sections 
were rinsed twice in distilled water, for 1 min each, and then transferred to and shaken 
gently in 0.0004% Fluoro-Jade B in 0.1% acetic acid and distilled water for 20 min. 
Sections were then washed with distilled water three times, for 1 min each, and then 
rapidly dried by blowing cool air onto the slides with an air-gun for approximately 20 
min. Dried slides were immersed in xylene twice, for 5 min each, and then coverslipped 
with DPX mounting media. 
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Fluoro-Jade B-positive cells were viewed with a Zeiss Axioplan 2 microscope 
(Carl Zeiss, Thornwood, NY) using a fluorescein isothiocyanate (FITC) filter and 
equipped with a Color AxioCam camera. Fluoro-Jade B positive cells were counted in 
each of the ten lobules of the cerebellar vermis and distinguished among the molecular, 
Purkinje, and granule cell layers. Positive cells also were counted in the dentate gyrus 
and hippocampus proper of the hippocampal formation. In the dentate gyrus, positive 
cells were distinguished among the granular and subgranular zones, and the hilus. 
Positive cells in the pyramidal cell layer of the hippocampus proper were distinguished 
between the CA1 and CA3 regions. Slides were coded to blind the investigator as to the 
treatment and gender of the sections during data collection. 
Positive cell counts from each region, using a minimum of four sections per 
animal (six male and six female per treatment), were averaged to obtain the positive 
counts for each individual animal. Data from the dentate gyrus, hippocampus proper, and 
cerebellum were analyzed independently by three-way ANOVA to determine main 
effects and interactions associated with sex, brain region, and MeHg treatment. 
Differences, as indicated by three-way ANOVA, were analyzed by Tukey’s HSD or 
Student’s t post hoc tests, as appropriate, to determine differences among all treatments 
or brain regions. 
 
Activated caspase 3 immunohistochemistry 
Caspase 3 is activated in the process of apoptosis (Burke et al., 2006). Activated 
caspase 3 immunohistochemistry was used to detect neurons dying by apoptosis. Whole 
brain fixed/frozen sections adjacent to those used for Fluoro-Jade B staining were used 
for activated caspase 3 analysis (see Fluoro-Jade B section for tissue and slide 
preparation procedures). Frozen sections were dried at room temperature for 1 hour, and 
then permeabilized by immersed in 0.3% Triton-X in 0.1 M phosphate buffered saline 
(PBS) for 1 hour, followed by three washes in 0.1 M PBS for 10 min each. Washed 
slides were immersed in 1% hydrogen peroxide in 0.1 M PBS for 5 min, followed by 
two washes in 0.1 M PBS for 5 min each with gently agitation. Sections were transferred 
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to 5% normal goat serum in 0.1 M PBS for 1 hour, and then into anti-activated caspase 3 
primary antibody (1:25000) in 2% normal goat serum and 0.1 M PBS over night at 4°C 
(approximately 16 hours). Following application of the primary antibody, sections were 
rinsed in 0.1 M PBS three times, for 10 min each, and then immersed in biotynilated 
secondary antibody (1:400) in 0.1 M PBS for 2 hours. Sections were then washed in 0.1 
M PBS three times, for 10 min each, followed by immersion in Streptavidin horseradish 
peroxidase (1:5000) in 0.1 M PBS for 2 hours. Sections were rinsed in 0.1 M PBS once, 
for 10 min, and then in 0.05 M Tris-HCl buffer (pH 7.6) twice, for 10 min each. Finally, 
sections were placed in 0.024% diaminobenzadine (DAB) (5.0 µL of 30% hydrogen 
peroxide, 150.0 mg of 5% nickel ammonium sulfate, 1.0 mL of 6.2 mg DAB per 500 µL, 
and 24.0 mL of 0.05 M Tris-HCl buffer, at pH 7.6) for 20 min, and then washed in 0.05 
M Tris-HCl buffer (pH 7.6) for 5 min, followed by two washes in 0.1 M PBS for 5 min 
each. Stained slides were dehydrated in a graded series of ethanols (EtOH) and 
counterstained with a dilute solution of eosin (0.1%) in 95% EtOH. Alcohol dehydration 
was as follows: 5 min in 70% EtOH, 5 min in 80% EtOH, 4 dips in Eosin in 95% EtOH, 
5 min in 95% EtOH, 5 min in 95% EtOH, 5 min in 100% EtOH, and 5 min in 100% 
EtOH. Following dehydration, tissue was cleared by immersion in xylene two times for 
5 min each, and then coverslipped with Permount® mounting media. Activated caspase 3 
positive cells were counted and the data analyzed as described for Fluoro-Jade B. As 
with Fluoro-Jade B, sections from testes of non-treated adult mice and sections of brains 
from P20-P60 leaner mouse cerebella were used as negative (activated caspase 3 
antibody was excluded from the protocol) and positive controls. 
 
Acute isolation of cerebellar granule and hippocampal neurons 
Acutely isolated neurons were prepared as described by Oberdoerster (2001) and 
Bellum et al. (2007a). This isolation method yields more than 90% viable cells as 
demonstrated using 0.08% Trypan blue exclusion and has been used successfully in 
other published experiments (Bellum et al., 2007a). Cell isolations and subsequent 
MMP, [Ca2+]i, and ROS imaging were carried out in batches containing one animal from 
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each treatment group, all of the same gender. Batch experiments allow comparison of 
data from one day to the next. Mice were anesthetized with isoflurane, and then 
decapitated. Whole brains were removed and cerebella and hippocampi dissected and 
placed in SMEM (without Ca2+ and Mg2+, with 2.5 mM L-alanyl-L-glutamine). All 
solutions were cold and on ice unless otherwise specified. Tissues were chopped into ~ 1 
mm pieces with a scalpel blade, and then placed in dissociation media (DM), consisting 
of SMEM, 1.5 U/mL protease, and 2.5 mM L-alanyl-L-glutamine. Neurons were 
isolated in DM by mechanical disruption on a stir-plate. Each of five stir-cycles included 
stirring with a stir-bar for 10 min, followed by a 2 min rest period to allow large tissue 
pieces to sediment. After each stir-cycle, approximately 80% of the DM/cell solution 
was carefully removed, so as not to disturb large settled pieces of brain tissue, and then 
combined with growth media (MEM, sodium bicarbonate, L-alanyl-L-glutamine, 10% 
FBS) and kept on ice. Fresh DM, to replace the removed media, was added to each 
beaker before beginning the next stir-cycle. DNase I (80 U/mL working concentration) 
was added during the second stir-cycle. Cell solutions were centrifuged at 1100 x g for 
10 minutes and the supernatant discarded. Cell pellets were reconstituted in growth 
media at 37°C and plated onto chambered coverslips coated in 2.5% gelatin and 1x poly-
D-lysine. Prior to use, chambered coverslips were coated with gelatin for 10 min and 
then in 1x poly-D-lysine overnight (approximately 12 hours) at 4°C. The poly-D-lysine 
was removed and the coverslips rinsed in warmed (37°C) HBSS a few minutes before 
the cells were added. The coverslips were not allowed to dry. Each individual isolated 
cell sample was divided and plated onto three separate coverslips, one for each analysis: 
MMP, basal [Ca2+]i, and ROS. Plated cells were incubated at 37°C (5% CO2) for 30 min 
to allow cells to attach to the coverslip surface. 
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Identification and validation of acutely isolated cells as neurons 
NeuN and DAPI staining of isolated cells were used to identify neurons for 
subsequent analysis. NeuN is a marker for neurons. In the cerebellum, NeuN is specific 
for granule cells (Weyer and Schilling, 2003), and in the hippocampus, NeuN is specific 
for neurons in the granular and subgranular zone and for pyramidal cells of the CA1 and 
CA3 regions (Domoráková et al., 2006). NeuN intensely labels the nucleus and lightly 
labels the cytoplasm of neurons (Domoráková et al., 2006;  Mullen et al., 1992). DAPI 
is a fluorescent stain that binds strongly to DNA and is used to identify the nucleus of 
cells (Robinson et al., 2008). After isolation and a 30 min incubation of plated cells, the 
growth medium was removed and the cerebellar and hippocampal cells were fixed in 4% 
paraformaldehyde for 15 min. Cells were then washed in 0.1 M PBS twice for 1 min 
each, and then permeabilized with 0.3% Triton-X for 5 min. Cells were washed in 0.1 M 
PBS twice for 3 min each, and then immersed in 5% normal goat serum in 0.1 M PBS 
for 1 hour. Cells were then placed into NeuN primary antibody (1:2000) (Mullen et al., 
1992;  Weyer and Schilling, 2003) in 2% normal goat serum and 0.1 M PBS over night 
(approximately 16 hours) at 4°C. Following incubation in the primary antibody, cells 
were washed twice for 3 min each, and then immersed in Biotynilated Goat Anti-mouse 
AF594t secondary antibody (1:400) for 2 hours. Finally, the cells were washed in 0.1 M 
PBS twice for 3 min each, and then coverslipped with ProLong® Antifade with DAPI 
(Turville et al., 2008). The DAPI within the ProLong® Antifade solution enters the 
nuclei of the cells and binds to the nucleic acids during the coverslip drying period. Cells 
were imaged using a Zeiss Axioplan 2 microscope (Carl Zeiss, Thornwood, NY) with 
Texas Red and DAPI filters, and equipped with a Color AxioCam camera. 
 
Mitochondrial membrane potential 
Tetramethylrhodamine methyl ester (TMRM) was used to detect changes in 
MMP (Barhoumi et al., 2004). TMRM is a lipophilic potentiometric mitochondrial dye 
that accumulates in mitochondria in proportion to the membrane potential (Scaduto Jr 
and Grotyohann, 1999). TMRM dye stock solution (1.0 mM) was prepared in 100% 
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methanol and stored in desiccant at -20°C. TMRM working solution (150.0 nM) was 
prepared from the 1.0 mM stock solution in HBSS just before use. The methanol 
concentration in the working solution was 0.015%. HBSS was used in the TMRM 
working solution instead of growth media to prevent the TMRM dye from binding to 
proteins within the medium and inhibiting movement of dye into the cells. After cell 
isolation and a 30 min incubation, the growth medium was removed from the acutely 
isolated cerebellar and hippocampal neuronal cultures and replaced with a 150.0 nM 
solution of TMRM in HBSS for 20 min at 37°C. The TMRM solution was replaced with 
HBSS for imaging. Three negative controls (HBSS and cells with no dye, HBSS with no 
cells and no dye, and HBSS with dye, but no cells) and a positive control (HBSS and 
cells with dye and 20.0 µM CCCP) were included. CCCP was used to determine that the 
observed fluorescence was associated with the mitochondrial membrane and not other 
non-specific TMRM fluorescence (Julian et al., 2005). CCCP is a lipid-soluble weak 
acid that uncouples oxidative phosphorylation in the inner mitochondrial membrane. It 
enters the mitochondria in a protonated form, discharges the pH gradient, then leaves the 
mitochondria as an anion, depolarizing the mitochondrial membrane (Lim et al., 2001). 
When CCCP is co-administered to cells with TMRM, the CCCP-induced depolarization 
of the inner mitochondrial membrane results in release of accumulated TMRM from 
mitochondria into the cytosol, and a decrease in fluorescence occurs. 
Fluorescent mitochondrial images were collected over a 10 min time period at 
63x using a Zeiss Axiovert 200M microscope equipped with a Cy3 filter set (excitation: 
560/40 nm, dichroic FT 585; emission: BP 630/75 nm) and SlideBook™ 4.1.0 software 
from Intelligent Imaging Innovations Inc. (3I, Denver, CO). Image retrieval and MMP 
fluorescent data collection were performed using Simple PCI and Imaging System 
Software (v5.0.0.1503, Compix Inc.). Relative MMP values of individual mitochondria 
from a minimum of ten cells from each animal were measured and averaged to give the 
MMP value for each of six individual animals from each sex, brain region, and treatment 
group. Mitochondria were identified as fluorescent, round or oblong-shaped, punctate 
fluorescence objects within the granule cells. 
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MMP data were calculated as percentage of control within each batch (one 
control and one of each treated sample analyzed at the same time) to allow comparison 
of data from one day to the next. MMP data were analyzed by three-way ANOVA to 
determine main effects and interactions associated with sex, brain region and MeHg 
treatment. Differences, as indicated by ANOVA, were analyzed by Tukey’s HSD or 
Student’s t post hoc tests, as appropriate, to determine differences among all treatments 
or brain regions. 
 
Basal intracellular Ca2+ 
Calcium Green™-1 AM was used to measure the relative concentration of basal 
intracellular Ca2+ (Gilroy and Jones, 1992). Calcium Green™-1 AM is a long-
wavelength Ca2+ indicator that exhibits an increase in fluorescence emission intensity 
upon binding to Ca2+ (Eberhard and Erne, 1991). The dye is in the AM ester form, which 
enhances cell permeability and is non-fluorescent in the absence of Ca2+ (Lee et al., 
1999). Upon binding to Ca2+, the dye exhibits an approximately 100-fold increase in 
emission intensity, which enables detection of changes in Ca2+ concentration within a 
large dynamic range (Lee et al., 1999). Calcium Green™-1 AM stock solution (2.0 mM) 
was prepared in DMSO (19.37 µL DMSO to 50.0 µg dye) and stored in desiccant at -
20°C for up to two weeks. Working solutions of Calcium Green™-1 AM (1.0 µM) were 
prepared just before use in 0.01% Pluronic® F-127 and HBSS. The DMSO 
concentration in the working solution was 0.05%. HBSS was used in the Calcium 
Green™-1 AM working solution instead of growth media to prevent the Calcium 
Green™-1 AM dye from binding to proteins within the medium and inhibiting 
movement of dye into the cells. After cell isolation and a 30 min incubation, the growth 
medium was removed and replaced with a 1.0 µM solution of Calcium Green™-1 AM in 
0.01% Pluronic® F-127 and HBSS for 20 min at room temperature. Incubation of the 
cells with Calcium Green™-1 AM dye at room temperature prevented 
compartmentalization of the dye into cellular organelles. The Calcium Green™-1 AM 
solution was removed and replaced with HBSS for 20 min to allow de-esterification of 
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the dye. The AM ester of the molecule, which enhances the movement of the dye into 
the cell, must be removed by endogenous esterases for the dye to fluoresce when bound 
to Ca2+. 
Three negative controls (HBSS and cells with no dye, HBSS with no cells and no 
dye, and HBSS with dye, but no cells) and a positive control (HBSS and cells with dye 
and thapsigargin) were included. Thapsigargin is an inhibitor of sarco-endoplasmic 
reticulum Ca2+ ATPases and raises cytosolic free Ca2+ by blocking the ability of the cell 
to pump Ca2+ into the endoplasmic reticulum (ER) (Treiman et al., 1998). ER-store 
depletion can secondarily activate plasma membrane Ca2+ channels, allowing an influx 
of Ca2+ into the cytosol (Barhoumi et al., 2006). When thapsigargin is co-administered 
to cells with Calcium Green™-1 AM, the thapsigargin-induced increase in cytosolic free 
Ca2+ causes a dramatic increase in fluorescence. Fluorescent Ca2+ images were collected 
and analyzed as described for MMP, with the exception that the FITC filter set 
(excitation: BP 470/20, dichroic FT493; emission: BP 505-530 nm) was used. Relative 
[Ca2+]i values from a minimum of ten cells from each animal were measured and 
averaged to give the value for each of six individual animals from each sex, brain region, 
and treatment group. [Ca2+]i data were calculated as percentage of control within each 
batch (one control and one of each treated sample analyzed at the same time) to allow 
comparison of data from one day to the next. [Ca2+]i data were analyzed by three-way 
ANOVA to determine main effects and interactions associated with sex, MeHg 
treatment, and brain region. Differences, as indicated by three-way ANOVA, were 
analyzed by Tukey’s HSD and Student’s t post hoc tests, as appropriate, to determine 
differences among all treatments or brain regions. 
 
Reactive oxygen species 
5-(and 6)-chloromethyl-2’7’-dichlorodihydrofluorescein diacetate acetyl ester 
(CM-H2DCFDA) was used to determine the relative rate of ROS production over time 
(Bellum et al., 2007a) (Oyama et al., 1994). CM-H2DCFDA is a non-fluorescent 
compound that is oxidized to highly fluorescent 2’,7’-dichlorofluorescein (DCF) by the 
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action of ROS (LeBel et al., 1992). The attached chloromethyl (CM) group allows the 
dye to passively diffuse into cells. Subsequent oxidation of the dye molecule by 
endogenous esterases traps the derivatives within the cell where they can react with 
ROS. The CM-H2DCFDA stock solution (2.0 mM) was prepared in DMSO (43.268 µL 
DMSO to 50 µg dye) and stored in desiccant at -20°C for up to two weeks. Working 
solutions of CM-H2DCFDA (1.0 µM) were prepared just before use in 0.01% Pluronic® 
F-127 and HBSS. DMSO concentration in the working solution was 0.05%. HBSS was 
used in the CM-H2DCFDA working solution instead of growth media to prevent the 
CM-H2DCFDA dye from binding to or reacting with proteins within the medium and 
inhibiting movement of dye into the cells. After the isolation and 30 min incubation, the 
growth medium was removed and replaced with a 1.0 µM solution of CM-H2DCFDA in 
0.01% Pluronic® F-127 and HBSS for 5 min at room temperature. Incubation of the 
cells with CM-H2DCFDA dye at room temperature prevented compartmentalization of 
the dye into cellular organelles. The CM-H2DCFDA was removed and replaced with 
HBSS for imaging. Three negative controls (HBSS and cells with no dye, HBSS with no 
cells and no dye, and HBSS with dye, but no cells) and a positive control (HBSS and 
cells with dye and tertiary-butyl hydroperoxide (tBHP)) were included (Drahota et al., 
2005). tBHP is a lipophilic, membrane-permeant oxidant (Elliott et al., 1992) that reacts 
with iron in heme-proteins and produces alkoxyl radicals (Kim et al., 2005b). When 
tBHP is co-administered to cells with CM-H2DCFDA dye, the tBHP-induced increase in 
ROS causes an increase in fluorescence. Fluorescent images were collected every 2.5 
min for 30 min, as described for MMP and [Ca2+]i, using the FITC filter set. The relative 
amount and rate of ROS production was calculated using a minimum of five cells from 
each animal. 
ROS data were calculated as percentage of control within each batch (one control 
and one of each treated sample analyzed at the same time) to allow comparison of data 
from one day to the next. A three-way MANOVA with repeated measures for ROS 
reading time was used to assess between- and within-subject differences and interactions 
associated with sex, brain region, and MeHg treatment. The condition of sphericity was 
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analyzed. The condition of sphericity was not met in any of the ROS data analyzed; 
therefore, the Greenhouse-Geisser adjusted univariate analysis was used for subsequent 
within-subject analyses (Grieve, 1984). 
 
Statistical analyses 
All data were represented as mean (M) ± standard error of the mean (SEM). 
Detailed descriptions of statistical analyses have been described within the text for each 
experiment. In brief, data for MMP, [Ca2+]i, and ROS were calculated as percentage of 
control to normalize batch differences. A three-way MANOVA with repeated measures 
for ROS reading time, followed by the Greenhouse-Geisser adjusted univariate test was 
used to assess differences among sex, brain regions, and MeHg treatment for ROS. All 
other experiments were analyzed using a two- or three-way ANOVA and Tukey’s HSD 
or Student’s t post hoc tests, as appropriate, to determine main effects and interactions 
for sex, brain regions, and MeHg treatment. For all experiments, α = 0.05, and all data 
were analyzed using JMP 7.0.2 statistical software from the SAS Institute Inc. (Cary, 
NC). 
 
RESULTS 
General observations 
Over the course of the study, mice appeared healthy with no obvious changes in 
movement or behavior. Data are represented as (M = mean, SEM = standard error of the 
mean). Body, cerebellar, and hippocampal weight for young adult mice were analyzed 
by two-way ANOVA to determine differences and interactions associated with sex and 
MeHg treatment. Two-way ANOVA for body weights indicated a main effect for sex, F 
(1, 78) = 56, p < 0.0001. Student’s t post hoc analysis indicated that male mice (M = 
19.3 g, SEM = 0.2) weighed more than female mice (M = 16 g, SEM = 0.20). No body 
weight differences were indicated among MeHg treatments. There was no difference in 
the weight of cerebella (M = 0.054 g, SEM = 0.0008) or hippocampi (M = 0.027 g, SEM 
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= 0.0008) between sexes or among MeHg treatment groups as analyzed by two-way 
ANOVA.  
 
Mercury accumulation 
Total mercury (Hg) concentrations presented as total Hg content (ng Hg) per unit 
volume of wet brain (w. w.) tissue (ng/g), were calculated by dividing the total Hg 
measured in each sample by the measured wet brain tissue weight for that sample. Total 
Hg concentration values were analyzed by three-way ANOVA for differences and 
interactions associated with sex, cerebellar and hippocampal brain regions, and MeHg 
treatment. Analysis indicated a main effect for MeHg treatment, F (2, 34) = 332, p < 
0.0001. There was no difference in total Hg concentration between sexes or between 
cerebellar or hippocampal brain regions. Tukey’s HSD post hoc analysis indicated that 
total Hg concentration was increased in the 5.0 mg/kg total dose treatment (M = 980.0 
ng/g, SEM 52.0) compared to the 1.0 mg/kg total dose treatment (M = 170.0 ng/g, SEM 
= 7.0) and controls (M = 0.71 ng/g, SEM = 0.14), and that Hg accumulation was 
increased in the 5.0 mg/kg treatment compared to controls (Table II-1). The average 
amount of MeHg provided in the original dose was calculated to be 0 for controls, 
17,500 ng for 0.2 mg/kg per day, and 87,500 ng for 1.0 mg/kg per day (Hg dose mg/kg 
multiplied by five days of exposure, and then also multiplied by an average measured 
mouse body weight of 17.5 g). The percentage of Hg accumulated in the cerebellum and 
hippocampus compared to the amount of MeHg provided in the original dose was 
calculated by dividing the average amount of total Hg measured in brain samples divided 
by the amount of MeHg provided in the original dose and multiplying by 100. The 
percentage of total Hg accumulated in cerebellar and hippocampal regions of the brain 
were 0.04 % for the 1.0 mg/kg total dose MeHg treatment, and 0.05 % for the 5.0 mg/kg 
total dose MeHg treatment (Table II-1). Hg content for a method blank, two certified 
reference materials, a spiked sample, and a duplicate sample were analyzed to determine 
changes in an individual run from beginning to end, differences from one run to the next, 
and differences between duplicate samples within a run. No intra-run, between-run, or 
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between-duplicate sample differences were observed (data not shown). The recovery rate 
for certified reference materials and spiked samples ranged from 92 to 99% (data not 
shown). Total Hg content in the rodent chow was analyzed to identify potential Hg 
exposure other than what was intentionally administered. Total Hg levels in the rodent 
chow were below the level of detection for the analysis used (< 0.005 ng, data not 
shown). 
 
TABLE II-1 
Total Mercury Accumulation in Cerebella and Hippocampi of Young Adult Mice 
Following Exposure to 0, 1.0, or 5.0 mg/kg Total Dose Methylmercury Divided 
Over Five Days 
 Total Hg Accumulation in Cerebella and Hippocampi Combined 
 Hg (ng) Hg / w.w. (ng/g) % Original Dose 
Controls 0.029 (0.0050) 0.71 (0.14) NA 
1.0 mg/kg 7.0 (0.71) 170 (7.0) * 0.040 
5.0 mg/kg 39 (3.7) 980 (52) *† 0.045 
Data are represented as mean (standard error of the mean). 
Hg (ng) = total Hg content measured in both cerebella and hippocampi 
Hg / w.w. (ng/g) = total Hg content measured divided by the wet tissue weights of cerebella and 
hippocampi 
% Original Dose = total Hg content measured in cerebella and hippocampi expressed as a percentage of 
the entire MeHg dose administered to the whole animal 
Total Hg concentration was analyzed by three-way ANOVA to determine differences associated with sex, 
brain region, and MeHg treatment, followed by Tukey’s HSD post hoc test. Both MeHg treatments were 
significantly increased compared to controls (*). The 5.0 mg/kg MeHg treatment was increased compared 
to the1.0 mg/kg treatment (†). No differences in total Hg concentration were observed between sexes or 
between cerebellar and hippocampal brain regions. 
Three-way ANOVA: F (2, 34) = 332, p < 0.0001, α = 0.05.  
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Fluoro-Jade B and activated caspase 3 
The number of Fluoro-Jade B positive dying cells in the dentate gyrus was 
analyzed by three-way ANOVA to determine differences and interactions associated 
with sex, dentate gyrus cell layer, and MeHg treatment. Data indicated differences in the 
number of dying cells among the cell layers of the dentate gyrus, F (2, 87) = 42, p < 
0.0001, but no differences in sex or MeHg treatment (Fig II-1). Tukey’s HSD post hoc 
analysis indicated that the hilar region exhibited fewer dying cells compared to the 
granular and subgranular layers, and that the granular layer exhibited fewer dying cells 
than the subgranular layer. An interaction between cell layers and MeHg treatment also 
was observed, F (4, 87) = 3.56, p = 0.0098, indicating that the differences in the number 
of dying cells among the cell layers of the dentate gyrus were greater in controls than in 
MeHg treated mice. No differences were observed in the number of Fluoro-Jade B 
positive dying cells among sexes, cell layers, or MeHg treatments in the hippocampus 
proper (CA1 and CA3 pyramidal cells) when analyzed by three-way ANOVA. 
 Similar cell death results were observed in the dentate gyrus when analyzed by 
positive labeling for activated caspase 3 (Fig II-1). The number of activated caspase 3 
positive dying cells in the dentate gyrus was analyzed by three-way ANOVA. Data 
indicated differences in the number of dying cells among the cell layers of the dentate 
gyrus, F (2, 87) = 34, p < 0.0001, but no differences in sex or MeHg treatment. Tukey’s 
HSD post hoc analysis indicated that the hilar region exhibited fewer activated caspase 
3-positive cells compared to the granular and subgranular layers, and that the granular 
layer exhibited fewer activated caspase 3-positive cells than the subgranular layer. An 
interaction between cell layers and MeHg treatment also was observed, F (4, 87) = 2.5, p 
= 0.0490, indicating that the differences in the number of dying cells among the cell 
layers of the dentate gyrus were greater in controls than in MeHg treated mice. Similar 
to the results indicated by Fluoro-Jade B staining, no differences were observed in the 
number of activated caspase 3 positive dying cells among sex, cell layer, or MeHg 
treatment in the hippocampus proper when analyzed by three-way ANOVA. 
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FIG. II-1.  Fluoro-Jade B and activated caspase 3 positive cell counts in the granular, hilar, and 
subgranular cell layers of the dentate gyrus of young adult mice treated with 0, 1.0, or 5.0 mg/kg total dose 
MeHg divided over five days. There was a difference in the number of dying cells among cell layers of the 
dentate gyrus for both the Fluoro-Jade B (F (2, 87) = 42, p < 0.0001) and activated caspase 3 (F (2, 87) = 
34, p < 0.0001) methods when analyzed by three-way ANOVA. Tukey’s HSD post hoc analysis indicated 
that the subgranular and granular layers exhibited more dying cells than the hilar region (*), and the 
subgranular layer exhibited more dying cells than the granular layer (†). No difference was observed in the 
number of Fluoro-Jade B or activated caspase 3 positive dying cells between sexes or among treatments. 
An interaction in the number of dying cells between cell layers and MeHg treatments was observed 
(Fluoro-Jade B: F (4, 87) = 3.56, p = 0.0098; activated caspase 3: F (4, 87) = 2.5, p = 0.0490) indicating 
that the differences in the number of dying cells among the dentate gyrus cell layers was greater in 
controls than in MeHg treated mice. Data are represented as mean ± standard error of the mean. α = 0.05 
for all statistical analyses.  
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 The number of Fluoro-Jade B positive dying cells was analyzed by three-way 
ANOVA to determine differences associated with sex, cell layers of the cerebellum, and 
MeHg treatment. Data indicated an overall effect, F (17, 846) = 38.6, p < 0.0001, with 
main effects exhibited for sex, F (1, 846) = 8, p = 0.0048, cell layer, F (2, 846) = 46, p < 
0.0001, and MeHg treatment, F (2, 846) = 38, p < 0.0001 (Fig II-2). An interaction 
among sex, cell layer, and MeHg treatment also was observed, F (4, 846) = 4.42, p = 
0.0015, indicating that the MeHg treatment differences were greater in females than 
males and greater in the molecular layer than the granule and Purkinje cell layers. 
Tukey’s HSD post hoc analysis indicated that the molecular and granule cell layers had 
more dying cells than the Purkinje cell layer for both males and females at all MeHg 
treatment concentrations. The molecular layer exhibited more dying cells than the 
granule cell layer for female control and 5.0 mg/kg total dose MeHg treated cerebella, 
and for male control cerebella. The Student’s t-test post hoc analysis indicated that 
Fluoro-Jade positive dying cells were increased in female control molecular, granule, 
and Purkinje cell layers compared to those same layers in control male cerebella. 
Increased numbers of dying cells in females compared to males were observed only in 
the molecular layer of 5.0 mg/kg treated mice. Tukey’s HSD post hoc analysis for 
treatment differences indicated that Fluoro-Jade B positive dying cells were increased in 
the 5.0 mg/kg MeHg treatment compared to controls in all cerebellar cell layers in both 
males and females. The 1.0 mg/kg total dose MeHg treatment exhibited increases in the 
number of dying cells compared to controls in the granule cell layer of male mice only. 
Fluoro-Jade B positive dying cells were also analyzed by three-way ANOVA to 
determine differences associated with sex, cerebellar forebrain / hindbrain, and MeHg 
treatment for each of the cell layers, independently. No difference was observed in the 
number of dying cells between the forebrain and hindbrain regions of the cerebellum in 
any of the three cerebellar cell layers in male or female mice. 
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FIG. II-2.  Fluoro-Jade B positive cell counts in the granular, molecular, and Purkinje cell layers of the 
cerebellum of female and male young adult mice treated with 0, 1.0, or 5.0 mg/kg total dose MeHg 
divided over five days. Main effects were indicated for sex, F (1, 846) = 8, p = 0.0048, cell layer, F (2, 
846) = 46, p < 0.0001, and MeHg treatment, F (2, 846) = 38, p < 0.0001. Tukey’s HSD post hoc analysis 
indicated more dying cells in the molecular layer than the granule cell layer for 0 and 5.0 mg/kg MeHg 
treated females and for control males (*). Dying cells were increased in females compared to males in 
controls for the molecular, granule, and Purkinje cell layers, and in the 5.0 mg/kg MeHg treatment 
molecular layer (†). Increased dying cells were observed in the 5.0 mg/kg MeHg treatment compared to 
controls in all three cell layers for both males and females (‡). Dying cells were increased in the 1.0 mg/kg 
MeHg treatment compared to controls in the male granule cell layer (•). An interaction in the number of 
dying cells for sex, cell layer, and MeHg treatment was observed indicating that MeHg treatment 
differences were greater in females than males and greater in the molecular layer than the granule and 
Purkinje cell layers, F (4, 846) = 4.42, p = 0.0015. Data are represented as mean ± standard error of the 
mean. α = 0.05 for all statistical analyses. 
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Results in the cerebellum for activated caspase 3 were similar to those observed 
for Fluoro-Jade B staining. Three-way ANOVA, used to determine differences 
associated with sex, cell layers of the cerebellum, and MeHg treatment, indicated an 
overall effect, F (17, 846) = 30.0, p < 0.0001 (Fig II-3). Main effects were indicated for 
sex, F (1, 846) = 17, p < 0.0001, cell layer, F (2, 846) = 30, p < 0.0001, and MeHg 
treatment, F (2, 846) = 33, p < 0.0001. An interaction among sex, cell layer, and MeHg 
treatment also was observed, F (4, 846) = 4.15, p = 0.0025, indicating that the MeHg 
treatment differences were greater in female mice compared to male mice, and greater in 
the molecular layer than the granule and Purkinje cell layers. Tukey’s HSD post hoc 
analysis indicated that the molecular and granule cell layers exhibited increased dying 
cells compared to the Purkinje cell layer in both male and female mice for all MeHg 
treatments, including controls. In addition, the molecular layer exhibited increased dying 
cells compared to the granule cell layer in the female control mice and in mice treated 
with a total dose of 5.0 mg/kg MeHg. Student’s t-test post hoc analysis indicated 
increased numbers of dying cells in female mice compared to male mice for all control 
cell layers and for both the 1.0 and 5.0 mg/kg treated molecular layers. Tukey’s HSD 
post hoc analysis for treatment differences indicated that the number of dying cells in the 
male molecular and granule cell layers exhibited increased dying cells in the 1.0 and 5.0 
mg/kg total dose MeHg treatments compared to controls, and that there were increased 
numbers of dying cells in the female molecular layer for the 5.0 mg/kg MeHg treatment 
compared to controls. As with Fluoro-Jade B analysis, a three-way ANOVA was 
performed to determine differences associated with sex, rostral and caudal regions of the 
cerebellar vermis, and MeHg treatment for each of the cell layers, independently. 
Analysis indicated no differences in the number of dying cells between the rostral and 
caudal regions of the cerebellar vermis in any of the three cerebellar cell layers for male 
or female mice. 
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FIG. II-3.  Activated caspase 3 positive cell counts in the granular, molecular, and Purkinje cell layers of 
the cerebellum of female and male young adult mice treated with 0, 1.0, or 5.0 mg/kg total dose MeHg 
divided over five days. When analyzed by three-way ANOVA, main effects were indicated for sex, F (1, 
846) = 17, p < 0.0001, cell layer, F (2, 846) = 30, p < 0.0001, and MeHg treatment, F (2, 846) = 33, p < 
0.0001. Tukey’s HSD post hoc analysis indicated that dying cells were increased in the molecular layer 
compared to the granule cell layer in female control and 5.0 mg/kg MeHg treatments (*). Increased 
numbers of dying cells were observed in females compared to males for all control cell layers and for the 
5.0 mg/kg MeHg treated molecular layer (†). In females, the 5.0 mg/kg MeHg treated molecular layer 
exhibited increased numbers of dying cells compared to controls (‡). In males, the 1.0 and 5.0 mg/kg 
MeHg treated molecular and granule cell layers exhibited increased numbers of dying cells compared to 
controls (‡). An interaction in the number of dying cells for sex, cell layer, and MeHg treatment was 
observed indicating that MeHg treatment differences were greater in females than males and greater in the 
molecular layer than the granule and Purkinje cell layers, F (4, 846) = 4.15, p = 0.0025. Data are 
represented as mean ± standard error of the mean. α = 0.05 for all statistical analyses. 
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Identification and validation of acutely isolated cells as neurons 
Examples of neurons isolated from cerebella and hippocampi of young adult 
mice are shown in Fig II-4. Double fluorescence imaging using NeuN to label nuclei and 
cytoplasm of neurons and DAPI to label nuclei of all cells showed the isolation 
procedure used in this study yielded predominantly more neurons than other cell types. 
All nuclei were labeled with DAPI (blue) and nuclei and some cytoplasm of neurons 
were labeled with NeuN (red). Granule cells were distinguished from other neurons 
based on their small cell size (5 – 8 µm). 
 
 
FIG. II-4. NeuN and DAPI double-labeled cells isolated from the cerebellum and hippocampus of young 
adult control mice. A, B, and C are cells from the cerebellum. D, E, and F are cells from the hippocampus. 
A and D show cells labeled with NeuN; B and E show cells labeled with DAPI; C and F are overlay 
images of cell labeled with NeuN and DAPI. Granule cells were distinguished from other neurons based 
on their small size (5 – 8µm). The majority of isolated cells were double-labeled granule cells. Scale bar = 
10 µm. 
 
 
Mitochondrial membrane potential 
Membrane potential (MMP) of the inner mitochondrial membrane of isolated 
cerebellar and hippocampal granule cells was analyzed using TMRM dye and 
fluorescence microscopy to determine whether in vivo treatment with MeHg altered 
mitochondrial function. Images of fluorescent mitochondria in hippocampal granule 
cells are shown in Fig II-5. Analysis by three-way ANOVA indicated an overall 
difference, F (11, 61) = 6.66, p < 0.0001, with between-subject differences among 
MeHg treatments, F (2, 61) = 12, p < 0.0001. Tukey’s HSD post hoc analysis indicated 
that MMP was increased in female cerebellar granule cells exposed to a total dose of 1.0 
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mg/kg MeHg compared to controls. MMP also was increased in female hippocampal 
cells exposed to a total dose of 5.0 mg/kg MeHg compared to the 1.0 mg/kg MeHg 
treatment and controls. In males, Tukey’s HSD post hoc analysis for MeHg treatment 
indicated that male cerebellar granule cells exposed to 5.0 mg/kg MeHg exhibited 
increased MMP compared to controls (Fig II-6). No between-subject differences were 
observed between sexes or between cerebellar and hippocampal brain regions; however, 
an interaction was observed among sex, brain region, and MeHg treatment, F (2, 61) = 
7.2, p = 0.0015, indicting that the increased MMP associated with MeHg treatment was 
greater in females than males, and greater in the cerebellum than the hippocampus. 
CCCP was added to isolated control granule cells (positive method control) to verify that 
the method used to measure changes in MMP was, in fact, measuring changes in MMP. 
CCCP uncouples oxidative phosphorylation within mitochondria which results in 
decreased MMP. Addition of CCCP to control cells incubated with TMRM resulted in a 
dramatic decrease in the fluorescence intensity of mitochondria indicating depolarization 
of the mitochondrial membrane (data not shown); no auto-fluorescence was observed in 
samples without TMRM dye, nor in samples without cells that contained TMRM dye 
(negative controls, data not shown). 
 
 
FIG. II-5. Representative images of young adult isolated female hippocampal granule cells treated with 0 
or 5.0 mg/kg total dose MeHg divided over five days. Cells were acutely isolated, incubated with 150 nM 
TMRM for 20 min, and imaged by fluorescence microscopy. Mitochondria accumulated TMRM and 
appeared as individual red dots within the granule cells. Fluorescence intensity is relative to mitochondrial 
membrane potential. Mitochondria in 5.0 mg/kg total dose MeHg treated female hippocampal cells 
exhibited increased fluorescence compared to mitochondria in control cells indicating that MMP was 
increased in treated cells compared to controls. Scale bar = 10 µM. 
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FIG. II-6.  Relative mitochondrial membrane potential (MMP) in isolated cerebellar and hippocampal 
granule cells from young adult mice treated with 0, 1.0, of 5.0 mg/kg total dose MeHg divided over five 
days. Cells were incubated with 150.0 nM TMRM for 20 min and imaged by fluorescence microscopy. 
Data were collected for individual mitochondria within the isolated granule cells. Analysis by three-way 
ANOVA indicated between-subject differences for MeHg treatment, F (2, 61) = 12, p < 0.0001, but not for 
sex and brain regions. An interaction was indicted among sex, brain region, and MeHg treatment, F (2, 61) 
= 7.2, p = 0.0015. Cerebellar granule cells from females treated with 1.0 mg/kg MeHg exhibited increased 
MMP compared to controls (*). MMP also was increased in female hippocampal granule cells treated with 
5.0 mg/kg MeHg compared to 1.0 mg/kg MeHg treated cells and controls (*).  For males, MMP was 
increased in cerebellar granule cells treated with 5.0 mg/kg MeHg compared to controls (*). The observed 
interaction indicated that differences in MMP associated with MeHg treatment were greater in females 
than males and greater in the cerebellum than the hippocampus. Data are represented as mean ± standard 
error of the mean and as % control to eliminate experimental various from day to day; α = 0.05 for all 
statistical analyses. 
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Basal intracellular Ca2+ 
Calcium ion homeostasis was examined by measuring [Ca2+]i in isolated 
cerebellar and hippocampal granule cells from male and female young adult mice treated 
with 0, 1.0, or 5.0 mg/kg MeHg for five days. Representative images of fluorescent Ca2+ 
in isolated female hippocampal granule cells from control and mice treated with a total 
dose of 5.0 mg/kg MeHg treated mice are shown in Fig. 7. Analysis by three-way 
ANOVA indicated an overall effect, F (11, 60) = 6.75, p < 0.0001, with no between-
subject differences, but with interactions between brain region and MeHg treatment, F 
(2, 60) = 4, p = 0.0247, and between sex and MeHg treatment, F (2, 60) = 13, p < 
0.0001. Tukey’s HSD post hoc analysis indicated that [Ca2+]i was increased in the 5.0 
mg/kg MeHg treated female hippocampus compared to controls, increased compared to 
similarly treated male hippocampi, and increased compared to 5.0 mg/kg MeHg treated 
female cerebellar granule cells. These data and the exhibited interaction indicated that 
the increase in [Ca2+]i in the 5.0 mg/kg MeHg treatment were greater in females than 
males, and greater in the hippocampus than the cerebellum (Fig. 8). Thapsigargin was 
added to isolated control cerebellar and hippocampal granule cells as a method control to 
validate the measurement of changes in [Ca2+]i. Thapsigargin is an inhibitor of sarco-
endoplasmic reticulum Ca2+ ATPases and raises cytosolic free Ca2+ by blocking the 
ability of the cell to pump Ca2+ into the endoplasmic reticulum (Treiman et al., 1998). 
Addition of thapsigargin to isolated control cerebellar and hippocampal granule cells 
(positive method control) resulted in a substantial increase in the fluorescence within the 
cells, indicating an increase in [Ca2+]i; no auto-fluorescence was observed in samples 
without Calcium Green-1, nor in samples without cells that contained Calcium Green-1 
(negative controls), indicating minimal atmospheric and/or photo-oxidation (data not 
shown). 
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FIG. II-7. Representative images of isolated hippocampal granule cells from a female young adult mouse 
treated with 0 or 5.0 mg/kg total dose MeHg divided over five days. Free [Ca2+]i bound to Calcium Green-
1 dye is green when examined by fluorescence microscopy. Granule cells from the 5.0 mg/kg MeHg 
treated female hippocampus exhibited increased intensity of green color indicating that the MeHg treated 
hippocampal cells contained higher levels of free [Ca2+]i than did control hippocampal cells. Scale bar = 
10 µm. 
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FIG. II-8. Relative basal intracellular free Ca2+ ([Ca2+]i) in isolated cerebellar and hippocampal neurons 
from young adult male and female mice treated with 0, 1.0, or 5.0 mg/kg total dose MeHg divided over 
five days. Analysis by three-way ANOVA, F (11, 60) = 6.75, p < 0.0001, indicated an overall difference, 
but no between-subject differences associated with sex, brain region, and MeHg treatment. However, 
interactions were indicated between sex and MeHg treatment, F (2, 60) = 4, p = 0.0247, and between brain 
regions and MeHg treatment, F (2, 60) = 13, p < 0.0001. Tukey’s HSD post hoc analysis indicated that 
female hippocampal granule cells treated with 1.0 mg/kg MeHg exhibited higher [Ca2+]i than controls (*). 
In addition, female hippocampal granule cells treated with 5.0 mg/kg MeHg also exhibited higher [Ca2+]i 
than similar treated male hippocampal granule cells (†) and female cerebellar granule cells treated with 5.0 
mg/kg MeHg (‡). The interactions suggested by three-way ANOVA and specific differences suggested by 
Tukey’s HSD post hoc analyses indicated that the differences in [Ca2+]i observed in the 5.0 mg/kg MeHg 
treatment were greater in females than males, and greater in the hippocampus than the cerebellum. Data 
are represented as mean ± standard error of the mean and as % control to eliminate experimental variation 
from day to day; α = 0.05 for all statistical analyses. 
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Reactive oxygen species 
The rate of generation and the level of ROS in isolated cerebellar and 
hippocampal granule cells from mice treated with 0, 1.0, or 5.0 mg/kg MeHg divided 
over five days was measured by fluorescence microscopy and imaging of the 
fluorescence of the dye CM-H2DCFDA every 2.5 min for 30 min. Data for the rate of 
ROS generation were analyzed by three-way MANOVA with repeated measures for 
ROS reading time to determine between-subject differences associated with sex, brain 
region, and MeHg treatment. Analysis indicated no between-subject differences or 
interactions in the rate of ROS production for sex, brain regions, or MeHg treatment. 
Data did not meet the condition of sphericity; therefore data were analyzed by the 
Greenhouse-Geisser adjusted univariate analysis to determine within-subject differences 
(Grieve, 1984). Adjusted univariate analysis for the rate of ROS production indicated 
within-subject interactions between ROS reading time and sex, F (2, 122) = 3.74, p = 
0.0259, and between ROS reading time and MeHg treatment, F (4, 122) = 3.98, p = 
0.0043. Within-subject differences in both sex, and MeHg treatment, did not occur until 
reading time point twelve. These with-subject interactions indicated that the rate of ROS 
production was increased in males compared to females, and increased in controls 
compared to the 1.0 and 5.0 mg/kg MeHg treatments over the 30 minutes of reading time 
(Fig II-9).  
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FIG. II-9. Relative rate of reactive oxygen species (ROS) production in isolated granule cells from the 
cerebellum and hippocampus of young adult mice exposed to 0, 1.0, or 5.0 mg/kg total dose MeHg 
divided over five days. The rate of ROS production were measured in isolated granule cells from the 
cerebellum and hippocampus every 2.5 min for 30 min. Data were analyzed by three-way MANOVA with 
repeated measures for ROS reading time. No between-subject effects were indicated for sex, brain region 
(cerebellum and hippocampus), or MeHg treatment. Data were further analyzed by adjusted univariate 
analysis to determine with-subject differences. Data indicated within-subject interactions between ROS 
reading time and sex, and between ROS reading time and MeHg treatment, that occurred at reading time 
point twelve. The rate of ROS production was increased in males compared to females (*), and decreased 
in the 1.0 and 5.0 mg/kg MeHg treatments compared to controls (†). Within subject interactions: reading 
time and sex, F (2, 122) = 3.74, p = 0.0259, and reading time and MeHg treatment F (4, 122) = 3.98, p = 
0.0043; α = 0.05. 
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In addition to the rate of ROS generation, the relative amount of ROS produced 
was analyzed by three-way MANOVA with repeated measures for ROS reading time to 
determine between-subject differences and interactions associated with sex, brain region, 
and MeHg treatment. Analysis indicated between-subject differences in brain region, F 
(1, 60) = 10.3, p = 0.0021, and sex, F (1, 60) = 7.89, p = 0.0067. In addition, between-
subject interactions were indicated for brain region and sex, F (1, 60) = 10.95, p = 
0.0016, and for brain region and MeHg treatment, F (2, 60) = 4.36, p = 0.017. The 
indicated between-subject interactions suggested that the level of production of ROS is 
increased in males compared to females, and increased in the hippocampus compared to 
the cerebellum (Fig II-10). Data did not meet the condition of sphericity; therefore data 
were analyzed by the Greenhouse-Geisser adjusted univariate analysis to determine 
within-subject differences and interactions (Grieve, 1984). Adjusted univariate analysis 
for the level of ROS produced indicated within-subject interactions between ROS 
reading time and sex, F (2, 105) = 1.43, p = 0.0035, and between ROS reading time and 
MeHg treatment, F (4, 105) = 4.43, p = 0.0037. Within-subject differences in sex began 
at reading time six and continued to reading time twelve. Within-subject differences in 
MeHg treatment began at reading time seven and continued to reading time twelve. 
These within-subject interactions suggested that the level of ROS production was higher 
in males than females, and higher in controls than MeHg treatments over the 30 minutes 
of reading time (Fig II-10). Tertiary butyl hydroperoxide (tBHP) was added to isolated 
control cerebellar and hippocampal granule cells as a method control to validate the 
measurement of changes in [Ca2+]i. tBHP penetrates the cell membrane and react with 
heme-proteins to produce alkoxyl radicals. Addition of tBHP to isolated control granule 
cells (positive control) resulted in a dramatic increase in the fluorescence within the cells 
indicating an increase in the level of ROS; no auto-fluorescence was observed in 
samples without CMH2DCFDA dye, nor in samples without cells that contained 
CMH2DCFDA (negative control), indicating minimal atmospheric and/or photo-
oxidation (data not shown).
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FIG. II-10. Relative level of reactive oxygen species (ROS) in isolated granule cells from cerebella and hippocampi of young adult mice exposed to 0, 
1.0, or 5.0 mg/kg total dose MeHg divided over five days. The level of ROS were measured in isolated granule cells from the cerebellum and 
hippocampus every 2.5 min for 30 min. Data were analyzed by three-way MANOVA with repeated measures for ROS reading time. Between-subject 
effects were indicated for brain region (cerebellum and hippocampus) and sex. Between-subject interactions were indicated for brain region and sex, and 
for brain region and MeHg treatment. Level of ROS was greater in males than females, and greater in the hippocampus than the cerebellum. Data were 
further analyzed by adjusted univariate analysis to determine with-subject differences. Data indicated within-subject interactions between ROS reading 
time and sex, and between ROS reading time and MeHg treatment. Differences in males and females began at reading time six. Differences among 
MeHg treatments began at reading time seven. Between-subject effect: brain region, F (1, 60) = 10.3, p = 0.0021, and sex, F (1, 60) = 7.89, p = 0.0067. 
Between-subject interactions: brain region and sex, F (1, 60) = 10.95, p = 0.0016, brain region and MeHg treatment, F (2, 60) = 4.36, p = 0.017. Within 
subject interactions: reading time and sex, F (2, 105) = 1.43, p = 0.0035, and reading time and MeHg treatment, F (4, 105) = 4.43, p = 0.0037; α = 0.05.
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DISCUSSION 
As hypothesized, total Hg accumulated in brain tissue, and cell death and [Ca2+]i 
increased with MeHg exposure. However, MMP was increased and no differences in 
ROS were indicated with MeHg exposure. Total Hg accumulated in cerebella and 
hippocampi in a dose-dependent manner in both male and female mice exposed to MeHg 
in their food. No difference in the accumulation of total Hg was observed between males 
and females, or between the cerebellum and the hippocampus. A study by Vahter et al. 
(1995) using Macaca fascicularis monkeys given 50 µg/kg body weight MeHg for 
eighteen months showed evenly distributed total Hg throughout the brain. Similarly, in 
pigs given a single oral dose of 5.0 mg/kg MeHg (Platonow, 1968), and in mice given 
2.0 mg/kg MeHg for five days (Somjen et al., 1973a), no differences were observed in 
total Hg concentration in the cerebral cortex (4.1 ppm for pigs and 3.1 µg/kg w. w. for 
rats) and the cerebellum (4.0 ppm for pigs and 3.2 µg/kg w. w. for rats). This same study 
by Somjen et al. (1973a) reported the percentage of total Hg in all brain tissue compared 
to the total dose administered to be 0.02 to 0.12 %, which corresponds to our 0.04 to 
0.05 % values for the percentage of total Hg in brain tissue compared to the total dose 
administered. 
Fluoro-Jade B staining and activated caspase 3 immunohistochemistry were used 
to detect the presence of dying cells. Patterns of positively identified dying cells for 
Fluoro-Jade B and activated caspase 3 were similar in the dentate gyrus of the 
hippocampus. Although, the three-way ANOVA indicated an overall difference in cell 
death in the dentate gyrus, post hoc analysis showed increased numbers of dying cells in 
the granular and subgranular zones compared to the hilar region. The subgranular zone 
of the dentate gyrus is an area of neurogenesis in the adult hippocampus and will 
naturally contain greater numbers of dying cells than non-proliferating regions (Eriksson 
et al., 1998;  Gage et al.,1998). The data showed an interaction effect in the number of 
dying cells between cell layers and MeHg treatments, suggesting that the differences in 
the number of dying cells among regions of the dentate gyrus were decreased in the 
MeHg treated mice compared to controls. A decrease in cell death in the subgranular or 
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granular zone may be connected to decreased neurogenesis. MeHg has been shown to 
decrease cell proliferation and alter cell cycle regulation (Faustman et al., 2002;  
Mendoza et al., 2002) in developing neurons. This interaction may represent an affect of 
MeHg on the process of neurogenesis in the subgranular zone, but the low sample size (n 
= 6) may not be powerful enough to show significant main effects. 
Cell death in the cerebellum was increased in females compared to males, in the 
5.0 mg/kg total MeHg treatment compared to controls, and in the molecular and granule 
cell layers compared to the Purkinje cell layer. MeHg is known to cause cell death, 
particularly in granule cells of the cerebellum of adult humans and animals and in 
cultured cells (Bakir et al., 1980;  Fonfria et al., 2002;  Kunimoto, 1994). In the present 
study, both the granule and molecular layers exhibited increased numbers of dying cells, 
specifically in the high MeHg treatment group. In support of our findings, literature 
indicates that cerebellar degeneration associated with high exposure to MeHg involves 
significant cell death in the granule cell layer, although increased cell death is usually 
observed in basket and stellate cells of the molecular layer as well (Chang, 1977;  
Takeuchi et al., 1962). Purkinje cells, however, are preserved upon MeHg exposure 
(Sager et al., 1984). Although no extensive research in sex differences associated with 
MeHg-induced cell death exists, a study by Magos et al. (1981) revealed that female rats 
developed more intensive coordination disorders and had more extensive damage in the 
granular layer of the cerebellum than males with similar MeHg treatment. In contrast, 
Evans et al. (1977) showed that female macaques accumulated Hg within the brain and 
had neurological signs of MeHg toxicity similarly to male macaques exposed to the 
same MeHg treatment. Conflicting data on male and female differences in cell death 
caused by MeHg exposure could be due to species or MeHg concentration differences. 
As in the current study, Evans et al. (1977) used a rodent model, and a somewhat higher 
MeHg concentration (10 mg/kg total) compared to the present study, whereas Magos et 
al. (1981) used a primate model and higher MeHg concentrations for a longer period of 
time. Cell death in the present study was observed primarily in the 5.0 mg/kg total MeHg 
treatment, however, the 1.0 mg/kg total MeHg treatment resulted in increased cell death 
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in the male granule and molecular cell layers. No literature is available at this time to 
corroborate the sex difference in cell death observed at lower concentrations. However, 
Carrillo et al. (1992) and Taskiran et al. (1997) have reported sex-related differences in 
antioxidant defenses in the rat brain, with catalase activity being higher in females than 
males. In addition, liver mitochondria from female rats exhibit higher expression of 
antioxidant enzymes compared to males (Borrás et al., 2003). Estrogen also is known to 
exert protective affects by acting as a scavenger of ROS or inducing the synthesis of 
protective molecules via activation of estrogen receptors (Behl et al., 1995). These 
protective aspects associated with cells from females may play a role in the decrease in 
cell death observed in the 1.0 mg/kg total MeHg treated cerebella. 
Literature suggests that MeHg exposure decreases MMP (Dreiem and Seegal, 
2007), which result in increases in ROS (InSug et al., 1997) that increases [Ca2+]i (Marty 
and Atchison, 1998;  Ueha-Ishibashi et al., 2004) in dying cells. Our data suggest that 
changes in MMP, basal [Ca2+]i, and ROS associated with both the 1.0 and 5.0 mg/kg 
total MeHg treatment concentrations may be indicative of cellular activities other than 
apoptosis. Our data indicated increased cell death in the 5.0 mg/kg total MeHg 
treatment, but the typically reported pattern of MMP, [Ca2+]i, and ROS changes was not 
observed. 
The present study indicated that MMP and basal [Ca2+]i were increased with 
MeHg treatment to a greater extent in females than males, but that ROS were decreased 
in females compared to males. As stated previously, females exhibit increased 
antioxidant defenses compared to males (Behl et al., 1995;  Borrás et al., 2003;  Carrillo 
et al., 1992;  Taskiran et al., 1997). The process of activating the proteins necessary for 
these antioxidant defenses may involve increased transcription and translation, both of 
which would result in increased mitochondrial activity. 
We observed that MMP increases were greater in the cerebellum than the 
hippocampus, whereas [Ca2+]i increases were greater in the hippocampus than in the 
cerebellum. [Ca2+]i in the granule cells of the cerebellum may be held at a stable level by 
sequestration of Ca2+ in the mitochondria. One of the roles of mitochondria is to aid in 
  
120
the maintenance of [Ca2+]i homeostasis (Nicholls et al., 2007). Mitochondrial Ca2+ 
uptake is primarily driven by the electrochemical gradient established by the MMP. 
Energized mitochondria will move Ca2+ from the cytosol into the matrix in proportion to 
the MMP, thus preventing an even greater increase in cell death. 
Data also indicted that MeHg treatment had no effect on ROS production, but 
ROS production was increased in the hippocampus compared to the cerebellum. Studies 
indicate that ROS play a role in cell cycle progression and cell proliferation. Metabolic 
by-products of fatty acids have been shown to be stimulatory to cell proliferation (Bégin, 
1987). These by-products are a result of oxidation by ROS. The observed increase in 
ROS production in the hippocampus compared to the cerebellum may be associated with 
neurogenesis which occurs in the subgranular layer of the hippocampus.  
The hippocampus in the present study exhibited decreased cell death with MeHg 
treatment, in addition to the decreased MMP and increased ROS compared to the 
cerebellum. Studies show that TNFα induces cytoprotection by inducing the production 
of free radicals from mitochondria, which stimulates cytoprotective mechanisms. The 
short-term generation of ROS results in a modest and temporal membrane depolarization 
(Lacerda et al., 2006). MeHg exposure may exert stress upon hippocampal cells, leading 
to the production of cytoprotective ROS produced in association with a decrease in 
MMP over a short period of time. 
MMP, Ca2+, and ROS have many functions in neurons other than induction of 
apoptosis. Neurons exhibit [Ca2+]i oscillations that may be associated with synaptic 
strengthening among neurons in the same domain (Singer, 1993;  Stryker et al., 1990). 
In neuronal spines and dendrites, [Ca2+]i changes are mediated by the NMDA receptor 
which is crucial for the generation of long-term potentiation (LTP) associated with 
learning and memory (Alford et al., 1993;  Collingridge and Bliss, 1995). [Ca2+]i 
changes in neurons initiate signaling pathways that trigger gene transcription (Bailey et 
al., 1996;  Martin et al., 1997). Mitochondria are involved in more than energy 
production and induction of apoptosis (Green and Reed, 1998). They function in 
xenobiotic metabolism and glucose sensing (Maechler, 2002), as well as steroid 
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hormone synthesis and lipid metabolism (Brookes et al., 2004). In addition, ROS are 
involved not only in damage of membranes by lipid peroxidation (Gardner, 1989) and 
the crosslinking of proteins (Davies, 2005), but are important for cell signaling (Brookes 
and Darley-Usmar, 2002;  Brookes et al., 2002) and cell proliferation (Burdon et al., 
1989).  
In summary, we observed dose-dependent uptake of MeHg by the cerebellum 
and hippocampus. Cell death occurred primarily in the 5.0 mg/kg total MeHg treated 
cerebellum, but was also observed in the 1.0 mg/kg total MeHg treated male cerebellum. 
The changes observed in MMP, [Ca2+]i, and ROS were related primarily to sex and brain 
region differences rather than MeHg treatment. There were varying combinations of 
MMP, [Ca2+]i, and ROS changes that suggested responses associated with cell cycle 
regulation, cell proliferation and cytoprotection through Ca2+ sequestering by 
mitochondria, and induction of ROS as signaling molecules. It appears as though 
exposure to 1.0 mg/kg MeHg divided over five days does not cause cell death and 
changes in MMP, [Ca2+]i, and ROS in neurons similar to MeHg exposure concentrations 
at or greater than 5.0 mg/kg divided over five days or more, as indicated by current 
scientific literature. In addition, total MeHg exposure concentrations of 1.0 mg/kg 
divided over five days result in an increase in cell death, but the changes in MMP, 
[Ca2+]i, and ROS are different than what are observed with MeHg exposure 
concentrations of 5.0 mg/kg divided over five days. No thorough studies have been 
conducted to determine the mechanism by which MeHg acts at environmentally relevant 
concentrations. Therefore, based on the data for low-level MeHg exposure in the current 
study, further investigation into the mechanism of action of low-level MeHg exposure is 
warranted. 
  
122
CHAPTER III 
 
 
SUBCELLULAR CHANGES IN CEREBELLAR AND HIPPOCAMPAL 
GRANULE CELLS OF MOUSE PUPS EXPOSED TO METHYLMERCURY 
DURING GESTATION 
 
 
 
SUMMARY 
Neuropathology observed in children exposed to high levels of methylmercury 
(MeHg) during gestation or early development includes generalized brain atrophy and 
abnormal cytoarchitecture of the cerebral and cerebellar cortices. Recent 
epidemiological research from the Faroe Islands and Brazil suggests that chronic low 
levels of MeHg in the diets of pregnant females and young children may have a negative 
affect on motor function, attention, memory, and language development. High levels of 
MeHg exposure are known to cause changes in [Ca2+]i, mitochondrial membrane 
potential (MMP), and production of reactive oxygen species (ROS). However, little is 
known regarding cell death, MMP, [Ca2+]i, and ROS production in neurons from 
developing fetuses and infants exposed to low levels of MeHg. The purpose of this study 
was to determine whether developing mice prenatally exposed to MeHg at chronic low 
levels would exhibit cell death and changes in MMP, [Ca2+]i, and ROS similar to those 
known to occur with high MeHg exposure concentrations. 
Total Hg accumulation, cell death, changes in MMP, [Ca2+]i, and ROS 
production were determined in cerebella and hippocampi from C57Bl/6 male and female 
mouse pups at postnatal day (P) 0 and 10 exposed to a total dose of 0, 0.1, or 1.0 mg/kg 
dam body weight MeHg in food divided over gestational days (G)8 to 18. We observed 
dose-dependent uptake of MeHg by the cerebellum and hippocampus with decreased 
MeHg concentrations in the brains of mice at P10 compared to P0. Cell death was 
determined using Fluoro-Jade B staining and activated caspase 3 immunohistochemistry. 
No MeHg treatment-associated cell death was observed in cerebella or hippocampi. 
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MMP, [Ca2+]i, and ROS were measured in acutely isolated cerebellar and hippocampal 
granule cells using fluorescence microscopy. MMP was decreased in the 1.0 mg/kg 
MeHg treated P0 cerebella, but increased in the 0. 1 MeHg treated P10 cerebella. MMP 
was increased in female P10 hippocampi with 0.1 mg/kg MeHg treatment. [Ca2+]i was 
increased in the 0.1 and 1.0 mg/kg MeHg treated P0 cerebella, and in the 1.0 mg/kg 
MeHg treated P10 cerebella. [Ca2+]i was increased in male P10 hippocampi with 1.0 
mg/kg MeHg treatment. At both P0 and P10, ROS were increased in MeHg treated 
cerebella compared to controls, but decreased or similar to controls in MeHg treated 
hippocampi.  
The hypothesized pattern of increased cell death, decreased MMP, increased 
[Ca2+]i, and increased ROS which is typical with high MeHg and other toxicant 
exposures that initiate apoptosis, was not indicated for any MeHg treatment in the 
cerebellum or hippocampus at P0 or P10. Our data suggest that chronic low levels of 
MeHg exposure during development may cause mitochondrial dysfunction, oxidative 
stress, and changes in Ca2+ homeostasis that may result in abnormal cellular function, 
proliferation and/or migration rather than death of neurons. More thorough studies are 
necessary to determine the mechanism by which MeHg acts at environmentally relevant 
concentrations. Low-levels of MeHg may affect neuronal function. Therefore, further 
developmental whole animal investigation is warranted at chronic low-level MeHg 
concentrations. 
 
INTRODUCTION 
Methylmercury (MeHg) poisoning was first observed on a large scale in 
Minamata, Japan in 1956. Adults exposed to MeHg through consumption of fish and 
shellfish taken from the Minamata Bay in Japan exhibited visual and sensory 
disturbances and ataxia, along with pathological changes including massive loss of 
neurons in the visual, sensory, and motor cortices of the cerebral cortex and granule cells 
of the cerebellum (Harada, 1995;  Takeuchi et al., 1962). Children exposed to MeHg, 
both in utero and during early postnatal development, suffered a more severe array of 
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symptoms than were observed in adult victims. Mental retardation, primitive reflexes, 
alterations in physical development, and cerebral palsy were the most common side 
effects among surviving neonates and children (Harada, 1977). The immature blood-
brain barrier and the extensive proliferation, migration, and differentiation of neurons 
and glia during CNS development predispose the developing fetus and neonate to 
increased risk of MeHg neurotoxicity (Rodier et al., 1984;  Sager, 1988;  Sager et al., 
1984). Neuropathology observed in children exposed to MeHg included generalized 
brain atrophy, abnormal cytoarchitecture of the cerebral and cerebellar cortices, 
hypoplasia of the corpus callosum, and dysmyelination of the pyramidal tract 
(Matsumoto et al., 1965).  
Recent epidemiological research from the Faroe Islands (Grandjean et al., 1997;  
Steuerwald et al., 2000) and Brazil (Grandjean et al., 1999b) suggests that MeHg in the 
diets of pregnant females and young children may have a negative affect on motor 
function, attention, memory, and language development. Two areas of the brain 
associated with these functions are the cerebellum and the hippocampus (Mangina and 
Sokolov, 2006). Although the cerebellum is typically associated with motor function 
(Marr, 1969), studies over the last twenty years have indicated that the cerebellum plays 
a significant, although not clearly understood, role in cognitive function (Schmahmann, 
1997;  Schmahmann and Sherman, 1997). 
Developmental exposure to MeHg is known to inhibit cell proliferation and 
decrease cell cycle regulators in the cerebellum and hippocampus of rats (Burke et al., 
2006). Also in rats exposed to MeHg in utero, hippocampal and cerebellar size, DNA 
synthesis, cyclin mRNA, and proteins D1, D3 and E are decreased (Falluel-Morel et al., 
2007). Other affects of in utero MeHg exposure on the hippocampus and cerebellum 
include spontaneous release of noradrenaline (Gasso et al., 2000), neuronal degeneration 
(Wakabayashi et al., 1995), and alterations in the central dopaminergic and serotonergic 
systems (Castoldi et al., 2006). 
In primary cultures of mouse cerebellar granule cells, MeHg exposure results in 
abnormal cell migration (Kunimoto and Suzuki, 1997), inhibition of cell proliferation, 
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decrease in cell cycle regulators (Burke et al., 2006), disruption of glutamate transport, 
(Fonfria et al., 2005), decreased glutathione (Fonnum and Lock, 2004), reduced cellular 
antioxidant status, altered intracellular calcium ion homeostasis (Sirois and Atchison, 
2000), increased reactive oxygen species (ROS) (Ali et al., 1992), and impaired 
mitochondrial function (Mori et al., 2007). Similar results have been observed in 
cultured cortical neurons exposed to MeHg (Kauppinen et al., 1989;  LeBel et al., 1990;  
Mundy and Freudenrich, 2000;  O'Kusky, 1983). 
MeHg exposure is known to cause changes in [Ca2+]i, mitochondrial membrane 
potential (MMP), and ROS production. MeHg produces increased [Ca2+]i in 
cerebrocortical synaptosomes (Kauppinen et al., 1989), cerebellar granule cells 
(Sarafian, 1993), and NG108-15 neuroblastoma/glial hybrid cells (Hare et al., 1993). 
MMP is decreased by MeHg exposure in astrocytes (Yin et al., 2007) and rat cerebellar 
granule cells (Limke and Atchison, 2002). Mitochondrial function is altered by MeHg in 
rat striatal synaptosomes (Dreiem and Seegal, 2007). MeHg exposure results in 
increased production of ROS in rat brain mitochondria (Mori et al., 2007) as well as in 
C6-glial and B35-neuronal cell lines (Kaur et al., 2007).  
Mitochondria, Ca2+, and ROS are important in normal neuronal function. 
Neurons exhibit [Ca2+]i oscillations that may be associated with synaptic strengthening 
among neurons in the same domain (Singer, 1993;  Stryker et al., 1990). In neuronal 
spines and dendrites, [Ca2+]i changes, mediated by NMDA receptors, are crucial for the 
generation of long-term potentiation (LTP) (Alford et al., 1993;  Collingridge and Bliss, 
1995). Synaptic strengthening and LTP are believed to be important in learning and 
memory. [Ca2+]i changes in neurons initiate signaling pathways that trigger gene 
transcription (Bailey et al., 1996;  Martin et al., 1997). Mitochondria are involved not 
only in energy production. Mitochondria function in the induction of apoptosis (Green 
and Reed, 1998) xenobiotic metabolism, glucose sensing (Maechler, 2002), steroid 
hormone synthesis, and lipid metabolism (Brookes et al., 2004). Abnormal 
mitochondrial function has been implicated in diseases such as Leigh syndrome, spastic 
paraplegia, and Charcot-Marie Tooth, which result from alterations in the mitochondrial 
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respiratory chain or mitochondrial migration (DiMauro and Schon, 2008).  ROS are not 
only harmful byproducts of cellular respiration that can cause damage to membranes by 
lipid peroxidation (Gardner, 1989) and the crosslinking of proteins (Davies, 2005), but 
are important signalling molecules within the cell (Brookes and Darley-Usmar, 2002;  
Brookes et al., 2002) and function in cell proliferation (Burdon et al., 1989) and 
cytoprotection (Piantadosi and Zhang, 1996).  
The known associations of MeHg exposure with such important neuronal 
processes such as cell proliferation and migration suggests the mechanism(s) of MeHg 
developmental neurotoxicity may involve mitochondrial functions, Ca2+ homeostasis, 
and/or oxidative stress. However, most whole animal studies to date have used relatively 
high exposure levels of MeHg and routes of exposure that are not environmentally 
relevant to modern fish-eating populations (Grandjean et al., 1992a;  Mielke et al., 2006;  
Spurgeon, 2006). Typical MeHg concentrations used in previous in vivo studies range 
from 2.5 mg/kg body weight per day to 6.43 mg/kg per day for up to one month, and are 
administered via intraperitoneal injection or through drinking water (Burke et al., 2006;  
Castoldi et al., 2006;  Farina et al., 2005;  Weiss et al., 2005;  Yee and Choi, 1994). The 
general population is exposed to MeHg primarily through the diet, mainly saltwater 
and/or freshwater fish. The average human daily intake of MeHg is about 2.4 µg 
(International Programme on Chemical Safety, 1990), although some populations with 
high daily fish consumption may average 20  - 100 µg per day (WGMF, 1980). 
Maximum consumption rates are estimated to be 1800 µg per day (International 
Programme on Chemical Safety, 1990;  UNEP, 2002). A daily MeHg intake of 3 – 7 
µg/kg body weight (50 – 125 µg/g mercury in hair) for adults represents a 5% risk of 
neurological damage (International Programme on Chemical Safety, 1990). In addition, 
hair mercury (Hg) levels above 10 – 20 µg/g (0.6 – 1.2 µg/kg body weight daily MeHg) 
in adult females have been shown to correlate with neurological deficits in their children 
(Grandjean et al., 1998;  Grandjean et al., 1997). 
The design of the present study is based on the following known information 
about MeHg developmental toxicity: 1) the developing central nervous system is highly 
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susceptible to MeHg toxicity; 2) the cerebellum and hippocampus are specifically 
targeted; 3) mitochondrial function, Ca2+ homeostasis, and ROS are affected by MeHg 
exposure and are associated with developmental cell proliferation and migration; and 4) 
current MeHg developmental exposure studies use MeHg concentrations that are higher 
than or administered differently than what commonly occurs in human populations. 
The purpose of this study was to determine whether chronic low levels of MeHg 
administered during gestation, at or near exposure levels seen in humans, would produce 
similar effects observed at higher MeHg exposure levels. We hypothesized that total 
mercury (Hg) would accumulate, cell death would increase, mitochondrial membrane 
potential would decrease, and [Ca2+]i and ROS production would decrease in a dose-
dependent manner upon exposure to MeHg. To test this hypothesis, we exposed 
pregnant C57Bl/6 mice to a total dose of 0.1 or 1.0 mg/kg MeHg via their food divided 
over gestational days (G) 8 to 18 (parturition). Treatment days were selected based on 
the high susceptibility of the developing rodent brain to neurotoxicants beginning at G8, 
due to the start of neurulation (Rice and Barone, 2000). We examined the cerebellum 
and hippocampus from pups at P0 (day of birth) or P10 for total Hg accumulation, cell 
death, mitochondrial function, basal [Ca2+]i, and production of ROS. Sections from 
cerebella and hippocampi from mouse pups at P0 and P10 were stained with Fluoro-Jade 
B or immunolabeled with anti-activated caspase 3 antibody to determine the presence of 
cell death via apoptosis or by other means. Neurons from cerebella and hippocampi were 
acutely isolated and examined for changes in MMP, [Ca2+]i, and the production of ROS. 
This study will further the knowledge base of MeHg toxicity in relation to human 
exposure levels, enhance the understanding of MeHg toxicity as seen in young children, 
and provide information to aid in establishing an appropriate MeHg minimum exposure 
level, reference dose. 
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MATERIALS AND METHODS 
Chemicals 
Methylmercuric chloride, 95% (MeHg) was purchased from Alfa Aesar (Ward 
Hill, MA). DOLT-2, DORM-2, and DOLT-3 were purchased from the National 
Research Council Canada (NRCC), Institute for Environmental Chemistry (Ottawa, 
Canada). Fluoro-Jade® B was purchased from Millipore (Temecula, Ca). Affinity-
Purified Rabbit Anti-human/mouse Caspase 3 Active was purchased from R&D Systems 
Inc. (Minneapolis, MN). Biotynilated Goat Anti-Rabbit IgG (H+L), affinity purified was 
purchased from Vector Laboratories, Inc. (Burlingame, CA). Permount® was purchased 
from (Fisher Scientific). DPX Mounting Medium was purchased from (Electron 
Microscopy Sciences, Fort Washington, PA). Minimum Essential Medium Eagle 
(spinner modification with Earle’s salts and NaHCO3, without calcium chloride and L-
glutamine (SMEM)), Minimum Essential Medium Eagle (with Earle’s Salts and L-
glutamine, without sodium bicarbonate (MEM)), deoxyribonuclease I from bovine 
pancreas (DNase I), poly-D-lysine hydrobromide >300,000 kD, L-alanyl-L-glutamine, 
tertiary-Butyl hydroperoxide (tBHP), Hank’s Balanced Salt Solution (modified with 
NaHCO3 and without phenol red (HBSS)), protease type IX (bacterial from Bacillus 
polymyxa), carbonyl cyanide 3-chloro-phenylhydrazone (CCCP), and thapsigargin were 
purchased from Sigma-Aldrich, Inc. (St. Louis, MO). Fetal bovine serum (FBS) was 
purchased from Gemini (Woodland, CA). Anti-NeuN clone A60 IgG1was purchased 
from Chemicon. Tetramethylrhodamine methyl ester perchlorate (TMRM), Calcium 
Green™-1 AM, 5-(and 6)-chloromethyl-2’7’-dichlorodihydrofluorescein diacetate acetyl 
ester (CM-H2DCFDA), Pluronic® F-127, ProLong® Gold Antifade with DAPI, and 
Alexa Fluor® 488 donkey anti-rabbit IgG (H+L) were purchased from 
Invitrogen/Molecular Probes (Eugene, OR). Lab-Tek 2-well chambered coverglasses 
were purchased from Nunc Inc. (Naperville, IL). 
 
  
129
Animals 
All animal procedures were carried out in accordance with guidelines described 
in the Guide for the Care and Use of Laboratory Animals (NRC, 1996). Adult male and 
female C57Bl/6 mice, originally obtained from The Jackson Laboratory (Bar Harbor, 
MA), were housed at the Laboratory Animal Research and Resource building, Texas 
A&M University, at constant temperature (21 - 22°C) and humidity (45 – 55%) with a 
12-hour light/dark photoperiod. 
 
Treatment 
MeHg stock solution (1.0 mg/mL) was prepared in sterile distilled water, and 
then sterilized by filtration and stored at 4°C. Working MeHg solutions were prepared 
from the 1.0 mg/mL stock solution, diluted in sterile distilled water, and stored at 4°C. 
All animals were provided distilled drinking water ad libitum. Each evening, one male 
mouse was placed in a cage containing 3 to 5 female mice. Twelve hours later, the male 
mouse was removed and the female mice were checked for vaginal plugs. Female mice 
containing plugs were weighed, separated, and housed individually for seven days. 
During the seven days, the individually housed female mice were trained to consume all 
of 3.0 g of moistened rodent chow in a 12-hour time period. The feeding and MeHg 
administration procedures used in this study have been used successfully in previously 
published experiments (Bellum et al., 2007a;  Bellum et al., 2007b;  Bellum et al., 
2007c). Dry rodent chow was provided ad libitum only during the 12 hours of light. 
During the 12 hours of dark, dry chow was removed and replaced with 3.0 g of rodent 
chow that was moistened with distilled water to achieve a crumbled texture. The feeding 
dish and cage were examined each morning to ensure that each mouse was consistently 
consuming all of the moistened chow provided. On the seventh day, the individually 
housed female mice were re-weighed. A female mouse was considered pregnant if the 
body weight had increased at least 1.8 g since mating. Pregnant dams were assigned to 
control (distilled water) or a total dose of 0.1 or 1.0 mg/kg body weight MeHg. MeHg 
treatment began on gestational day (G) 8 and continued through G18. The feeding 
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regimen continued as described previously, but 0.01mg/kg or 0.1 mg/kg MeHg was 
added to the food of treated pregnant female mice daily. Treatment days were selected 
based on the high susceptibility of the developing rodent brain to neurotoxicants 
beginning at G8, due to the start of neurulation (Rice and Barone, 2000). All 
experimental procedures were conducted on postnatal day (P) 0 (+ 1 day) or P10 (± 1 
day). Litters were divided such that only one male and one female from a single litter 
were used for any one experiment per postnatal day age; the litter is the statistical unit of 
measure (EPA, 2000;  OECD, 2007). 
 
Mercury accumulation 
Total mercury (Hg) was measured to determine the amount of Hg transported 
into the cerebellum and hippocampus. Male and female mice, three to six for each 
treatment, at both P0 and P10 were anesthetized with isoflurane and decapitated. The 
whole brain was removed and the cerebellum and hippocampus dissected, weighed, 
rapidly frozen in powdered dry ice, and stored at -20°C. Cerebellar and hippocampal 
tissues were freeze-dried for 48 hours and total Hg content was measured in the Trace 
Element Research Laboratory at Texas A&M University, by combustion / trapping / 
atomic absorption (Salvata and Pirola, 1994) on a Milestone Direct Mercury Analyzer 
80, DMA 80 (Milestone Inc., Shelton, CT) equipped with an autosampler and dual cell 
detector. The DMA 80 was calibrated using a calibration blank and a series of seven 
aliquots of certified reference standard ranging from 1 to 750 ng Hg. The calibration line 
was verified using an independent CRM standard (NRCC DOLT-2) and a blank nickel 
boat. Samples were weighed to the nearest 0.00001 g and placed into the DMA 80 in 
pre-combusted nickel boats. A method blank, two certified reference materials (DORM-
2 and DOLT-3), a spiked sample, and a duplicate sample were included at the beginning 
and end of each sample run. The DMA 80 has a detection limit of 0.005 ng Hg and a 
working range of up to 1000 ng Hg (Milestone, Inc. Shelton, CT). Total Hg 
accumulation was determined for the cerebellum and hippocampus from each male and 
female mouse for each age and treatment group. Measured total Hg content (ng Hg) for 
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each sample was divided by the measured wet weight (w.w.) of that sample to determine 
the total Hg concentration in the brain tissue (ng Hg / g w.w.). In addition, total Hg 
concentrations were measured in cerebella and hippocampi from MeHg treated dams ten 
days following parturition. Total Hg concentrations were calculated as were for P0 and 
P10 pups. 
Three-way analysis of variance (ANOVA), followed by Tukey’s HSD or 
Student’s t post hoc tests, as appropriate, were used to determine between-subject 
differences and interactions in total Hg concentration (ng Hg / g w.w.) associated with 
sex, brain region, and MeHg treatment at P0 and P10, independently. Two-way 
ANOVA, followed by Tukey’s HSD or Student’s t post hoc tests, as appropriate, were 
used to determine between-subject differences and interactions in total Hg 
concentrations (ng Hg / g w.w.) associated with brain region and MeHg treatment in 
MeHg treated dams. 
 
Fluoro-Jade B staining 
To detect dying neurons, cells were stained with Fluoro-Jade B, an anionic 
fluorochrome that selectively stains cell bodies, dendrites, axons, and axon terminals of 
degenerating neurons, but does not stain healthy neurons, myelin, vascular elements or 
neuropil (Schmued et al., 1997a;  Schmued et al., 1997b). P0 mice were anesthetized by 
intraperitoneal injection of 150.0 g/kg ketamine and 15.0 mg/kg xylazine and 
decapitated. The whole head was fixed by immersion in 4% phosphate buffered 
paraformaldehyde for 72 hours at 4°C, and then cryoprotected by immersion in 20% 
sucrose in 0.1 M PBS for 48 to 72 hours, or until the head settled to the bottom of the 
sucrose solution. Once cryoprotected, whole heads were rapidly frozen in powdered dry 
ice and stored at -70°C. P10 mice were anesthetized by intraperitoneal injection of 150.0 
mg/kg ketamine and 15.0 mg/kg xylazine. Once anesthetized, they were fixed by 
transcardial perfusion with 6 mL Tyrode’s saline (room temperature) followed by 6 mL 
cold 4% phosphate buffered paraformaldehyde. The brain was removed, immersed in 
cold 4% phosphate buffered paraformaldehyde for 48 hours, and then cryoprotected by 
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immersion in 20% sucrose in 0.1 M PBS for 48 to 72 hours, or until the brain settled to 
the bottom of the sucrose solution. Once cryoprotected, brains were rapidly frozen in 
powdered dry ice and stored at -70°C. 
Serial sagittal sections (15 µm), through whole frozen heads (P0) or brains (P10), 
were cut with a SLEE cryostat (Slee, Mainz, Germany), mounted on gelatin-coated 
slides, and stored at -70°C. Every seventh section was used for Fluoro-Jade B staining to 
ensure that no labeled cell was counted twice. Sections from testes of non-treated adult 
mice and sections of cerebella from P20 to P60 leaner mice were used as negative 
(Fluoro-Jade B dye was excluded from the staining protocol) and positive controls. 
Leaner mice carry an autosomal recessive mutation in the CACNA1A gene coding for 
the α1A pore-forming subunit of CaV 2.1 voltage-gated calcium channel (P/Q-type) 
(Herrup and Wilczynski, 1982). This mutation results in extensive cerebellar granule cell 
death that begins around P10 and continues into adulthood (Herrup and Wilczynski, 
1982;  Lau et al., 2004). Frozen sections were dried for 1 hour at 50°C, cooled for 10 
min, and then stained as described by Schmued and Hopkins (2000). Dried sections were 
placed in a 1% sodium hydroxide in 80% alcohol solution for 5 min, followed by 70% 
alcohol for 5 min, distilled water for 2 min, and then immersed and gently shaken in 
0.06% potassium permanganate in distilled water for 10 min. Sections were rinsed in 
distilled water twice for 1 min each, and then transferred to and shaken gently in 
0.0004% Fluoro-Jade B in 0.1% acetic acid and distilled water for 20 min. Sections were 
then washed again with distilled water three times for 1 min each, and then rapidly dried 
by blowing cool air onto the slides with an air-gun for approximately 20 min. Dried 
slides were immersed in xylene twice for 5 min each, and then coverslipped with DPX 
mounting media. Fluoro-Jade B-positive cells were viewed with a Zeiss Axioplan 2 
microscope (Carl Zeiss, Thornwood, NY) using a fluorescein isothiocyanate (FITC) 
filter and equipped with a Color AxioCam camera. Fluoro-Jade B positive cells were 
counted in the cerebellar vermis and in the dentate gyrus and hippocampus proper of the 
hippocampal formation. At P0 and P10, within the cerebellar vermis, positive cells were 
distinguished between the rostral and caudal cerebellum and among the external 
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germinal, molecular, Purkinje, and granule cell layers. At P0 and P10, positive cells in 
the pyramidal cell layer of the hippocampus proper were distinguished between the CA1 
and CA3 regions. Demarcations of regions in the dentate gyrus were not visible at P0. 
Positive cells in the developing P0 dentate gyrus, regardless of location, were counted as 
a group. At P10, positive cells in the dentate gyrus were distinguished among the 
granular and subgranular zones, and the hilus. Slides were coded to blind the investigator 
as to the treatment and gender of the sections during data collection. 
 Fluoro-Jade positive cell counts were collected from cerebella and hippocampi 
from male and female mice (three to six individuals in each group) at P0 and P10 using a 
minimum of four sections per animal. Data from the four sections were averaged to 
obtain the positive cell counts for each individual animal. Data from the dentate gyrus of 
P0 pups were analyzed by two-way ANOVA to determine between-subject differences 
and interactions associated with sex and MeHg treatment. Data from the dentate gyrus of 
P10 pups were analyzed by three-way ANOVA to determine between-subject 
differences and interactions associated with sex, cell layer of the dentate gyrus, and 
MeHg treatment. Data from the hippocampus proper of P0 and P10 pups were analyzed 
by three-way ANOVA to determine between-subject differences and interactions 
associated with sex, pyramidal cell region, and MeHg treatment. Data from pups at P0 
and P10 were analyzed by three-way ANOVA to determine between-subject differences 
and interactions associated with sex, cerebellar cell layer, and MeHg treatment. Data 
from pups at P0 and P10 were analyzed by three-way ANOVA to determine between-
subject differences and interactions associated with sex, rostral and caudal cerebellar 
vermis, and MeHg treatment for each cerebellar cell layer, independently. Differences, 
as indicated by three-way ANOVA, were analyzed by Tukey’s HSD or Student’s t post 
hoc tests, as appropriate, to determine differences among all treatments or brain regions. 
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Activated caspase 3 immunohistochemistry 
Caspase 3 is activated in the process of apoptosis (Burke et al., 2006). Activated 
caspase 3 immunohistochemistry was used to detect neurons dying by apoptosis. Fixed 
and frozen brain sections adjacent to those for Fluoro-Jade B staining were used for 
activated caspase 3 analysis (see Fluoro-Jade B section for tissue and slide preparation 
procedures). Frozen sections were dried at room temperature for 1 hour, and then 
immersed in 0.3% Triton-X in 0.1 M phosphate buffered saline (PBS) for 1 hour, 
followed by three washes in 0.1 M PBS for 10 min each. Washed slides were immersed 
in 1% hydrogen peroxide 0.1 M PBS for 5 min, followed by two washes in 0.1 M PBS 
for 5 min each with gentle agitation. Sections were transferred to 5% normal goat serum 
in 0.1 M PBS for 1 hour, and then into anti-activated caspase 3 primary antibody 
(1:25000) in 2% normal goat serum and 0.1 M PBS over-night at 4°C (approximately 16 
hours). Following application of the primary antibody, sections were rinsed in 0.1 M 
PBS three times for 10 min each, and then immersed in the biotynilated secondary 
antibody (1:400) in 0.1 M PBS for 2 hours. Sections were then washed in 0.1 M PBS 
three times for 10 min each, followed by immersion in Streptavidin horseradish 
peroxidase (1:5000) in 0.1 M PBS for 2 hours. Sections were rinsed in 0.1 M PBS for 10 
min, and then in 0.05 M Tris-HCl buffer (pH 7.6) twice for 10 min each. Finally, 
sections were placed in 0.024% diaminobenzadine (DAB) (5.0 µL of 30% hydrogen 
peroxide, 150.0 mg of 5% nickel ammonium sulfate, 1.0 mL of 6.2 mg DAB per 500 µL, 
and 25.0 mL of 0.05 M Tris-HCl buffer, pH 7.6) for 20 min, and then washed in 0.05 M 
Tris-HCl buffer (pH 7.6) for 5 min, followed by two washes in 0.1 M PBS for 5 min 
each. Stained slides were dehydrated in a graded series of ethanols (EtOH) and 
counterstained with eosin. Alcohol immersions were as follows: 5 min in 70% EtOH, 5 
min in 80% EtOH, 4 dips in eosin in 80% EtOH, 5 min in 95% EtOH, 5 min in 95% 
EtOH, 5 min in 100% EtOH, and 5 min in 100% EtOH. Following dehydration, tissue 
was cleared by immersion in xylene two times for 5 min each, and then coverslipped 
with Permount® mounting media. Activated caspase 3 positive cells were counted and 
the data analyzed as described for Fluoro-Jade B. As with Fluoro-Jade B, sections from 
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testes of non-treated adult mice and sections of P20 to P60 leaner mouse cerebella were 
used as negative (activated caspase 3 antibody was excluded from the protocol) and 
positive controls. 
 
Acute isolation of cerebellar granule and hippocampal neurons 
Acutely isolated neurons were prepared as described by Oberdoerster (2001) and 
Bellum et al. (2007a). This isolation method yields more than 90% viable cells as 
demonstrated using 0.08% Trypan blue exclusion (Bellum et al., 2007a). Cell isolations 
and subsequent MMP, Ca2+, and ROS imaging were carried out in batches containing 
cells obtained from one animal from each treatment group, all of the same age and 
gender. Mice were anesthetized with isoflurane, and then decapitated. Whole brains 
were removed and cerebella and hippocampi dissected and placed in SMEM (with 2.5 
mM L-alanyl-L-glutamine). All solutions were cold and on ice unless otherwise 
specified. Tissues were chopped into ~ 1 mm pieces with a razor or scalpel blade, and 
then placed in dissociation media (DM), consisting of SMEM, 1.5 U/mL protease, and 
2.5 mM L-alanyl-L-glutamine. Neurons were isolated in DM by mechanical disruption 
by trituration with a 10 mL glass serological pipette. Each of four trituration-cycles 
involved ten triturations followed by a 1 min rest period to allow large tissue pieces to 
sediment. After each cycle, approximately 80% of the DM/cell solution was carefully 
removed, so as not to disturb large settled pieces of brain tissue, and then combined with 
growth media (MEM, sodium bicarbonate, L-alanyl-L-glutamine, 10% FBS) and kept on 
ice. The removed media was replaced with fresh DM before beginning the next 
trituration cycle. DNase I (80 U/ml) was added during the second cycle. Cell solutions 
were centrifuged at 1100 g for 10 minutes and the supernatant discarded. Cell pellets 
were reconstituted in growth media at 37°C and plated onto 2.5% gelatin and 1x poly-D-
lysine-coated chambered coverslips. Chambered coverslips were coated with 2.5% 
gelatin for 10 min and then in 1x poly-D-lysine overnight (approximately 12 hours) at 
4°C. The poly-D-lysine was removed and the coverslips rinsed in warmed (37°C) HBSS 
a few minutes before the cells were added. The HBSS was removed before the cells in 
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growth media were plated. Each individual sample was divided and plated onto three 
separate coverslips, one for each analysis: MMP, basal [Ca2+]i, and ROS. Plated cells 
were incubated at 37°C (5% CO2) for 30 min to allow cells to attach to the coverslip 
surface. 
 
Identification and validation of acutely isolated cells as neurons 
NeuN and DAPI staining of isolated cells were used to identify neurons for 
subsequent analysis. NeuN is a marker for neurons. In the cerebellum, NeuN is specific 
for granule cells (Weyer and Schilling, 2003), and in the hippocampus, NeuN is specific 
for neurons in the granular and subgranular zone and for pyramidal cells of the CA1 and 
CA3 regions (Domoráková et al., 2006). NeuN intensely labels the nucleus and lightly 
labels the cytoplasm of neurons (Domoráková et al., 2006;  Mullen et al., 1992). DAPI 
is a fluorescent stain that binds strongly to DNA and is used to identify the nucleus of 
cells (Robinson et al., 2008). After isolation and 30 min incubation of plated cells, 
growth medium was moved and the cerebellar and hippocampal cells were fixed in 4% 
paraformaldehyde for 15 min. Cells were then washed in 0.1 M PBS twice for 1 min 
each, and then permeabilized with 0.3% Triton-X for 5 min. Cells were washed in 0.1 M 
PBS twice for 3 min each, and then immersed in 5% normal goat serum in 0.1 M PBS 
for 1 hour. Cells were then placed into NeuN primary antibody (1:2000) (Mullen et al., 
1992;  Weyer and Schilling, 2003) in 2% normal goat serum and 0.1 M PBS over night 
(approximately 16 hours) at 4°C. Following application of the primary antibody, cells 
were washed twice for 3 min each, and then immersed in Biotynilated Goat Anti-mouse 
AF594t secondary antibody (1:400) for 2 hours. Finally, the cells were washed in 0.1 M 
PBS twice for 3 min each, and then coverslipped with ProLong® Antifade with DAPI 
(Turville et al., 2008). Cells were imaged using a Zeiss Axioplan 2 microscope (Carl 
Zeiss, Thornwood, NY) with Texas Red and DAPI filters, and equipped with a Color 
AxioCam camera. 
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Mitochondrial membrane potential 
Tetramethylrhodamine methyl ester (TMRM) was used to detect changes in 
mitochondrial membrane potential (MMP) (Barhoumi et al., 2004). TMRM is a 
lipophilic potentiometric mitochondrial dye that accumulates in mitochondria in 
proportion to the membrane potential (Scaduto Jr and Grotyohann, 1999). TMRM dye 
stock solution (1.0 mM) was prepared in 100% methanol and stored in desiccant at -
20°C. TMRM working solution (150.0 nM) was prepared from the 1.0 mM stock 
solution in HBSS just before use.  The methanol concentration in the working solution 
was 0.015%. HBSS was used in the TMRM working solution instead of growth media to 
prevent the TMRM dye from binding to proteins within the medium and inhibiting 
movement of dye into the cells. After cell isolation and a 30 min incubation, growth 
media was removed from the acutely isolated cerebellar and hippocampal neuronal 
cultures and replaced with a 150.0 nM solution of TMRM in HBSS for 20 min at 37°C. 
The TMRM solution was replaced with HBSS for imaging. Three negative controls 
(HBSS and cells with no dye, HBSS with no cells and no dye, and HBSS with dye and 
no cells) and a positive control (HBSS and cells with dye and 20 µM CCCP) were 
included. CCCP was used to determine that the observed fluorescence was associated 
with the mitochondrial membrane and not other non-specific TMRM fluorescence 
(Julian et al., 2005). CCCP is a lipid-soluble weak acid that uncouples oxidative 
phosphorylation in the inner mitochondrial membrane. It enters the mitochondria in a 
protonated form, discharges the pH gradient, then leaves the mitochondria as an anion, 
depolarizing the mitochondrial membrane (Lim et al., 2001). When CCCP is co-
administered to cells with TMRM, the CCCP-induced depolarization of the inner 
mitochondrial membrane results in release of accumulated TMRM from mitochondria 
into the cytosol, and a decrease in fluorescence occurs. 
Fluorescent mitochondrial images were collected over a 10 min time period at 
63x using a Zeiss Axiovert 200M microscope equipped with a Cy3 filter set (excitation: 
560/40 nm, dichroic FT 585; emission: BP 630/75 nm) and SlideBook™ 4.1.0 software 
from Intelligent Imaging Innovations Inc. (3I, Denver, CO). Image retrieval and MMP 
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fluorescent data collection were performed using Simple PCI and Imaging System 
Software (v5.0.0.1503, Compix Inc.). Relative MMP values of individual mitochondria 
from a minimum of ten cells from each animal were measured and averaged to give the 
MMP value for each of three individual animals from each treatment, brain region, sex, 
and age group. Mitochondria were identified as fluorescent round or oblong-shaped 
punctate fluorescence objects within the granule cells. 
MMP data were calculated as percentage of control within each batch (one 
control and one of each treated sample, at a single age, analyzed at the same time) to 
control for inter-analysis variation and allow comparison of data from one day to the 
next. MMP data were analyzed by three-way ANOVA to determine significant between-
subject differences associated with sex, brain region (cerebellum and hippocampus), and 
MeHg treatment. Differences, as indicated by three-way ANOVA, were analyzed by 
Tukey’s HSD or Student’s t post hoc tests, as appropriate to determine differences 
among all brain regions, ages, and MeHg treatments. 
 
Basal intracellular Ca2+ 
Calcium Green™-1 AM was used to measure the relative concentration of basal 
intracellular Ca2+ (Gilroy and Jones, 1992). Calcium Green™-1 AM is a long-
wavelength Ca2+ indicator that exhibits an increase in fluorescence emission intensity 
upon binding to Ca2+ (Eberhard and Erne, 1991). The dye is in the AM ester form, which 
enhances cell permeability and is non-fluorescent in the absence of Ca2+ (Lee et al., 
1999). Upon binding to Ca2+, the dye exhibits an approximately 100-fold increase in 
emission intensity, which enables detection of changes in Ca2+ concentration within a 
large dynamic range (Lee et al., 1999). Calcium Green™-1 AM stock solution (2.0 mM) 
was prepared in 100% DMSO and stored in desiccant at -20°C for up to two weeks. 
Working solutions of Calcium Green™-1 AM (1.0 µM) were prepared just before use in 
0.01% Pluronic® F-127 and HBSS. The final DMSO concentration in the working 
solution was 0.05%. HBSS was used in the Calcium Green™-1 AM working solution 
instead of growth media to prevent the Calcium Green™-1 AM dye from binding to 
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proteins within the medium and inhibiting movement of dye into the cells. After the cell 
isolation and 30 min incubation, growth media was removed and replaced with a 1.0 µM 
solution of Calcium Green™-1, AM in 0.01% Pluronic® F-127 and HBSS for 20 min at 
room temperature. Incubation of the cells with Calcium Green™-1 AM dye at room 
temperature prevents compartmentalization of the dye into cellular organelles. The 
Calcium Green™-1 AM solution was removed and replaced with HBSS for 20 min to 
allow de-esterification of the dye; the AM ester of the molecule, which enhances the 
movement of the dye into the cell, must be removed by endogenous esterases for the dye 
to fluoresce when bound to Ca2+. Three negative controls (HBSS and cells with no dye, 
HBSS with no cells and no dye, and HBSS with dye, but no cells) and a positive control 
(HBSS and cells with dye and thapsigargin) were included. Thapsigargin is an inhibitor 
of sarco-endoplasmic reticulum Ca2+ ATPases and raises cytosolic free Ca2+ by blocking 
the ability of the cell to pump Ca2+ into the endoplasmic reticulum (ER) (Treiman et al., 
1998). ER-store depletion can secondarily activate plasma membrane Ca2+ channels, 
allowing an influx of Ca2+ into the cytosol (Barhoumi et al., 2006). When thapsigargin is 
co-administered to cells with Calcium Green™-1 AM, the thapsigargin-induced increase 
in cytosolic free Ca2+ causes a dramatic increase in fluorescence. 
Fluorescent Ca2+ images were collected and analyzed as described for MMP, 
with the exception that the FITC filter set (excitation: BP 470/20, dichroic FT493; 
emission: BP 505-530 nm) was used. Relative [Ca2+]i values from a minimum of ten 
cells from each animal were measured and averaged to give the Ca2+ value for each of 
three individual animals from each treatment, brain region, sex, and age group. [Ca2+]i 
data were calculated as percentage of control within each batch (one control and one of 
each treated sample, at a single age, analyzed at the same time) to control for inter-
analysis variation and allow comparison of data from one day to the next. [Ca2+]i data 
were analyzed by three-way ANOVA to determine significant between-subject 
differences associated with sex, brain region, and MeHg treatment. Differences, as 
indicated by three-way ANOVA, were analyzed by Tukey’s HSD or Student’s t post hoc 
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tests, as appropriate, to determine differences among brain regions, ages, and MeHg 
treatments. 
 
Reactive oxygen species 
5-(and 6)-chloromethyl-2’7’-dichlorodihydrofluorescein diacetate acetyl ester 
(CM-H2DCFDA) was used to determine the relative amount and rate of ROS production 
over time (Bellum et al., 2007a;  Oyama et al., 1994). CM-H2DCFDA is a non-
fluorescent compound that is oxidized to highly fluorescent 2’,7’-dichlorofluorescein 
(DCF) by the action of ROS (LeBel et al., 1992). The chloromethyl (CM) group on the 
dye allows the dye to passively diffuse into cells. Subsequent oxidation of the dye 
molecule by endogenous esterases traps its derivatives within the cell where they can 
react with ROS. CM-H2DCFDA stock solution (2.0 mM) was prepared in DMSO and 
stored in desiccant at -20°C for up to two weeks. Working solutions of CM-H2DCFDA 
(1.0 µM) were prepared just before use in 0.01% Pluronic® F-127 and HBSS. The 
DMSO concentration in the working solution was 0.05%. HBSS was used in the CM-
H2DCFDA working solution instead of growth media to prevent the CM-H2DCFDA dye 
from binding to or reacting with proteins within the medium and inhibiting movement of 
dye into the cells. After the isolation and 30 min incubation, the growth medium was 
removed and replaced with a 1.0 µM solution of CM-H2DCFDA in 0.01% Pluronic® F-
127 and HBSS for 5 min at room temperature. Incubation of the cells with CM-
H2DCFDA dye at room temperature prevents compartmentalization of the dye into 
cellular organelles. The CM-H2DCFDA was removed and replaced with HBSS for 
imaging. Three negative controls (HBSS and cells with no dye, HBSS with no cells and 
no dye, and HBSS with dye, but no cells) and a positive control (HBSS and cells with 
dye and tertiary-butyl hydroperoxide (tBHP) were included (Drahota et al., 2005). tBHP 
is a lipophilic, membrane-permeant oxidant (Elliott et al.,1992). It reacts with iron in 
heme-proteins and produces alkoxyl radicals (Kim et al.,2005b). When tBHP is co-
administered to cells with CM-H2DCFDA dye, the tBHP-induced increase in ROS 
causes an increase in fluorescence. Fluorescent images were collected every 2.5 min for 
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30 min as described for MMP and [Ca2+]i using the FITC filter set. The relative rate of 
ROS production was calculated using a minimum of five cells from each animal. 
ROS data were calculated as percentage of control within each batch (one control 
and one of each treated sample, at a single age, analyzed at the same time) to control for 
inter-analysis variation and allow comparison of data from one day to the next. A three-
way MANOVA with repeated measures for reading time was used to assess between- 
and within-subject differences and interactions associated with sex, brain region, and 
MeHg treatment. The condition of sphericity was analyzed to determine the appropriate 
univariate analysis test. The condition of sphericity was not met in any of the ROS data 
analyzed. Therefore, the Greenhouse-Geisser adjusted univariate test was used for 
repeated measures analysis of reading time (Grieve, 1984). 
 
Statistical analysis 
All data were represented as mean ± standard error of the mean (SEM). Detailed 
descriptions of statistical analyses have been described within the text for each 
experiment. In brief, data for MMP, [Ca2+]i, and ROS were calculated as percentage of 
control to normalize batch differences. A three-way MANOVA adjusted univariate-
repeated measures for time was used to assess differences among brain regions, gender, 
and MeHg treatment for ROS. All other experiments were analyzed using a three-way 
ANOVA and Tukey’s HSD or Student’s t post hoc tests, as appropriate, for brain 
regions, sex, and MeHg treatment. For all experiments, α = 0.05 (JMP 7.0.2, SAS 
Institute Inc., Cary, NC). 
 
RESULTS 
General observations 
Over the course of the study, pregnant female mice and offspring appeared 
healthy with no obvious changes in movement or behavior. Data are represented as (M = 
mean, SEM = standard error of the mean). Body, cerebellar, and hippocampal weights 
for mouse pups at P0 and P10 were analyzed by two-way ANOVA to determine 
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differences and interactions associated with sex and MeHg treatment. Two-way 
ANOVA for body, cerebellar, and hippocampal weights in pups at P0 and P10 indicted 
no differences or interactions in sex or MeHg treatment for body (for P0, M = 1.4 g, 
SEM = 0.05; for P10, M = 6.2 g, SEM = 0.15), cerebellar (for P0, M = 0.0092 g, SEM = 
0.0004; for P10, M = 0.036 g, SEM = 0.0007), or hippocampal (for P0, M = 0.010 g, 
SEM = 0.0005; for P10, M = 0.025 g, SEM = 0.0006) weights. Body, cerebellar, and 
hippocampal weights for adult female mice, ten days following parturition, were 
analyzed by one-way ANOVA to determine differences in MeHg treatments. One-way 
ANOVA for body, cerebellar, and hippocampal weights in previously-pregnant dams 
indicated no differences in MeHg treatments for body (M = 30.0, SEM = 0.87), 
cerebellar (M = 0.053, SEM = 0.0005), or hippocampal weights (M = 0.030, SEM = 
0.002).  
 
Mercury (Hg) accumulation 
Total Hg concentration, presented as total Hg content (ng Hg) per unit volume of 
wet brain weight (w. w.) tissue (ng/g), was calculated by dividing the total Hg measured 
in each sample by the wet brain tissue weight for that sample. Total Hg concentration 
values were analyzed by three-way ANOVA, at P0 and P10, for differences and 
interactions in total Hg concentration associated with sex, cerebellar and hippocampal 
brain regions, and MeHg treatment. Data for mice at P0 indicated an overall effect, F 
(11, 36) = 13, p < 0.0001, with total Hg concentrations increased in the 1.0 mg/kg MeHg 
treatment (M = 300 ng/g, SEM = 39) compared to the 0.1 mg/kg MeHg treatment (M = 
18 ng/g, SEM = 1.7) and compared to controls (M = 1.8 ng/g, SEM = 0.60), (Table III-1). 
No differences were observed in total Hg concentration between sexes or cerebellar and 
hippocampal brain regions. Data from P10 mice indicated an overall effect, F (11, 51) = 
9.1, p < 0.0001, with total Hg concentration increased in the 1.0 mg/kg MeHg treatment 
(M = 29 ng/g, SEM = 15) compared to the 0.1 mg/kg MeHg treatment (M = 5.2 ng/g, 
SEM = 3.1) and compared to controls (M = 4.1 ng/g, SEM = 0.56), (Table III-1). Total 
Hg concentration was evaluated by Student’s t-test post hoc analysis to compare total Hg 
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concentration between P0 and P10 pup brains at each MeHg treatment. Data indicated 
that total Hg concentration was increased in the P10 pup brains compared to the P0 pup 
brains in the controls, F (1, 42) = 7.7, p = 0.0081. However, the P0 pup brains exhibited 
increased total Hg concentration compared to P10 pup brains for both the 0.1 mg/kg, F 
(1, 31) = 70, p < 0.0001, and 1.0 mg/kg, F (1, 32) = 92, p < 0.0001, MeHg treatments. 
Hg content (ng Hg) per unit volume of wet brain weight (w. w.) tissue (ng/g) also was 
calculated for previously pregnant female mice ten days following parturition. Analysis 
by two-way ANOVA for differences associated with brain region and treatment 
indicated an overall effect, F (5, 12) = 33, p < 0.0001, with total Hg concentration in 
adult female brains increased in the 1.0 mg/kg MeHg treatment (M = 55 ng/g, SEM = 
8.8) compared to the 0.1 mg/kg MeHg treatment (M = 4.9 ng/g, SEM = 0.28) and 
compared to controls (M = 0.81 ng/g, SEM = 0.12) (Table III-1). No difference in total 
Hg concentration was observed between cerebellar and hippocampal brain regions. 
However, two-way ANOVA showed an interaction effect between MeHg treatment and 
brain regions, F (2, 12) = 6.1, p = 0.015, indicating that treatment differences were 
greater in the hippocampus than in the cerebellum of previously pregnant adult female 
mice. Hg content for a method blank, two certified reference materials, a spiked sample, 
and a duplicate sample were analyzed to determine changes within individual runs from 
beginning to end, from one run to the next, and between duplicate samples within a run. 
No intra-run, between-run, or between-duplicate sample differences were observed (data 
not shown); recovery rate for certified reference materials and spiked samples ranged 
from 92 to 99% (data not shown). Total Hg content in the rodent chow was analyzed to 
identify potential Hg exposure other than what was intentionally administered. Total Hg 
levels in rodent chow were below the level of detection for the analysis used (< 0.005 
ng, data not shown). 
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Fluoro-Jade B and activated caspase 3 
P0 cerebella 
The number of Fluoro-Jade B positive dead cells in the cerebellum of mice at P0 
was analyzed by three-way ANOVA to determine between-subject differences and 
interactions associated with sex, cerebellar cell layer, and MeHg treatment. Data 
indicated a main effect for cerebellar cell layer, F (3, 56) = 39.1, p < 0.0001. Differences 
in Fluoro-Jade positive dead cell counts, as determine by Tukey’s HSD post hoc 
analysis, were as follows: Purkinje cell layer = external germinal cell layer < molecular 
cell layer < granule cell layer (Fig III-1). Differences were not observed between sexes 
or among MeHg treatments in cerebella from mice at P0. Fluoro-Jade positive dead cell 
count data for cerebella from mice at P0 were analyzed by three-way ANOVA to 
determine between-subject differences and interactions associated with sex, rostral and 
caudal cerebellum, and MeHg treatment for each cerebellar cell layer, independently. 
Differences were not observed in Fluoro-Jade positive dead cells for sex, rostral and 
caudal cerebellum, and MeHg treatment for the different cell layers of cerebella from 
mice at P0. 
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TABLE III-1 
Total Mercury Concentration in Cerebella and Hippocampi of Adult Female Mice 
and Their Pups at Postnatal Days 0 and 10 Following Exposure to 0, 0.1, or 1.0 
mg/kg Total Dose of Methylmercury Divided Over Gestational Days 8 to 18 
 Total Hg Concentration in Both Cerebella and Hippocampi (Hg/w.w., ng/g) 
 Controls 0. 1 mg/kg 1.0 mg/kg 
0 1.8 (0.6) 18 (1.7) † 300 (39) * † 
10 4.1 (0.56) ‡ 5.2 (3.1) 29 (15) * 
Dams 0.81 (0.12) 4.9 (0.28) 55 (8.8) * 
Data are represented as mean (standard error of the mean). 
Hg / wet weight (w.w.) as ng/g = total Hg content measured divided by the wet tissue weights in cerebella 
and hippocampi. Total Hg concentration was analyzed by three-way ANOVA to determine differences 
associated with sex, brain region, and MeHg treatment, followed by Tukey’s HSD or Student’s t post hoc 
tests, α = 0.05. Total Hg concentration was increased in the 1.0 mg/kg MeHg treatment compared to the 
0.1 mg/kg MeHg treatment and controls for pups at both P0 and P10 (*). No differences were observed 
between sexes or between cerebellar and hippocampal brain regions for P0 or P10 pups. P0 three-way 
AVOVA: overall F (11, 36) = 13, p < 0.0001, and P10 three-way ANOVA: overall F (11, 51) = 9.1, p < 
0.0001; α = 0.05. Total Hg concentration was increased in the P0 pups (†) compared to the P10 pups in 
both the 0.1 and 1.0 mg/kg MeHg treatments, whereas the P10 pups exhibited increased total Hg 
concentration compared to P0 control pups (‡). One-way ANOVA for 0.1 mg/kg, F (1, 31) = 70, p < 
0.0001, for 1.0 mg/kg, F (1, 32) = 92, p < 0.0001, and for controls, F (1, 42) = 7.7, p = 0.0081; α = 0.05. 
Total Hg concentration in cerebella and hippocampi from previously pregnant female mice was measured 
ten days following parturition and analyzed by two-way ANOVA for brain region and MeHg treatment 
differences. Data indicated that total Hg concentration was increased in the 1.0 mg/kg MeHg treatment (*) 
compared to the 0.1 mg/kg MeHg treatment and controls. No differences were observed between 
cerebellar and hippocampal brain regions. Two-way ANOVA: overall F (5, 12) = 33, p < 0.0001; α = 0.05. 
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The number of activated caspase 3 positive dying cells in the cerebellum of mice 
at P0 was analyzed by three-way ANOVA to determine between-subject differences and 
interactions associated with sex, cerebellar cell layer, and MeHg treatment. Main effects 
were observed for treatment, F (2, 48) = 3.56, p = 0.04, and cerebellar cell layer, F (3, 
48) = 12.09, p < 0.0001. Tukey’s HSD post hoc analysis indicated that the 1.0 mg/kg 
total dose MeHg treatment exhibited increased numbers of activated caspase 3 positive 
cells than did controls in the Purkinje cell layer (Fig III-2). No treatment differences 
were observed in any of the other cerebellar cell layers. Data also indicated that the 
granule and external germinal cell layers exhibited increased numbers of activated 
caspase 3 positive cells compared to the molecular and Purkinje cell layers in controls. 
In the 0.1 mg/kg MeHg treatment, only the granule cell layer exhibited increased 
numbers of activated caspase 3 positive cells compared to the molecular and Purkinje 
cell layers (Fig III-2). No differences were observed in the number of activated caspase 3 
positive cells among the cell layers for the 1.0 mg/kg MeHg treatment. Three-way 
ANOVA for sex, anterior and posterior cerebellum, and MeHg treatments for each of the 
P0 cerebellar cell layers showed main effects for anterior/posterior region in the granule 
cell layer, F (1, 24) = 5.03, p = 0.03, and for MeHg treatment in the Purkinje cell layer, 
F (2, 24) = 6.30, p = 0.01. Student’s t post hoc analysis indicated that activated caspase 3 
positive cells were increased in the posterior cerebellum compared to the anterior 
cerebellum in the granule cell layer (Fig III-3). Tukey’s HSD post hoc analysis indicated 
that activated caspase 3 positive cells were increased in the 1.0 and 0.1 mg/kg MeHg 
treatments compared to the Purkinje cell layer in age-matched and sex-matched control 
mice (Fig III-3). 
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FIG. III-1. Fluoro-Jade positive cell counts in the cerebellum of mice at postnatal day 0 following 
exposure to 0, 0.1, or 1.0 mg/kg total dose MeHg divided over gestational days 8 to 18. The number of 
Fluoro-Jade positive cells was different among all cerebellar cell layers (*). The number of Fluoro-Jade 
positive cell counts were ordered as follows: granule cell layer (Gran) > molecular (Mol) > external 
germinal layer (Egc) > Purkinje cell layer (Purk). Analysis indicated no differences associated with sex or 
MeHg treatment. Data are presented as mean ± standard error of the mean and were analyzed by three-way 
ANOVA and Tukey’s HSD post hoc analysis, F (3, 56) = 39.1, p < 0.0001, α = 0.05. 
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FIG. III-2. The number of activated caspase 3 positive cells in the layers of the cerebellum of mice at 
postnatal day 0 following exposure to 0, 0.1, or 1.0 mg/kg total dose MeHg divided over gestational days 8 
to 18. Cerebellar cell layers are represented as: Egc (external germinal cell layer), Gran (granule cell 
layer), Mol (molecular cell layer), and Purk (Purkinje cell layer). Main effects were indicated for MeHg 
treatment and cerebellar cell layer. The number of activated caspase 3 positive cells was increased in the 
1.0 mg/kg treatment compared to controls in the Purkinje cell layer (*). No MeHg treatment differences 
were observed in any of the other cell layers. The number of activated caspase 3 positive cells was 
increased in the granule and external germinal cell layers compared to the molecular and Purkinje cell 
layers in control cerebella (†). The molecular and Purkinje cell layers exhibited decreased numbers of 
activated caspase 3 positive cells compared to the granule cell layer in 0.1 mg/kg MeHg treated cerebella 
(‡). No differences were indicated for sex. Data are presented as mean ± standard error of the mean and 
were analyzed by three-way ANOVA and Tukey’s HSD post hoc analysis. MeHg treatment, F (2, 48) = 
3.56, p = 0.04, and cerebellar cell layer, F (3, 48) = 12.09, p < 0.0001, α = 0.05. 
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FIG. III-3. The number of activated caspase 3 positive cells in the cerebellum of mice at postnatal day 0 
following exposure to 0, 0.1, or 1.0 mg/kg total dose MeHg divided over gestational days 8 to 18. Data 
indicated that the number of activated caspase 3 positive cells in the granule cell layer of the rostral 
cerebellum was decreased compared to those in the granule cell layer of the caudal cerebellum (*). The 
number of activated caspase 3 positive cells was increased in 0.1 and 1.0 MeHg treated cerebella 
compared to controls (†). No differences were indicated for sex. Data are presented as mean ± standard 
error of the mean and were analyzed by three-way ANOVA and Tukey’s HSD post hoc or Student’s t 
analysis. Granule cell layer, F (1, 24) = 5.03, p = 0.03, and Purkinje cell layer, F (1, 24) = 6.30, p = 0.01, α 
= 0.05. 
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P10 cerebella 
The number of Fluoro-Jade positive dying cells in the cerebellum of mice at P10 
was analyzed by three-way ANOVA to determine between-subject differences and 
interactions associated with sex, cerebellar cell layer, and MeHg treatment. Data 
indicated main effects for MeHg treatment, F (2, 48) = 4.3, p = 0.02, and cerebellar cell 
layers, F (3, 48) = 24.13, p < 0.0001. Tukey’s HSD post hoc analysis indicated that 
Fluoro-Jade positive cells were increased in the 0.1 total dose MeHg treatment compared 
to the 1.0 MeHg treatment in the external germinal cell layer (Fig III-4). No treatment 
differences were observed in any of the other cerebellar cell layers. Data also indicated 
increased numbers of Fluoro-Jade positive dying cells for controls in the molecular layer 
compared to the external germinal cell layer. Both the molecular and external germinal 
cell layers exhibited increased numbers of Fluoro-Jade positive cells compared to the 
Purkinje cell layer in controls. In the 0.1 mg/kg MeHg treatment, increased numbers of 
Fluoro-Jade positive cells were observed in the molecular layer compared to the granule 
and external granule cell layers, and in all three of these layers compared to the Purkinje 
cell layer. In the 1.0 mg/kg MeHg treatment, increased numbers of Fluoro-Jade positive 
cells were observed in the molecular and granule cell layers compared to the external 
germinal cell layer, and in all three of these layers compared to the Purkinje cell layer 
(Fig III-4). Three-way ANOVA was used to determine between-subject differences and 
interactions in the number of Fluoro-Jade positive dying cells associated with sex, 
cerebellar lobule, and MeHg treatment for each cerebellar cell layer, independently. 
Main effects were indicated for MeHg treatment, F (2, 96) = 8.89, p = 0.0003, and 
cerebellar lobule, F (9, 96) = 2.15, p = 0.05 in the external granule cell layer only. 
Tukey’s HSD post hoc analysis indicated decreased numbers of Fluoro-Jade positive 
dying cells in the 1.0 mg/kg MeHg treatment compared to controls in lobule IV/V and 
IX of the external germinal layer of P10 cerebella (Fig III-5). Data also indicated that 
lobules III and IV/V exhibited increased numbers of Fluoro-Jade positive dying cells 
compared to lobule VII in the external germinal layer of control P10 cerebella (Fig III-
5). 
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FIG. III-4. The number of Fluoro-Jade positive cells in the layers of the cerebellum of mice at postnatal 
day 10 following exposure to 0, 0.1, or 1.0 mg/kg total dose MeHg divided over gestational days 8 to 18. 
Cerebellar cell layers are represented as: Egc (external germinal cell layer), Gran (granule cell layer), Mol 
(molecular cell layer), and Purk (Purkinje cell layer). Analysis indicated differences in cerebellar cell 
layers and MeHg treatments. The number of Fluoro-Jade positive dying cells was increased in the 0.1 
MeHg treatment compared to the 1.0 MeHg treatment in the external germinal cell layer (*). No MeHg 
treatment differences were observed in any of the other cerebellar cell layers. Fluoro-Jade positive cell 
numbers were increased in the molecular layer controls compared to the external germinal layer controls 
(†). The molecular layer controls and the external germinal layer controls both exhibited increased 
numbers of Fluoro-Jade positive cells compared to Purkinje cell layer controls (‡). The number of Fluoro-
Jade positive cells in 0.1 mg/kg MeHg treated cerebella was decreased in the external germinal layer and 
granule cell layer compared to the molecular layer (•). The number of Fluoro-Jade positive cells in 0.1 
mg/kg MeHg treated cerebella was decreased in the Purkinje cell layer compared to the molecular, 
granule, and external germinal cell layers (°). No differences were indicated for sex. Data are presented as 
mean ± standard error of the mean and were analyzed by three-way ANOVA and Tukey’s HSD post hoc 
analysis. MeHg treatment, F (2, 48) = 4.3, p = 0.02, and cerebellar cell layers, F (9, 48) = 24.13, p < 
0.0001, α = 0.05.  
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FIG. III-5. The number of Fluoro-Jade positive cells in the cerebellum of mice at postnatal day 10 following exposure to 0, 0.1, or 1.0 mg/kg total dose 
MeHg divided over gestational days 8 to 18. Roman numerals identify the cerebellar lobules. Analysis indicated differences in MeHg treatments and 
cerebellar lobules in the external germinal cell layer. No differences were observed in any of the other cerebellar cell layers. No differences were 
observed for sex. Data indicated decreased numbers of Fluoro-Jade positive dying cells in the 1.0 mg/kg MeHg treatment compared to controls in 
cerebellar lobules IV/V and IX of the external germinal layer (*). Data also indicated that lobule VII exhibited decreased numbers of Fluoro-Jade 
positive cells compared to lobules III and IV/V in the external germinal layer of control cerebella (†). Data are presented as mean ± standard error of the 
mean and were analyzed by three-way ANOVA and Tukey’s HSD post hoc analysis. MeHg treatment, F (2, 96) = 8.89, p = 0.0003, and cerebellar 
lobule, F (9, 96) = 2.15, p = 0.05, α = 0.05. 
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 The number of activated caspase 3 positive cells in the cerebellum of P10 mice 
was analyzed by three-way ANOVA to determine between-subject differences and 
interactions associated with sex, cerebellar cell layer, and MeHg treatment. Main effects 
were indicated for sex, F (1, 48) = 9.74, p = 0.003, and for cerebellar cell layer, F (3, 48) 
= 6.43, p = 0.0009. Student’s t post hoc analysis indicated no differences in the numbers 
of activated caspase 3 positive cells in females compared to males in any of the cell 
layers of the P10 cerebellum (Fig III-6). For P10 female and male cerebella, Tukey’s 
HSD post hoc analysis indicated that activated caspase 3 positive cells were increased in 
the molecular, granule and external germinal cell layers compared to the Purkinje cell 
layer (Fig III-6). Three-way ANOVA was used to determine between-subject differences 
and interactions in the number of activated caspase 3 positive cells associated with sex, 
cerebellar lobule, and MeHg treatment for each cerebellar cell layer, independently. No 
differences were observed in the number of activated caspase 3 positive cells between 
males and females, among MeHg treatments, or among lobules in any of the cerebellar 
cell layers.  
 
P0 hippocampi 
The number of Fluoro-Jade and activated caspase 3 positive cells in the dentate 
gyrus, CA1, and CA3 regions of the hippocampus of mice at P0 was analyzed by three-
way ANOVA to determine between-subject differences and interactions associated with 
sex, hippocampal region, and MeHg treatment. Analysis indicated no differences in sex, 
hippocampal region, or MeHg treatment in P0 hippocampi for the Fluoro-Jade or the 
activated caspase 3 experiments. 
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FIG. III-6. The number of activated caspase 3 positive cells in the cerebellum of mice at postnatal day 10 
following exposure to 0, 0.1, or 1.0 mg/kg total dose MeHg divided over gestational days 8 to 18. 
Cerebellar cell layers are represented as: Egc (external germinal cell layer), Gran (granule cell layer), Mol 
(molecular cell layer), and Purk (Purkinje cell layer). Analysis indicated differences in sex and cerebellar 
cell layer. No differences were observed in MeHg treatments. Data indicated increased numbers of 
activated caspase 3 positive cells in the external germinal, granule, and molecular cell layers compared to 
the Purkinje cell layer of P10 male and female cerebella (*). Although a main effect was indicated for sex, 
Student’s t post hoc analysis indicated no differences in the number of activated caspase 3 positive cells 
between males and females in any of the cell layers. Data are presented as mean ± standard error of the 
mean and were analyzed by three-way ANOVA and Tukey’s HSD or Student’s t post hoc analysis. Sex, F 
(1, 48) = 9.74, p = 0.003, and cerebellar cell layer, F (3, 48) = 6.43, p = 0.0009, α = 0.05. 
 
 
P10 hippocampi 
The number of Fluoro-Jade positive cells in the dentate gyrus and the 
hippocampus proper was analyzed by three-way ANOVA to determine between-subject 
differences and interactions associated with sex, cell layer, and MeHg treatment. Data 
indicated a main effect for cell layer in the dentate gyrus, F (2, 36) = 4.10, p = 0.03.  
Tukey’s HSD post hoc analysis indicated increased numbers of Fluoro-Jade positive 
dying cells in the granule and subgranular cell layers compared to the hilar region of the 
dentate gyrus from mice at P10 (Fig III-7). Analysis by three-way ANOVA also 
  
155
0.0 
0.2 
0.4 
0.6 
0.8 
1.0 
1.2 
1.4 
Gran Hilar Subgran 
Dentate Gyrus Cell Layer 
*
*
N
um
be
r o
f F
lu
or
o-
Ja
de
 P
os
iti
ve
 
C
el
ls
 P
er
 S
ec
tio
n 
indicated a main effect for region (CA1 and CA3) in the hippocampus proper, F (1, 24) 
= 5.13, p = 0.03. Student’s t post hoc analysis indicated increased numbers of Fluoro-
Jade positive dying pyramidal cells in the CA3 region compared to the CA1 region of 
the hippocampus proper from mice at P10 (Fig III-8). No main effects were observed for 
sex or MeHg treatment in either the dentate gyrus or the hippocampus proper for Fluoro-
Jade analysis. The number of activated caspase 3 positive cells in the dentate gyrus and 
the hippocampus proper was analyzed by three-way ANOVA to determine between-
subject differences and interactions associated with sex, cell layer/region, and MeHg 
treatment. No between-subject main effects were observed in either the dentate gyrus or 
the hippocampus proper for activated caspase 3 positive cells in mice at P10. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIG. III-7. The number of Fluoro-Jade positive cells in the dentate gyrus of the hippocampus of mice at 
postnatal day 10 following exposure to 0, 0.1, or 1.0 mg/kg total dose MeHg divided over gestational days 
8 to 18. Dentate gyrus cell layers are represented as: Gran (granule cell layer), Hilar (hilar region), and 
Subgran (subgranular layer). Data indicated increased numbers of Fluoro-Jade positive cells in the granule 
and subgranular cell layers compared to the hilar region of the P10 dentate gyrus (*). No differences were 
indicated for sex or MeHg treatment. Data are presented as mean ± standard error of the mean and were 
analyzed by three-way ANOVA and Tukey’s HSD post hoc analysis. F (2, 36) = 4.10, p = 0.03, α = 0.05. 
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FIG. III-8. The number of Fluoro-Jade positive pyramidal cells in the hippocampus proper of mice at 
postnatal day 10 following exposure to 0, 0.1, or 1.0 mg/kg total dose MeHg divided over gestational days 
8 to 18. Data indicated increased numbers of Fluoro-Jade positive pyramidal cells in the CA3 region 
compared to the CA1 region of the hippocampus proper of P10 mice hippocampi (*). No differences were 
observed in MeHg treatments or sex. Data are presented as mean ± standard error of the mean and were 
analyzed by three-way ANOVA and Student’s t post hoc analysis. F (1, 24) = 5.13, p = 0.03, α = 0.05. 
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Identification and validation of acutely isolated cells as neurons 
Examples of neurons isolated from cerebella and hippocampi of mice at P0 are 
shown in Fig III-9. Double fluorescence imaging using NeuN to label nuclei and 
cytoplasm of neurons and DAPI to label nuclei of all cells showed the isolation 
procedure used in this study yielded predominantly more neurons than other cell types. 
All nuclei were labeled with DAPI (blue), and nuclei and some cytoplasm of neurons 
were labeled with NeuN (red). Granule cells were distinguished from other neurons 
based on their small cell size (5 – 8 µm). 
 
 
FIG. III-9. NeuN and DAPI double-labeled cells isolated from the cerebellum and hippocampus of mouse 
pups at postnatal day 0. Panels A, B, and C are cells from the cerebellum. Panels D, E, and F are cells 
from the hippocampus. Panels A and D show cells labeled with DAPI; B and E show cells labeled with 
NeuN; C and F are overlay images of NeuN and DAPI. Granule cells were distinguished from other 
neurons based on their small size (5 - 8 µm). The majority of isolated cells were double-labeled granule 
cells. Scale bar = 5 µm. 
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Mitochondrial membrane potential 
Membrane potential (MMP) of the inner mitochondrial membrane of isolated 
cerebellar and hippocampal granule cells was measured using TMRM dye and 
fluorescence microscopy to determine whether treatment with MeHg from gestational 
day 8 to 18 would alter mitochondrial function in mouse pups at P0 and P10. Relative 
MMP for pups at P0 was analyzed by three-way ANOVA for differences and 
interactions in sex, brain regions, and MeHg treatment. Analysis indicated main effects 
for MeHg treatment, F (2, 36) = 3.99, p = 0.0273, but not for sexes or cerebellar and 
hippocampal brain regions. In addition, an interaction was indicated between MeHg 
treatment and brain region, F (2, 36) = 12.26, p < 0.0001. Tukey’s HDS post hoc 
analysis indicated decreased MMP in the 1.0 mg/kg total dose MeHg treatment 
compared to controls (Fig III-10). The interaction observed for MeHg treatment and 
structure indicated that treatment differences were greater for the cerebellum than for the 
hippocampus.  
Relative MMP for pups at P10 was analyzed by three-way ANOVA to determine 
differences associated with sex, brain region, and MeHg treatment. Data indicated main 
effects for MeHg treatment, F (2, 48) = 30.79, p < 0.0001, and interactions between 
MeHg treatments and brain region, F (2, 48) = 3.98, p = 0.0251, and among sex, MeHg 
treatments, and brain region, F (2, 48) = 9.83, p = 0.0003. Tukey’s HSD post hoc 
analysis indicated that MMP was increased in the 0.01 mg/kg MeHg treatment compared 
to the 1.0 mg/kg MeHg treatment and controls. The interactions indicated for sex, brain 
region, and MeHg treatment suggested that MeHg treatment differences were greater in 
females than males, and greater in the cerebellum than the hippocampus (Fig III-11). 
CCCP was added to isolated control granule cells (positive method control) to verify that 
the method used to measure changes in MMP was, in fact, measuring changes in MMP. 
CCCP uncouples oxidative phosphorylation within mitochondria which results in 
decreased MMP. Addition of CCCP to control cells incubated with TMRM resulted in a 
dramatic decrease in the fluorescence intensity of mitochondria indicating depolarization 
of the mitochondrial membrane (data not shown); no auto-fluorescence was observed in 
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samples without TMRM dye, nor in samples without cells that contained TMRM dye 
(negative controls, data not shown). 
 
 
 
 
FIG. III-10. Relative mitochondrial membrane potential for cerebella and hippocampi of mice at postnatal 
day 0 exposed to 0, 0.1, or 1.0 mg/kg total dose MeHg divided over gestational days 8 to 18. Cells were 
incubated with 150 nM TMRM for 20 min and imaged by fluorescence microscopy. Data were collected 
for individual mitochondria within the isolated granule cells. Analysis by three-way ANOVA indicated 
differences in MeHg treatment, but not in sex and brain region. However, an interaction was indicated for 
MeHg treatment and brain region. Tukey’s HDS post hoc analysis indicated decreased MMP in the 1.0 
mg/kg MeHg treatment compared controls (*). The indicated interaction suggested that observed MeHg 
treatment differences were greater in the cerebellum than the hippocampus. Data are represented as 
percentage of control and mean ± standard error of the mean. Three-way ANOVA for MeHg treatment, F 
(2, 36) = 3.99, p = 0.0273, and interaction F (2, 36) = 12.26, p < 0.0001; α = 0.05. 
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FIG. III-11. Relative mitochondrial membrane potential for cerebella and hippocampi of mice at postnatal 
day 10 exposed to 0, 0.1, or 1.0 mg/kg total dose MeHg divided over gestational days 8 to 18. Analysis by 
three-way ANOVA indicated differences in MeHg treatment, but not in sex and brain region. However, an 
interaction was indicated for MeHg treatment and brain region, and for sex, MeHg treatment and brain 
region. Tukey’s HDS post hoc analysis indicated increased MMP in the 0.1 mg/kg MeHg treatment 
compared to the 1.0 mg/kg MeHg treatment and controls (*). The indicated interaction suggested that 
observed MeHg treatment differences were greater in the cerebellum than the hippocampus, and greater in 
females than males. Data are represented as percentage of control and mean ± standard error of the mean. 
Three-way ANOVA for MeHg treatment, F (2, 48) = 30.79, p < 0.0001, and MeHg treatment and brain 
region interaction F (2, 48) = 3.98, p = 0.0251, and sex, MeHg treatment, and brain region interaction F 
(2, 48) = 9.83, p = 0.0003; α = 0.05. 
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Basal free intracellular Ca2+ 
Calcium ion homeostasis was examined by measuring [Ca2+]i in isolated 
cerebellar and hippocampal granule cells from male and female mice at P0 and P10 
following exposure to 0, 0.1, and 1.0 mg/kg total dose MeHg divided over G8 to G18. 
Relative [Ca2+]i data from pups at P0 were analyzed by three-way ANOVA to determine 
differences associated with sex, brain region, and MeHg treatment. Data indicated a 
main effect for MeHg treatment, F (2, 36) = 10.39, p = 0.0003, but not for sex or brain 
region. In addition, an interaction was indicated for MeHg treatment and brain region, F 
(2, 36) = 11.68, p = 0.0001. Tukey’s HSD post hoc analysis indicated that [Ca2+]i was 
increased in both the 0.1 and 1.0 mg/kg MeHg treatments compared to controls (Fig III-
12). The indicated interaction between MeHg treatment and brain region suggested that 
the observed differences in MeHg treatment were greater in the cerebellum than the 
hippocampus (Fig III-12). 
Relative [Ca2+]i data from pups at P10 were analyzed by three-way ANOVA to 
determine differences associated with sex, brain region, and MeHg treatment. 
Representative images of isolated cerebellar and hippocampal granule cells incubated 
with Calcium Green-1 dye are shown in Fig III-13. Data indicated a main effect for 
MeHg treatment, F (2, 44) = 31.97, p < 0.0001, and an interaction among sex, brain 
region, and MeHg treatment, F (2, 44) = 11.05, p = 0.0001. Tukey’s HSD post hoc 
analysis indicated that basal [Ca2+]i was increased in the 1.0 mg/kg MeHg treatment 
compared to the 0.1 mg/kg MeHg treatment and controls (Fig III-14). The indicated 
interaction suggested that the observed MeHg treatment differences were greater in 
females than males, and greater in the cerebellum than the hippocampus (Fig III-14). 
Thapsigargin was added to isolated control cerebellar and hippocampal granule cells as a 
method control to validate the measurement of changes in [Ca2+]i. Thapsigargin is an 
inhibitor of sarco-endoplasmic reticulum Ca2+ ATPases and raises cytosolic free Ca2+ by 
blocking the ability of the cell to pump Ca2+ into the endoplasmic reticulum (Treiman et 
al., 1998). Addition of thapsigargin to isolated control cerebellar and hippocampal 
granule cells (positive method control) resulted in a substantial increase in the 
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fluorescence within the cells, indicating an increase in [Ca2+]i; no auto-fluorescence was 
observed in samples without Calcium Green-1, nor in samples without cells that 
contained Calcium Green-1 (negative controls), indicating minimal atmospheric and/or 
photo-oxidation (data not shown). 
 
 
 
 
FIG. III-12. Relative basal intracellular calcium ion concentration [Ca2+]i for cerebella and hippocampi of 
mice at postnatal day 0 exposed to 0, 0.1, or 1.0 mg/kg total dose MeHg divided over gestational days 8 to 
18. Analysis by three-way ANOVA indicated differences in MeHg treatment, but not in sex and brain 
region. However, an interaction was indicated between MeHg treatment and brain region. Tukey’s HDS 
post hoc analysis indicated increased [Ca2+]i in the 0.1 and 1.0 mg/kg MeHg treatments compared to 
controls (*). The indicated interaction suggested that observed MeHg treatment differences were greater in 
the cerebellum than the hippocampus. Data are represented as percentage of control and mean ± standard 
error of the mean. Three-way ANOVA for MeHg treatment, F (2, 36) = 10.39, p = 0.0003, and MeHg 
treatment and brain region interaction F (2, 36) = 11.68, p = 0.0001, α = 0.05. 
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FIG. III-13. Representative images of isolated granule cells from postnatal day 10 male and female 
hippocampi and cerebella. Free intracellular Ca2+ binds to Calcium Green-1 dye within the cell and 
appears fluorescent green. Cells from cerebella and hippocampi treated with 1.0 mg/kg total dose MeHg 
exhibited increased fluorescence compared to controls. The increased fluorescence indicated an increased 
level of intracellular Ca2+ in the MeHg treated cells compared to controls. Scale bar is 10 µm. 
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FIG. III-14. Relative basal intracellular calcium ion concentrations [Ca2+]i for cerebella and hippocampi 
of mice at postnatal day 10 exposed to 0, 0.1, or 1.0 mg/kg total dose MeHg divided over gestational days 
8 to 18. Analysis by three-way ANOVA indicated differences in MeHg treatment, but not in sex and brain 
region. However, an interaction was indicated between sex, MeHg treatment, and brain region. Tukey’s 
HDS post hoc analysis indicated increased [Ca2+]i in the 1.0 mg/kg MeHg treatment compared to the 0.1 
mg/kg MeHg treatment and controls (*). The indicated interaction suggested that the observed MeHg 
treatment differences were greater in females than males, and greater in the cerebellum than the 
hippocampus. Data are represented as percentage of control and mean ± standard error of the mean. Three-
way ANOVA for MeHg treatment, F (2, 44) = 31.97, p < 0.0001, and MeHg treatment and brain region 
interaction F (2, 44) = 11.05, p = 0.0001, α = 0.05. 
R
el
at
iv
e 
B
as
al
 F
re
e 
[C
a2
+ ]
i (
%
C
on
tr
ol
)  
  
165
Reactive oxygen species 
The rate of generation of and the level of ROS in isolated cerebellar and 
hippocampal granule cells from mouse pups at P0 and P10 exposed to 0, 0.1, and 1.0 
mg/kg total dose MeHg divided over gestational days 8 to 18 was measured by 
fluorescence microscopy and imaging of the fluorescence of the dye CM-H2DCFDA 
every 2.5 min for 30 min. Data for the rate of generation of ROS for mice at P0 were 
analyzed by three-way MANOVA with repeated measures for ROS reading time to 
determine between-subject differences and interactions associated with sex, brain region, 
and MeHg treatment. No between-subject effects were indicated. Data did not meet the 
condition of sphericity, therefore, within-subject data were analyzed using the 
Greenhouse-Geisser adjusted univariate analysis (Grieve, 1984). No within-subject 
differences were indicated in cerebella or hippocampi from mice at P0. Although there 
was no difference in the rate at which ROS were produced in mice at P0, data were 
subsequently analyzed to determine if there were differences in the relative amount of 
ROS produced. Relative amount of ROS produced in cells isolated from cerebella and 
hippocampi from mice at P10 were analyzed by three-way MANOVA with repeated 
measures for ROS reading time to determine between-subject differences and 
interactions associated with sex, brain region, and MeHg treatment. Data indicated a 
between-subject interaction effect between brain region and MeHg treatment, F (2, 72) = 
6.49, p = 0.0502. The indicated interaction suggests that MeHg treatment effects are 
greater in the cerebellum than in the hippocampus (Fig III-15). Data did not meet the 
condition of sphericity, therefore, within-subject data were analyzed using the 
Greenhouse-Geisser adjusted univariate analysis. No within-subject effects were 
indicated for the amount of ROS produced in cerebella and hippocampi of P0 mice. 
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FIG. III-15. Relative level of reactive oxygen species produced in granule cells isolated from cerebella 
and hippocampi of mouse pups at postnatal day 0 exposed to 0, 0.1, or 1.0 mg/kg total dose MeHg divided 
over gestational days 8 to 18. The amount of ROS produced was measured over a 30 min time period at 
intervals of 2.5 min. ROS data were analyzed by three-way MANOVA with repeated measures for reading 
time. Analysis indicated a between-subject interaction effect of brain regions and MeHg treatments. 
Although no between-subject differences were indicated for MeHg treatment, the brain region and MeHg 
treatment interaction suggested that the MeHg treatments differed more in the cerebellum than in the 
hippocampus (*). The condition of sphericity was not met; therefore with-in subject differences were 
analyzed by the Greenhouse-Geisser adjusted univariate analysis. No with-in subject differences were 
observed in the amount of ROS produced. Three-way MANOVA interaction, F (2, 72) = 6.49, p = 0.0502, 
α = 0.05. 
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Data for the rate of generation of ROS for mice at P10 were analyzed by three-
way MANOVA with repeated measures for ROS reading time to determine between-
subject differences and interactions associated with sex, brain region, and MeHg 
treatment.  No between-subject differences were indicated. Data did not meet the 
condition of sphericity, therefore, within-subject data were analyzed using the 
Greenhouse-Geisser adjusted univariate analysis (Grieve, 1984). No within-subject 
differences were indicated for cerebella or hippocampi from mice at P10. Although there 
was no difference in the rate at which ROS were produced in mice at P10, data were 
subsequently analyzed to determine if there were differences in the relative amount of 
ROS produced. Relative amount of ROS produced in cells isolated from cerebella and 
hippocampi from mice at P10 were analyzed by three-way MANOVA with repeated 
measures for ROS reading time to determine between-subject differences and 
interactions associated with sex, brain region, and MeHg treatment. Data indicated a 
between-subject interaction effect between brain region and MeHg treatment, F (2, 56) = 
4.65, p = 0.0147. The indicated interaction suggested that MeHg treatment effects were 
greater in the cerebellum than in the hippocampus (Fig III-16). Data did not meet the 
condition of sphericity, therefore, within-subject data were analyzed using the 
Greenhouse-Geisser adjusted univariate analysis (Grieve, 1984). No within-subject 
effects were indicated for the amount of ROS produced in cerebella and hippocampi of 
P10 mice. Tertiary butyl hydroperoxide (tBHP) was added to isolated control cerebellar 
and hippocampal granule cells as a method control to validate the measurement of 
changes in ROS. tBHP penetrates the cell membrane and reacts with heme-proteins to 
produce alkoxyl radicals. Addition of tBHP to isolated control granule cells (positive 
control) resulted in a dramatic increase in the fluorescence within the cells indicating an 
increase in the level of ROS; no auto-fluorescence was observed in samples without 
CMH2DCFDA dye, nor in samples without cells that contained CMH2DCFDA (negative 
control), indicating minimal atmospheric and/or photo-oxidation (data not shown). 
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FIG. III-16. Relative amount of reactive oxygen species produced in granule cells isolated from cerebella 
and hippocampi of mouse pups at postnatal day 10 exposed to 0, 0.1, or 1.0 mg/kg total dose MeHg 
divided over gestational days 8 to 18. The amount of ROS produced was measured over a 30 min time 
period at intervals of 2.5 min. ROS data were analyzed by three-way MANOVA with repeated measures 
for reading time. Analysis indicated a between-subject interaction effect between brain regions and MeHg 
treatment. Although no between-subject differences were indicated for MeHg treatment, the brain region 
and MeHg treatment interaction suggested that the MeHg treatments differed more in the cerebellum than 
in the hippocampus (*). The condition of sphericity was not met; therefore with-in subject differences 
were analyzed by the Greenhouse-Geisser adjusted univariate analysis. No with-in subject differences 
were observed in the amount of ROS produced. Three-way MANOVA interaction, F (2, 56) = 4.65, p = 
0.0147, α = 0.05. 
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DISCUSSION 
Total Hg in the cerebellum and hippocampus of mouse pups exposed to MeHg 
from G8 to G18 was measured. As hypothesized, total Hg accumulated in cerebella and 
hippocampi of P0 and P10 mice in a dose-dependent manner. Although some literature 
suggests there may be sex differences in the metabolism and biotransformation of MeHg 
(Nielsen and Andersen, 1991;  Rahola et al., 1973;  Thomas et al., 1987), no sex 
differences were observed in accumulation of total Hg within cerebella or hippocampi of 
P0 or P10 MeHg mice that were exposed to MeHg prenatally. In support of Hg 
accumulation data in the present study, similar results were shown by Stern et al. (2001); 
mice prenatally exposed to MeHg accumulated total Hg in a dose-dependent manner, 
with no gender differences. In addition, Stern et al. (2001) showed that the concentration 
of total Hg in the brains of prenatally exposed pups decreased significantly between P4 
and P12. In the present study, total Hg concentrations in the brains of mice at P10 were 
significantly lower than mice at P0 for both treatment concentrations. Background total 
Hg levels in controls ranged from 0.3635 ng/g wet weight (w. w.) to 0.9311 ng/g w.w. 
The background levels in the present study fall below what has been reported for 
mammalian brain tissue. Background levels in non-treated monkeys were reported as 1.4 
– 2.3 ng/g w.w. (Lind et al., 1988).  
Fluoro-Jade B staining and activated caspase 3 immunohistochemistry were used 
to detect the presence of dying cells. Dying cells were detected in both the cerebellum 
and hippocampus of mice at P0 and P10. With Fluoro-Jade staining of cerebella at P0, 
dying cells were greatest in the granule cell layer, followed by the molecular, then the 
external germinal, and finally the Purkinje cell layer. Similarly, the number of dying 
cells in the cerebellum of mice at P0 as analyzed by activated caspase 3 were increased 
in the granule and external germinal cell layers compared to the molecular and Purkinje 
cells layers, with no influence from MeHg treatment observed. Apoptotic cell death is 
known to occur normally in the various layers of the developing cerebellum (Cowan et 
al., 1984). As many as 20 to 30 percent of proliferating cells, and 8 to 15 percent of 
postmitotic cells undergo apoptosis in the granule cell and external granule cell layers 
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during the third trimester of human cerebellar development (Nat et al., 2001). Similar 
apoptotic cell death occurs in the rat cerebellum from P0 to P21 (Altman, 1972a;  
Altman, 1972b). Therefore, our cell death data is consistent with known patterns of cell 
death in the normal developing rodent cerebellum. 
However, P0 mice exposed to a total dose of 1.0 mg/kg MeHg exhibited 
increased numbers of activated caspase 3 positive cells compared to age- and sex-
matched controls in the Purkinje cell layer, and the increase was greater in the posterior 
cerebellum than the anterior cerebellum. Increases in the number of activated caspase 3 
positive cells in the caudal cerebellum also were observed in the granule cell layer. This 
pattern of positively identified cells was not observed with Fluoro-Jade staining. Studies 
have shown that caspase 3 is activated in Bergmann glia during the process of glial 
differentiation and granule cell and Purkinje cell migration (Oomman et al., 2006). 
Bergmann glia are located in the same area of the cerebellum as Purkinje cells. In 
addition, glial stem cell production and migration, the dispersal of the external granule 
cell layer, and the ascent and settling of Purkinje cells begins first in the posterior 
cerebellum (G18 in the rat) and shifts to the anterior cerebellum (G22 in the rat) (Altman 
and Bayer, 1997). The cells identified by activated caspase 3 in the P0 pups, in fact, may 
be Bergmann glia as opposed to Purkinje cells, and the difference in the number of 
activated caspase 3 positive cells in the rostral versus caudal cerebellum may be a result 
of the delayed development of the rostral compared to the caudal cerebellum. 
MeHg is known to be cytotoxic to glia in culture at concentrations of 1.0 µM or 
greater and to induce gliosis at concentrations as low as 1.0 nM (Monnet-Tschudi et al., 
1996). In addition, Bergmann glia take up MeHg in whole animals (Takeuchi et al., 
1989), and abnormal Bergmann glia have been shown to adversely affect neuronal 
migration (Rakic and Sidman, 1973). Dual labeling with GFAP and anti-activated 
caspase 3 would be appropriate to determine if the activated caspase 3 identified cells 
are Bergmann glia as opposed to Purkinje cells. Our data indicate that MeHg may affect 
glia, and subsequently neuronal migration, as opposed to causing neuronal death in the 
developing cerebellum. 
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The number of dying cells also was determined for cerebella from P10 mouse 
pups using both Fluoro-Jade B staining and detection by anti-activated caspase 3. 
Fluoro-Jade B analysis indicated increased numbers of dying cells in the molecular layer 
compared to the external germinal and granule cell layers, with the Purkinje cell layer 
exhibiting decreased numbers of Fluoro-Jade positive cells compared to all other layers 
in mice at P10. Beginning around P10 in mice, significant numbers of cells begin 
migrating from the external germinal layer to the molecular layer (basket and stellate 
cells) and the granule cell layer (granule cells) (Altman, 1972a;  Altman, 1972b). During 
migration, within the molecular layer, stationary basket and stellate cells as well as 
vertically migrating granule cells can be observed (Altman, 1972a;  Altman, 1972b). 
During the migration and settling processing, some cells will die. Therefore, it is not 
unusual to observe increased numbers of dying cells in the molecular layer around P10 
in rodents. 
The external germinal layer of P10 mice was the only cerebellar layer that 
exhibited a MeHg treatment effect on cell death, with the 1.0 mg/kg total dose MeHg 
treatment exhibiting decreased numbers of Fluoro-Jade positive cells, specifically in 
lobules IV/V and IX. The external germinal cell layer reaches maximal thickness by P10 
in rats, and is composed of proliferating and differentiating stem cells (Altman, 1972a). 
Typically, increased numbers of dying cells can be observed in areas of high cell 
proliferation (Cowan et al., 1984). In the case of our data, we observed decreased 
numbers of dying cells in the 1.0 mg/kg MeHg treated external germinal cell layer. 
These results may be explained by a decrease in cell proliferation rate, thus a decrease in 
the number of observed dying cells, or no difference in cell proliferation rate, and an 
actual decrease in the rate of cell death. Analysis of the cells using bromodeoxyuridine 
(BrdU) and terminal deoxynucleotidyl transferase biotin-dUTP nick end labeling 
(TUNEL), BrdU and activated caspase 3, or BrdU and Fluoro-Jade double labeling 
would aid in determining possible correlations between the rate of cell death and the rate 
of cell proliferation. In addition, volume measurements and total cell counts of the cells 
in the external germinal layer might be helpful in determining cell death and 
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proliferation associations. We also observed a decrease in the number of Fluoro-Jade 
positive cells in cerebellar lobule VII in all treatments. Literature suggests that granule 
cells are generated in lobules I and X prior to P11 in the rat, and that granule cells are 
generated last in lobules VI, VII, and VIII (Altman and Bayer, 1997). The decrease in 
the number of Fluoro-Jade positive cells observed in lobule VII in the present study may 
be a result of different developmental stages among the cerebellar lobules.  
Cell death associated with MeHg exposure was not indicated in the hippocampus 
of P0 or P10 treated pups. MeHg is known to target granule cells of the cerebellum. 
Although literature suggests the hippocampus may be affected by MeHg (Burke et al., 
2006;  Falluel-Morel et al., 2007;  Falluel-Morel et al., 2006), significant amounts of cell 
death have not been observed in this brain location. In addition, the hippocampus 
develops more fully at an earlier time point that does the cerebellum (Supèr and Soriano, 
1994). Because of the time point in development selected for the present study, P0 and 
P10, any cell death that occurred at an earlier time point in hippocampal development 
that would be comparable to the developmental stage of the cerebellum at P0 or P10 
would have been missed. 
Cell death in the hippocampus was increased in the granule and subgranule 
layers of the dentate gyrus compared to the hilar region. These data are consistent with 
literature suggesting that cell proliferation in the hilar region decreases significantly 
postnatally, while proliferation in the granule and subgranule layers remains high 
(Bayer, 1980). High cell proliferation rates would result in increased numbers of dying 
cells (Cowan et al., 1984). In addition, increased cell death was observed in the CA3 
region compared to the CA1 region in the present study. In contrast to these data, a study 
by Ferrer, (1990) suggests that cell death is increased in the CA1 region compared to the 
CA3 region from P5 to P10 in rats, and that there is increased cell death along the 
CA2/CA3 border. The border between the CA2 and CA3 region is not distinct and 
represents a transition from CA3-type cells to CA1-type cells (Boss et al., 1987;  Ferrer 
et al., 1990). The increased number of Fluoro-Jade positive cells observed in the present 
study may be a result of counting CA2/CA3 border cells as cells within the CA3 region. 
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The combination of these border cells with the CA3 cells could result in an apparent 
increase in CA3 dying cells compared to cells of CA1. 
Mitochondrial membrane potential (MMP) was measured in cerebella and 
hippocampi of mouse pups at P0 and P10. As hypothesized, a dose-dependent decrease 
in MMP was observed in cerebella of P0 mouse pups, but no difference was observed in 
MMP among MeHg treatments for the hippocampus. At P10 however, MMP was 
increased, rather than decreased, but only in the 0.1 mg/kg total dose MeHg treatment. In 
addition, no difference in MMP was indicated for the male P10 hippocampus. Our data 
suggest that MeHg may have a short-term immediate affect on developing neurons that 
results in dissipation of the mitochondrial membrane electrochemical gradient, but a 
latent affect, specifically at very low concentrations (0.1 mg/kg total dose), that results in 
increased mitochondrial activity. Mitochondrial activity is often increased in response to 
cellular stress as mitochondria are recruited to provide energy for the upregulation of 
cytoprotective mechanisms or as cytoprotective mechanisms act on the mitochondria to 
prevent apoptosis (Kirchhoff et al., 2002;  Peart and Headrick, 2007;  Polla et al., 1996).  
Increases in [Ca2+]i may be toxic to a cell and trigger the cell to die. However, 
transient increases in [Ca2+]i are necessary signaling mechanisms in normal cellular 
function. As hypothesized, we observed increased [Ca2+]i in the cerebellum of mice at P0 
exposed to 0.1 and 1.0 mg/kg total dose MeHg; however, we observed no changes in 
[Ca2+]i within cells from the hippocampus. Because the increased [Ca2+]i in cerebella at 
P0 is accompanied by decreased MMP, the signal may likely to be one leading to cell 
death. However, no MeHg induced cell death was indicated for P0 cerebella. For P10 
mice, [Ca2+]i was increased in the high (1.0 mg/kg) MeHg treatment in cerebella and 
female hippocampi, but no change in [Ca2+]i was indicated for the male hippocampus. 
Comparing MMP and [Ca2+]i for P10 mouse pups, when MMP was decreased, there was 
no change in [Ca2+]i, and when [Ca2+]i was increased, there was no change in MMP. 
Similarly however, neither MMP nor [Ca2+]i were altered in P10 male hippocampi. 
There is also no indication that MeHg associated changes in MMP or [Ca2+]i are 
associated with an increase in cell death. Therefore the changes in MMP and [Ca2+]i may 
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be associated with processes other than apoptosis, such as cellular development, 
proliferation, migration, or cytoprotection.  
We hypothesized a dose-dependent increase in the level of ROS produced in the 
cerebellum and hippocampus. Instead, at P0, there were no between-subject differences 
in ROS level, but an interaction was observed between MeHg treatment and cerebellar 
and hippocampal brain regions. ROS levels were ranked from highest to lowest as 
controls, 1.0 mg/kg, and 0.1 mg/kg for the cerebellum, but were inverted as 0.1 mg/kg, 
1.0 mg/kg, and controls for the hippocampus. Similarly at P10, an interaction was 
indicated with ROS levels ranked highest to lowest as controls, 0.1 mg/kg, and 1.0 
mg/kg MeHg in the cerebellum, compared to 1.0 mg/kg, controls, and 0.1mg/kg MeHg 
in the hippocampus. High levels of ROS can result in lipid and protein oxidation and 
permanent damage to membranes (de Groot and Littauer, 1989). Low-levels of ROS 
may indicate that mitochondria are less energetic. Cells may function abnormally if 
mitochondria are not metabolizing substrate at a rate equal to the cell’s needs. Current 
data suggests that transient increases in ROS levels are important signals in 
cytoprotection (Martindale and Holbrook, 2002;  Thannickal and Fanburg, 2000).  
The purpose of our study was to determine whether low levels of MeHg, at or 
near exposure levels seen in humans, would produce similar effects observed at higher 
MeHg exposure levels. A summary of these results are located in Table III-2. As 
hypothesized, total Hg accumulated in the brains in a dose-dependent manner, and the 
concentration of MeHg dropped in mice from P0 to P10. We expected to see MeHg 
associated cell death in both the cerebellum and hippocampus, but instead, observed no 
cell death, or slight decreases in cell death with MeHg treatment. The hypothesized 
pattern of increased cell death, decreased MMP, increased [Ca2+]i, and increased ROS, 
which is typical with high MeHg exposure and exposure to other toxicants that initiate 
apoptosis, was not indicated for any MeHg treatment in the cerebellum or hippocampus 
at P0 or P10. Our data indicated, very clearly, that chronic low-levels of MeHg exposure 
during gestation do not result in effects observed for high MeHg concentrations. Instead, 
our data suggested mitochondrial dysfunction, oxidative stress, and changes in Ca2+ 
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homeostasis that may result in abnormal cellular function, proliferation and/or migration 
rather than death of neurons. 
Published literature suggests that neuronal dysfunction may be of particular 
importance in diseases such as Alzheimer’s (Mattson et al., 2008;  Wojda et al., 2008), 
Parkinson’s (Sugrue and Tatton, 2001), mood disorders (Campbell and Macqueen, 
2004), and autism (Bauman and Kemper, 2005;  Monnet-Tschudi et al., 2006), all of 
which are becoming increasingly more prevalent in society. MeHg exposure in today’s 
human population, although low, is chronic and measurable. The United States 
Environmental Protection Agency (U.S. E.P.A.) has set the reference dose (RfD) for 
MeHg at 0.1 µg/kg body weight per day. RfD is considered to be a concentration at 
which a chemical can be consumed on a daily basis over a lifetime without expectation 
of adverse effects. However, no MeHg behavioral or functional neuronal developmental 
studies have been conducted at or near the reference dose to determine whether 
developing and infant young are truly unaffected by this level of MeHg exposure. Our 
data indicate that low-levels of MeHg may affect neuronal function, and therefore 
suggest that further developmental whole animal investigation is warranted at chronic 
low MeHg concentrations. 
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TABLE III-2 
Summary of Cell Death, Mitochondrial Membrane Potential (MMP), Intracellular 
Ca2+ Concentration (Ca2+), and Level of Reactive Oxygen Species Production 
(ROS) in Cerebella (Ce) and Hippocampi (Hc) of Mouse Pups at Postnatal Day (P) 
0 and 10 Following Exposure to 0 (C), 0.1, or 1.0 mg/kg Total Dose Methylmercury 
(MeHg) Divided Over Gestational Days 8 to 18 
Postnatal 
Day 
Cerebellum / 
Hippocampus 
[MeHg] 
mg/kg Cell Death MMP Ca
2+ ROS High to low 
P0 
Ce 0.1 no NC Incr C, 1.0, 0.1 1.0 no Decr Incr  
Hc 0.1 no NC NC 0.1, 1.0, C 1.0 no NC NC  
P10 
Ce 0.1 no Incr NC C, 0.1, 1.0 1.0 no NC Incr  
Hc 0.1 no Incr(F), NC(M) NC 1.0, C, 0.1 1.0 no NC Incr(F), NC(M)  
NC  = no change compared to controls 
Decr = decreased compared to controls 
Incr = increased compared to controls 
(F) or (M) indicates change in female or male specifically 
If sex is not designated, then no differences in sex were indicated. 
High to low  = ROS levels were ranked from highest to lowest mean. 
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CHAPTER IV 
 
 
SUBCELLUAR CHANGES IN HUMAN SY5Y NEUROBLASTOMA CELLS 
EXPOSED TO METHYLMERCURY AND MERCURIC CHLORIDE 
 
 
 
SUMMARY 
High exposure levels of methylmercury (MeHg) cause the death of cerebellar and 
cerebral neurons in both adult and developing individuals. Increased apoptosis has been 
observed in cultured cerebellar granule cells and immortalized neurons exposed to 
MeHg in vitro. Mitochondrial dysfunction, alterations in Ca2+ homeostasis, and 
production of reactive oxygen species (ROS) have been implicated in the process of 
apoptosis, as well as with exposure to high concentrations of MeHg. The vast majority 
of MeHg in vitro experimentation has been conducted at high concentrations for short 
periods of time and in non-human cultured cell lines. Few studies have involved the use 
of SH-SY5Y (SY5Y) cells, a nearly diploid human neuroblastoma cell line, making this 
cell line genetically similar to “normal” human cells. The purpose of our study was to 
develop a human cell culture model for chronic low-level MeHg exposure by using a 
cell line known to be sensitive to the affects of MeHg, to examine parameters known to 
be associated with MeHg toxicity in whole animals and humans, and to compare the 
action of low levels of the organic and inorganic forms of mercury (Hg) which are both 
known to be present in the brains of humans exposed to MeHg. 
We exposed human neuroblastoma SY5Y cells to 0, 0.01, 0.1, or 1.0 µM MeHg 
or HgCl2 for 24, 48, or 72 hours and examined the cells for total Hg accumulation, cell 
death, mitochondrial function, basal [Ca2+]i, and production of reactive oxygen species 
(ROS). Both MeHg and HgCl2 exposure resulted in a concentration-dependent 
accumulation of total Hg, and MeHg exposure resulted in higher levels of total Hg in the 
cells compared to HgCl2 exposure. Total Hg uptake in all treated cells increased over 
time. The uptake of total Hg in the lower exposure concentrations did not increase as 
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rapidly as did higher concentrations, and the uptake of total Hg in the HgCl2 exposed 
cells did not increase as rapidly as in the MeHg exposed cells. Cell death was 
determined based on three assays: Trypan blue exclusion, lactate dehydrogenase activity, 
and cytotoxicity. The highest (1.0 µM) concentrations of MeHg and HgCl2 resulted in 
cell death, and the proportion of cells dying was increased with longer exposure times. 
Cell death was increased with 1.0 µM MeHg treatment compared to 1.0 µM HgCl2 
treatment. Mitochondrial membrane potential (MMP), [Ca2+]i, and production of ROS 
were measured by fluorescence microscopy or microplate assays. Both MeHg and HgCl2 
treatments resulted in decreased MMP in SY5Y cells. However, HgCl2-induced 
depolarization of mitochondria did not occur until 48 hours, compared to 24 hours for 
MeHg. In addition, 0.01 and 0.1 µM HgCl2-induced depolarization of mitochondria that 
began at 48 hours continued at 72 hours, whereas only the 1.0 µM MeHg-induced 
depolarization of mitochondria continued at 72 hours. MeHg treatments were associated 
with increased MMP at 24 hours in the lowest exposure group (0.01 µM), but this 
increase was followed at 48 hours by a dramatic decrease in MMP, and then a return to 
control levels at 72 hours. There was no difference in [Ca2+]i between MeHg and HgCl2. 
[Ca2+]i was increased at 24 hours, was decreased at 48 hours, and returned to control 
levels at 72 hours in the 1.0 µM treated cells. The rate of ROS production was decreased 
over time for all treatment concentrations. Decreased rates of ROS production were 
indicated for the 0.01 µM HgCl2 and the 1.0 µM MeHg treatments compared to controls 
at 24 hours, and for the 1.0 µM MeHg treatment compared to controls at 48 hours. 
The low concentrations used in the present study (0.01, 0.1, and 1.0 µM) do not 
appear to result in mitochondrial, Ca2+, and ROS-induced apoptosis. It appears that 
stimulation of mechanisms of cytoprotection, or those involved in cell proliferation or 
migration may be an early response of neurons exposed to low levels of MeHg. The 
potential to induce cytoprotective genes may play a role in determining which 
individuals (cells and whole organisms) exhibit negative effects at low levels of MeHg 
exposure and those which do not. Proliferation and migration of neurons in developing 
young is time-dependent, and alterations in the timing or rate of these events could 
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significantly alter normal brain development. Non-apoptotic changes in mitochondrial 
activity, [Ca2+]i, and ROS, specifically at very low MeHg concentrations, have not been 
previously indicated in current scientific literature, and further studies of these effects 
and associated mechanisms are warranted. Understanding the mechanism(s) of low-level 
MeHg toxicity is necessary for the protection of developing young. 
 
INTRODUCTION 
Methylmercury (MeHg) is a particularly neurotoxic pollutant ubiquitously found 
in the environment. Humans are chronically exposed to low-levels of MeHg primarily 
through consumption of contaminated fish. The deleterious effects of MeHg in humans 
have been well documented. Adults exposed to high concentrations of MeHg exhibit 
auditory, motor, and sensory disturbances, while individuals exposed to high levels of 
MeHg during gestation or early postnatal development show signs of mental retardation 
and cerebral palsy (Harada, 1977;  Takeuchi et al., 1962). Epidemiological studies over 
the last twenty years have shown that low levels of MeHg exposure in pregnant human 
females can produce poor motor coordination, decreased attention, and abnormal 
memory and language development in their children (Grandjean et al., 1997;  Grandjean 
et al., 1999b;  Steuerwald et al., 2000). Although the signs and symptoms of MeHg 
neurotoxicity are known, the mechanisms of MeHg neurotoxicity remain unclear. 
Granule cells in the cerebellum and neurons of the cerebral cortex are 
particularly sensitive to MeHg toxicity. Human studies have shown that high exposure 
levels of MeHg cause the death of cerebellar and cerebral neurons in both adult and 
developing individuals (Harada, 1977;  Matsumoto et al., 1965;  Takeuchi, 1977). 
Increased apoptosis and necrosis also have been observed in cultured cerebellar granule 
cells and immortalized neurons exposed to MeHg in vitro (Castoldi et al., 2000;  Fonfria 
et al., 2002;  Gatti et al., 2004;  Toimela and Tähti, 2004;  Vendrell et al., 2007). 
Mitochondrial dysfunction, alterations in Ca2+ homeostasis, and production of 
reactive oxygen species (ROS) have been implicated in the process of apoptosis (Alberdi 
et al., 2005;  Brookes et al., 2004;  Kakkar and Singh, 2007;  Smaili et al., 2003;  
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Waterhouse, 2003), as well as in MeHg toxicity. Studies in adult mice have shown that 
MeHg exposure causes increases in reactive oxygen species (ROS), abnormal 
mitochondrial function (Mori et al., 2007;  Yee and Choi, 1994) and alterations in 
intracellular calcium ion ([Ca2+]i) homeostasis (Bellum et al., 2007a) in neurons of the 
central nervous system (CNS). MeHg affects on mitochondrial membrane potential 
(MMP)  (Bondy and McKee, 1991;  InSug et al., 1997;  Limke and Atchison, 2002), 
production of ROS (Ceccatelli et al., 2007;  Mori et al., 2007;  Yin et al., 2007), and 
[Ca2+]i signaling (Hare et al., 1993;  Levesque and Atchison, 1991;  Marty and Atchison, 
1998) have been described for both primary cells and immortalized cell lines in culture. 
MeHg exposure produces increases in [Ca2+]i in cerebrocortical synaptosomes 
(Kauppinen et al., 1989), cerebellar granule cells (Sarafian, 1993), and NG108-15 
neuroblastoma/glial hybrid cells (Hare et al., 1993). MMP is decreased by MeHg 
exposure in astrocytes (Yin et al., 2007) and rat cerebellar granule cells (Limke and 
Atchison, 2002); and mitochondrial function is altered by MeHg in rat striatal 
synaptosomes (Dreiem and Seegal, 2007). The production of ROS is increased by 
exposure to MeHg in rat brain mitochondria (Mori et al., 2007) and C6-glial and B35-
neuronal cell lines (Kaur et al., 2007). In these studies, and the vast majority of others, 
MeHg exposure occurred at high concentrations for short periods of time, using cultured 
primary or immortalized cell lines, which may or may not respond to MeHg in the same 
manner as cells in the whole animal. 
Much of the published MeHg in vitro experimentation has been conducted at 
high concentrations for short periods of time and result in cell death. Typical in vitro 
experiments have used MeHg exposure concentrations ranging from 2.0 to 100.0 µM 
(Kauppinen et al., 1989;  Limke and Atchison, 2002;  Sarafian, 1993;  Yin et al., 2008). 
Exposure time periods have most commonly been 30 min and 1 hour, with exposure 
time periods ranging from 15 min to 24 hours (Dreiem and Seegal, 2007;  Kauppinen et 
al., 1989;  Kaur et al., 2007;  Limke and Atchison, 2002;  Sarafian, 1993). These 
exposure scenarios do not reflect the typical low dose chronic human MeHg exposure. 
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Nor do they consider the possibility that MeHg may exert subcellular changes that affect 
neuronal function, without the gross display of cell death. 
The observation that MeHg targets neurons for cell death in vivo suggests that 
neuronal cell cultures would be a prime candidate to develop an in vitro model to study 
MeHg toxicity. The majority of neuronal cell lines used for MeHg studies include NB-1 
human neuroblastoma (Kunimoto et al., 1992;  Kunimoto and Suzuki, 1995;  Pramanik 
et al., 2002), PC12 (Miura et al., 1999), N1E-115 mouse neuroblastoma (Miura et al., 
1999;  Uki and Narahashi, 1996), Neuro-2a mouse neuroblastoma (Repetto et al., 1993), 
NBP2 murine neuroblastoma (Prasad, 1991), and Nb2a-AB-1 mouse neuroblastoma 
cells (Sager and Syversen, 1984). These cell lines display genetic abnormalities such as 
polyploidy or are not species specific for humans.  
Few studies have involved the use of SH-SY5Y (SY5Y) human neuroblastoma 
cells. SY5Y cells are a nearly diploid subclone of the SK-N-SH human neuroblastoma 
cell line, making this cell line genetically similar to “normal” human cells. SY5Y cells 
are a third generation neuroblastoma, cloned from the SK-N-SH cell line isolated from a 
metastatic bone tumor of a four-year old girl in 1970 (Biedler et al., 1973). The SY5Y 
cells possess two X chromosomes and lack a Y chromosome, making them genetically 
female. The cells posses an abnormal chromosome 1, where there is an additional copy 
of the 1q segment, also referred to as trisomy 1q. SY5Y cells have been used to model 
dopaminergic pathogenesis (Takahashi et al., 1994) because it expresses dopaminergic 
phenotypes such as the presence of tyrosine β-hydroxylase activity (Chen et al., 1998;  
Shaul et al., 2003), dopamine transporters (Manáková et al., 2004), and dopamine 
metabolism (Legros et al., 2004). SY5Y cells have low levels of choline 
acetyltransferase, a cholinergic neurotransmitter (Biedler and Spengler, 1976). They are 
morphologically similar to neuroblasts in culture and can be differentiated by exposure 
to nerve growth factor, taking on a neuronal cell morphology (Perez-Polo et al., 1979). 
SY5Y cells have been used to study neurotoxicants such as organophosphates (Ehrich, 
1995;  Yang and Tiffany-Castiglioni, 2007) and polycyclic aromatic hydrocarbons 
(PCBs) (Magi et al., 2005;  Ndountse and Chan, 2009). SY5Y cells also have been used 
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to characterize various effects of MeHg (Kim et al., 2007;  Sanfeliu et al., 2001) and 
inorganic mercury (Toimela and Tähti, 2004). MeHg studies using SY5Y cells have 
shown depletion of cellular reduced glutathione (GSH) pools (Sanfeliu et al., 2001), 
inhibition of differentiation (Kim et al., 2007), down-regulation of selenoprotein W 
associated with depletion of GSH (Kim et al., 2005a), and increased cell death, with 
SY5Y cells being more sensitive to MeHg toxicity than either glioma or retinal epithelial 
cells (Toimela and Tähti, 2004).  
A confounding aspect in determining the mechanism(s) of MeHg toxicity stems 
from the ability of MeHg to demethylate within the brain, resulting in the presence of the 
divalent form of mercury (Hg2+) (Aschner and Clarkson, 1987;  Berlin et al., 1975;  
Charleston et al., 1995;  Syversen, 1974). The inherent differences in hydrophilic 
divalent cations and lipophilic organic molecules suggest that the mechanisms of action 
of the two forms of mercury would be different. Hare and Atchison, (1992) showed that 
both forms of Hg resulted in mitochondrial and plasma membrane depolarization, but 
that the inorganic form produced depolarization at lower concentrations than the methyl 
form. Other comparisons between the two forms of Hg include increased inhibition of 
protein synthesis by MeHg compared to Hg2+ in sarcoma cells (Nakada et al., 1980), but 
similar effects on glutathione oxidation in mouse brain mitochondria (Franco et al., 
2007). 
The objective of the present study was based on the following known 
information about MeHg toxicity: 1) MeHg exposure in humans causes neuronal cell 
death by apoptosis, 2) cell death by apoptosis involves mitochondrial disruption, altered 
Ca2+ homeostasis, and increased production of ROS, 3) apoptosis, mitochondrial 
disruption, altered Ca2+ homeostasis, and increased production of ROS have been shown 
to occur in neuronal cell lines exposed to MeHg, 4) mitochondrial, Ca2+, and ROS 
changes associated with MeHg have not previously been studied in the sensitive human 
neuroblastoma cell line, SH-SY5Y, 5) studies involving side-by-side comparison of 
MeHg and Hg2+ are limited. The purpose of our study was to develop a human cell 
culture model for chronic low-level MeHg exposure toxicity by using a cell line known 
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to be sensitive to the affects of MeHg, to examine parameters known to be associated 
with MeHg toxicity in whole animals and humans, and to compare the action of the 
organic and inorganic forms of Hg which are both known to be present in the brains of 
humans exposed to MeHg. We hypothesized that: 1) there would be a dose-dependent 
increase in the uptake of total Hg and in cell death in the SY5Y cells, 2) MMP would 
decrease, and basal [Ca2+]i and the level of ROS production would increase in a dose-
dependent manner associated with the presence of cell death, 3) cell death and associated 
changes in MMP, Ca2+, and ROS production would be greater in SY5Y cells exposed to 
MeHg compared to those exposed to Hg2+ in the form of HgCl2, and 4) changes in 
MMP, Ca2+, and ROS production would occur at Hg concentrations that did not result in 
cell death. To determine whether changes in MMP, Ca2+, and ROS production occur at 
Hg concentrations that do not result in cell death, we selected exposure concentrations 
ranging from those known to cause cell death with MeHg at 24 hours (1.0 µM) to those 
in which cell death has not been observed (0.01 µM) or documented. 
To test these hypotheses, we exposed human neuroblastoma SY5Y cells to 0, 
0.01, 0.1, or 1.0 µM concentrations of MeHg or HgCl2 for 24, 48, or 72 hours and 
examined the cells for total Hg accumulation, cell death, mitochondrial function, basal 
[Ca2+]i, and production of ROS. Exposure time periods of 24, 48, and 72 hours were 
selected to allow at least one division period for the cells, with a maximum of 72 hours 
to eliminate the necessity of splitting the cells. At each time point, the amount of total 
Hg in the cells was measured. Cell death was determined based on three assays: Trypan 
blue exclusion, lactate dehydrogenase activity, and a cytotoxicity assay. MMP, basal 
[Ca2+]i, and the level of ROS production were measured by fluorescence microscopy or 
microplate assays. 
 
MATERIALS AND METHODS 
Materials 
Methylmercuric chloride, (MeHg), 95%, was purchased from Alfa Aesar (Ward 
Hill, MA). Human SH-SY5Y human neuroblastoma cells were purchased from 
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American Type Culture Collection (ATCC, Rockville, MD). Mercuric chloride, (HgCl2), 
>99.5%, Dulbecco’s Modified Eagle’s Medium (DMEM), Nutrient Mixture F-12 Ham 
(F-12), Puck’s saline solution with EDTA (Puck’s EDTA, no Ca2+, no Mg2+, with 5.4 
mM KCl, 1.37 mM NaCl, 4.2 mM NaHCO3, 5.5 mM glucose, and 0.5 mM Na2 EDTA), 
poly-D-lysine hydrobromide >300,000 kD, tertiary-butyl hydroperoxide (tBHP), Hank’s 
Balanced Salt Solution (HBSS, modified with NaHCO3 and without phenol red), 
carbonyl cyanide 3-chloro-phenylhydrazone (CCCP), thapsigargin, and Janus Green B 
were purchased from Sigma-Aldrich, Inc. (St. Louis, MO). Fetal bovine serum (FBS) 
was purchased from Gemini (Woodland, CA). B27 serum-free supplement was 
purchased from Invitrogen (Carlsbad, CA). DOLT-2, DORM-2, and DOLT-3 were 
purchased from the National Research Council Canada (NRCC), Institute for 
Environmental Chemistry (Ottawa, Canada). The Cytotoxicity Detection Kit (LDH) was 
purchased from Roche Applied Science (Germany). The MultiTox-Fluor Multiplex 
Cytotoxicity Assay was purchased from Promega (Madison, WI). 
Tetramethylrhodamine, methyl ester perchlorate (TMRM), Calcium Green™-1 AM, 5-
(and 6)-chloromethyl-2’,7’-dichlorodihydrofluorescein diacetate acetyl ester (CM-
H2DCFDA), and Pluronic® F-127 were purchased from Invitrogen/Molecular Probes 
(Eugene, OR). Lab-Tek 2-well chambered coverglasses were purchased from Nunc Inc. 
(Naperville, IL). 
 
Cell cultures 
SY5Y cells, passage numbers 55 to 65 were routinely maintained in T-75 flasks 
in DMEM/F12 (1:1) supplemented with 10% fetal bovine serum (FBS) in a humidified, 
37°C, 5% CO2 environment. No antibiotics or fungicides were used in the stock cell 
preparations or those used for experimentation. Experimental cells were detached by 
application of Puck’s EDTA for 5 min at 37°C, plated in DMEM/F12 supplemented with 
1x B27, and allowed to attach and grow for 24 hours before treatment. Cells used for 
total Hg accumulation analysis were seeded in 150 mm x 25 mm round gridded 
polystyrene culture dishes (BD Falcon, San Jose, CA) at 70,000, 50,000, and 30,000 
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cells per cm2 for experiments conducted at 24, 48, and 72 hours, respectively. Cells used 
for all other experiments were seeded at 30,000 cells per cm2. Treatments included 0, 
0.01, 0.1, or 1.0 µM methylmercury (MeHg) or inorganic mercury (HgCl2) for 24, 48, or 
72 hours. MeHg and HgCl2 stock solutions (100 µM) were prepared in distilled / 
deionized water, filtered, and stored at 4°C. Working MeHg and HgCl2 solutions were 
prepared from the 100 µM stock solution in growth media just before use. 
 
Mercury accumulation 
Total mercury (Hg) was measured to determine the amount of total Hg 
accumulated within the SY5Y cells. Three independently processed samples were 
collected for each time point and treatment (n = 3). Following MeHg or HgCl2 exposure, 
the treatment medium was removed and the cells and plate rinsed with 4 mL Puck’s plus 
EDTA. The Puck’s plus EDTA solution was removed and added to the treatment 
medium. The treatment/EDTA solution was centrifuged at 1000 g for 5 min to pellet any 
floating cells. Puck’s plus EDTA (5 mL) was added to the plate of cells and incubated 
for 5 min at 37°C to release the cells. The dislodged cells in Puck’s plus EDTA were 
added to the previously pelleted cells. The total volume of cell-containing solution for 
each sample was 5 mL. 0.5 mL of the cell-containing solution was removed and added to 
4.5 mL DMEM/F12 for counting. The cell suspension was mixed at a ratio of 4:1 with 
0.4 % Trypan blue solution and incubated for 5 min. The viable (clear) and dead (blue) 
cells were counted using a hemacytometer and an inverted-phase contrast microscope 
(Nikon, Model TMS, Tokyo, Japan) (Costa et al., 2007). The remaining cell solution 
was centrifuged at 1000 g for 5 min, the supernatant removed, and the pellet frozen at -
20°C. The frozen pellet of cells was freeze-dried and total Hg content was measured in 
the Trace Element Research Laboratory at Texas A&M University, by combustion / 
trapping / atomic absorption (Salvata and Pirola, 1994) on a Milestone Direct Mercury 
Analyzer 80 (DMA 80) equipped with an autosampler and dual cell detector. The DMA 
80 was calibrated using a calibration blank and a series of seven aliquots of certified 
reference standard ranging from 1 to 750 ng Hg. The calibration line was verified with 
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an independent CRM standard (NRCC DOLT-2) and a blank nickel boat. Samples were 
weighed to the nearest 0.00001 g and placed into the DMA 80 in pre-combusted nickel 
boats. A method blank, two certified reference materials (DORM-2 and DOLT-3), a 
spiked sample, and a duplicate sample were included at the beginning and end of each 
sample run. The DMA 80 has a detection limit of 0.005 ng Hg and a working range of 
up to 1000 ng Hg (Milestone, Inc. Shelton, CT). 
 
Trypan blue exclusion 
The Trypan blue dye exclusion assay was performed to determine the number of 
living and dead cells. The experiment was conducted three times; each experiment 
included four replicates for each toxicant, treatment, and time point. Cells (30,000 cells 
per cm2) were plated in 24-well polystyrene, cell culture treated plates (BD Falcon, San 
Jose, CA). Following MeHg or HgCl2 exposure, the cells were released by incubation 
with Puck’s plus EDTA for 5 min at 37°C. 0.5 mL of the cell solution was removed and 
added to 4.5 mL DMEM/F12 for counting. The cell suspension was mixed at a ratio of 
4:1 with 0.4 % Trypan blue solution and incubated for 5 min. The viable (clear) and 
dead (blue) cells were counted using a hemacytometer and an inverted-phase contrast 
microscope (Nikon, Model TMS, Tokyo, Japan). The average of four counts per 
replicate was used for data analysis. 
 
Lactate dehydrogenase 
The activity of lactate dehydrogenase released into the culture medium was 
measured to evaluate plasma membrane integrity, which is compromised in dead cells. 
The experiment was conducted three times; each experiment included seven replicates 
for each toxicant, treatment, and time point. LDH release was measured with the Roche 
Cytotoxicity Detection Kit (LDH) (Kondo et al., 1993). Cells (30,000 cells per cm2) 
were plated in 24-well polystyrene, cell culture treated plates (BD Falcon, San Jose, 
CA). After 24 hours of treatment with MeHg or HgCl2, the medium was removed and 
centrifuged at 1100 g for 5 min to remove floating cells. The supernatant was transferred 
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into 96-well polystyrene, cell culture treated plates (BD Falcon, San Jose, CA) and 
incubated with the LDH dye solution and catalyst mixture (included in the kit). Degree 
of color change was measured in a BioTek® Synergy 4™ microplate reader with 
Gen5™ data analysis software (Winooski, VT) at absorbance 490 nm. Once released 
from dying cells, LDH breaks down at 37°C after 24 hours. Therefore, LDH release was 
measured every 24 hours in the 48 and 72 hour treatment samples. LDH release values at 
24 and 48 were summed to attain the value for the total amount LDH released over the 
48 hour exposure time. LDH release values at 24, 48, and 72 hours were summed to 
attain the value for the total amount of LDH released over the 72 hour exposure time. 
Media used for analysis was replaced with fresh MeHg or HgCl2-treated media in the 48 
and 72 hour treatment samples, and the cells were allowed to grow for the next 24-hour 
time period. 
 
Cytotoxicity assay 
A cytotoxicity assay was conducted to determine the relative number of live and 
dead cells following treatment with 0, 0.01, 0.1, or 1.0 µM MeHg or HgCl2 for 24, 48, or 
72 hours. The MultiTox-Fluor Assay measures live-cell protease activity that is 
restricted to intact viable cells and is measured using a fluorogenic, cell-permeant, 
peptide substrate (glycyl-phenylalanyl-amino-fluorocoumarin, GF-AFC) (AFC). A 
second, fluorogenic cell-impermeant peptide substrate (bis-alanyl-alanyl-phenylalanyl-
rhodamine 110, bis-AAF-R110) (R110) was used to measure dead-cell protease activity, 
which is released from cells that have lost membrane integrity (Niles et al., 2006). The 
experiment was conducted three times; each experiment included six replicates of each 
toxicant, treatment, and time point. Cells were plated in 96-well polystyrene, cell culture 
treated plates (BD Falcon, San Jose, CA) at 30,000 cells per cm2. Following MeHg or 
HgCl2 exposure, live cell substrate (AFC) or dead cell substrate (R110) was added to 
each well and incubated for 30 min at 37°C. Plates were analyzed on a BioTek® 
Synergy 4™ microplate reader with Gen5™ data analysis software (Winooski, VT) at 
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fluorescence settings of excitation/emission 400/505 nm for live cells (AFC), and 
excitation/emission 485/520 for dead cells (R110). 
 
Mitochondrial membrane potential 
Tetramethylrhodamine methyl ester (TMRM) was used to detect changes in 
mitochondrial membrane potential (MMP) (Barhoumi et al., 2004) in SY5Y cells treated 
with 0, 0.01, 0.1, or 1.0 µM MeHg or HgCl2 for 24, 48, or 72 hours. TMRM is a 
lipophilic potentiometric mitochondrial dye that accumulates in mitochondria in 
proportion to the membrane potential (Scaduto Jr and Grotyohann, 1999). TMRM dye 
stock solution (1.0 mM) was prepared in 100% methanol and stored with desiccant at -
20°C. TMRM working solution (150.0 nM) was prepared from the 1.0 mM stock 
solution in HBSS just before use. The methanol concentration in the working solution 
was 0.015%. HBSS was used in the TMRM working solution instead of growth medium 
to prevent the TMRM dye from binding to proteins within the medium and inhibiting 
movement of dye into the cells. Cells were plated in 2-well chambered coverslips coated 
with gelatin and 1x poly-D-lysine. Cells were treated and analyzed in batches consisting 
of a control and one of each toxicant at each treatment concentration to control 
variability from day to day and allow comparison of data from one day to the next.  
Following treatment with MeHg or HgCl2, media was removed and replaced with 
a 150.0 nM solution of TMRM in HBSS for 20 min at 37°C. The TMRM solution was 
replaced with HBSS for imaging. Three negative controls (HBSS and cells with no dye, 
HBSS with no cells and no dye, and HBSS with dye, but no cells) and a positive control 
(HBSS and cells with dye and 20 µM CCCP) were included. CCCP was used to 
determine that the observed fluorescence was associated with the mitochondrial 
membrane and not other non-specific fluorescence (Julian et al., 2005). CCCP is a lipid-
soluble weak acid that uncouples oxidative phosphorylation in the inner mitochondrial 
membrane. It enters the mitochondria in a protonated form, discharges the pH gradient, 
then leaves the mitochondria as an anion, depolarizing the mitochondrial membrane 
(Lim et al., 2001). When CCCP is co-administered to cells with TMRM, the CCCP-
  
191
induced depolarization of the inner mitochondrial membrane results in release of 
accumulated TMRM from mitochondria into the cytosol, and a decrease in fluorescence 
occurs. 
Fluorescent mitochondrial images were collected over a 10 min time period at 
20x using an Olympus 1X-70 microscope with a Hamamatsu ORCA-ER camera at 
excitation/emission 488/520 nm. Image retrieval and MMP analysis were performed 
using Simple PCI and Imaging System Software (v5.0.0.1503, Compix Inc.). The 
relative MMP values of individual mitochondria from a minimum of ten cells per sample 
were measured and averaged to give the value for each individual sample. Mitochondria 
were identified as fluorescent round or oblong-shaped punctate fluorescent objects 
within the SY5Y cells. MMP data were calculated as percentage of control within each 
batch. 
 
Basal intracellular Ca2+ 
Calcium Green™-1 AM was used to measure the relative concentration of basal 
intracellular calcium ions ([Ca2+]i) (Gilroy and Jones, 1992) in SY5Y cells treated with 
0, 0.01, 0.1, or 1.0µM MeHg or HgCl2 for 24, 48, or 72 hours. Calcium Green™-1 AM 
is a long-wavelength Ca2+ indicator that exhibits an increase in fluorescence emission 
intensity upon binding to Ca2+ (Eberhard and Erne, 1991). The dye is in the AM ester 
form, which enhances cell permeability and is non-fluorescent in the absence of Ca2+ 
(Lee et al., 1999). Upon binding to Ca2+, the dye exhibits an approximately 100-fold 
increase in emission intensity, which enables detection of changes in Ca2+ concentration 
within a large dynamic range (Lee et al., 1999). Calcium Green™-1 AM stock solution 
(2 mM) was prepared in 100% DMSO and stored with desiccant at -20°C for up to two 
weeks. Working solutions of Calcium Green™-1 AM (1.0 µM) were prepared just 
before use in 0.01% Pluronic® F-127 in HBSS. The final DMSO concentration in the 
working solution was 0.05%. HBSS was used in the Calcium Green™-1 AM working 
solution instead of growth media to prevent the Calcium Green™-1 AM dye from 
binding to proteins within the medium and inhibiting movement of dye into the cells. 
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The experiment was conducted three times; each experiment included eight 
replicates of each toxicant, treatment, and time point. Cells were plated at a density of 
30,000 cells per cm2 in 48-well polystyrene, cell culture treated plates (BD Falcon, San 
Jose, CA). Following MeHg or HgCl2 exposure, the medium was removed and replaced 
with a 1.0 µM solution of Calcium Green™-1, AM in 0.01% Pluronic® F-127 and 
HBSS for 20 min at room temperature. Calcium Green™-1 was removed and replaced 
with HBSS for 20 min to allow de-esterification of the dye. The AM ester of the 
molecule, which enhances the movement of the dye into the cell, must be removed by 
endogenous esterases for the dye to fluoresce when bound to Ca2+. Three negative 
controls (HBSS and cells with no dye, HBSS with no cells and no dye, and HBSS with 
dye, but no cells) and a positive control (HBSS and cells with dye and thapsigargin) 
were included. Thapsigargin is an inhibitor of sarco-endoplasmic reticulum Ca2+ 
ATPases and raises cytosolic free Ca2+ by blocking the ability of the cell to pump Ca2+ 
into the endoplasmic reticulum (ER) (Treiman et al., 1998). ER-store Ca2+ depletion can 
secondarily activate plasma membrane Ca2+ channels, allowing an influx of Ca2+ into the 
cytosol (Barhoumi et al., 2006). When thapsigargin is co-administered to cells with 
Calcium Green™-1 AM, the thapsigargin-induced increase in cytosolic free Ca2+ causes 
a dramatic increase in fluorescence. Plates were analyzed on a BioTek® Synergy 4™ 
microplate reader (Winooski, VT) at fluorescence settings of excitation 485/20 and 
emission 528/20 to determine relative [Ca2+]i. Following [Ca2+]i analysis, Janus Green 
dye was used to determine the relative number of cells within each well. This value was 
used to normalize the [Ca2+]i data among wells. Janus Green B 
(diethylsafraninazodimethylaniline chloride) is a basic histological stain (Rieck et al., 
1993). By staining the cells attached to the surface of the individual wells, and then 
measuring the absorbance of the Janus Green dye within the wells, we were able to 
determine a relative value for the cell number that could be used to normalize the data 
for each well. HBSS was removed from the wells and replaced with 100% ethanol 
(EtOH) for 90 sec. The EtOH was removed and the wells were allowed to dry for 3 min. 
Janus Green dye (1 mg/mL in 0.1 M phosphate buffered saline) was added to each well 
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for 1 min, and then removed and the wells rinsed twice with HBSS. To extract the 
accumulated dye from the cells, 100% EtOH was added to each well and mixed by 
pipetting twice. The absorbance was measured at 654 nm in a BioTek® Synergy 4™ 
microplate reader (Winooski, VT). [Ca2+]i readings for each well were normalized to the 
relative cell number absorbance value for the same well. Normalized [Ca2+]i data were 
calculated as percentage of control for each plate to eliminate inter-run variability and 
allow comparison of one experiment to another. 
 
Reactive oxygen species 
5-(and 6)-chloromethyl-2’7’-dichlorodihydrofluorescein diacetate acetyl ester 
(CM-H2DCFDA) was used to determine the relative rate of ROS production over time 
(Bellum et al., 2007a;  Oyama et al., 1994) in SY5Y cells exposed to 0. 0.01, 0.1, and 
1.0 µM MeHg or HgCl2 for 24, 48, or 72 hours. CM-H2DCFDA is a non-fluorescent 
compound that is oxidized to highly fluorescent 2’,7’-dichlorofluorescein (DCF) by the 
action of ROS (LeBel et al., 1992). The chloromethyl (CM) group on the dye allows the 
dye to passively diffuse into cells. Subsequent oxidation of the dye molecule by 
endogenous esterases traps the metabolites within the cell where they can react with 
ROS. CM-H2DCFDA stock solution (2 mM) was prepared in 100% DMSO and stored 
withn desiccant at -20°C for up to two weeks. Working solutions of CM-H2DCFDA (1.0 
µM) were prepared just before use in 0.01% Pluronic® F-127 in HBSS. The final 
DMSO concentration in the working solution was 0.05%. The experiment was 
conducted three times; each experiment included eight replicates of each toxicant, 
treatment, and time point. Cells were plated at a density of 30,000 cells per cm2 in 48-
well polystyrene, cell culture treated plates (BD Falcon, San Jose, CA). Following 
MeHg or HgCl2 exposure, the medium was removed and replaced with a 1 µM solution 
of CM-H2DCFDA in 0.01% Pluronic® F-127 in HBSS for 5 min at room temperature. 
The CM-H2DCFDA was removed and replaced with HBSS for plate-reader analysis. 
Three negative controls (HBSS and cells with no dye, HBSS with no cells and no dye, 
and HBSS with dye, but no cells) and a positive control (HBSS and cells with dye and 
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tertiary-butyl hydroperoxide (tBHP) were included) (Drahota et al., 2005). tBHP is a 
lipophilic, membrane-permeant oxidant (Elliott et al., 1992). It reacts with iron in heme-
proteins and produces alkoxyl radicals (Kim et al., 2005b). When tBHP is co-
administered to cells with CM-H2DCFDA dye, the tBHP-induced increase in ROS 
causes an increase in fluorescence. Fluorescence data were collected every 2.5 min for 
30 min at excitation 485/20 and emission 528/20 to determine the relative rate of ROS 
production (Bellum et al., 2007a) and the amount of ROS produced. Following ROS 
analysis, Janus Green dye was used to determine the relative number of cells within the 
well. Janus Green dye procedures are described in the basal intracellular Ca2+ section. 
This value was used to normalize the [Ca2+]i data among wells. ROS readings for each 
well were normalized to the relative cell number absorbance value for the same well. 
Normalized ROS data were calculated as percentage of control for each plate to 
eliminate inter-run variability and allow comparison of one experiment to another.  
 
Statistical analysis 
All data are represented as mean ± standard error of the mean (SEM). All data, 
except Hg accumulation data, were calculated as percentage of control to eliminate inter-
run variability and to normalize data collected at different days and times. A three-way 
MANOVA with repeated measures for reading time was used to assess between- and 
within-subject differences in the rate of ROS production associated with exposure time, 
toxicant, and treatment concentration. The condition of sphericity was analyzed for all 
ROS data. The condition of sphericity was not met in any of the ROS data analyzed; 
therefore the Greenhouse-Geisser adjusted univariate test was used for repeated 
measures analysis of ROS production over reading time (Grieve, 1984). All other data 
were analyzed by three-way ANOVA and Tukey’s honest significant difference (HSD) 
or Student’s t post hoc tests, as appropriate, to determine main effects and interactions 
associated with exposure time, toxicant, and treatment concentrations. In cases where the 
experiment was conducted three times, each experiment was statistically analyzed 
individually, and then the three were compared to each other to determine similarity 
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between experiments. Data from one of the three experiments has been presented as 
representative results. For all experiments, α = 0.05 (JMP 7.0.2, SAS Institute Inc., Cary, 
NC). 
 
RESULTS 
Mercury accumulation 
Total mercury (Hg) incorporated into SY5Y cells exposed to 0, 0.01. 0.1, or 1.0 
µM MeHg or HgCl2 for 24, 48, or 72 hours was measured, and then analyzed by three-
way ANOVA to determine differences and interactions associated with treatment time, 
toxicant, and treatment concentration. Total Hg incorporated is reported as ng Hg per g 
of freeze dried cell volume. The freeze dried cell volume consisted of the entire Hg 
treated cell population within the growth chamber. Between-subject factors were time 
(24, 48, or 72 hours), toxicant (MeHg or HgCl2), and treatment (0, 0.01, 0.1, and 1.0 
µM). Data are represented as M = mean and SEM = standard error of the mean. Analysis 
indicated a main effect for treatment, F (3, 54) = 28.3, p < 0.0001 (Table IV-1). Tukey’s 
HSD post hoc analysis indicated that the 0.1 (M = 46000 ng/g, SEM = 10000) and 1.0 
µM (M = 310000 ng/g, SEM = 81000) treatments accumulated more total Hg than did 
the 0.01 µM treatment (M = 4900 ng/g, SEM = 490) and controls (M = 250 ng/g, SEM = 
45). The 1.0 µM treatment accumulated more total Hg than did the 0.1 µM treatment. In 
addition, interactions were indicated for time and treatment, F (3, 54) = 69.15, p < 
0.0001, for toxicant and treatment, F (3, 54) = 15.11, p < 0.0001, and for time, toxicant, 
and treatment, F (3, 54) = 62.44, p < 0.0001. These interactions suggested that the 
observed differences in treatment were greater for the MeHg toxicant compared to the 
HgCl2 toxicant, and that the treatment differences increased over exposure time (Table 
IV-1). 
 
Trypan blue exclusion 
The number of dead and total SY5Y cells following exposure to 0, 0.01. 0.1, or 
1.0 µM MeHg or HgCl2 for 24, 48, or 72 hours was counted using the Trypan blue 
  
196
exclusion assay and a hemacytometer. Live cells exclude Trypan blue, while Trypan 
blue accumulates within dead and dying cells with damaged plasma membranes. The 
experiment was conducted three times using a sample size of four for each experiment. 
Data from each experiment were independently analyzed by three-way ANOVA to 
determine differences and interactions associated with treatment time, toxicant, and 
treatment concentration. Analysis of live and dead cell count data indicated similar 
results for all three experiments. Data reported are representative of one of the three 
experiments conducted. Analysis of the number of dead cells indicated main effects for 
time, F (2, 72) = 6.29, p = 0.003, and for treatment concentration, F (3, 72) = 3.55, p = 
0.019 (Fig IV-1). Data for dead cells also indicated an interaction effect between time 
and treatment concentration, F (3, 72) = 3.11, p = 0.0092. Tukey’s HSD post hoc 
analysis for dead cells indicated that the number of dead cells was increased in the 1.0 
µM MeHg treatment compared to controls at 24, 48, and 72 hours. The number of dead 
cells was increased in the 1.0 µM HgCl2 treatment compared to controls at 72 hours. The 
number of dead cells was increased in the 1.0 µM MeHg treatment compared to the 1.0 
µM HgCl2 treatment at 24 and 48 hours. Data also indicated that there were more dead 
cells in all treatment concentrations at 72 hours compared to 24 hours. The dead cell 
time and treatment concentration interaction suggested that the observed treatment effect 
increased with exposure time. Analysis of the number of total cells indicated a main 
effect for exposure time, F (2, 72) = 25.04, p < 0.0001. Tukey’s HSD post hoc analysis 
indicated that the total number of cells was increased at 72 hours compared to 48 hours, 
and increased at 72 and 48 hours compared to 24 hours (Fig IV-1). No main effects for 
total cell counts were indicated for toxicant or treatment concentration. 
 
Lactate dehydrogenase 
LDH activity was measured for SY5Y cells following exposure to 0, 0.01, 0.1 or 
1.0 µM MeHg or HgCl2 for 24, 48, or 72 hours. LDH is released from dying cells when 
the plasma membrane is damaged. LDH activity was measured in media as a relative 
representation of cell death. The relative cell number was determined for each well. Each 
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LDH value per well was normalized by the relative cell number determined for that 
same well. The LDH experiment was conducted three times with a sample size of eight 
for each experiment. Data from each experiment were independently analyzed by three-
way ANOVA to determine differences and interactions associated with treatment time, 
toxicant, and treatment concentration. Analysis of LDH data indicated similar results for 
all three experiments. Data reported are representative of one of the three experiments 
conducted. Analysis of LDH dead cell data indicated a main effect for treatment, F (3, 
136) = 37.77, p < 0.0001, and interaction effects between time and treatment, F (3, 136) 
= 2.78, p = 0.0141, between toxicant and treatment, F (3, 136) = 28.81, p < 0.0001, and 
among time, toxicant and treatment, F (3, 136) = 3.05, p = 0.0079 (Fig IV-2). Tukey’s 
HSD post hoc analysis indicated that LDH was increased in the 1.0 µM HgCl2 and 1.0 
µM MeHg treatments at 24, 48, and 72 hours. LDH also was increased in the 1.0 µM 
MeHg treatment compared to the 1.0 µM HgCl2 at 24, 48, and 72 hours. The interaction 
effects suggested that LDH levels increased with increased exposure time and with 
increased treatment concentration. Student’s t post hoc test indicated that LDH levels 
were higher in cells treated with MeHg than in those treated with HgCl2 (Fig IV-2). 
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TABLE IV-1 
Mean Total Mercury Concentration in SY5Y Cells Following Exposure to 0, 0.01, 
0.1, or 1.0 µM MeHg or HgCl2 for 24, 48, or 72 Hours 
Treatment 
Concentration 
(µM) 
 Total Hg (ng/g) for Exposure Time and Toxicant 
 24  48  72 
 M H  M H  M H 
0  346 346 338 338 141 141 
0.01  5781 2689 6791 2748 7890 2907 
0.1  76386* 6298* 83321* 5904* 98517* 5878* 
1.0  206035* 33416* 876250*† 49045*† 650156*† 50170*†
Total Hg concentration data were analyzed by three-way ANOVA for exposure time (24, 48, or 72 hours), 
toxicant (MeHg or HgCl2), and treatment concentration (0, 0.01, 0.1, or 1.0 µM) differences. Total Hg 
concentration is reported as mean ng/g (ng total Hg/g of freeze dried cells). The freeze dried cells used for 
total Hg measurement consisted of the entire cell population within the growth chamber. Analysis 
indicated a main effect for treatment concentration. Tukey’s HSD post hoc analysis indicated that total Hg 
concentration in the 0.1 and 1.0 µM treatments was increased compared to the total Hg concentration in 
the 0.01 µM treatment and controls (*). The total Hg concentration the 1.0 µm treatment was increased 
compared to the total Hg concentration in the 0.1 µM treatment (†). Interaction effects were indicated for 
time and treatment, for toxicant and treatment, and for time, toxicant, and treatment. The interactions 
suggested that the observed differences in treatment were greater in the MeHg toxicant compared to the 
HgCl2 toxicant, and that the treatment differences increased over exposure time. Three-way ANOVA main 
effect for treatment, F (3, 54) = 28.3, p < 0.0001; interactions for time and treatment, F (3, 54) = 69.15, p 
< 0.0001, for toxicant and treatment, F (3, 54) = 15.11, p < 0.0001, and for time, toxicant and treatment, F 
(3, 54) = 62.44, p < 0.0001; α = 0.05. 
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FIG. IV-1. The number of dead and total SY5Y cells following treatment with 0, 0.01, 0.1, or 1.0 µM 
MeHg or HgCl2 for 24, 48, or 72 hours. Dead and live cells were distinguished by Trypan blue exclusion. 
Data from three experiments were analyzed independently by three-way ANOVA to determine differences 
associated with exposure time, toxicant, and treatment concentration. Analysis indicated similar results for 
all three experiments. Graphical data are representative of one of the three experiments conducted. Data 
were analyzed by Tukey’s HSD or Student’s t post hoc tests when appropriate. Panel A: for dead cells, 
mains effects for time and treatment, and an interaction for time and treatment were indicated. Dead cells 
were increased in the 1.0 µM MeHg treatment compared to controls at 24, 48 and 72 hours (*). Dead cells 
were increased in the 1.0 µM HgCl2 treatment compared to controls at 72 hours (*). The number of dead 
cells was increased in the 1.0 µM MeHg treatment compared to the 1.0 µM HgCl2 treatment at 24 and 48 
hours (†). The interaction effect suggested that the number of dead cells in all treatments was increased at 
72 hours compared to those treatments at 24 hours. Panel B: for total number of cells, a main effect was 
indicated for exposure time. The total number of cells were increased at 72 hours compared to 48 hours, 
and at 72 and 48 hours compared to 24 hours (‡). Data represented as percentage of control and as mean ± 
standard error of the mean. Three-way ANOVA dead cell count main effect for time, F (2, 72) = 6.29, p = 
0.003, and for treatment, F (3, 72) = 3.55, p = 0.019; interaction effect for time and treatment, F (3, 72) = 
3.11, p = 0.0092. Three-way ANOVA total cell count main effect for time, F (2, 72) = 25.04, p < 0.0001. 
α = 0.05. 
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FIG.  IV-2.  Lactate dehydrogenase (LDH) levels in SY5Y cells exposed to 0, 0.01, 0.1, or 1.0 µM MeHg 
or HgCl2 for 24, 48, or 72 hours. LDH levels represent the relative amount of cell death. Data from three 
experiments were analyzed independently by three-way ANOVA to determine differences associated with 
exposure time, toxicant, and treatment concentration. Analysis indicated similar results for all three 
experiments. Graphical data are representative of one of the three experiments conducted. Data were 
analyzed by Tukey’s HSD or Student’s t post hoc analyses when appropriate. Analysis indicated a main 
effect for treatment, and interactions for time and treatment, for toxicant and treatment, and for time, 
toxicant and treatment. LDH was increased in the 1.0 µM HgCl2 and MeHg treatments at 24, 48, and 72 
hours (*). LDH also was increased in the 1.0 µM MeHg treatment compared to the 1.0 µM HgCl2 at 24, 
48, and 72 hours (†). The interaction effects suggested that LDH levels increased with increased exposure 
time, with increased treatment concentration, and were higher in cells treated with MeHg than in those 
treated with HgCl2. LDH values were normalized by values for relative cell number. Data are shown as 
percentage of control and mean ± standard error of the mean. Three-way ANOVA main effect for 
treatment, F (3, 136) = 37.77, p < 0.0001; interaction effects for time and treatment, F (3, 136) = 2.78, p = 
0.0141, for toxicant and treatment, F (3, 136) = 28.81, p < 0.0001, and for time, toxicant and treatment, F 
(3, 136) = 3.05, p = 0.0079. α = 0.05. 
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Cytotoxicity 
Relative numbers of live and dead cells were measured in SY5Y cells following 
exposure to 0, 0.01, 0.1 or 1.0 µM MeHg or HgCl2 for 24, 48, or 72 hours. The live cell 
indicator protein is retained within live cells, while the dead cell indicator protein is 
released into the medium when the plasma membrane is damaged. The relative cell 
number was determined for each well. The live and dead cell values from each well were 
normalized by the relative cell number measured for that same well. The cytotoxicity 
experiment was conducted three times with a sample size of six for each experiment. 
Data from each experiment were independently analyzed by three-way ANOVA to 
determine differences and interactions associated with treatment time, toxicant, and 
treatment concentration. Analysis of cytotoxicity data indicated similar results for all 
three experiments. Data reported are representative of one of the three experiments 
conducted. Analysis of dead cells indicated a main effect for treatment, F (3, 119) = 
16.49, p < 0.0001, and interactions between time and treatment, F (3, 119) = 95.10, p < 
0.0001, between toxicant and treatment, F (3, 199) = 9.18, p < 0.0001, and among time, 
toxicant and treatment, F (3, 119) = 84.90, p < 0.0001 (Fig IV-3). Tukey’s HSD post hoc 
analysis indicated that the number of dead cells in the 1.0 µM MeHg treatment was 
increased compared to all other MeHg and HgCl2 treatments and controls at 24 and 48 
hours. The number of dead cells also was increased in the 1.0 µM HgCl2 treatment 
compared to the 0.01 and 0.1 µM HgCl2 treatments and controls at 48 hours. The 
number of dead cells was decreased in the 1.0 µM MeHg treatment compared to controls 
at 72 hours. The interaction among time, treatment, and toxicant indicated that the 
number of dead cells increased over time, and that exposure to MeHg resulted in a 
greater increase in cell death than exposure to HgCl2. Analysis of live cells indicated a 
main effect for treatment, F (3, 120) = 17.57, p < 0.0001, and interactions between time 
and treatment, F (3, 120) = 5.78, p < 0.0001, between toxicant and treatment, F (3, 120) 
= 12.67, p < 0.0001, and among time, toxicant and treatment, F (3, 120) = 3.95, p = 
0.0012. Tukey’s HSD post hoc analysis indicated that the number of live cells was 
decreased in the 1.0 µM MeHg treatment compared to all other MeHg and HgCl2 
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treatments and controls at 24, 48, and 72 hours. The interaction among time, treatment, 
and toxicant indicated that the number of live cells decreased over time as the treatment 
concentration increased, and that the MeHg treatments resulted in decreased numbers of 
live cells compared to the HgCl2 treatments (Fig IV-3). 
 
Mitochondrial membrane potential 
Membrane potential (MMP) of the inner mitochondrial membrane of SY5Y cells 
was measured using TMRM dye and fluorescence microscopy to determine whether 
exposure to 0, 0.01, 0.1 or 1.0 µM MeHg or HgCl2 for 24, 48, or 72 hours would alter 
mitochondrial function. Representative images of SY5Y cells incubated with TMRM are 
shown in Fig IV-4. SY5Y cells were incubated with 150.0 nM TMRM for 20 min and 
imaged by fluorescence microscopy. Data were collected for individual mitochondria 
within a minimum of ten SY5Y cells from each of four replicate experiments. The 
mitochondrial data from a single experiment were averaged and represent a sample size 
of one. Relative MMP data for SY5Y cells was analyzed by three-way ANOVA to 
determine differences and interactions associated with treatment time, toxicant, and 
treatment concentration. Analysis indicated a main effect for treatment, F (3, 72) = 
32.46, p < 0.0001, and interactions between time and treatment, F (3, 72) = 12.52, p < 
0.0001, and between toxicant and treatment, F (3, 72) = 4.46, p = 0.0062 (Fig IV-5). 
Tukey’s HSD post hoc analysis indicated that MMP was decreased in the 1.0 µM 
treatment compared to the 0.01 and 0.1 µM treatments and controls, and that MMP was 
increased in the 0.01 µM treatment compared to the 0.1 and 1.0 µM treatments and 
controls. Tukey’s HSD post hoc analysis by toxicant and exposure time indicated that 
MMP was decreased in the 1.0 µM MeHg treatment compared to controls at 24, 48, and 
72 hours. MMP was decreased in the 0.01 and 0.1 µM MeHg treatments compared to 
controls at 48 hours. However, MMP was increased in the 0.01 MeHg treatment 
compared to the 0.1 and 1.0 µM MeHg treatments and controls at 24 hours.    
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FIG.  IV-3.  Relative number of live and dead SY5Y cells following exposure to 0, 0.01, 0.1, or 1.0 µM MeHg or HgCl2 for 24, 48, or 72 hours. Cells were 
analyzed using the MultiTox-Fluor Multiplex Cytotoxicity plate reader assay. Data from three experiments were analyzed independently by three-way ANOVA 
to determine differences associated with exposure time, toxicant, and treatment concentration. Analysis indicated similar results for all three experiments. 
Graphical data are representative of one of the three experiments conducted. Data were analyzed by Tukey’s HSD or Student’s t post hoc analyses when 
appropriate. For live and dead cells, data indicated a main effect for treatment, and interactions for time and treatment, for toxicant and treatment, and for time, 
toxicant and treatment. The number of live cells was decreased in the 1.0 µM MeHg treatment compared to all other MeHg and HgCl2 treatments and controls at 
24, 48, and 72 hours (*). The interaction among time, treatment, and toxicant indicated that the number of live cells decreased over time as the treatment 
concentration increased, and that the MeHg treatments resulted in decreased numbers of live cells compared to the HgCl2 treatments. The number of dead cells in 
the 1.0 µM MeHg treatment was increased compared to all other MeHg and HgCl2 treatments and controls at 24 and 48 hours (†). The number of dead cells also 
was increased in the 1.0 µM HgCl2 treatment compared to the other HgCl2 treatments and controls at 48 hours (†). The number of dead cells was decreased in the 
1.0 µM MeHg treatment compared to controls at 72 hours (‡). The interaction among time, treatment, and toxicant indicated that the number of dead cells 
increased over time, and are increased with exposure to MeHg compared to exposure to HgCl2. Live and dead cell values were normalized by values for relative 
cell number. Data are shown as percentage of control and mean ± standard error of the mean. Three-way ANOVA live cell main effect for treatment, F (3, 120) = 
17.57, p < 0.0001, and interactions for time and treatment, F (3, 120) = 5.78, p < 0.0001, for toxicant and treatment, F (3, 120) = 12.67, p < 0.0001, and for time, 
toxicant and treatment, F (3, 120) = 3.95, p = 0.0012. Three-way ANOVA dead cell main effect for treatment, F (3, 119) = 16.49, p < 0.0001, and interactions for 
time and treatment, F (3, 119) = 95.10, p < 0.0001, for toxicant and treatment, F (3, 199) = 9.18, p < 0.0001, and for time, toxicant and treatment, F (3, 119) = 
84.90, p < 0.0001. α = 0.05.
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For cells exposed to HgCl2, MMP was decreased in the 0.01 and 0.1 µM HgCl2 
treatment compared to controls at 48 and 72 hours. MMP was decreased in the 1.0 µM 
HgCl2 treatment compared to controls at 72 hours. The indicated interactions suggested 
that MMP decreased with increased exposure time, and was decreased in the MeHg 
treatments compared to the HgCl2 treatments (Fig IV-5). CCCP was added to control 
SY5Y cells (positive method control) to verify that the method used to measure changes 
in MMP was, in fact, measuring changes in MMP. CCCP uncouples oxidative 
phosphorylation within mitochondria, which results in decreased MMP. Addition of 
CCCP to control cells incubated with TMRM resulted in a dramatic decrease in the 
fluorescence intensity of mitochondria indicating depolarization of the mitochondrial 
membrane (data not shown); no auto-fluorescence was observed in samples without 
TMRM dye, nor in samples without cells that contained TMRM dye (negative controls, 
data not shown). 
 
 
 
FIG. IV-4. Representative images of SY5Y cells following exposure to 0.01 or 1.0 µM MeHg for 24 
hours. Cells exhibited fluorescent mitochondria following incubation with 150.0 nM TMRM dye for 20 
min. Active mitochondria exposed to TMRM appeared as red circles or tubes. Fluorescence intensity is 
proportional to mitochondrial membrane potential. Mitochondria in the 0.01 µM MeHg treated SY5Y cells 
exhibited increased fluorescence compared to controls. Mitochondria in the 1.0 µM MeHg treated SY5Y 
cells exhibited decreased fluorescence compared to both the 0.01 µM MeHg treated cells and controls. 
Scale bar = 25 µm. 
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FIG.  IV-5.  Relative mitochondrial membrane potential (MMP) in mitochondria from SY5Y cells 
following exposure to 0, 0.01, 0.1, or 1.0 µM MeHg or HgCl2 for 24, 48, or 72 hours. Cells were incubated 
with 150.0 nM TMRM for 20 min and imaged by fluorescence microscopy. Data were collected for 
individual mitochondria within the SY5Y cells, and then analyzed by three-way ANOVA to determine 
differences associated with exposure time, toxicant, and treatment concentration, followed by Tukey’s 
HSD or Student’s t post hoc analyses when appropriate. Analysis indicated a main effect for treatment, 
and interactions for time and treatment, and for toxicant and treatment. MMP was increased at 0.01 µM 
MeHg (†), but decreased at 1.0 µM MeHg compared to controls at 24 hours (*). At 48 hours, MMP was 
decreased in all MeHg treatments compared to controls (*). MMP was decreased in the 1.0 µM MeHg 
treatment compared to controls at 72 hours (*). For cells exposed to HgCl2, MMP in the 0.01 and 0.1 µM 
HgCl2 treated cells was decreased compared to controls at 48 hours. MMP in all three HgCl2 treatments 
was decreased compared to controls at 72 hours. The indicated interactions suggested that MMP decreased 
with increased exposure time, and was decreased in the MeHg treatments compared to the HgCl2 
treatments. Data are represented as percentage of control and mean ± standard error of the mean. Three-
way ANOVA main effect for treatment, F (3, 72) = 32.46, p < 0.0001, and interactions for time and 
treatment, F (3, 72) = 12.52, p < 0.0001, and for toxicant and treatment, F (3, 72) = 4.46, p = 0.0062; α = 
0.05. 
* *
*
* *
* *
*
*
*
† 
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Basal free intracellular Ca2+ 
Calcium ion homeostasis was examined by measuring the relative basal 
intracellular calcium ion concentration ([Ca2+]i) in SY5Y cells exposure to 0, 0.01, 0.1 or 
1.0 µM MeHg or HgCl2 for 24, 48, or 72 hours. SY5Y cells were incubated with 1.0 µM 
Calcium Green-1 AM dye for 20 min. Relative [Ca2+]i was determined by microplate 
reader analysis. The relative cell number was determined for each well. The [Ca2+]i value 
from each well was normalized by the relative cell number measured for that same well. 
The [Ca2+]i experiment was conducted three times with a sample size of eight for each 
experiment. Data from each experiment were independently analyzed by three-way 
ANOVA to determine differences and interactions associated with treatment time, 
toxicant, and treatment concentration. Analysis of [Ca2+]i data indicated similar results 
for all three experiments. Data reported are representative of one of the three 
experiments conducted. Analysis indicated a main effect for treatment, F (3, 142) = 
10.86, p < 0.0001, and an interaction effect between treatment and time, F (3, 142) = 
6.25, p < 0.0001 (Fig IV-6). No differences were indicated for toxicant. Tukey’s HDS 
post hoc analysis indicated that [Ca2+]i was increased in the 1.0 µM treatment compared 
to controls at 24 hours, but decreased compared to controls at 48 hours. Data also 
indicated that [Ca2+]i was decreased at 48 and 72 hours compared to 24 hours for the 1.0 
µM treated cells. The indicated interaction between time and treatment suggested that 
[Ca2+]i decreased over time with increased treatment concentration (Fig IV-6). 
Thapsigargin was added to control SY5Y cells as a method control to validate the 
measurement of changes in [Ca2+]i . Thapsigargin is an inhibitor of sarco-endoplasmic 
reticulum Ca2+ ATPases and raises cytosolic free Ca2+ by blocking the ability of the cell 
to pump Ca2+ into the endoplasmic reticulum (Treiman et al., 1998). Addition of 
thapsigargin to control SY5Y cells (positive method control) resulted in a substantial 
increase in the fluorescence within the cells, indicating an increase in [Ca2+]i; no auto-
fluorescence was observed in samples without Calcium Green-1, nor in samples without 
cells that contained Calcium Green-1 (negative controls), indicating minimal 
atmospheric and/or photo-oxidation (data not shown). 
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FIG.  IV-6.  Relative basal intracellular calcium ion concentration ([Ca2+]i) in SY5Y cells exposed to 
MeHg or HgCl2 for 24, 48, or 72 hours. Cells were incubated with 1.0 µM Calcium Green-1 AM dye for 
20 min and fluorescence data was collected by microplate reader analysis. Data from three experiments 
were analyzed independently by three-way ANOVA to determine differences associated with exposure 
time, toxicant, and treatment concentration. Analysis indicated similar results for all three experiments. 
Graphical data are representative of one of the three experiments conducted. Data were analyzed by 
Tukey’s HSD or Student’s t post hoc analyses when appropriate. Analysis indicated a main effect for 
treatment, and an interaction between treatment and time. No differences were indicated for toxicant. 
[Ca2+]i was increased in the 1.0 µM treatment compared to controls at 24 hours (*), but decreased 
compared to controls at 48 hours (†). Data also indicated that [Ca2+]i was decreased at 48 and 72 hours 
compared to 24 hours for the 1.0 µM treated cells (‡). The indicated interaction between time and 
treatment suggested that [Ca2+]i decreased over time with increased treatment concentration. Data are 
presented as percentage of control and mean ± standard error of the mean. Three-way ANOVA main effect 
for treatment, F (3, 142) = 10.86, p < 0.0001, and interaction effect for treatment and time, F (3, 142) = 
6.25, p < 0.0001. α = 0.05. 
 
 
Production of reactive oxygen species 
The rate of generation of and the level of ROS were determined for SY5Y cells 
exposed to 0, 0.01, 0.1, or 1.0 µM MeHg or HgCl2 for 24, 48, or 72 hours. SY5Y cells 
were incubated with 1.0 µM CM-H2DCFDA dye for 5 min and then analyzed for ROS 
production every 2.5 min for 30 min in a plate reader. ROS data were analyzed by three-
way MANOVA with repeated measures for reading time. Analysis of ROS data 
indicated similar results for all three experiments. Data reported are representative of one 
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of the three experiments conducted. Analysis indicated a between-subject difference in 
the rate of ROS production for exposure time, F (2, 192) = 54.46, p < 0.0001 (Fig IV-7). 
The condition of sphericity was not met; therefore, subsequent within-subject analyses 
were conducted using the Greenhouse-Geisser adjusted univariate analysis (Grieve, 
1984). Within-subject differences for rate of ROS production were indicated for 
exposure time, F (4, 350) = 85.11, p < 0.0001, for treatment, F (6, 350) = 5.19, p < 
0.0001, and for a toxicant and treatment interaction, F (6, 350) = 3.59, p = 0.0016. For 
both MeHg and HgCl2, and for all treatment concentrations, the rate of ROS production 
in the 24 hour exposure time was increased compared to the rates in the 48 and 72 hour 
exposure times, and the rate of ROS production in the 48 hour exposure time was 
increased compared to the rate in the 72 hour exposure time. At 24 hours, the 0.01 µM 
HgCl2 treated cells exhibited a decreased rate of ROS production compared to controls. 
The decreased rate of ROS production in the 0.01 µM HgCl2 treated cells was exhibited 
at reading times eleven and twelve. At 24 hours, the 1.0 µM MeHg treated cells 
exhibited a decreased rate of ROS production compared to controls. The decreased rate 
of ROS production in the 1.0 µM HgCl2 treated cells began at reading time two and 
continued to reading time twelve. At 48 hours, the 1.0 µM MeHg treated cells exhibited 
a decreased rate of ROS production compared to controls. The decreased rate of ROS 
production in the 1.0 µM MeHg treated cells began at reading time seven and continued 
to reading time twelve. 
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FIG. IV-7. Relative rate of reactive oxygen species (ROS) production in SY5Y cells exposed to 0. 0.01, 0.1, or 1.0 µM MeHg or HgCl2 for 24, 48, or 72 
hours. SY5Y cells were incubated with 1.0 µM CM-H2DCFDA fluorescent dye for 5 min, and then the rate of ROS production as fluorescence was 
measured every 2.5 min for 30 min using a microplate reader. Data from three experiments were analyzed independently by three-way MANOVA with 
repeated measures for time, followed by the Greenhouse-Geisser adjusted univariate analysis to determine between- and within-subject differences and 
interactions associated with exposure time, toxicant, and treatment concentration over the 30 min time period. Analysis indicated similar results for all 
three experiments. Graphical data are representative of one of the three experiments conducted. Analysis indicated a between-subject difference in the 
rate of ROS production for exposure time. For both MeHg and HgCl2, and for all treatment concentrations, the rate of ROS production in the 24 hour 
exposure time was increased compared to the rates in the 48 and 72 hour exposure times (*), and the rate of ROS production in the 48 hour exposure 
time was increased compared to the rate in the 72 hour exposure time (†). Within-subject differences for rate of ROS production were indicated for 
exposure time, for treatment, and for a toxicant and treatment interaction. At 24 hours, the 0.01 µM HgCl2 treated cells exhibited a decreased rate of 
ROS production compared to controls at reading times eleven and twelve (0.01 < Controls), and the 1.0 µM MeHg treated cells exhibited a decreased 
rate of ROS production compared to controls at reading times two through twelve (1.0 < Controls). At 48 hours, the 1.0 µM MeHg treated cells 
exhibited decreased rate of ROS production compared to controls at reading times seven through twelve (1.0 < Controls). Three-way MANOVA 
between-subject difference for exposure time, F (2, 192) = 54.46, p < 0.0001. Within-subject differences for exposure time, F (4, 350) = 85.11, p < 
0.0001, for treatment, F (6, 350) = 5.19, p < 0.0001, and for a toxicant and treatment interaction, F (6, 350) = 3.59, p = 0.0016; α = 0.05.
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In addition to the rate of ROS production, data were analyzed by three-way 
MANOVA with repeated measures for reading time to determine the amount of ROS 
produced. No between-subject differences were indicated for the amount of ROS 
produced. The condition of sphericity was not met; therefore, data were subsequently 
analyzed using the Greenhouse-Geisser adjusted univariate analysis to determine within-
subject differences and interactions (Grieve, 1984). Data indicated no within-subject 
differences in the level of ROS produced over the 30 minute reading time. Tertiary butyl 
hydroperoxide (tBHP) was added to control SY5Y cells as a method control to validate 
the measurement of changes in [Ca2+]i. tBHP penetrates the cell membrane and reacts 
with heme-proteins to produce alkoxyl radicals. Addition of tBHP to control SY5Y cells 
(positive control) resulted in a dramatic increase in the fluorescence within the cells 
indicating an increase in the level of ROS; no auto-fluorescence was observed in 
samples without CMH2DCFDA dye, nor in samples without cells that contained 
CMH2DCFDA (negative control), indicating minimal atmospheric and/or photo-
oxidation (data not shown). 
 
DISCUSSION 
The accumulation of total Hg was measured in SY5Y cells exposed to 0. 0.01, 
0.1, and 1.0 µM MeHg or HgCl2 for 24, 48, or 72 hours. We hypothesized that the 
uptake of total Hg would be concentration- and time-dependent, and would be higher 
with MeHg treatment than with HgCl2 treatment. As expected, both MeHg and HgCl2 
exposure resulted in a concentration-dependent accumulation of total Hg, and MeHg 
exposure resulted in higher levels of total Hg in the cells compared to HgCl2 exposure. 
Meacham et al. (2005) showed that MeHg is taken up by PC12 cells, primary cultures of 
rat neocortical cells, and adult rat hippocampal slices in a concentration- and time-
dependent manner. MeHg is lipophilic and can enter cells more readily than the 
inorganic form of Hg (Philbert et al., 2000). In addition, MeHg is likely transported 
across the membrane bound to cysteine by the neutral amino acid transport carrier 
system (Aschner and Clarkson, 1989) providing multiple access points for MeHg into 
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the cell. Nakada and Imura (1982) showed that both MeHg and Hg2+ are taken up by 
mouse neuroblastoma cells, but that MeHg is taken up preferentially to Hg2+.  
In addition to preferential uptake of MeHg to Hg2+ observed in our study, total 
Hg uptake in all treated cells increased over time, as indicted by the time and treatment 
interaction effect. The uptake of total Hg in the lower exposure concentrations did not 
increase as rapidly as did higher concentrations, and the uptake of total Hg in the HgCl2 
exposed cells did not increase as rapidly as the MeHg exposed cells, as indicated by the 
time, treatment, and toxicant interaction effect. Studies of total Hg accumulation in vivo 
indicate that both MeHg and HgCl2 can reach steady-state concentrations. Similar results 
have been shown by Berlin et al. (1975) in squirrel monkeys. After approximately four 
days following administration of MeHg, the MeHg concentrations in the blood and brain 
came into equilibrium in the closed system. The level of MeHg in the brain did not 
increase until there was additional exposure to MeHg. The model system in our study 
was also a closed system, where no additional MeHg or Hg2+ was being added following 
the initial exposure concentration. Similarly, MeHg in the blood of monkeys 
administered 50.0 µg/kg per day MeHg for eighteen months reached steady-state 
concentrations (1.1 µg/g of blood) after about four months, even with the continued 
exposure of MeHg for another fourteen months (Vahter et al., 1994). MeHg 
concentrations in the brain reached steady-state at 12 months, not increasing with 
continued MeHg exposure up to thirty nine months (Lind et al., 1988;  Vahter et al., 
1994). The total Hg accumulation in SY5Y cells in the current study appeared to model 
the total Hg accumulation reported in scientific literature for in vivo MeHg exposures. 
The amount of cell death with MeHg or HgCl2 exposure was measured by three 
methods: Trypan blue exclusion, LDH activity, and the MultiTox-Fluor Multiplex 
Cytotoxicity assay. We hypothesized that cell death would increase in a concentration- 
and time-dependent manner, and that cell death would be higher with MeHg treatment 
than with HgCl2 treatment. Based on the three cell death assays conducted in this study, 
the highest (1.0 µM) concentrations of MeHg and HgCl2 exposure resulted in cell death, 
and cell death was increased with longer exposure times. In addition, cell death was 
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increased with 1.0 µM MeHg treatment compared to 1.0 µM HgCl2 treatment. Similar 
results were observed by Kunimoto (1994) in cultured cerebellar granule cells. They 
showed that MeHg concentrations of 0.1, 0.3, and 1.0 µM resulted in cell death after 72 
hours of exposure, but not after 24 hours. Also in cultured cerebellar granule cells, 
Vendrell et al. (2007) showed that 0.3 µM MeHg resulted in cell death after 96 hours of 
exposure. In contrast to the study by Kunimoto (1994), we did not observe cell death 
with 0.1 µM MeHg treatment even after 72 hours of exposure. The discrepancy in cell 
death at the 0.1 µM concentration is likely because of the type of cell used in the study. 
Although SY5Y cells are known to be sensitive to MeHg toxicity, cerebellar granule 
cells, as used by Kunimoto (1994), are a specific target for MeHg toxicity in vivo and 
would likely be more sensitive to MeHg treatment than SY5Y cells. 
Inconsistencies in the number of dead cells estimated by Trypan blue exclusion 
compared to the LDH assay are evident in the 24 and 48 hour time points for HgCl2 
exposure. Although cell death was increased at 24 and 48 hours, the Trypan blue 
exclusion measures were likely underestimated due to degradation of dying cells. 
Degraded cells could not be measured with Trypan blue exclusion, but the lactate 
dehydrogenase released from the dead cells remained active and could be measured by 
the LDH activity assay. By 72 hours, large enough numbers of cells had died with HgCl2 
exposure that statistically significant numbers of them were still intact for Trypan blue 
exclusion to be a valid measurement. The cytotoxicity assay data substantiates the results 
of the Trypan blue exclusion and the LDH assays. Although the level of cell death in the 
1.0 µM HgCl2 at 72 hours was not significantly different from controls in the 
cytotoxicity assay, the trend was evident based on the time, toxicant, and treatment 
interaction effect measured for the cytotoxicity assay as well as the main effect for 
treatment concentration indicated for the Trypan blue and LDH assays. 
The three cytotoxicity assays used in this study individually contain inherent 
potential limitations. Therefore the three assays were used in combination to obtain a 
more accurate assessment of viability and cell death. Trypan blue exclusion cannot label 
disintegrated cells, but may be able to enter a dying cell prior to the release of LDH and 
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other cell death associated factors. However, Trypan blue exclusion allows for individual 
cell data, i.e., actual cell counts of both live and dead cells. In contrast, LDH activity and 
the MultiTox-Fluor Multiplex Cytotoxicity assays provide population data. Furthermore, 
LDH degrades after 24 hours, and therefore cells dying during early time points may be 
underestimated unless media is collected at regular intervals. In addition, LDH activity 
provides no information regarding numbers of live cells. The MultiTox-Fluor Multiplex 
Cytotoxicity assay was designed to overcome flaws associated with the Trypan blue 
exclusion and LDH activity methods. When performed as designed, the live and dead 
cell indicator dyes are added to the wells simultaneously and are analyzed back to back 
at two different absorbance wavelengths that produce two discernable emission 
wavelengths. Problems would result when the excitation wavelengths were not set 
optimally resulting in significant crossover of the two emission wavelengths. Many 
microplate readers are fitted with general excitation/emission filter sets that function at a 
fixed optimal range. This was the case for the microplate reader used in our experiment. 
The live and dead cell emission peaks were not separated enough for the two dyes to be 
analyzed in the same well at the same time; therefore, we plated two sets of cells for 
each run and assayed the live and dead cells separately. 
Mitochondrial activity in SY5Y cells was determined by fluorescence 
microscopy and measuring the mitochondrial membrane potential (MMP). We 
hypothesized that MMP would decrease in a concentration- and time-dependent manner, 
and that MMP would be decreases to a greater degree with MeHg treatment compared to 
HgCl2 treatment. Both MeHg and HgCl2 treatments decreased MMP in SY5Y cells. 
However, HgCl2-induced depolarization of mitochondria did not occur until 48 hours, 
compared to 24 hours for MeHg. In addition, 0.01 and 0.1 µM HgCl2-induced 
depolarization of mitochondria beginning at 48 hours continued at 72 hours, whereas 
only the 1.0 µM MeHg-induced depolarization of mitochondria continued at 72 hours. 
Our data suggest that HgCl2 may enter the cell more slowly that MeHg, thus resulting in 
a lag-time for mitochondrial membrane depolarization. However, once inside the cell, 
HgCl2 depolarized the mitochondrial membrane to a greater degree and for a longer 
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period of time than did MeHg. Similar results were shown by Hare and Atchison (1992). 
Their results indicated that Hg 2+ was more effective than MeHg at depolarizing both 
plasma and mitochondrial membranes. They suggested that Hg2+ was more effective at 
mitochondrial depolarization because it has a higher affinity for thiol groups (-SH) than 
does MeHg. However, Hg 2+ depolarized the plasma membrane at lower concentrations 
than were necessary to depolarize the mitochondrial membrane, whereas MeHg 
depolarized the plasma membrane at concentrations that also depolarized the 
mitochondria membrane (Hare and Atchison, 1992). Their data were consistent with 
other studies that showed that Hg2+ was less efficient at penetrating the plasma 
membrane than was MeHg (Nakada and Imura, 1982). Therefore, intracellular changes 
associated with Hg2+ may appear latent to those produced by MeHg exposure. 
MeHg treatment was associated with an increase in MMP at 24 hours in the 
lowest exposure group (0.01 µM), but this increase was followed at 48 hours by a 
dramatic decrease in MMP, and then a return to control levels at 72 hours. These data 
indicate increased mitochondrial activity, followed by a sharp decrease in mitochondrial 
activity, and ultimately, a shift back to normal mitochondrial activity. Initial insults to 
cells often initiate cytoprotective processes. For example, heat shock proteins expressed 
in the brain are important in the maintenance of cellular homeostasis, particularly in 
response to stressful conditions that adversely affect normal cellular structure and 
function. Transcription and translation of heat shock proteins are induced by 
hyperthermia and viral infection, against which the proteins act as protective molecules 
(Buccellato et al., 2007). The increased production of heat shock proteins is powered by 
an increase in mitochondrial activity and an increase in MMP. TNFα is another molecule 
that induces cytoprotection by promoting the production of free radicals from the 
mitochondria. The free radicals, or ROS, stimulate the action of other cytoprotective 
molecules (Lacerda et al., 2006). In the process of ROS production, there is an initial 
increase in MMP necessary to produce the excess ROS (Lacerda et al., 2006). These 
data provide an explanation for the increased MMP observed in the first 24 hours of 0.01 
µM MeHg exposure. Higher levels of MeHg (1.0 µM) or lower exposures for longer 
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periods of times may overwhelm the ROS defense system. The increased levels of ROS, 
if not metabolized, can feed back on the mitochondria and cause a dissipation of the 
membrane potential (Brookes et al., 2004). Even with a decrease in MMP, various ROS 
defense molecules, such as glutathione peroxidase (Kromidas et al., 1990), glutathione 
transferase (Custodio et al., 2004), catalase (Saez et al., 1982), and superoxide dismutase 
(Fridovich, 1995b) can act to neutralize the ROS, preventing further damage to the 
mitochondrial membrane, allowing the MMP to return to homeostatic levels.  
The concentration of intracellular Ca2+ was measured using a microplate reader. 
We hypothesized that [Ca2+]i would increase in a concentration- and time-dependent 
manner and would be higher in cell treated with MeHg compared to those treated with 
HgCl2. Data indicated, however, that [Ca2+]i was increased at 24 hours, was decreased at 
48 hours, and returned to control levels at 72 hours in the 1.0 µM treated cells. In 
addition, there was no difference in [Ca2+]i between MeHg and HgCl2. The observed 
changes in [Ca2+]i may be correlated with the observed changes in MMP. We observed 
decreases MMP and increases [Ca2+]i at 24 hours in the 1.0 µM treatments, a possible 
result of release of Ca2+ from the depolarized mitochondria. Mitochondria sequester Ca2+ 
when excess Ca2+ is present in the cytosol (Duchen, 2000). If the Ca2+ concentration in 
mitochondria become too high, or if mitochondria are damaged by another means, the 
sequestered Ca2+ is released (Duchen, 2000), thus increasing the Ca2+ concentration 
within the cytosol, as was observed in the current study. This process may also result in 
cell death (Duchen, 2000), which was also observed in the 1.0 µM treatments in the 
present study. At 48 hours, the 1.0 µM treatments exhibit cell death and decreased 
MMP, but also decreased [Ca2+]i. By 48 hours, the cells may be damaged such that the 
plasma membrane has become leaky allowing Ca2+ to move out of the dying cell and 
into the media, particularly due to the presence of Hg2+. Upon entry into a cell, Hg2+ 
damages and depolarizes the plasma membrane (Nakada and Imura, 1982). MeHg enters 
the cell without disrupting the plasma membrane, whereas Hg2+ disrupts the plasma 
membrane when gaining access to the cell (Hare and Atchison, 1992). Decreased 
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integrity of the plasma membrane of dying cells at 48 hours may be the reason for the 
observed decrease in [Ca2+]i. 
The rate at which ROS were produced was measured by microplate assay. We 
hypothesized that the rate of ROS production would increase in a concentration- and 
time-dependent manner and that the increased rate of ROS production would be greater 
with MeHg treatment than HgCl2 treatment. Instead, we observed a decrease in the rate 
of ROS production over time for all treatment concentrations, and decreased rates of 
ROS production for the 0.01 µM HgCl2 and the 1.0 µM MeHg treatments at 24 hours, 
and a decreased rate of ROS production for the 1.0 µM MeHg treatment at 48 hours. 
Although unexpected, these data indicate no increase in ROS in conjunction with the 
decreased MMP observed in the 1.0 µM treatments. Several possibilities exist to explain 
the decrease in ROS production. First, increased mitochondrial Ca2+ causes an increase 
in ROS produced from the mitochondria when the Ca2+ increase is accompanied by 
uncoupling of Complex I of the respiratory chain (Sousa et al., 2003). However, when 
the increase in mitochondrial Ca2+ is accompanied by inhibition of Complex III, no 
increase in ROS is observed (Sousa et al., 2003). MeHg is known to inhibit Complex III 
(Yee and Choi, 1996). In the present study, Ca2+ was increased, but the rate of ROS 
production was decreased at 24 hours in the 1.0 µM treatments. These data suggest that 
ROS may not have been generated by all complexes of the electron transport chain, and 
the amount of ROS produced was not high enough to overwhelm the antioxidant 
processes within the cells. In addition, any temporal increase in the production of ROS 
may have resulted in the upregulation and activity of antioxidant molecules, further 
decreasing the level of detectable ROS. Similarly, 0.01 µM HgCl2 treatment resulted in a 
decreased rate of ROS production compared to controls at 24 hours. This decrease in 
ROS production did not coincide with any changed in cell death, MMP or [Ca2+]i. These 
data indicate the possible induction of cytoprotective mechanisms (Buccellato et al., 
2007;  Lacerda et al., 2006). 
Although not expected, the observed pattern of MMP, [Ca2+]i, ROS, and cell 
death changes cannot easily be explained by the known process of mitochondria-related 
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apoptosis. In contrast to exposures to high concentrations of MeHg, the concentrations 
used in the present study (0.01, 0.1, and 1.0 µM) do not appear to result in 
mitochondrial-related and ROS-induced apoptosis. It does appear however, that an early 
response of neurons exposed to low levels of MeHg may be the stimulation of 
mechanisms of cytoprotection. The potential to induce cytoprotective genes may play a 
role in determining which individuals (cells and whole organisms) exhibit negative 
effects at low-levels of MeHg exposure and those who do not. For example, organisms 
inherently exhibit genetic polymorphisms that alter one’s ability to detoxify various 
compounds and change one’s susceptibility to toxicity and disease (Bellinger, 2007;  
Eaton, 2000;  Wolff and Weston, 1997). Some individuals may be able to sustain a 
greater “hit” of MeHg than others, based on these genetic differences (Klautau-
Guimarães et al., 2005;  Weghorst and Buzard, 1993).  
Not only were the pattern of changes in MMP, [Ca2+]i, and ROS not consistent 
with those known to be associated with apoptotic cell death, but at the lowest MeHg and 
HgCl2 concentrations (0.01 and 0.1 µM), no cell death occurred at all, even though 
MMP, [Ca2+]i, and ROS were altered. MMP, Ca2+, and ROS have many functions in 
neurons other than induction of apoptosis. Neurons exhibit [Ca2+]i oscillations that may 
be associated with synaptic strengthening among neurons in the same domain (Singer, 
1993;  Stryker et al., 1990). In neuronal spines and dendrites, [Ca2+]i changes are 
mediated by the NMDA receptor which is crucial for the generation of long-term 
potentiation (LTP) which is associated with learning and memory (Alford et al., 1993;  
Collingridge and Bliss, 1995). [Ca2+]i changes in neurons initiate signaling pathways that 
trigger gene transcription (Bailey et al., 1996;  Martin et al., 1997). Mitochondria are 
involved in more than energy production and induction of apoptosis (Green and Reed, 
1998). They function in xenobiotic metabolism and glucose sensing (Maechler, 2002), as 
well as steroid hormone synthesis and lipid metabolism (Brookes et al., 2004). In 
addition, ROS are involved not only in damage of membranes by lipid peroxidation 
(Gardner, 1989) and the crosslinking of proteins (Davies, 2005), but are important for 
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cell signaling (Brookes and Darley-Usmar, 2002;  Brookes et al., 2002) and cell 
proliferation (Burdon et al., 1989).  
The human population is exposed to chronic low levels of MeHg, and MeHg is 
highly toxic to the developing fetus, infant, and young child. The incomplete blood-brain 
barrier allows increased access of MeHg to the developing brain. Proliferation and 
migration of neurons in developing young is time-dependent, and alterations in the 
timing or rate of these events could significantly alter normal brain development. Once 
neurons are placed, proper synaptic development and function are necessary for the 
neurons to function normally. Changes in mitochondrial activity, [Ca2+]i, and levels of 
ROS could adversely affect proliferation, migration, or synaptic plasticity, and 
ultimately function, of the neurons in developing brains, without causing the death of the 
neurons. Data from our study indicate that SY5Y cells are sensitive to low levels of both 
MeHg and HgCl2, and respond to MeHg and HgCl2 exposure in ways known to occur in 
the brains of humans and animals, thus making them realistic candidates for mechanistic 
studies that may mimic the responses of the cerebellar granule cell to MeHg exposure in 
vivo. In addition, changes in MMP, [Ca2+]i, and ROS were observed at MeHg and HgCl2 
concentrations that did not produce cell death. These changes, specifically at very low 
MeHg concentrations, have not been previously indicated in current scientific literature 
and further studies of these effects and associated mechanisms are warranted. 
Understanding the mechanism of low-level MeHg toxicity is necessary for the protection 
of the developing central nervous system. 
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CHAPTER V 
 
 
CONCLUSIONS 
 
 
 
SUMMARY AND CONCLUSIONS 
The objective of this dissertation was to better understand the mechanism of 
MeHg induced neurotoxicity by comparing sub-cellular changes between mice exposed 
to MeHg as young adults to mouse pups exposed during gestation, and to develop an in 
vitro model to more fully investigate in vivo MeHg exposure. 
Previously, four mechanistic processes have been considered for MeHg 
neurotoxicity: 1) dissipation of mitochondrial membrane potential (MMP), 2) increase in 
[Ca2+]i to cytotoxic levels, 3) increased production of reactive oxygen species (ROS), 
and 4) apoptosis. In the 1950’s and 1970’s during the Japanese and Iraqi poisonings, the 
bulk of pathological data indicated large amounts of apoptosis in the brains of sick 
individuals. Therefore, historically, MeHg experiments have investigated apoptosis. 
Early in vivo exposure studies employed high doses of MeHg, although they were 
similar to or lower than those experienced in the Minamata and Iraq human poisonings. 
The high concentrations used in early MeHg studies are no longer relevant to the lower-
level human exposures experienced today from diet and environment. MeHg is found in 
the daily diet of most everyone in developed countries and in developing countries with 
high fish-eating populations. Along with the benefits of omega-3 fatty acids and 
selenium in the “oh so healthful” fish we eat, comes MeHg, an insidious and quiet 
“predator of the CNS”. 
MeHg is ingested orally and distributed throughout the body via the blood 
stream. On average, ten percent of ingested MeHg enters the brain through the blood-
brain barrier and becomes trapped within. Three sets of total Hg accumulation data were 
presented in this dissertation. MeHg was provided to young adult and fetal mice at or 
near environmentally relevant exposure levels, through oral ingestion of food. The 
experimental dosing designs were: 1) administration to young adult animals from 
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postnatal day (P) 35 to 39, with examination at P40, 2) administration to pregnant 
females from gestational day (G) 8 to 18, whose pups were examined at P0 and P10, and 
3) exposure of SH-SY5Y human neuroblastoma cells to MeHg or HgCl2 in growth 
media. MeHg exposure levels were selected such that the lowest levels were within 
range of what could be experienced by a portion of today’s human population. The 
results of these experiments indicated that even the lowest concentrations of MeHg are 
taken up into the brains of mice as young adults and during gestation, and into SY5Y 
cells at levels that are significantly higher than control levels. Cell culture total Hg 
accumulation results were consistent with in vivo findings. 
Included in the cell culture study, in addition to MeHg exposure, was the 
exposure of the cells to the inorganic form of Hg as HgCl2. The aspect of the study 
involving either MeHg or HgCl2 was important because when MeHg enters the brain, it 
is demethylated. Studies have shown that in primates and humans exposed to moderate 
and high levels of MeHg, 10 – 33% of the original MeHg in the brain will be converted 
into the inorganic form after one year; 80 – 100% of the original MeHg in the brain will 
be converted to the inorganic form after 20 years. Previous studies indicate that even 
after five days of exposure to MeHg in mice, a measurable portion of total Hg in the 
brain is converted to the inorganic form. Some studies have shown that the concentration 
of inorganic Hg in specific brain regions correlates with the degree of cellular damage in 
that area. However, many other studies, mainly in vitro, indicate MeHg to be more 
directly cytotoxic than inorganic Hg. SY5Y cells in the present study showed a 
concentration-dependent accumulation of total Hg for both MeHg and HgCl2, but the 
concentration of total Hg in the HgCl2 exposed cells was significantly less than the 
concentration in those exposed to MeHg. 
Cell death, typically by apoptosis, is a hallmark of MeHg toxicity, at least at high 
concentrations. Associated with apoptosis are dissipation of the MMP, increase in 
[Ca2+]i, and increase in ROS. These events were expected upon MeHg exposure. 
Therefore, the presence of these events was monitored in young adult mice, pups, and 
SY5Y cells. Cell death was increased in SY5Y cells with MeHg and HgCl2 exposure, 
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but only at the highest concentrations used in these experiments. In addition, with similar 
treatment concentrations, cell death of SY5Y cells was either increased to a lesser degree 
in the HgCl2 treated cells compared to those treated with MeHg, or cell death was 
observed starting at a later time point in cells exposed to HgCl2 compared to MeHg. 
These results are in agreement with other in vitro studies indicating that MeHg is more 
directly cytotoxic at similar concentrations of HgCl2. Two techniques were used to 
determine cell death in mice, Fluoro-Jade B staining and activated caspase 3 
immunohistochemistry. Cell death was observed in the molecular and granule cell layers 
of adult cerebella with 1.0 mg/kg MeHg treatment. In contrast, mouse pups at P0 showed 
no MeHg associated increase in cell death within the cerebellum as analyzed by Fluoro-
Jade B. However, cell death was increased in the Purkinje cell layer in the cerebellum of 
P0 mouse pups as analyzed by activated caspase 3 immunohistochemistry. Previous 
studies have shown that Bergmann glia are involved in the migration of granule cells 
from the external germinal cell layer to the internal granule cell layer. In addition, 
caspase 3 is activated in Bergmann glia during development. Instead of measuring cell 
death in the Purkinje cell layer at P0, we may have inadvertently measured the activation 
of caspase 3 in Bergmann glia. However, the caspase 3 activation was MeHg exposure 
dependent, suggesting that MeHg may affect Bergmann glia and the migration of 
granule cells rather than causing cell death in early postnatally developing cerebella. 
Also in contrast to the increased cell death observed in adult cerebella, the 
cerebella of mice at P10 exhibited MeHg associated decreases in the number of dying 
cells with the 0.1 mg/kg MeHg treatment in the external germinal cell layer. The 
external germinal cell layer of the cerebellum is an area of high cell proliferation. These 
newly formed cells then migrate to the internal granule cell layer. Areas of high cell 
proliferation will naturally have a percentage of cells that die. If, however, the cells are 
not proliferating as rapidly as normal, the observed number of dying cells may decrease 
as well. The P10 data suggest, similar to the P0 data, that cell proliferation may be 
altered by MeHg exposure as opposed to MeHg increasing cell death. In future work, the 
  
225
TUNEL assay for apoptosis, rather than detection of activated caspase 3 might be a 
better choice for determining cell death in developing animals.  
MMP, [Ca2+]i, and ROS are involved in many processes within the cell other than 
apoptosis. All three play roles in cell cycle progression, proliferation, migration, and 
differentiation. They also function in the induction of transcription and translation of 
genes and proteins involved in regular cell processes as well as cytoprotection. To use a 
term from the paper by Brookes et al. (2004), the three are a “love-hate triangle”. There 
are endless numbers of permutations and combinations in which changes in MMP, 
[Ca2+]i, and ROS may interact, not only directly, but indirectly as well. In addition, the 
degree of increased or decreased adds multiple layers of interaction to further confound 
this complex interplay. 
Although we know the difficulties in understanding the interaction of MMP, 
[Ca2+]i, and ROS, we investigated these processes specifically for the purpose of 
determining whether low-levels of MeHg would produce effects similar to those known 
to occur with high MeHg exposure levels. As mentioned previously, the insidious nature 
of low levels of MeHg may manifest as subtle alterations in learning and behavior, 
which have been observed in children in the Faroe Islands and in Brazil, following 
exposure to chronic low levels of MeHg. 
MMP in adult cerebella was increased in both the 0.2 and 1.0 mg/kg MeHg 
treatments, and increased in female hippocampi at 1.0 mg/kg MeHg. MMP in P0 pups 
was decreased in cerebella at 0.1 m/kg MeHg (highest dose); but increased in cerebella 
and female hippocampi with 0.01 mg/kg MeHg (lowest dose). In SY5Y cells, MMP was 
decreased compared to controls in the highest (1.0 µM) MeHg treatment at 24, 48, and 
72 hours, but only at 48 and 72 hours for 1.0 µM HgCl2 treatment. However, MMP was 
increased at 0.01 µM MeHg (lowest dose) at 24 hours. These data indicated that MMP is 
affected by MeHg and HgCl2 exposure. However, both increases and decreases in MMP 
were observed in the present study. Increased MMP is not what the previously published 
literature suggests for high exposure levels of MeHg. Our data indicate that MeHg at low 
concentrations affects MMP, but does not always result in the decreased MMP typically 
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associated with higher MeHg concentrations. In addition, the male hippocampus 
appeared particularly protected from changes in MMP associated with MeHg exposure. 
Basal [Ca2+]i was changed throughout the in vivo experiments in a manner that 
was age- and sex- and brain region-dependent. In adults, female hippocampi exhibited 
increased [Ca2+]i, whereas no differences in [Ca2+]i were observed in male hippocampi or 
in male or female cerebella. For pups exposed to MeHg during gestation and analyzed at 
P0, no differences were observed in [Ca2+]i in the hippocampus, but [Ca2+]i was 
increased in MeHg treated cerebella. For pups analyzed at P10, female hippocampi and 
both male and female cerebella exhibited increased [Ca2+]i, with the 0.1 mg/kg MeHg 
treatment. In the in vitro experiment using SY5Y cells, increased [Ca2+]i was observed in 
the high HgCl2 exposure after 24 hours, but after 48 hours, [Ca2+]i in the high exposure 
level had decreased and was lower than controls. No difference in [Ca2+]i was indicated 
between treatment with MeHg and HgCl2 in SY5Y cells. Overall, [Ca2+]i was generally 
increased with MeHg treatment, particularly in cerebella and female hippocampi. 
Increases in [Ca2+]i can be cytotoxic. However, a major function of mitochondria is to 
sequester Ca2+ to prevent Ca2+-induced cytotoxicity. In our study, we observed increases 
in MMP, which typically indicates increased mitochondrial activity. Because we 
observed increases in [Ca2+]i, without synchronous cell death and increased MMP, our 
data suggested that mitochondrial may be sequestering Ca2+ and preventing cell death at 
the low-level MeHg concentrations used. 
The rate at which ROS were produced over time was measured for adult and 
developing mice, and in SY5Y cells. Upon investigation we discovered that across the 
experiments the rate at which ROS were produced changed very little. We did notice, 
however, that the total quantity of ROS appeared different among treatments. Therefore, 
we investigated both the rate and level of ROS production. The rate of ROS production 
in adult mice was decreased at both the 0.2 and 1.0 mg/kg MeHg treatments and the 
decrease was greater in males than females. For P0 mouse pups, no difference was 
observed in the rate of ROS production, but the level of ROS production was dependent 
on brain region. In the cerebellum, ROS levels were decreased with MeHg treatment, but 
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in the hippocampus, ROS levels were increased with MeHg treatment. For P10 mouse 
pups, no difference was observed in the rate of ROS production, but the level of ROS 
production was again dependent on brain region. In the cerebellum, the 0.1 mg/kg MeHg 
treatment exhibited decreased ROS levels compared to controls, whereas, in the 
hippocampus, there was no difference in the levels of ROS produced. In SY5Y cells, the 
rate of ROS production was time-, toxicant-, and treatment-dependent. Over time, the 
rate of ROS production decreased for all treatments, including controls. Differences in 
the rate of ROS production was greater for MeHg treatments compared to HgCl2 
treatments. HgCl2 0.1 µM treatment resulted in decreased rate of ROS production at 24 
hours, whereas, 1.0 µM MeHg treatment resulted in decreased ROS production at 24 and 
48 hours. Overall, the rate and levels of ROS production were decreased with MeHg and 
HgCl2 treatment, suggesting that increased generation of ROS and the induction of 
oxidative stress is not a major factor in low and moderate MeHg concentrations. These 
data are in contrast to what current literature suggests concerning ROS production and 
oxidative stress at higher concentrations of MeHg and HgCl2. 
 
IMPORTANCE AND FUTURE STUDIES 
Our data indicate that low and moderate MeHg exposure, both in vivo and in 
vitro produce effects in mitochondrial function, Ca2+ homeostasis, and oxidative stress 
unlike those reported in previous literature for higher MeHg exposures. In addition, data 
from our study indicate that SY5Y cells are sensitive to low levels of both MeHg and 
HgCl2, and respond to MeHg and HgCl2 exposure in ways similar to those observed in 
the whole animal studies, thus making them realistic candidates for mechanistic studies 
that may mimic the responses of neurons to MeHg exposure in vivo. 
MMP, Ca2+, and ROS have many functions in neurons other than induction of 
apoptosis. Neurons exhibit [Ca2+]i oscillations that may be associated with synaptic 
strengthening among neurons in the same domain. In neuronal spines and dendrites, 
[Ca2+]i changes are mediated by NMDA receptors, which is crucial for the generation of 
long-term potentiation (LTP) which is associated with learning and memory. [Ca2+]i 
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changes in neurons initiate signaling pathways that trigger gene transcription. 
Mitochondria are involved in more than energy production and induction of apoptosis. 
They function in xenobiotic metabolism and glucose sensing, as well as steroid hormone 
synthesis and lipid metabolism. In addition, ROS are involved not only in damage of 
membranes by lipid peroxidation (Gardner, 1989)and the crosslinking of proteins, but 
are important for cell signaling and cell proliferation.  
Literature suggests that neuronal dysfunction may be of particular importance in 
diseases such as Alzheimer’s, Parkinson’s, mood, and autism (Bauman and Kemper, 
2005;  Monnet-Tschudi et al., 2006), all of which are becoming increasingly more 
prevalent in our aging society. In addition, the developing CNS is particularly 
susceptible to adverse affects of toxicants. The incomplete blood-brain barrier allows 
increased access of MeHg to the developing brain. Proliferation and migration of 
neurons in developing young is time-dependent, and alterations in the timing or rate of 
these events could significantly alter normal brain development. Once neurons are 
placed, proper synaptic development and function are necessary for the neurons to 
function normally. Changes in mitochondrial activity, [Ca2+]i, and levels of ROS could 
adversely affect proliferation, migration, or synaptic plasticity, and ultimately function, 
of the neurons in developing brains without causing the death of the neurons. 
MeHg exposure in today’s human population, although low, is chronic and 
measurable. The United States Environmental Protection Agency (U.S. E.P.A.) has set 
the reference dose (RfD) for MeHg at 0.1 µg/kg body weight per day. RfD is considered 
to be a concentration at which a chemical can be consumed on a daily basis over a 
lifetime without expectation of adverse effects. Whole animal adults and developmental 
behavioral and neuronal functional studies at chronic low levels of MeHg are limited. 
Also limited are low level MeHg and inorganic Hg neuronal functional studies in 
cultured cells. Our data indicated that low levels of MeHg may affect neuronal function, 
and therefore suggested that further chronic low-level MeHg studies are warranted. 
Research involving very low concentrations of MeHg should be continued both 
in vivo and in vitro. In addition, long-term, repeated exposure studies should be 
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incorporated because MeHg is rarely ingested only once, but many times over many 
years. Advancing technology allows visualization of cytoplasmic microdomains within 
cells over several hours to days. Cultured neurons could be set up in a heated / 
humidified / CO2 infused flow-through system and visualized by fluorescence 
microscopy. MeHg or HgCl2 as well as various levels of extracellular Ca2+, or specific 
mitochondrial or plasma membrane channel inhibitors or stimulators could be 
administered in a times sequence and the reaction of the cell, or areas within the cell 
could be monitored in real time. 
The developing nervous system is particularly sensitive to MeHg toxicity. The 
brains of animals exposed to MeHg in utero often display altered cytoarchitecture. 
Daily, along the developmental time-line, neurological changes occur, both 
morphologically and internally within the cell. Appropriate and timely gene expression 
is a necessity for orderly and complete neural development. Cells from the brains of 
developing pups exposed to MeHg in utero could be harvested at various times during 
gestation and analyzed for changes in expression of mRNA or proteins critical for neural 
development at those specific time points. Proteins associated with cell proliferation and 
migration would be an appropriate starting point.  
In the adult hippocampus, new cells are formed in the subgranular layer of the 
dentate gyrus. Processes such as proliferation, migration, differentiation, and 
synaptogenesis are vital for these new cells to become incorporated into the functioning 
brain. Learning and memory take place, not only during development, but during the 
lifetime of an individual. Synaptic plasticity, dendritic processing, and long-term 
potentiation are necessary for sustained learning and retention of memories. The proper 
function of the brain and all its neural components are of utmost importance to the 
human population from developing fetuses to the aged. 
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